data_1kma_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kma _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -176.13 133.75 0.25 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.14 -31.07 0.95 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.097 1.332 . . . . 0.0 114.701 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -67.08 -56.27 13.84 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.726 1.263 . . . . 0.0 111.024 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.23 -48.42 0.62 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.238 1.959 . . . . 0.0 112.299 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.04 125.41 41.46 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.469 0.708 . . . . 0.0 109.654 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -154.47 -24.33 0.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.981 1.712 . . . . 0.0 110.93 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -49.61 158.35 0.84 Allowed Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 125.972 1.709 . . . . 0.0 114.753 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.13 169.35 22.75 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 121.928 1.752 . . . . 0.0 111.179 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -80.29 43.65 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.075 0.95 . . . . 0.0 110.044 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.24 19.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.501 1.52 . . . . 0.0 109.247 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 42.79 0.33 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 111.08 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -84.93 63.26 7.98 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 121.149 -0.969 . . . . 0.0 108.698 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -55.77 134.9 51.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.108 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.34 -178.27 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 125.151 1.381 . . . . 0.0 111.516 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -125.21 137.34 54.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.512 1.125 . . . . 0.0 110.564 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.91 168.78 26.36 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 165.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 p -50.69 -31.3 15.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.02 0.0 5.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.25 66.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.359 0.981 . . . . 0.0 111.624 -163.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.09 110.82 9.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.337 1.455 . . . . 0.0 109.553 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -65.84 143.95 57.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.969 0.414 . . . . 0.0 110.366 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -119.4 145.39 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.368 2.267 . . . . 0.0 108.225 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -58.33 -29.22 65.77 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.344 1.057 . . . . 0.0 113.002 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -163.89 155.96 14.8 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 125.208 1.403 . . . . 0.0 109.78 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.27 -16.37 35.4 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.486 2.124 . . . . 0.0 111.023 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.162 -0.336 . . . . 0.0 110.953 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.8 mtm -66.08 -31.73 72.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.656 172.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 7.7 tt -59.6 -68.26 0.3 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.397 0.998 . . . . 0.0 109.38 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -51.98 -39.27 59.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.824 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -68.49 0.17 Allowed 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.76 1.95 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 126.592 1.957 . . . . 0.0 110.506 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -51.04 -63.44 1.13 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.926 0.89 . . . . 0.0 110.647 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.6 -16.87 64.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.69 1.196 . . . . 0.0 112.727 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -66.18 0.87 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.51 23.74 0.36 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.896 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -127.33 60.67 44.55 Favored Pre-proline 0 C--O 1.222 -0.392 0 CA-C-N 119.618 1.709 . . . . 0.0 109.835 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -61.23 -17.73 54.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.657 1.571 . . . . 0.0 113.166 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -26.36 45.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.399 2.28 . . . . 0.0 113.333 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.466 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.04 153.38 42.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.5 m -150.88 149.42 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -72.55 85.67 1.16 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -47.16 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.563 0.745 . . . . 0.0 109.747 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 166.12 151.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.862 2.865 . . . . 0.0 106.957 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -68.34 -173.26 0.4 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.844 2.058 . . . . 0.0 111.388 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.71 142.1 0.79 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.08 143.68 18.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.225 1.513 . . . . 0.0 110.475 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 119.274 -0.394 . . . . 0.0 110.85 177.197 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.39 -89.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.269 1.028 . . . . 0.0 109.667 156.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.19 76.24 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.112 -0.993 . . . . 0.0 112.555 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -43.98 79.63 Favored Pre-proline 0 C--N 1.34 0.161 0 CA-C-O 117.217 -1.373 . . . . 0.0 114.378 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.83 -51.41 0.48 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.538 2.159 . . . . 0.0 111.928 159.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.42 70.16 8.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.027 1.285 . . . . 0.0 113.081 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -83.92 -14.09 51.87 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.38 162.42 61.22 Favored Pre-proline 0 C--O 1.236 0.373 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -158.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.83 165.47 28.52 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.934 2.423 . . . . 0.0 110.783 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.81 43.56 1.0 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.386 0.674 . . . . 0.0 109.381 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.33 122.56 17.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.124 1.77 . . . . 0.0 110.498 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.89 43.77 0.36 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.56 1.944 . . . . 0.0 111.246 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -92.36 58.01 3.13 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 120.5 -1.375 . . . . 0.0 108.751 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -53.65 147.42 11.39 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.345 1.858 . . . . 0.0 113.207 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -149.14 153.75 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.024 0.929 . . . . 0.0 111.751 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 t -86.44 133.88 33.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 110.473 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.16 164.15 23.46 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 158.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.1 p -51.28 -25.12 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -168.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 0.01 11.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 112.385 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.58 50.17 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.838 -1.163 . . . . 0.0 110.692 -158.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -66.71 96.99 0.43 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 131.347 3.859 . . . . 0.0 110.974 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -66.13 144.39 56.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.756 0.422 . . . . 0.0 111.344 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -123.81 153.3 41.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.776 2.03 . . . . 0.0 107.809 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -65.97 -21.56 66.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -163.76 159.99 17.3 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.215 1.806 . . . . 0.0 108.883 168.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.75 -20.13 52.72 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.877 . . . . 0.0 110.996 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -68.89 -45.57 70.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.224 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -37.57 87.24 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.623 1.101 . . . . 0.0 111.311 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 1.1 tt -56.7 -66.74 0.39 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.222 1.009 . . . . 0.0 109.964 168.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -32.16 70.71 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.536 -0.727 . . . . 0.0 111.327 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.7 -68.5 0.18 Allowed 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.03 -52.85 1.82 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.052 1.741 . . . . 0.0 111.525 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 42.9 tttm -48.18 -61.75 1.83 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.193 1.397 . . . . 0.0 110.544 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -67.92 -21.16 65.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -48.9 16.18 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.74 25.4 0.1 OUTLIER Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.234 -1.315 . . . . 0.0 114.887 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -130.35 63.65 70.05 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 120.014 1.907 . . . . 0.0 109.789 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -61.33 -19.99 66.36 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.446 1.552 . . . . 0.0 112.664 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -23.92 46.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.513 2.725 . . . . 0.0 113.494 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -66.49 154.67 39.69 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 m -150.66 150.6 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 124.901 1.28 . . . . 0.0 108.753 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -71.77 84.88 0.92 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.41 -53.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.303 0.641 . . . . 0.0 110.112 166.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -169.98 175.63 5.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.224 1.809 . . . . 0.0 110.148 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.21 171.93 10.28 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.88 2.472 . . . . 0.0 108.239 164.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.5 138.43 0.85 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 127.373 2.416 . . . . 0.0 112.216 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.18 142.42 21.58 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 110.834 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.123 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 p90 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -176.7 -86.56 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.709 2.003 . . . . 0.0 107.597 141.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.22 -15.82 80.5 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.19 0.9 . . . . 0.0 113.637 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -50.02 65.79 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 119.317 1.558 . . . . 0.0 111.923 171.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -60.7 -51.89 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.291 1.327 . . . . 0.0 112.261 160.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.1 m -89.29 71.7 8.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.473 1.033 . . . . 0.0 112.323 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -116.85 84.15 2.09 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.11 165.24 19.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 123.282 0.633 . . . . 0.0 111.307 -172.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 165.07 20.73 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.251 2.634 . . . . 0.0 111.357 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.55 43.3 0.47 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.878 0.871 . . . . 0.0 111.067 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.0 128.32 35.59 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.899 1.279 . . . . 0.0 111.066 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.03 43.26 1.04 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.648 1.579 . . . . 0.0 110.674 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -83.42 64.59 7.92 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 120.597 -1.314 . . . . 0.0 107.975 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -55.84 134.74 52.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.699 1.136 . . . . 0.0 111.721 -167.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.68 169.68 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 110.443 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.9 143.17 50.53 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.4 1.0 . . . . 0.0 110.933 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.18 166.5 28.46 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -34.35 -40.86 0.1 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.278 2.631 . . . . 0.0 115.562 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.85 0.05 10.05 Favored 'General case' 0 N--CA 1.436 -1.16 1 C-N-CA 132.919 4.487 . . . . 0.0 111.654 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.2 -4.32 33.42 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.969 0.804 . . . . 0.0 112.086 -166.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.76 102.96 4.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.98 2.512 . . . . 0.0 110.163 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -66.37 143.56 57.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.219 0.463 . . . . 0.0 111.54 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -123.93 155.95 37.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.117 2.967 . . . . 0.0 108.499 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.1 t -63.88 -28.79 70.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -163.87 160.65 17.14 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.918 1.687 . . . . 0.0 107.637 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.37 -14.9 28.2 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 120.744 0.963 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.01 -44.68 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 118.101 0.409 . . . . 0.0 110.596 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mmm -59.0 -46.36 88.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.009 0.924 . . . . 0.0 110.515 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.78 -62.22 1.84 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.111 1.365 . . . . 0.0 110.876 173.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -35.56 77.18 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.713 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.38 -68.32 0.18 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 171.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.81 -52.75 1.72 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.872 2.069 . . . . 0.0 112.104 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -48.53 -59.11 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.731 1.612 . . . . 0.0 110.323 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -71.0 -23.97 62.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.576 0.75 . . . . 0.0 112.64 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -75.88 -38.65 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.514 0.726 . . . . 0.0 110.718 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.2 18.91 0.03 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.057 -1.413 . . . . 0.0 115.488 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -128.79 62.42 61.1 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 120.327 2.063 . . . . 0.0 110.073 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.23 -25.34 71.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.979 1.786 . . . . 0.0 112.786 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.06 -32.66 74.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 131.273 3.829 . . . . 0.0 114.304 175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.2 157.54 31.13 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 109.183 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.47 149.79 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 126.516 1.926 . . . . 0.0 109.74 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.77 83.96 1.64 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 164.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.1 -46.29 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.743 0.817 . . . . 0.0 108.946 174.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.462 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 24.7 t60 -161.22 178.78 8.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 161.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' H ' ' CG ' ' A' ' 44' ' ' HIS . 29.3 mt-10 -83.36 178.83 7.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 159.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.01 144.14 1.38 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -172.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.45 158.64 25.74 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.868 1.712 . . . . 0.0 110.853 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 162.003 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -176.81 -81.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.94 1.696 . . . . 0.0 107.113 140.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.25 -39.38 44.15 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 119.2 -0.778 . . . . 0.0 112.222 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -43.51 77.81 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 116.682 -1.628 . . . . 0.0 115.127 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.11 -28.24 69.15 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 122.266 1.845 . . . . 0.0 112.228 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -105.25 29.15 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.769 1.628 . . . . 0.0 111.915 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -56.78 -27.67 60.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.57 163.42 3.73 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.129 2.572 . . . . 0.0 114.997 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.21 162.24 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.376 2.051 . . . . 0.0 110.912 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 43.15 0.97 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.633 -0.667 . . . . 0.0 110.236 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.43 127.69 33.27 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.093 2.157 . . . . 0.0 110.89 172.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.18 43.54 0.63 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.556 1.542 . . . . 0.0 112.019 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -82.78 55.92 3.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.458 -1.401 . . . . 0.0 109.959 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -54.65 144.26 22.37 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.61 1.564 . . . . 0.0 114.881 -161.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 m -146.36 162.16 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.726 0.81 . . . . 0.0 111.844 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.6 t -101.43 130.77 47.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.279 0.632 . . . . 0.0 112.0 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.08 163.39 23.23 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 158.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.439 ' HA ' ' CG1' ' A' ' 43' ' ' VAL . 88.5 p -34.03 -57.56 0.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 118.237 2.68 . . . . 0.0 118.237 -161.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.71 42.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.219 -162.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.36 42.44 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 123.758 0.694 . . . . 0.0 112.617 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.18 75.51 2.33 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.824 3.249 . . . . 0.0 108.946 -159.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.0 m -66.31 143.74 57.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.662 -0.649 . . . . 0.0 110.225 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.02 155.42 46.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.597 2.359 . . . . 0.0 108.562 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -59.85 -25.45 65.03 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.434 1.494 . . . . 0.0 114.047 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -163.55 162.66 17.01 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.806 2.043 . . . . 0.0 107.675 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.83 -21.82 50.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.185 1.257 . . . . 0.0 111.368 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.01 -37.84 84.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.599 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 mmm -68.85 -35.68 77.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.792 1.178 . . . . 0.0 111.704 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 2.1 tt -61.9 -63.99 1.08 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.38 -32.64 70.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.777 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.1 t -51.4 -71.44 0.06 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.02 -52.9 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.431 1.893 . . . . 0.0 111.317 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -48.66 -63.96 0.94 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.844 1.657 . . . . 0.0 110.466 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -73.15 -18.4 61.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.54 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -73.55 -55.08 6.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.97 0.508 . . . . 0.0 110.131 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.08 16.49 0.09 OUTLIER Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.818 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -126.76 57.77 24.06 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.693 1.746 . . . . 0.0 108.646 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.22 -22.85 66.78 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 122.48 1.921 . . . . 0.0 112.724 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.07 -31.89 73.24 Favored 'General case' 0 CA--C 1.533 0.312 1 C-N-CA 132.415 4.286 . . . . 0.0 114.873 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.448 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -65.69 156.59 32.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.188 1.395 . . . . 0.0 108.542 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.4 m -152.36 155.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.853 1.661 . . . . 0.0 109.431 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -73.84 87.01 1.75 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 163.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.93 -48.51 63.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 123.165 0.586 . . . . 0.0 110.491 167.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -162.73 164.37 26.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.135 1.774 . . . . 0.0 107.534 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -84.26 166.01 17.85 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 166.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.83 150.18 2.81 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 111.357 -170.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -83.23 157.55 14.94 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.659 -166.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.0 m . . . . . 0 C--N 1.342 0.241 0 CA-C-O 119.31 -0.376 . . . . 0.0 110.656 165.26 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 p90 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.96 -68.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.978 . . . . 0.0 105.965 166.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.9 -17.87 42.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.849 1.214 . . . . 0.0 115.289 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -64.91 -52.02 52.69 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 119.011 1.406 . . . . 0.0 111.81 165.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.46 -58.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.015 3.143 . . . . 0.0 112.629 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.89 96.79 10.34 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.953 1.706 . . . . 0.0 111.082 -167.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.84 0.02 2.16 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 125.007 1.442 . . . . 0.0 113.947 -175.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 163.9 62.59 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.354 1.462 . . . . 0.0 113.884 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.52 165.18 31.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.595 2.197 . . . . 0.0 110.69 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.36 47.51 0.09 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.83 1.252 . . . . 0.0 112.066 167.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.84 118.73 10.1 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.146 165.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -77.55 42.44 0.36 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.407 1.883 . . . . 0.0 111.473 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -79.58 64.89 4.58 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.67 137.61 57.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.657 1.572 . . . . 0.0 111.55 -168.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 m -141.54 167.32 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.89 0.876 . . . . 0.0 112.097 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 t -105.53 141.56 36.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.071 0.948 . . . . 0.0 110.719 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.39 166.14 24.1 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.892 1.234 . . . . 0.0 111.217 159.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -37.9 -40.35 0.45 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.385 2.274 . . . . 0.0 115.665 -176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.47 16.5 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 110.314 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.77 65.47 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.219 -165.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -68.68 92.62 0.48 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.46 1.504 . . . . 0.0 109.354 -163.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -65.9 143.46 57.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -126.54 155.02 43.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.827 2.051 . . . . 0.0 108.707 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.1 p -65.46 -27.88 68.82 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.688 1.195 . . . . 0.0 113.212 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -163.41 152.63 12.42 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 127.326 2.25 . . . . 0.0 108.957 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.86 -23.65 22.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.118 1.212 . . . . 0.0 110.92 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -56.76 -44.47 81.81 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 111.105 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.31 70.14 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 3.6 tt -64.46 -65.86 0.62 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 t -52.39 -29.47 24.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.445 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -62.05 -60.74 3.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' N ' ' SG ' ' A' ' 31' ' ' CYS . . . -42.35 -51.9 4.72 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.992 2.117 . . . . 0.0 110.206 175.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 tttm -50.95 -63.2 1.2 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.339 1.024 . . . . 0.0 110.562 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.73 -14.0 62.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.518 1.127 . . . . 0.0 113.943 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -58.23 3.26 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.75 34.14 0.14 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.591 -1.116 . . . . 0.0 113.09 -173.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -134.85 62.1 51.29 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 119.271 1.535 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.0 -13.44 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 CA-C-N 121.058 1.414 . . . . 0.0 114.027 -172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.66 -27.01 37.25 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.503 2.721 . . . . 0.0 112.735 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.454 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 3.9 tp -66.39 153.56 42.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.2 m -147.74 144.05 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -74.38 87.28 2.03 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -50.67 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.44 1.496 . . . . 0.0 108.885 171.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 19.0 t60 -179.39 -171.52 0.2 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.51 3.124 . . . . 0.0 107.574 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.641 ' H ' ' CG ' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -85.09 -164.82 1.05 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.81 2.444 . . . . 0.0 108.604 166.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 123.15 0.19 Allowed Glycine 0 CA--C 1.544 1.895 0 C-N-CA 124.862 1.22 . . . . 0.0 113.975 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.16 135.23 13.54 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 120.823 2.311 . . . . 0.0 112.312 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.534 0.337 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.444 178.422 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.22 -54.9 0.01 OUTLIER 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.18 0.992 . . . . 0.0 111.448 170.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.75 67.0 1.12 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 127.017 2.246 . . . . 0.0 109.39 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -176.62 -55.87 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.259 1.824 . . . . 0.0 109.851 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -72.74 -58.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.733 1.622 . . . . 0.0 110.004 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.17 133.83 35.53 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 176.57 34.41 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 O-C-N 125.967 2.042 . . . . 0.0 111.726 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.7 165.78 12.72 Favored Pre-proline 0 C--O 1.233 0.234 0 O-C-N 121.293 -0.88 . . . . 0.0 112.28 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.48 172.38 14.34 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.233 1.956 . . . . 0.0 109.709 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -77.01 44.26 0.39 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.661 1.584 . . . . 0.0 110.722 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 120.31 11.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.77 1.228 . . . . 0.0 110.046 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.49 54.49 2.36 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.802 1.641 . . . . 0.0 110.54 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 1.5 m80 -91.04 61.3 4.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -46.2 100.37 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.52 178.81 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 124.932 1.293 . . . . 0.0 112.299 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 4.1 t -115.97 135.33 54.07 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.457 1.503 . . . . 0.0 109.025 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.75 173.07 41.38 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.58 -32.1 62.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.21 -0.03 30.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.914 1.286 . . . . 0.0 110.567 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.93 -0.82 61.16 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.67 1.129 . . . . 0.0 111.991 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.97 115.32 11.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.2 m -65.79 150.14 49.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.77 136.02 53.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -37.17 -37.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.777 2.031 . . . . 0.0 113.241 170.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -163.69 155.79 15.0 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 128.072 2.549 . . . . 0.0 111.361 -176.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.3 -24.87 16.19 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.471 2.781 . . . . 0.0 110.292 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.74 -30.04 69.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.3 mtp -74.61 -41.51 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.002 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 3.6 tt -51.26 -70.03 0.1 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 t -50.24 -38.07 38.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.741 0.416 . . . . 0.0 111.804 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -72.18 0.05 Allowed 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 175.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -35.91 -55.85 0.73 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 127.679 2.392 . . . . 0.0 109.79 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.52 -66.03 0.43 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.481 -1.69 . . . . 0.0 114.054 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.87 63.24 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 124.584 1.177 . . . . 0.0 111.249 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -78.33 0.11 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.399 1.48 . . . . 0.0 107.778 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.43 48.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 127.078 2.275 . . . . 0.0 109.503 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -148.03 59.99 4.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 117.891 0.845 . . . . 0.0 111.753 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.83 -10.56 17.62 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 122.967 2.445 . . . . 0.0 113.612 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.55 -28.93 21.67 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 127.0 2.12 . . . . 0.0 113.709 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 2.4 tp -65.59 154.2 39.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 m -146.89 145.33 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -73.42 82.83 1.45 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -49.75 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.669 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 174.78 176.94 0.15 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.009 2.124 . . . . 0.0 109.032 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -174.85 5.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.009 2.124 . . . . 0.0 110.522 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.34 134.37 0.53 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.37 1.462 . . . . 0.0 112.909 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.9 145.52 36.2 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.532 2.166 . . . . 0.0 111.372 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.441 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.69 174.97 14.22 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 102.989 -2.967 . . . . 0.0 102.989 139.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.15 -70.22 2.82 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.768 1.175 . . . . 0.0 112.041 166.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -43.97 83.86 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 116.553 -1.689 . . . . 0.0 114.739 -173.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -57.5 -22.32 50.35 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.652 1.568 . . . . 0.0 113.206 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.75 46.55 1.82 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.684 1.594 . . . . 0.0 112.309 -167.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -29.73 70.38 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.692 -1.255 . . . . 0.0 112.018 168.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.06 157.14 54.19 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 126.436 1.894 . . . . 0.0 115.513 -163.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.59 164.64 30.16 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.015 2.477 . . . . 0.0 110.572 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.72 43.52 0.84 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.599 -0.688 . . . . 0.0 109.994 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.13 132.73 49.17 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.382 1.873 . . . . 0.0 110.578 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.85 43.62 1.05 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.953 1.701 . . . . 0.0 110.82 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -87.96 63.93 7.59 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.248 -1.533 . . . . 0.0 108.761 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -60.11 146.96 41.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.894 1.278 . . . . 0.0 113.344 -160.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 m -147.36 158.41 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.499 1.12 . . . . 0.0 111.819 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -91.55 136.51 33.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.666 0.786 . . . . 0.0 110.967 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.79 163.97 23.8 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 159.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.1 p -47.15 -32.61 4.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.109 2.164 . . . . 0.0 116.17 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.65 -7.27 25.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.844 1.658 . . . . 0.0 113.019 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.78 -9.67 50.58 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.359 0.98 . . . . 0.0 111.046 -158.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.7 96.5 0.28 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.133 2.573 . . . . 0.0 108.921 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -66.63 144.33 56.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 110.504 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -123.71 145.12 49.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.843 1.657 . . . . 0.0 107.389 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -62.69 -16.25 56.35 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.46 158.5 17.5 Favored Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 108.607 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.38 -15.77 31.17 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.785 1.657 . . . . 0.0 111.99 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -72.82 -40.23 65.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.0 ttp -61.87 -45.33 94.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.22 -63.55 1.12 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.991 174.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -34.44 74.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.226 -174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.9 t -50.31 -69.02 0.12 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 124.806 1.243 . . . . 0.0 108.616 169.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.09 -52.63 2.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.099 2.16 . . . . 0.0 111.884 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -49.13 -61.61 1.98 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.869 1.668 . . . . 0.0 110.586 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 123.957 0.786 . . . . 0.0 112.512 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -46.6 21.45 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.5 18.82 0.09 OUTLIER Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.312 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -133.48 65.45 71.94 Favored Pre-proline 0 C--O 1.223 -0.338 0 CA-C-N 119.932 1.866 . . . . 0.0 110.25 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -61.55 -20.07 67.22 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.482 1.565 . . . . 0.0 112.615 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -22.14 47.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.654 2.782 . . . . 0.0 113.774 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 6.9 tp -66.48 152.15 45.76 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -151.52 155.98 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.773 1.629 . . . . 0.0 108.801 174.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -73.79 84.3 1.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -50.25 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 C-N-CA 122.944 0.498 . . . . 0.0 110.194 171.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -159.33 -174.32 4.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.231 1.813 . . . . 0.0 106.26 165.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HG2' ' H ' ' A' ' 46' ' ' GLY . 26.2 tt0 -71.35 -137.39 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.18 1.392 . . . . 0.0 107.4 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 45' ' ' GLU . . . 51.87 116.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 128.104 2.764 . . . . 0.0 117.881 158.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.76 127.61 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 CA-C-N 119.709 1.755 . . . . 0.0 112.376 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.6 m . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 118.999 -0.524 . . . . 0.0 112.11 173.719 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -176.62 -78.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.546 2.338 . . . . 0.0 105.72 159.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 50.48 3.79 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 127.234 2.349 . . . . 0.0 112.911 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -144.29 -53.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.585 1.954 . . . . 0.0 109.299 163.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.27 -29.94 91.62 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.377 2.051 . . . . 0.0 114.199 166.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.95 102.15 9.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.004 1.274 . . . . 0.0 112.889 -172.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -126.31 -0.0 7.02 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.106 1.362 . . . . 0.0 112.763 163.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -75.91 165.72 50.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -165.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.99 167.25 20.28 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.225 1.95 . . . . 0.0 110.728 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp85 -85.46 43.83 1.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.621 -0.675 . . . . 0.0 110.639 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.03 24.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.901 1.68 . . . . 0.0 110.304 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.35 43.48 1.02 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.538 1.535 . . . . 0.0 111.652 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -78.23 70.65 4.62 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 120.603 -1.31 . . . . 0.0 107.89 170.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -52.96 130.52 33.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.4 1.08 . . . . 0.0 111.308 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.74 162.93 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 123.455 0.702 . . . . 0.0 111.746 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.0 135.29 45.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 111.422 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.01 163.86 23.5 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 158.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.2 p -42.28 -36.49 1.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 -164.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.1 -1.47 14.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 112.757 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.81 82.7 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 119.145 0.884 . . . . 0.0 112.175 -159.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -67.73 90.47 0.28 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.967 2.507 . . . . 0.0 109.75 -171.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.4 m -65.89 144.15 56.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.368 0.667 . . . . 0.0 111.832 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.18 158.39 39.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.473 2.709 . . . . 0.0 108.282 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 t -61.33 -28.49 69.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.818 1.247 . . . . 0.0 113.926 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -163.82 161.9 16.85 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 125.931 1.692 . . . . 0.0 108.376 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.81 -16.63 23.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 120.968 1.112 . . . . 0.0 111.87 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -64.85 -45.93 84.01 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.565 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.3 mtp -58.15 -41.6 84.1 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.979 0.809 . . . . 0.0 112.57 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 1.7 tt -55.76 -67.2 0.31 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 109.095 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -33.78 71.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.595 -0.69 . . . . 0.0 111.485 -172.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.9 t -53.32 -70.93 0.08 Allowed 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.239 1.416 . . . . 0.0 107.679 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.51 0.82 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 126.606 1.963 . . . . 0.0 111.851 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -49.86 -63.96 0.95 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.851 1.261 . . . . 0.0 110.979 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -15.07 63.46 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.663 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -59.62 2.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.42 28.25 0.26 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.47 -1.183 . . . . 0.0 114.146 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.02 66.56 79.35 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 119.5 1.65 . . . . 0.0 109.737 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.58 -19.4 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.817 1.327 . . . . 0.0 112.402 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.56 -25.77 50.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.794 2.838 . . . . 0.0 113.904 176.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.446 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.5 tp -66.52 154.54 40.08 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 m -150.95 154.65 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.737 1.215 . . . . 0.0 110.182 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -75.08 86.56 2.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -53.87 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.777 0.831 . . . . 0.0 109.788 166.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 15.1 t60 -164.66 -175.24 3.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.198 1.799 . . . . 0.0 108.503 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.6 ' H ' ' CG ' ' A' ' 44' ' ' HIS . 12.0 tt0 -86.0 -175.05 5.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.132 1.373 . . . . 0.0 108.045 158.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 45' ' ' GLU . . . 75.91 142.34 1.12 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.425 1.012 . . . . 0.0 112.12 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -83.24 146.86 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.177 1.918 . . . . 0.0 111.1 -171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 168.823 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.23 -79.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.521 1.928 . . . . 0.0 106.614 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.16 -27.23 41.17 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.636 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -44.08 78.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 116.902 -1.523 . . . . 0.0 114.557 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -68.47 -50.14 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.058 1.838 . . . . 0.0 111.562 166.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -90.7 76.32 6.47 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.856 1.207 . . . . 0.0 111.188 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.65 102.76 6.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 159.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.71 165.81 6.96 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.308 1.443 . . . . 0.0 109.253 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.43 159.09 32.73 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.124 1.883 . . . . 0.0 110.7 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -78.42 43.32 0.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.55 0.74 . . . . 0.0 110.488 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.48 126.15 27.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.593 1.957 . . . . 0.0 110.943 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.95 43.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.602 1.561 . . . . 0.0 111.511 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -83.53 62.76 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.496 -1.377 . . . . 0.0 109.913 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -53.69 140.28 29.8 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -165.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -146.45 176.65 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 125.424 1.49 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.7 t -125.5 146.19 49.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.435 1.016 . . . . 0.0 111.705 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.18 163.6 23.21 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.029 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.5 p -53.24 -14.46 0.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.114 1.766 . . . . 0.0 114.482 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.79 -15.24 58.22 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.212 2.205 . . . . 0.0 112.14 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.43 -9.73 40.28 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 124.856 1.217 . . . . 0.0 111.358 -163.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.52 114.9 15.76 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.561 1.945 . . . . 0.0 110.151 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -65.64 143.84 57.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.957 0.799 . . . . 0.0 109.536 166.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -121.26 147.4 45.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.323 1.849 . . . . 0.0 106.87 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 m -60.61 -23.43 64.71 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.555 0.742 . . . . 0.0 112.501 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -163.59 161.09 17.7 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.958 2.103 . . . . 0.0 107.95 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.3 -14.64 34.61 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.973 1.782 . . . . 0.0 112.201 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.64 -40.11 84.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.864 0.466 . . . . 0.0 110.986 173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 89.5 mtp -65.06 -39.72 93.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.013 0.824 . . . . 0.0 111.551 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -63.66 1.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.073 0.949 . . . . 0.0 110.043 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.33 -32.4 71.2 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.668 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -69.07 0.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.02 -52.89 1.39 Allowed 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 126.47 1.908 . . . . 0.0 111.657 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -50.06 -63.09 1.22 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.385 1.874 . . . . 0.0 110.29 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -66.83 -25.91 66.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.331 1.052 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -57.43 5.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.282 0.633 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.11 21.31 0.11 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.565 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -125.62 62.22 40.52 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 119.589 1.694 . . . . 0.0 109.382 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -61.16 -18.3 57.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 121.45 1.554 . . . . 0.0 113.141 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -23.36 42.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.329 2.652 . . . . 0.0 113.625 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tp -66.39 152.4 45.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.0 m -156.08 161.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.341 2.256 . . . . 0.0 108.87 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -75.73 80.81 2.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.24 -41.01 49.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 124.99 1.316 . . . . 0.0 111.147 172.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.36 143.04 18.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -84.63 55.23 3.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.478 1.132 . . . . 0.0 108.761 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.67 158.41 31.35 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.247 2.356 . . . . 0.0 108.488 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -82.15 153.47 16.53 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.835 2.357 . . . . 0.0 113.375 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 CA--C 1.529 0.152 0 C-N-CA 126.377 1.871 . . . . 0.0 108.88 169.059 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . 0.469 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.1 133.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 162.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.16 -36.75 1.1 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.061 0.839 . . . . 0.0 113.552 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -50.3 72.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.401 1.08 . . . . 0.0 109.767 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.14 -36.08 6.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.628 2.218 . . . . 0.0 113.875 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -108.32 95.15 5.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.547 1.067 . . . . 0.0 110.232 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -119.91 5.51 10.91 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.025 1.33 . . . . 0.0 111.051 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.92 165.85 20.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 0.0 114.325 -167.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.92 167.98 10.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mtt85 -74.67 44.33 0.21 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.137 1.375 . . . . 0.0 111.448 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.78 120.31 12.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.716 1.207 . . . . 0.0 110.173 164.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.44 43.81 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.119 2.167 . . . . 0.0 111.709 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -78.7 67.86 4.54 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.782 -1.198 . . . . 0.0 108.213 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -57.59 133.66 55.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.741 1.609 . . . . 0.0 110.483 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.34 167.86 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.364 1.066 . . . . 0.0 111.158 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -106.15 137.69 43.65 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.229 1.012 . . . . 0.0 111.592 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.99 163.97 23.57 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 159.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -45.83 -34.27 3.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -168.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -0.04 6.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.475 1.11 . . . . 0.0 112.384 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.82 1.52 90.6 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 111.666 -159.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.86 100.48 4.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.836 1.654 . . . . 0.0 110.584 -166.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -66.1 143.61 57.21 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.858 -0.526 . . . . 0.0 111.355 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -122.27 153.62 38.65 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.87 2.468 . . . . 0.0 108.641 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -63.12 -28.42 70.05 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.462 1.505 . . . . 0.0 113.178 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -163.58 158.87 17.48 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.071 1.748 . . . . 0.0 110.126 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.63 -20.07 31.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.247 1.298 . . . . 0.0 111.496 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -66.1 -43.94 85.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.943 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtm -62.58 -35.54 79.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.6 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 3.7 tt -60.42 -66.05 0.59 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.213 0.915 . . . . 0.0 109.495 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -56.11 -36.49 68.25 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.337 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -68.93 0.13 Allowed 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.333 1.053 . . . . 0.0 108.945 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -37.94 -53.12 1.36 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.343 1.857 . . . . 0.0 110.784 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -51.54 -63.8 1.02 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.549 1.14 . . . . 0.0 110.523 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.36 -15.43 63.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.522 1.129 . . . . 0.0 112.742 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -78.27 -64.21 1.22 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.9 27.66 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.896 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -128.69 64.53 69.45 Favored Pre-proline 0 C--N 1.343 0.326 0 CA-C-N 119.141 1.471 . . . . 0.0 110.194 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -63.08 -16.65 55.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.97 1.382 . . . . 0.0 112.777 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.35 -25.99 42.16 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.179 2.192 . . . . 0.0 113.228 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.32 153.85 41.55 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -151.11 147.29 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.258 1.423 . . . . 0.0 107.72 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -76.9 86.2 3.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.92 -53.65 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.936 0.894 . . . . 0.0 110.401 168.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.65 177.21 5.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.274 1.43 . . . . 0.0 109.721 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 178.26 7.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.923 1.689 . . . . 0.0 107.713 166.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.76 142.03 1.05 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 119.039 0.836 . . . . 0.0 112.972 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -80.82 147.4 17.05 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.923 1.749 . . . . 0.0 111.119 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.523 -0.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.021 171.607 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -176.52 -71.08 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.311 1.844 . . . . 0.0 107.605 167.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.64 67.75 3.63 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.101 1.81 . . . . 0.0 110.727 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.6 -52.18 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.41 2.284 . . . . 0.0 107.556 169.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.77 -43.0 5.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.17 2.58 . . . . 0.0 114.521 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.11 93.59 5.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.809 1.64 . . . . 0.0 112.389 -169.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.11 2.43 9.83 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.063 1.745 . . . . 0.0 113.315 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.93 170.94 9.43 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -162.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.61 167.21 11.71 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.417 2.745 . . . . 0.0 111.474 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.43 45.73 0.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.388 -0.82 . . . . 0.0 111.24 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 119.5 9.9 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 165.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.06 42.94 0.27 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.018 2.527 . . . . 0.0 112.217 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.08 63.53 5.12 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.489 -1.382 . . . . 0.0 108.758 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.3 140.08 54.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.738 1.215 . . . . 0.0 113.419 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.2 160.19 13.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.84 135.25 35.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.702 1.601 . . . . 0.0 110.798 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.65 164.72 24.29 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 159.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 88.5 p -43.96 -38.26 3.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -169.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -0.24 7.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.671 1.188 . . . . 0.0 113.119 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.97 -5.36 85.31 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.821 0.737 . . . . 0.0 111.576 -165.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -71.7 99.98 2.24 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.599 2.359 . . . . 0.0 110.287 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -67.06 145.61 55.18 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.745 -0.597 . . . . 0.0 112.284 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -126.42 158.56 35.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.159 2.184 . . . . 0.0 108.876 171.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -62.75 -29.17 70.49 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.311 1.844 . . . . 0.0 114.178 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -163.71 155.02 14.25 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 109.148 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.33 -17.91 34.69 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.634 2.223 . . . . 0.0 110.736 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.1 t -62.61 -46.33 88.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.026 0.93 . . . . 0.0 110.06 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mtm -66.16 -31.81 72.87 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.233 -0.889 . . . . 0.0 112.823 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -60.98 -63.89 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.74 1.155 . . . . 0.0 109.72 171.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.86 -35.44 72.95 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.278 -176.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.13 -66.56 0.37 Allowed 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.53 -53.54 1.57 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 127.188 2.195 . . . . 0.0 110.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 43.4 tttm -50.85 -62.47 1.59 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.835 1.254 . . . . 0.0 109.746 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -18.82 65.41 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.379 1.049 . . . . 0.0 113.168 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -56.76 4.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 18.58 0.1 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.171 -1.35 . . . . 0.0 114.219 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.99 61.99 10.19 Favored Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.816 1.808 . . . . 0.0 108.515 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.98 -21.57 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 121.61 1.611 . . . . 0.0 112.847 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -29.67 67.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.338 2.255 . . . . 0.0 113.448 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.448 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 7.1 tp -66.14 157.27 31.67 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.96 149.35 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 106.789 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -72.88 89.2 1.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -54.53 20.31 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 C-N-CA 124.58 1.152 . . . . 0.0 110.517 168.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.8 t60 174.97 170.87 0.27 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.357 2.663 . . . . 0.0 105.84 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -168.5 2.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.011 0.924 . . . . 0.0 109.077 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.83 131.74 2.04 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.1 128.09 8.85 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.929 1.865 . . . . 0.0 111.209 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.47 0.565 0 CA-C-N 118.188 0.449 . . . . 0.0 110.624 175.217 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -166.5 159.2 14.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 145.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.55 -50.11 2.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.813 1.197 . . . . 0.0 115.341 162.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -63.77 -43.73 77.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.251 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.58 -61.92 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 CA-C-N 121.244 1.48 . . . . 0.0 110.384 159.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.3 m -92.36 74.07 5.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -158.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 130.31 25.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 158.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.95 167.21 0.77 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.207 1.803 . . . . 0.0 109.355 -174.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.1 156.73 51.48 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.018 1.145 . . . . 0.0 110.065 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -82.9 43.17 0.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.44 123.86 21.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.477 2.311 . . . . 0.0 109.886 166.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.73 54.03 2.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.443 1.897 . . . . 0.0 111.561 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -72.29 81.8 1.02 Allowed 'General case' 0 C--O 1.223 -0.311 0 O-C-N 120.726 -1.233 . . . . 0.0 107.877 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -65.98 86.22 0.09 Allowed 'General case' 0 C--O 1.221 -0.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.365 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.47 154.05 3.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 126.364 1.865 . . . . 0.0 114.123 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.7 t -86.11 127.66 34.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.65 -0.656 . . . . 0.0 109.371 167.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.5 163.19 26.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 158.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.3 p -33.79 -51.66 0.4 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.116 2.567 . . . . 0.0 117.399 -167.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 27.54 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 126.34 1.856 . . . . 0.0 110.945 -166.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.08 -1.4 8.56 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.547 1.546 . . . . 0.0 112.759 -165.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.55 89.2 2.18 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 129.885 3.274 . . . . 0.0 108.048 -166.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -65.87 143.71 57.27 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.713 -0.617 . . . . 0.0 109.55 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.77 151.96 47.53 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 127.121 2.168 . . . . 0.0 109.096 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -65.53 -18.68 65.51 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.706 1.603 . . . . 0.0 114.736 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -164.26 154.81 13.09 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 125.914 1.686 . . . . 0.0 109.597 166.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.93 -20.63 38.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.108 1.872 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.4 t -60.0 -58.2 9.57 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.172 168.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.5 mmm -61.12 -34.01 74.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.09 1.314 . . . . 0.0 112.928 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.413 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -54.76 -65.09 0.64 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.178 0.899 . . . . 0.0 109.242 166.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -28.08 69.68 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.991 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -63.23 1.37 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -42.93 -52.87 4.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.956 2.102 . . . . 0.0 111.62 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -48.42 -62.13 1.65 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.166 1.786 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -72.28 -16.43 61.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.489 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -67.89 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 171.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.11 22.86 0.68 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.288 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -129.3 56.87 26.44 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.208 1.504 . . . . 0.0 109.167 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -58.95 -21.6 58.91 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 CA-C-N 122.587 1.96 . . . . 0.0 113.012 -171.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.13 -34.15 77.4 Favored 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.001 4.12 . . . . 0.0 114.657 173.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.413 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 7.4 tp -65.63 153.84 40.49 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 125.437 1.495 . . . . 0.0 107.914 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.62 151.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 124.863 1.265 . . . . 0.0 109.212 169.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.67 85.83 3.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -34.98 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.395 1.478 . . . . 0.0 110.456 172.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 179.67 170.24 1.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.734 2.414 . . . . 0.0 107.319 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.72 177.5 7.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 158.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.08 139.67 0.88 Allowed Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.728 1.156 . . . . 0.0 111.68 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -85.52 152.57 10.39 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.555 2.837 . . . . 0.0 112.478 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 166.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -72.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.17 1.788 . . . . 0.0 107.446 160.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.84 51.82 4.36 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.872 2.177 . . . . 0.0 111.98 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.35 -53.49 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 127.102 2.161 . . . . 0.0 107.784 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.87 -42.32 46.31 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.125 1.217 . . . . 0.0 112.11 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.0 m -101.53 99.91 10.28 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.586 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.62 78.36 1.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 159.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -156.33 166.4 16.56 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.433 1.093 . . . . 0.0 110.79 -165.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.71 161.73 24.53 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.914 2.41 . . . . 0.0 112.212 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -75.06 44.47 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.923 1.289 . . . . 0.0 111.046 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 131.28 46.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.531 1.132 . . . . 0.0 110.643 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -85.98 43.07 1.02 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.997 2.119 . . . . 0.0 110.329 167.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -92.52 61.7 3.78 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.719 -1.238 . . . . 0.0 107.749 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -58.58 142.5 49.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -159.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.71 168.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.023 0.929 . . . . 0.0 112.186 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 t -114.12 136.51 52.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.13 163.34 22.09 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 158.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -52.87 -27.36 18.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -164.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -13.7 59.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.185 0.994 . . . . 0.0 112.216 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.76 -3.17 65.03 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -159.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.89 87.54 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.941 2.896 . . . . 0.0 107.846 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -66.53 143.5 57.02 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -125.1 155.7 39.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.212 2.205 . . . . 0.0 107.692 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 t -58.15 -29.6 65.7 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.866 0.866 . . . . 0.0 112.307 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -163.9 160.41 17.06 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.247 1.419 . . . . 0.0 108.509 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.84 -18.92 36.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.314 2.01 . . . . 0.0 111.632 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -67.54 -45.82 74.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.711 0.404 . . . . 0.0 110.524 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.4 mtp -62.66 -37.36 86.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.03 0.832 . . . . 0.0 111.573 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.478 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 4.0 tt -60.08 -66.62 0.49 Allowed 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.616 0.766 . . . . 0.0 109.879 170.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -32.68 66.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.852 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.68 -70.47 0.11 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.86 -52.94 0.94 Allowed 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 126.531 1.933 . . . . 0.0 111.993 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -48.69 -64.21 0.87 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.466 1.507 . . . . 0.0 110.7 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.99 -26.64 68.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.266 0.979 . . . . 0.0 112.338 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -59.7 2.73 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.11 21.27 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.524 -1.154 . . . . 0.0 113.946 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -130.16 54.09 13.56 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 119.434 1.617 . . . . 0.0 109.537 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -59.4 -22.34 65.39 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 CA-C-N 122.933 2.083 . . . . 0.0 113.074 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.3 -30.45 71.5 Favored 'General case' 0 CA--C 1.534 0.336 1 C-N-CA 132.616 4.366 . . . . 0.0 115.313 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.478 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 1.5 tp -65.37 158.8 25.6 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.838 1.255 . . . . 0.0 107.888 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.3 m -153.63 155.7 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.591 1.956 . . . . 0.0 108.072 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -75.81 88.07 2.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 164.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -48.86 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 122.583 0.353 . . . . 0.0 110.211 169.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.04 155.63 23.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.334 1.053 . . . . 0.0 108.223 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 170.32 15.71 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.94 156.2 0.07 OUTLIER Glycine 0 CA--C 1.544 1.847 0 O-C-N 121.006 -1.059 . . . . 0.0 112.13 -162.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -91.05 164.96 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 CA-C-N 119.263 1.532 . . . . 0.0 113.592 -164.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.9 m . . . . . 0 C--N 1.341 0.209 0 C-N-CA 123.432 0.693 . . . . 0.0 109.169 167.79 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -170.91 134.55 0.99 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.44 -41.39 1.15 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 115.849 1.1 . . . . 0.0 115.849 164.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.6 -47.04 83.42 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 119.701 1.75 . . . . 0.0 110.46 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -55.42 -43.27 59.92 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.321 2.014 . . . . 0.0 113.065 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -105.38 66.1 0.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.765 1.226 . . . . 0.0 111.992 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.14 -0.04 30.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.641 0.776 . . . . 0.0 112.061 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.04 165.3 17.26 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -159.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.45 164.18 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.908 2.405 . . . . 0.0 111.173 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -81.61 43.38 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.582 -0.699 . . . . 0.0 110.104 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.84 124.9 24.23 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.459 1.904 . . . . 0.0 110.846 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.92 43.55 0.93 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.419 1.088 . . . . 0.0 109.791 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.62 60.69 6.25 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.833 -1.167 . . . . 0.0 109.104 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.6 mmm-85 -53.07 140.2 26.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.247 1.819 . . . . 0.0 112.735 -162.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.99 156.63 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 123.898 0.879 . . . . 0.0 111.498 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.9 t -94.47 141.82 28.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.002 0.364 . . . . 0.0 110.774 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.88 166.29 24.81 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 160.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.0 p -49.65 -19.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -85.63 -8.32 58.31 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.323 1.42 . . . . 0.0 111.986 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.27 -9.65 69.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.06 -1.025 . . . . 0.0 110.85 -160.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -64.91 92.97 0.1 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 128.336 2.654 . . . . 0.0 110.934 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -66.06 144.06 56.95 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.549 0.74 . . . . 0.0 110.366 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -122.84 157.69 31.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.811 2.844 . . . . 0.0 108.625 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 m -62.64 -30.8 71.63 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.53 1.532 . . . . 0.0 113.909 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -163.81 163.46 15.88 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 127.497 2.319 . . . . 0.0 107.301 174.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.67 -16.36 30.13 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.31 1.34 . . . . 0.0 112.014 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -67.55 -46.84 71.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.654 170.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 mmm -59.43 -39.75 84.53 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.599 1.09 . . . . 0.0 111.024 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 2.1 tt -56.71 -69.44 0.15 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.994 0.918 . . . . 0.0 109.42 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -30.92 68.22 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.095 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -70.74 0.09 Allowed 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.3 -53.05 2.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.407 1.883 . . . . 0.0 112.191 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -46.64 -61.47 1.81 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.819 1.247 . . . . 0.0 110.716 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -21.18 64.6 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -79.74 -31.12 41.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.541 1.064 . . . . 0.0 110.721 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.73 21.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.993 -1.449 . . . . 0.0 114.824 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.7 64.77 70.38 Favored Pre-proline 0 C--O 1.224 -0.267 0 CA-C-N 120.004 1.902 . . . . 0.0 110.055 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.71 -17.49 59.24 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.222 1.472 . . . . 0.0 112.961 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.58 -26.26 41.36 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.935 2.494 . . . . 0.0 113.308 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.445 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 4.7 tp -66.37 152.01 45.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -150.06 153.22 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.391 0.676 . . . . 0.0 109.831 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -74.53 85.76 2.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -56.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.441 1.097 . . . . 0.0 110.62 164.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.76 -171.47 2.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.837 2.455 . . . . 0.0 106.426 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.74 -137.8 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.792 2.037 . . . . 0.0 107.194 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.98 122.76 0.01 OUTLIER Glycine 0 CA--C 1.543 1.788 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.55 144.0 35.25 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 119.992 1.896 . . . . 0.0 111.706 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.339 0.142 0 C-N-CA 122.652 0.381 . . . . 0.0 110.106 172.597 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.19 0.519 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -157.79 160.22 37.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 140.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.06 -50.99 2.76 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.43 1.014 . . . . 0.0 113.918 167.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -63.56 -45.34 83.06 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.109 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -57.21 -61.36 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.758 1.639 . . . . 0.0 111.099 166.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.45 59.1 5.32 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.402 -0.811 . . . . 0.0 112.122 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.88 -11.16 59.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.078 -0.389 . . . . 0.0 111.706 166.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.1 164.66 55.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.886 1.674 . . . . 0.0 113.928 -171.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.97 164.36 13.57 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.893 2.395 . . . . 0.0 111.727 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -79.59 43.9 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.499 1.12 . . . . 0.0 111.162 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.11 129.06 38.51 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.738 1.615 . . . . 0.0 110.332 170.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.95 43.84 1.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.481 1.513 . . . . 0.0 111.755 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.7 64.85 6.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.757 -1.214 . . . . 0.0 109.175 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -57.46 142.75 43.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -160.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.66 169.88 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 117.68 -1.152 . . . . 0.0 111.63 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -118.57 137.04 53.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.611 1.096 . . . . 0.0 111.907 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.26 164.72 28.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.2 p -36.21 -41.04 0.25 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.535 2.734 . . . . 0.0 115.929 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.67 -1.91 3.14 Favored 'General case' 0 N--CA 1.436 -1.165 1 C-N-CA 135.019 5.328 . . . . 0.0 111.939 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.91 -8.37 11.85 Favored Glycine 0 CA--C 1.539 1.559 0 CA-C-N 119.391 0.996 . . . . 0.0 112.025 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.47 95.89 0.23 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 130.487 3.515 . . . . 0.0 109.335 -170.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.2 m -66.45 143.7 56.95 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.072 0.463 . . . . 0.0 110.404 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -119.86 157.57 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 128.113 2.565 . . . . 0.0 107.512 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 m -59.16 -31.79 69.3 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.745 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -163.73 160.42 17.4 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 125.338 1.455 . . . . 0.0 108.779 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.01 -15.19 32.44 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.705 1.603 . . . . 0.0 111.399 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.33 -40.04 64.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 123.233 0.613 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.7 ttp -65.01 -44.84 87.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -54.77 -63.5 1.13 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.125 174.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.13 -31.51 70.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.994 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -68.48 0.18 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.68 -53.11 3.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 127.524 2.33 . . . . 0.0 111.856 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -45.37 -61.27 1.74 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.355 1.462 . . . . 0.0 110.722 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -66.01 -27.94 68.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 112.545 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.76 -26.22 40.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.211 0.204 . . . . 0.0 111.33 -173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 17.87 0.02 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.296 -1.28 . . . . 0.0 115.066 -177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -131.7 54.38 14.15 Favored Pre-proline 0 C--O 1.22 -0.456 0 CA-C-N 119.557 1.678 . . . . 0.0 109.099 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.2 -23.1 60.19 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 CA-C-N 122.545 1.945 . . . . 0.0 112.859 -170.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.24 -32.66 74.33 Favored 'General case' 0 CA--C 1.533 0.316 1 C-N-CA 132.882 4.473 . . . . 0.0 114.922 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 1.8 tp -65.37 157.79 28.32 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.959 1.303 . . . . 0.0 107.674 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -152.8 146.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 128.339 2.656 . . . . 0.0 107.676 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.97 83.69 5.84 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 m -53.64 -40.56 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.641 1.577 . . . . 0.0 109.625 -176.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -155.98 162.51 40.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 159.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.78 -179.74 5.58 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 163.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.11 149.22 0.09 OUTLIER Glycine 0 CA--C 1.544 1.874 0 O-C-N 120.796 -1.19 . . . . 0.0 112.534 -161.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.65 152.56 17.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.125 1.883 . . . . 0.0 111.7 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 C--N 1.339 0.119 0 CA-C-O 121.716 0.769 . . . . 0.0 109.048 169.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -163.29 165.4 24.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 153.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.58 9.86 82.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.243 0.925 . . . . 0.0 115.246 158.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.445 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.29 -44.02 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 126.961 2.104 . . . . 0.0 112.64 172.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 8.4 Cg_endo -56.43 -50.69 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.73 2.287 . . . . 0.0 112.457 163.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -95.23 107.99 20.11 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.74 0.816 . . . . 0.0 110.286 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -140.92 52.93 1.59 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.071 1.348 . . . . 0.0 108.071 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -144.77 163.43 33.51 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -161.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.57 166.84 13.59 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.255 2.637 . . . . 0.0 111.813 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -83.15 46.1 1.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.928 0.891 . . . . 0.0 109.734 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.88 123.08 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.117 0.967 . . . . 0.0 109.203 168.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.03 43.09 0.5 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.129 1.772 . . . . 0.0 111.975 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -78.6 76.71 5.1 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 169.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -61.59 141.3 57.86 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.686 -1.259 . . . . 0.0 110.957 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -150.18 164.98 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 124.71 1.204 . . . . 0.0 110.884 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -108.94 135.76 49.59 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.3 163.6 23.08 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 158.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.5 p -43.87 -39.1 3.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -165.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.15 2.09 5.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.489 1.041 . . . . 0.0 112.969 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.09 5.68 80.03 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 120.919 -1.113 . . . . 0.0 111.523 -161.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -71.79 90.21 1.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.119 2.968 . . . . 0.0 109.831 -169.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -65.92 143.89 57.13 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.076 0.853 . . . . 0.0 110.781 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.02 154.01 41.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 127.6 2.36 . . . . 0.0 107.831 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 p -66.06 -24.21 66.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.915 1.686 . . . . 0.0 114.106 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 14.3 p30 -164.01 156.31 14.88 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 126.714 2.006 . . . . 0.0 109.748 170.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.74 -17.03 37.9 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.939 1.759 . . . . 0.0 111.57 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.9 t -66.19 -48.19 71.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.518 168.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.8 mmm -58.09 -39.77 79.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.312 0.96 . . . . 0.0 111.565 175.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 2.7 tt -57.39 -67.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.124 0.97 . . . . 0.0 109.783 171.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 t -60.01 -29.28 68.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.987 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -71.36 0.11 Allowed 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.91 -52.99 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.409 1.884 . . . . 0.0 111.932 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 42.9 tttm -48.08 -64.16 0.87 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.818 1.247 . . . . 0.0 110.893 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -65.55 -20.17 66.22 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 124.005 0.815 . . . . 0.0 112.763 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -74.63 -62.69 1.44 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.54 0.3 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.822 -174.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -128.69 63.08 64.05 Favored Pre-proline 0 C--O 1.221 -0.409 0 CA-C-N 119.193 1.497 . . . . 0.0 109.604 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.11 -19.08 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.206 1.466 . . . . 0.0 112.744 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.67 -22.82 43.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.202 2.601 . . . . 0.0 113.557 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 6.0 tp -66.52 153.91 41.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -150.9 152.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.174 1.39 . . . . 0.0 108.59 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -75.34 83.9 2.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 166.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.52 -54.45 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.69 168.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.23 -170.44 2.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.809 2.043 . . . . 0.0 107.502 174.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -137.3 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.06 1.744 . . . . 0.0 106.881 167.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.32 118.25 0.01 OUTLIER Glycine 0 CA--C 1.539 1.57 0 C-N-CA 127.555 2.502 . . . . 0.0 118.664 158.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.7 137.65 30.41 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.189 1.926 . . . . 0.0 111.908 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.115 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 p90 . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 122.233 1.016 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -169.0 162.57 11.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 143.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.92 -64.65 1.92 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.56 1.552 . . . . 0.0 112.087 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.33 80.57 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-O 116.364 -1.779 . . . . 0.0 115.108 -172.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -50.0 -26.61 14.72 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 122.072 1.776 . . . . 0.0 113.35 168.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.6 m -105.01 22.01 16.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.127 1.771 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.85 73.66 0.1 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.47 1.108 . . . . 0.0 109.524 170.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.09 167.93 11.77 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.416 1.886 . . . . 0.0 109.905 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.8 157.33 24.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.598 2.199 . . . . 0.0 110.936 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -79.06 43.7 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.492 -0.755 . . . . 0.0 110.233 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.07 140.84 58.28 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.417 1.487 . . . . 0.0 110.786 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.61 43.82 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.898 1.679 . . . . 0.0 110.497 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -89.58 46.13 1.34 Allowed 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.332 -1.48 . . . . 0.0 110.509 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -49.01 145.78 3.8 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.575 1.95 . . . . 0.0 115.262 -164.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 m -148.53 174.31 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.237 1.415 . . . . 0.0 110.606 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -116.53 137.09 52.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 0.794 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.58 163.55 22.75 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.216 0.898 . . . . 0.0 112.059 161.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.9 p -54.64 -17.73 3.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 118.653 2.835 . . . . 0.0 118.653 -168.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -9.32 59.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.354 0.662 . . . . 0.0 111.724 171.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.7 -3.93 65.75 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.739 1.161 . . . . 0.0 111.043 -171.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.755 ' ND2' ' HH ' ' A' ' 23' ' ' TYR . 4.9 p30 -71.14 113.91 8.66 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 127.487 2.315 . . . . 0.0 109.902 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -66.15 144.77 56.45 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 122.207 -0.308 . . . . 0.0 110.424 167.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.755 ' HH ' ' ND2' ' A' ' 21' ' ' ASN . 64.1 m-85 -122.53 150.33 42.71 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.946 2.098 . . . . 0.0 107.156 173.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -60.64 -27.31 67.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.399 1.08 . . . . 0.0 113.498 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -163.79 163.43 15.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.673 2.389 . . . . 0.0 107.028 174.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.99 -17.1 32.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.042 1.161 . . . . 0.0 112.065 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 -40.32 93.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.487 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.4 mmm -66.15 -40.87 90.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.751 1.159 . . . . 0.0 111.86 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.456 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 2.3 tt -59.25 -65.24 0.7 Allowed 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.453 0.701 . . . . 0.0 109.163 171.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -31.5 70.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.797 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.9 t -52.77 -69.01 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.39 -53.06 3.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.516 1.526 . . . . 0.0 111.589 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -50.57 -63.71 1.04 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.034 1.734 . . . . 0.0 110.914 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -62.31 -26.75 68.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.814 1.646 . . . . 0.0 112.221 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -63.32 1.2 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.0 20.27 0.29 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.179 -1.345 . . . . 0.0 114.479 -173.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -124.95 63.84 41.45 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 119.859 1.83 . . . . 0.0 110.139 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.59 -16.06 45.67 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 CA-C-N 121.506 1.574 . . . . 0.0 113.392 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -22.97 33.73 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.28 2.632 . . . . 0.0 113.508 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.456 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.47 150.59 48.72 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 174.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.6 m -153.63 159.77 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.712 1.605 . . . . 0.0 108.784 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.44 82.07 1.44 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.72 -42.17 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -157.24 140.3 15.33 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.554 1.141 . . . . 0.0 108.627 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.12 37.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.111 1.365 . . . . 0.0 112.697 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.15 159.99 27.75 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.73 148.95 29.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.234 1.956 . . . . 0.0 111.632 -167.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m . . . . . 0 CA--C 1.517 -0.317 0 C-N-CA 124.273 1.029 . . . . 0.0 108.54 174.456 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -176.44 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.415 1.886 . . . . 0.0 108.319 151.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.8 61.96 3.97 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.66 2.076 . . . . 0.0 111.023 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.92 -54.93 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 126.964 2.106 . . . . 0.0 107.463 170.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.01 -49.97 7.13 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 120.337 1.156 . . . . 0.0 111.705 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -91.42 87.24 6.35 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.804 0.729 . . . . 0.0 109.242 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -141.2 48.59 1.67 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.584 1.154 . . . . 0.0 108.406 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.64 164.85 38.41 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -163.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -82.86 168.48 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.068 2.512 . . . . 0.0 112.169 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -85.15 44.31 1.08 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.01 0.924 . . . . 0.0 110.968 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.33 135.01 56.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 109.663 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.99 43.37 1.04 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.453 2.301 . . . . 0.0 114.131 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -78.45 82.25 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 120.709 -1.244 . . . . 0.0 107.649 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.48 120.05 9.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 119.569 -1.957 . . . . 0.0 107.588 172.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -138.36 155.29 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -107.64 136.81 46.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.782 0.719 . . . . 0.0 110.319 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.54 163.81 24.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -34.23 -41.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.131 2.972 . . . . 0.0 116.184 -172.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 0.04 5.16 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.436 4.694 . . . . 0.0 111.75 -172.39 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.38 -4.81 39.49 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.373 0.987 . . . . 0.0 111.65 -165.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -76.49 106.12 7.94 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 127.229 2.211 . . . . 0.0 110.632 -170.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -66.24 144.29 56.71 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.453 0.57 . . . . 0.0 111.302 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -124.28 152.06 43.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.772 2.429 . . . . 0.0 107.041 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.477 1.111 . . . . 0.0 113.838 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -163.91 156.52 15.27 Favored Pre-proline 0 C--N 1.343 0.303 0 C-N-CA 126.958 2.103 . . . . 0.0 109.331 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.45 -18.65 43.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.412 2.075 . . . . 0.0 111.274 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -66.46 -42.52 87.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.69 -0.672 . . . . 0.0 111.005 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 86.4 mtp -61.61 -41.6 97.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.549 1.068 . . . . 0.0 112.031 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.86 -64.93 0.71 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.73 171.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.39 -30.04 70.3 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.843 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.15 -69.63 0.13 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.18 -53.04 2.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.284 1.833 . . . . 0.0 111.053 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -48.06 -62.51 1.44 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.597 1.559 . . . . 0.0 110.632 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -18.14 63.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.227 -0.892 . . . . 0.0 112.799 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -51.34 9.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.942 0.792 . . . . 0.0 108.885 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.9 22.51 0.11 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.153 -1.359 . . . . 0.0 114.641 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -129.57 61.3 56.91 Favored Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 120.015 1.908 . . . . 0.0 110.338 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.04 -24.64 66.82 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.814 1.676 . . . . 0.0 112.703 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.16 -30.44 68.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 131.163 3.785 . . . . 0.0 115.042 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 tp -66.33 155.27 37.76 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.3 m -153.76 153.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.067 1.747 . . . . 0.0 109.788 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -74.86 83.37 2.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 m -57.37 -38.27 61.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 122.775 0.43 . . . . 0.0 110.378 169.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -162.89 138.38 6.89 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.652 1.181 . . . . 0.0 109.502 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.18 68.25 10.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.452 1.024 . . . . 0.0 108.805 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.99 157.46 20.2 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.51 153.99 13.81 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.965 1.776 . . . . 0.0 112.76 -159.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m . . . . . 0 CA--C 1.528 0.117 0 C-N-CA 124.875 1.27 . . . . 0.0 107.761 167.673 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.93 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.669 2.388 . . . . 0.0 105.873 166.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.88 -26.49 68.99 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.277 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.3 -48.49 82.54 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 119.593 1.697 . . . . 0.0 111.072 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.67 -65.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.388 2.059 . . . . 0.0 113.09 161.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.8 m -88.64 74.65 8.39 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 112.639 -158.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.91 8.89 6.84 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.866 1.266 . . . . 0.0 112.528 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.44 164.63 59.62 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 120.844 -1.16 . . . . 0.0 113.089 -175.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 169.18 20.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.882 2.388 . . . . 0.0 111.95 -174.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -75.17 43.73 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.539 1.536 . . . . 0.0 111.04 171.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 114.01 4.96 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 124.888 1.275 . . . . 0.0 108.888 168.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.7 101.86 5.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -148.47 79.86 1.44 Allowed 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -59.43 132.15 53.11 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.391 -0.818 . . . . 0.0 110.004 -170.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.98 167.38 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 123.507 0.723 . . . . 0.0 111.527 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.8 t -115.55 134.29 55.21 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.132 0.973 . . . . 0.0 110.887 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.24 164.96 23.7 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.983 1.277 . . . . 0.0 110.631 164.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -41.54 -40.37 1.83 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -164.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.78 0.03 4.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.589 1.556 . . . . 0.0 112.799 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.13 -0.71 88.43 Favored Glycine 0 CA--C 1.541 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 112.073 -159.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.02 94.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.959 2.104 . . . . 0.0 110.174 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.9 m -66.19 143.59 57.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -130.96 153.65 48.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.464 3.106 . . . . 0.0 110.254 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 m -45.62 -40.15 8.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 130.67 3.588 . . . . 0.0 116.157 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -163.76 158.73 17.02 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.603 1.961 . . . . 0.0 108.941 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.54 -19.82 27.84 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.519 1.479 . . . . 0.0 111.674 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.65 -46.84 88.81 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -63.35 -32.56 74.02 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 1.1 tt -61.67 -61.1 2.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 119.382 0.992 . . . . 0.0 109.022 172.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -60.5 -32.91 71.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.815 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -62.06 2.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.83 -52.99 6.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.903 2.081 . . . . 0.0 111.556 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 41.5 tttm -50.18 -60.96 2.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.381 1.073 . . . . 0.0 109.762 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 -17.14 63.56 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 124.259 0.974 . . . . 0.0 112.512 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -79.54 -44.55 20.94 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.811 0.732 . . . . 0.0 110.532 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.33 17.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.105 -1.386 . . . . 0.0 114.121 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -120.4 63.71 10.14 Favored Pre-proline 0 C--O 1.22 -0.485 0 CA-C-N 119.797 1.799 . . . . 0.0 109.38 -177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -60.22 -22.44 70.42 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.122 1.881 . . . . 0.0 112.988 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.44 -26.12 55.12 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 128.122 2.569 . . . . 0.0 113.441 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.05 154.53 39.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m -150.8 148.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -75.13 85.25 2.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.19 -58.99 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.46 1.104 . . . . 0.0 109.893 167.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.38 -173.26 1.42 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.361 1.464 . . . . 0.0 109.243 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -177.15 6.32 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.968 2.107 . . . . 0.0 109.929 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.14 141.96 1.14 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 119.248 0.931 . . . . 0.0 113.909 171.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -82.88 145.9 12.8 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.113 1.876 . . . . 0.0 111.756 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.338 0.067 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 172.558 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -176.68 -65.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.122 0.969 . . . . 0.0 110.514 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.26 -14.62 44.33 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.766 2.127 . . . . 0.0 114.674 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -55.04 3.88 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.325 2.25 . . . . 0.0 110.925 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.29 -53.79 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.929 2.42 . . . . 0.0 110.724 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.5 m -87.65 124.38 33.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 120.34 1.427 . . . . 0.0 108.94 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.14 29.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.468 1.507 . . . . 0.0 110.922 -173.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 164.98 13.59 Favored Pre-proline 0 C--O 1.236 0.355 0 O-C-N 121.677 -0.639 . . . . 0.0 111.043 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.69 172.92 13.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.268 1.979 . . . . 0.0 109.688 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -78.12 46.32 0.59 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.96 1.304 . . . . 0.0 110.373 171.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.64 123.89 20.9 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.29 49.71 1.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.113 1.365 . . . . 0.0 109.638 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -80.18 58.96 3.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -48.06 122.92 5.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.852 1.205 . . . . 0.0 111.329 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.0 m -134.23 178.15 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 C-N-CA 124.571 1.148 . . . . 0.0 111.153 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.6 144.11 51.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.76 171.05 31.34 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.18 -24.58 11.16 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 175.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -84.24 0.08 50.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.419 1.888 . . . . 0.0 112.516 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -7.55 36.96 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.823 -1.173 . . . . 0.0 111.859 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.58 107.34 1.37 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.182 1.393 . . . . 0.0 107.447 -176.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -66.27 146.25 54.81 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.9 139.94 53.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.796 2.039 . . . . 0.0 106.488 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.6 t -45.45 -32.08 2.01 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.997 2.119 . . . . 0.0 112.206 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -163.56 154.7 14.2 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.555 2.342 . . . . 0.0 111.135 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -74.91 -24.4 13.05 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 111.159 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -28.01 69.26 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.023 -0.423 . . . . 0.0 112.049 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -36.03 60.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.76 170.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.405 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 8.8 tt -56.43 -67.34 0.31 Allowed 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -50.27 -37.33 35.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.556 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -71.78 0.06 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 175.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.9 -51.11 4.42 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.099 2.16 . . . . 0.0 110.872 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -66.29 0.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -15.17 60.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -67.31 0.61 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.751 0.82 . . . . 0.0 108.86 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.75 39.97 0.25 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 126.489 1.995 . . . . 0.0 110.162 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -138.08 59.78 20.11 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.888 1.344 . . . . 0.0 111.341 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.92 -8.66 14.31 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.047 1.831 . . . . 0.0 112.764 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -90.5 -24.52 20.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.011 2.125 . . . . 0.0 113.769 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.405 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 3.1 tp -66.4 150.32 49.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.6 m -149.2 152.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -78.24 83.63 4.49 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -57.12 -46.15 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.861 0.865 . . . . 0.0 111.534 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -164.47 157.01 16.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 125.177 1.391 . . . . 0.0 109.084 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -87.68 54.99 3.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.964 2.906 . . . . 0.0 110.54 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.73 150.13 21.61 Favored Glycine 0 C--O 1.226 -0.358 0 O-C-N 119.836 -1.79 . . . . 0.0 109.041 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.2 146.62 28.7 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.235 1.956 . . . . 0.0 111.599 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 124.714 1.206 . . . . 0.0 110.502 179.426 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -176.13 133.75 0.25 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.14 -31.07 0.95 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.097 1.332 . . . . 0.0 114.701 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -67.08 -56.27 13.84 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.726 1.263 . . . . 0.0 111.024 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.23 -48.42 0.62 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.238 1.959 . . . . 0.0 112.299 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.04 125.41 41.46 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.469 0.708 . . . . 0.0 109.654 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -154.47 -24.33 0.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.981 1.712 . . . . 0.0 110.93 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -49.61 158.35 0.84 Allowed Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 125.972 1.709 . . . . 0.0 114.753 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.13 169.35 22.75 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 121.928 1.752 . . . . 0.0 111.179 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -80.29 43.65 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.075 0.95 . . . . 0.0 110.044 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.24 19.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.501 1.52 . . . . 0.0 109.247 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 42.79 0.33 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 111.08 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -84.93 63.26 7.98 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 121.149 -0.969 . . . . 0.0 108.698 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -55.77 134.9 51.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.108 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.34 -178.27 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 125.151 1.381 . . . . 0.0 111.516 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -125.21 137.34 54.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.512 1.125 . . . . 0.0 110.564 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.91 168.78 26.36 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 165.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 p -50.69 -31.3 15.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.02 0.0 5.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.25 66.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.359 0.981 . . . . 0.0 111.624 -163.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.09 110.82 9.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.337 1.455 . . . . 0.0 109.553 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -65.84 143.95 57.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.969 0.414 . . . . 0.0 110.366 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -119.4 145.39 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.368 2.267 . . . . 0.0 108.225 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -58.33 -29.22 65.77 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.344 1.057 . . . . 0.0 113.002 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -163.89 155.96 14.8 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 125.208 1.403 . . . . 0.0 109.78 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.27 -16.37 35.4 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.486 2.124 . . . . 0.0 111.023 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.162 -0.336 . . . . 0.0 110.953 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.8 mtm -66.08 -31.73 72.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.656 172.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 7.7 tt -59.6 -68.26 0.3 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.397 0.998 . . . . 0.0 109.38 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -51.98 -39.27 59.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.824 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -68.49 0.17 Allowed 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.76 1.95 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 126.592 1.957 . . . . 0.0 110.506 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -51.04 -63.44 1.13 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.926 0.89 . . . . 0.0 110.647 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.6 -16.87 64.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.69 1.196 . . . . 0.0 112.727 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -66.18 0.87 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.51 23.74 0.36 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.896 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -127.33 60.67 44.55 Favored Pre-proline 0 C--O 1.222 -0.392 0 CA-C-N 119.618 1.709 . . . . 0.0 109.835 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -61.23 -17.73 54.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.657 1.571 . . . . 0.0 113.166 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -26.36 45.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.399 2.28 . . . . 0.0 113.333 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.466 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.04 153.38 42.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.5 m -150.88 149.42 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -72.55 85.67 1.16 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -47.16 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.563 0.745 . . . . 0.0 109.747 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 166.12 151.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.862 2.865 . . . . 0.0 106.957 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -68.34 -173.26 0.4 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.844 2.058 . . . . 0.0 111.388 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.71 142.1 0.79 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.08 143.68 18.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.225 1.513 . . . . 0.0 110.475 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.61 -43.27 14.59 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 119.274 -0.394 . . . . 0.0 110.85 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -65.23 159.48 23.61 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.411 0.684 . . . . 0.0 109.717 171.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -57.96 -64.43 0.91 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.897 1.679 . . . . 0.0 109.903 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -167.45 34.51 0.03 OUTLIER 'General case' 0 C--N 1.343 0.304 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -173.28 -167.54 0.41 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 118.978 -2.326 . . . . 0.0 106.954 -164.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -153.39 45.98 0.65 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.123 1.328 . . . . 0.0 110.565 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -169.65 157.08 6.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.95 1.3 . . . . 0.0 108.591 -164.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.31 1.444 . . . . 0.0 110.125 -179.386 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.39 -89.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.269 1.028 . . . . 0.0 109.667 156.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.19 76.24 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.112 -0.993 . . . . 0.0 112.555 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -43.98 79.63 Favored Pre-proline 0 C--N 1.34 0.161 0 CA-C-O 117.217 -1.373 . . . . 0.0 114.378 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.83 -51.41 0.48 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.538 2.159 . . . . 0.0 111.928 159.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.42 70.16 8.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.027 1.285 . . . . 0.0 113.081 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -83.92 -14.09 51.87 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.38 162.42 61.22 Favored Pre-proline 0 C--O 1.236 0.373 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -158.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.83 165.47 28.52 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.934 2.423 . . . . 0.0 110.783 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.81 43.56 1.0 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.386 0.674 . . . . 0.0 109.381 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.33 122.56 17.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.124 1.77 . . . . 0.0 110.498 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.89 43.77 0.36 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.56 1.944 . . . . 0.0 111.246 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -92.36 58.01 3.13 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 120.5 -1.375 . . . . 0.0 108.751 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -53.65 147.42 11.39 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.345 1.858 . . . . 0.0 113.207 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -149.14 153.75 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.024 0.929 . . . . 0.0 111.751 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 t -86.44 133.88 33.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 110.473 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.16 164.15 23.46 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 158.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.1 p -51.28 -25.12 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -168.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 0.01 11.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 112.385 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.58 50.17 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.838 -1.163 . . . . 0.0 110.692 -158.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -66.71 96.99 0.43 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 131.347 3.859 . . . . 0.0 110.974 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -66.13 144.39 56.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.756 0.422 . . . . 0.0 111.344 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -123.81 153.3 41.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.776 2.03 . . . . 0.0 107.809 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -65.97 -21.56 66.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -163.76 159.99 17.3 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.215 1.806 . . . . 0.0 108.883 168.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.75 -20.13 52.72 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.877 . . . . 0.0 110.996 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -68.89 -45.57 70.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.224 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -37.57 87.24 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.623 1.101 . . . . 0.0 111.311 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 1.1 tt -56.7 -66.74 0.39 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.222 1.009 . . . . 0.0 109.964 168.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -32.16 70.71 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.536 -0.727 . . . . 0.0 111.327 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.7 -68.5 0.18 Allowed 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.03 -52.85 1.82 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.052 1.741 . . . . 0.0 111.525 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 42.9 tttm -48.18 -61.75 1.83 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.193 1.397 . . . . 0.0 110.544 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -67.92 -21.16 65.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -48.9 16.18 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.74 25.4 0.1 OUTLIER Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.234 -1.315 . . . . 0.0 114.887 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -130.35 63.65 70.05 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 120.014 1.907 . . . . 0.0 109.789 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -61.33 -19.99 66.36 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.446 1.552 . . . . 0.0 112.664 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -23.92 46.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.513 2.725 . . . . 0.0 113.494 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -66.49 154.67 39.69 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 m -150.66 150.6 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 124.901 1.28 . . . . 0.0 108.753 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -71.77 84.88 0.92 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.41 -53.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.303 0.641 . . . . 0.0 110.112 166.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -169.98 175.63 5.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.224 1.809 . . . . 0.0 110.148 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.21 171.93 10.28 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.88 2.472 . . . . 0.0 108.239 164.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.5 138.43 0.85 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 127.373 2.416 . . . . 0.0 112.216 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.18 142.42 21.58 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 110.834 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 m -83.47 -77.47 0.25 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -173.86 165.45 4.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.934 2.493 . . . . 0.0 107.514 -168.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.289 83.7 tt0 162.78 -72.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 128.479 2.712 . . . . 0.0 109.7 158.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -144.3 83.83 1.74 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.651 1.581 . . . . 0.0 107.905 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.19 146.4 23.46 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.808 0.843 . . . . 0.0 111.841 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -161.71 53.41 0.25 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.246 1.418 . . . . 0.0 109.534 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -81.37 171.65 14.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.359 1.064 . . . . 0.0 111.143 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 116.058 -1.925 . . . . 0.0 108.467 168.513 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 p90 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -176.7 -86.56 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.709 2.003 . . . . 0.0 107.597 141.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.22 -15.82 80.5 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.19 0.9 . . . . 0.0 113.637 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -50.02 65.79 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 119.317 1.558 . . . . 0.0 111.923 171.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -60.7 -51.89 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.291 1.327 . . . . 0.0 112.261 160.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.1 m -89.29 71.7 8.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.473 1.033 . . . . 0.0 112.323 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -116.85 84.15 2.09 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.11 165.24 19.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 123.282 0.633 . . . . 0.0 111.307 -172.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 165.07 20.73 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.251 2.634 . . . . 0.0 111.357 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.55 43.3 0.47 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.878 0.871 . . . . 0.0 111.067 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.0 128.32 35.59 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.899 1.279 . . . . 0.0 111.066 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.03 43.26 1.04 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.648 1.579 . . . . 0.0 110.674 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -83.42 64.59 7.92 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 120.597 -1.314 . . . . 0.0 107.975 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -55.84 134.74 52.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.699 1.136 . . . . 0.0 111.721 -167.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.68 169.68 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 110.443 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.9 143.17 50.53 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.4 1.0 . . . . 0.0 110.933 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.18 166.5 28.46 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -34.35 -40.86 0.1 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.278 2.631 . . . . 0.0 115.562 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.85 0.05 10.05 Favored 'General case' 0 N--CA 1.436 -1.16 1 C-N-CA 132.919 4.487 . . . . 0.0 111.654 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.2 -4.32 33.42 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.969 0.804 . . . . 0.0 112.086 -166.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.76 102.96 4.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.98 2.512 . . . . 0.0 110.163 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -66.37 143.56 57.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.219 0.463 . . . . 0.0 111.54 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -123.93 155.95 37.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.117 2.967 . . . . 0.0 108.499 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.1 t -63.88 -28.79 70.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -163.87 160.65 17.14 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.918 1.687 . . . . 0.0 107.637 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.37 -14.9 28.2 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 120.744 0.963 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.01 -44.68 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 118.101 0.409 . . . . 0.0 110.596 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mmm -59.0 -46.36 88.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.009 0.924 . . . . 0.0 110.515 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.78 -62.22 1.84 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.111 1.365 . . . . 0.0 110.876 173.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -35.56 77.18 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.713 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.38 -68.32 0.18 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 171.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.81 -52.75 1.72 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.872 2.069 . . . . 0.0 112.104 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -48.53 -59.11 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.731 1.612 . . . . 0.0 110.323 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -71.0 -23.97 62.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.576 0.75 . . . . 0.0 112.64 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -75.88 -38.65 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.514 0.726 . . . . 0.0 110.718 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.2 18.91 0.03 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.057 -1.413 . . . . 0.0 115.488 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -128.79 62.42 61.1 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 120.327 2.063 . . . . 0.0 110.073 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.23 -25.34 71.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.979 1.786 . . . . 0.0 112.786 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.06 -32.66 74.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 131.273 3.829 . . . . 0.0 114.304 175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 tp -66.2 157.54 31.13 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 109.183 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.47 149.79 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 126.516 1.926 . . . . 0.0 109.74 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.77 83.96 1.64 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 164.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.1 -46.29 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.743 0.817 . . . . 0.0 108.946 174.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.462 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 24.7 t60 -161.22 178.78 8.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 161.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' H ' ' CG ' ' A' ' 44' ' ' HIS . 29.3 mt-10 -83.36 178.83 7.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 159.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.01 144.14 1.38 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -172.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.45 158.64 25.74 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.868 1.712 . . . . 0.0 110.853 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 64.6 m -86.49 -91.05 0.1 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 162.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.23 -157.25 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.093 1.357 . . . . 0.0 108.876 174.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.27 -89.61 0.11 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.285 1.434 . . . . 0.0 108.377 164.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.88 -54.26 0.16 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.163 2.585 . . . . 0.0 108.47 169.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -173.6 157.07 3.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.558 2.343 . . . . 0.0 108.126 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -106.94 83.37 1.82 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.495 1.518 . . . . 0.0 111.12 171.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -70.14 170.67 11.06 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.785 0.721 . . . . 0.0 111.461 167.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.608 -1.187 . . . . 0.0 112.227 -176.178 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -176.81 -81.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.94 1.696 . . . . 0.0 107.113 140.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.25 -39.38 44.15 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 119.2 -0.778 . . . . 0.0 112.222 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -43.51 77.81 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 116.682 -1.628 . . . . 0.0 115.127 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.11 -28.24 69.15 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 122.266 1.845 . . . . 0.0 112.228 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -105.25 29.15 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.769 1.628 . . . . 0.0 111.915 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -56.78 -27.67 60.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.57 163.42 3.73 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.129 2.572 . . . . 0.0 114.997 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.21 162.24 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.376 2.051 . . . . 0.0 110.912 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 43.15 0.97 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.633 -0.667 . . . . 0.0 110.236 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.43 127.69 33.27 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.093 2.157 . . . . 0.0 110.89 172.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.18 43.54 0.63 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.556 1.542 . . . . 0.0 112.019 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -82.78 55.92 3.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.458 -1.401 . . . . 0.0 109.959 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -54.65 144.26 22.37 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.61 1.564 . . . . 0.0 114.881 -161.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.2 m -146.36 162.16 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.726 0.81 . . . . 0.0 111.844 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.6 t -101.43 130.77 47.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.279 0.632 . . . . 0.0 112.0 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.08 163.39 23.23 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 158.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.439 ' HA ' ' CG1' ' A' ' 43' ' ' VAL . 88.5 p -34.03 -57.56 0.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 118.237 2.68 . . . . 0.0 118.237 -161.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.71 42.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.219 -162.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.36 42.44 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 123.758 0.694 . . . . 0.0 112.617 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.18 75.51 2.33 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.824 3.249 . . . . 0.0 108.946 -159.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.0 m -66.31 143.74 57.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.662 -0.649 . . . . 0.0 110.225 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.02 155.42 46.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.597 2.359 . . . . 0.0 108.562 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -59.85 -25.45 65.03 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.434 1.494 . . . . 0.0 114.047 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -163.55 162.66 17.01 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.806 2.043 . . . . 0.0 107.675 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.83 -21.82 50.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.185 1.257 . . . . 0.0 111.368 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.01 -37.84 84.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.599 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 mmm -68.85 -35.68 77.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.792 1.178 . . . . 0.0 111.704 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 2.1 tt -61.9 -63.99 1.08 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.38 -32.64 70.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.777 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.1 t -51.4 -71.44 0.06 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.02 -52.9 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.431 1.893 . . . . 0.0 111.317 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -48.66 -63.96 0.94 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.844 1.657 . . . . 0.0 110.466 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -73.15 -18.4 61.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.54 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -73.55 -55.08 6.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.97 0.508 . . . . 0.0 110.131 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.08 16.49 0.09 OUTLIER Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.818 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -126.76 57.77 24.06 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.693 1.746 . . . . 0.0 108.646 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.22 -22.85 66.78 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 122.48 1.921 . . . . 0.0 112.724 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.07 -31.89 73.24 Favored 'General case' 0 CA--C 1.533 0.312 1 C-N-CA 132.415 4.286 . . . . 0.0 114.873 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.448 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -65.69 156.59 32.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.188 1.395 . . . . 0.0 108.542 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.4 m -152.36 155.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.853 1.661 . . . . 0.0 109.431 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -73.84 87.01 1.75 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 163.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.93 -48.51 63.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 123.165 0.586 . . . . 0.0 110.491 167.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -162.73 164.37 26.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.135 1.774 . . . . 0.0 107.534 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -84.26 166.01 17.85 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 166.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.83 150.18 2.81 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 111.357 -170.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -83.23 157.55 14.94 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.659 -166.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.42 -38.76 18.31 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 119.31 -0.376 . . . . 0.0 110.656 165.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.56 128.79 37.62 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 168.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -153.77 148.5 26.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 164.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -151.85 -47.42 0.11 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.253 1.421 . . . . 0.0 109.1 -173.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.57 164.7 4.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.236 2.215 . . . . 0.0 107.563 163.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -145.5 38.37 1.13 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.341 1.456 . . . . 0.0 109.056 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.02 -48.15 74.93 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.798 0.839 . . . . 0.0 111.517 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 125.481 1.513 . . . . 0.0 109.429 165.554 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 p90 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.96 -68.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.978 . . . . 0.0 105.965 166.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.9 -17.87 42.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.849 1.214 . . . . 0.0 115.289 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -64.91 -52.02 52.69 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 119.011 1.406 . . . . 0.0 111.81 165.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.46 -58.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.015 3.143 . . . . 0.0 112.629 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.89 96.79 10.34 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.953 1.706 . . . . 0.0 111.082 -167.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.84 0.02 2.16 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 125.007 1.442 . . . . 0.0 113.947 -175.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 163.9 62.59 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.354 1.462 . . . . 0.0 113.884 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.52 165.18 31.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.595 2.197 . . . . 0.0 110.69 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.36 47.51 0.09 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.83 1.252 . . . . 0.0 112.066 167.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.84 118.73 10.1 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.146 165.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -77.55 42.44 0.36 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.407 1.883 . . . . 0.0 111.473 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -79.58 64.89 4.58 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.67 137.61 57.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.657 1.572 . . . . 0.0 111.55 -168.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 m -141.54 167.32 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.89 0.876 . . . . 0.0 112.097 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 t -105.53 141.56 36.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.071 0.948 . . . . 0.0 110.719 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.39 166.14 24.1 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.892 1.234 . . . . 0.0 111.217 159.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -37.9 -40.35 0.45 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.385 2.274 . . . . 0.0 115.665 -176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.47 16.5 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 110.314 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.77 65.47 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.219 -165.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -68.68 92.62 0.48 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.46 1.504 . . . . 0.0 109.354 -163.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -65.9 143.46 57.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -126.54 155.02 43.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.827 2.051 . . . . 0.0 108.707 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.1 p -65.46 -27.88 68.82 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.688 1.195 . . . . 0.0 113.212 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -163.41 152.63 12.42 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 127.326 2.25 . . . . 0.0 108.957 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.86 -23.65 22.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.118 1.212 . . . . 0.0 110.92 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -56.76 -44.47 81.81 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 111.105 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.31 70.14 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 3.6 tt -64.46 -65.86 0.62 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 t -52.39 -29.47 24.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.445 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -62.05 -60.74 3.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' N ' ' SG ' ' A' ' 31' ' ' CYS . . . -42.35 -51.9 4.72 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.992 2.117 . . . . 0.0 110.206 175.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 tttm -50.95 -63.2 1.2 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.339 1.024 . . . . 0.0 110.562 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.73 -14.0 62.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.518 1.127 . . . . 0.0 113.943 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -58.23 3.26 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.75 34.14 0.14 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.591 -1.116 . . . . 0.0 113.09 -173.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -134.85 62.1 51.29 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 119.271 1.535 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.0 -13.44 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 CA-C-N 121.058 1.414 . . . . 0.0 114.027 -172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.66 -27.01 37.25 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.503 2.721 . . . . 0.0 112.735 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.454 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 3.9 tp -66.39 153.56 42.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.2 m -147.74 144.05 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -74.38 87.28 2.03 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -58.73 -50.67 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.44 1.496 . . . . 0.0 108.885 171.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 19.0 t60 -179.39 -171.52 0.2 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.51 3.124 . . . . 0.0 107.574 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.641 ' H ' ' CG ' ' A' ' 44' ' ' HIS . 0.2 OUTLIER -85.09 -164.82 1.05 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.81 2.444 . . . . 0.0 108.604 166.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 123.15 0.19 Allowed Glycine 0 CA--C 1.544 1.895 0 C-N-CA 124.862 1.22 . . . . 0.0 113.975 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.16 135.23 13.54 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 120.823 2.311 . . . . 0.0 112.312 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m -76.02 -43.02 46.13 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.444 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -74.84 125.44 28.81 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.304 1.041 . . . . 0.0 109.522 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.14 88.13 1.23 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.06 83.43 0.65 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.81 2.044 . . . . 0.0 109.098 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -58.22 111.92 1.37 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.464 1.906 . . . . 0.0 110.213 167.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -104.28 47.06 0.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.917 1.687 . . . . 0.0 109.443 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.53 174.68 12.67 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 166.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.195 1.398 . . . . 0.0 112.118 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.22 -54.9 0.01 OUTLIER 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.18 0.992 . . . . 0.0 111.448 170.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.75 67.0 1.12 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 127.017 2.246 . . . . 0.0 109.39 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -176.62 -55.87 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.259 1.824 . . . . 0.0 109.851 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -72.74 -58.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.733 1.622 . . . . 0.0 110.004 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.17 133.83 35.53 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 176.57 34.41 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 O-C-N 125.967 2.042 . . . . 0.0 111.726 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.7 165.78 12.72 Favored Pre-proline 0 C--O 1.233 0.234 0 O-C-N 121.293 -0.88 . . . . 0.0 112.28 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.48 172.38 14.34 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.233 1.956 . . . . 0.0 109.709 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -77.01 44.26 0.39 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.661 1.584 . . . . 0.0 110.722 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 120.31 11.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.77 1.228 . . . . 0.0 110.046 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.49 54.49 2.36 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.802 1.641 . . . . 0.0 110.54 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 1.5 m80 -91.04 61.3 4.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -46.2 100.37 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.52 178.81 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 124.932 1.293 . . . . 0.0 112.299 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 4.1 t -115.97 135.33 54.07 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.457 1.503 . . . . 0.0 109.025 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.75 173.07 41.38 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.58 -32.1 62.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.21 -0.03 30.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.914 1.286 . . . . 0.0 110.567 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.93 -0.82 61.16 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.67 1.129 . . . . 0.0 111.991 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.97 115.32 11.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.2 m -65.79 150.14 49.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.77 136.02 53.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -37.17 -37.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.777 2.031 . . . . 0.0 113.241 170.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -163.69 155.79 15.0 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 128.072 2.549 . . . . 0.0 111.361 -176.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.3 -24.87 16.19 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.471 2.781 . . . . 0.0 110.292 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.74 -30.04 69.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.3 mtp -74.61 -41.51 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.002 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 3.6 tt -51.26 -70.03 0.1 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 t -50.24 -38.07 38.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.741 0.416 . . . . 0.0 111.804 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -72.18 0.05 Allowed 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 175.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -35.91 -55.85 0.73 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 127.679 2.392 . . . . 0.0 109.79 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.52 -66.03 0.43 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.481 -1.69 . . . . 0.0 114.054 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.87 63.24 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 124.584 1.177 . . . . 0.0 111.249 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -78.33 0.11 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.399 1.48 . . . . 0.0 107.778 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.43 48.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 127.078 2.275 . . . . 0.0 109.503 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -148.03 59.99 4.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 117.891 0.845 . . . . 0.0 111.753 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.83 -10.56 17.62 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 122.967 2.445 . . . . 0.0 113.612 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.55 -28.93 21.67 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 127.0 2.12 . . . . 0.0 113.709 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 2.4 tp -65.59 154.2 39.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 m -146.89 145.33 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -73.42 82.83 1.45 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -49.75 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.669 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 174.78 176.94 0.15 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.009 2.124 . . . . 0.0 109.032 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -174.85 5.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.009 2.124 . . . . 0.0 110.522 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.34 134.37 0.53 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.37 1.462 . . . . 0.0 112.909 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.9 145.52 36.2 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.532 2.166 . . . . 0.0 111.372 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.441 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -86.53 -99.99 0.07 Allowed 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 178.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -178.67 135.92 0.14 Allowed 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 125.317 1.636 . . . . 0.0 108.419 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.99 -176.75 6.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.997 1.319 . . . . 0.0 110.674 173.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.32 52.62 2.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.482 1.513 . . . . 0.0 109.928 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -174.26 152.46 1.81 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.612 0.765 . . . . 0.0 110.022 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -135.51 75.17 1.55 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.033 0.933 . . . . 0.0 108.653 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.94 157.48 20.13 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.89 0.476 . . . . 0.0 110.353 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.254 1.325 0 CA-C-O 117.437 -1.268 . . . . 0.0 109.436 -179.675 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.69 174.97 14.22 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 102.989 -2.967 . . . . 0.0 102.989 139.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.15 -70.22 2.82 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.768 1.175 . . . . 0.0 112.041 166.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -43.97 83.86 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 116.553 -1.689 . . . . 0.0 114.739 -173.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -57.5 -22.32 50.35 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.652 1.568 . . . . 0.0 113.206 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.75 46.55 1.82 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.684 1.594 . . . . 0.0 112.309 -167.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -29.73 70.38 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.692 -1.255 . . . . 0.0 112.018 168.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.06 157.14 54.19 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 126.436 1.894 . . . . 0.0 115.513 -163.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.59 164.64 30.16 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.015 2.477 . . . . 0.0 110.572 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.72 43.52 0.84 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.599 -0.688 . . . . 0.0 109.994 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.13 132.73 49.17 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.382 1.873 . . . . 0.0 110.578 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.85 43.62 1.05 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.953 1.701 . . . . 0.0 110.82 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -87.96 63.93 7.59 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.248 -1.533 . . . . 0.0 108.761 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -60.11 146.96 41.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.894 1.278 . . . . 0.0 113.344 -160.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 m -147.36 158.41 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.499 1.12 . . . . 0.0 111.819 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -91.55 136.51 33.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.666 0.786 . . . . 0.0 110.967 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.79 163.97 23.8 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 159.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.1 p -47.15 -32.61 4.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.109 2.164 . . . . 0.0 116.17 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.65 -7.27 25.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.844 1.658 . . . . 0.0 113.019 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.78 -9.67 50.58 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.359 0.98 . . . . 0.0 111.046 -158.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.7 96.5 0.28 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.133 2.573 . . . . 0.0 108.921 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -66.63 144.33 56.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 110.504 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -123.71 145.12 49.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.843 1.657 . . . . 0.0 107.389 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -62.69 -16.25 56.35 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.46 158.5 17.5 Favored Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 108.607 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.38 -15.77 31.17 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.785 1.657 . . . . 0.0 111.99 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -72.82 -40.23 65.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.0 ttp -61.87 -45.33 94.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.22 -63.55 1.12 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.991 174.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -34.44 74.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.226 -174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.9 t -50.31 -69.02 0.12 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 124.806 1.243 . . . . 0.0 108.616 169.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.09 -52.63 2.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.099 2.16 . . . . 0.0 111.884 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -49.13 -61.61 1.98 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.869 1.668 . . . . 0.0 110.586 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 123.957 0.786 . . . . 0.0 112.512 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -46.6 21.45 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.5 18.82 0.09 OUTLIER Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.312 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -133.48 65.45 71.94 Favored Pre-proline 0 C--O 1.223 -0.338 0 CA-C-N 119.932 1.866 . . . . 0.0 110.25 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -61.55 -20.07 67.22 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.482 1.565 . . . . 0.0 112.615 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -22.14 47.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.654 2.782 . . . . 0.0 113.774 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 6.9 tp -66.48 152.15 45.76 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -151.52 155.98 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.773 1.629 . . . . 0.0 108.801 174.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -73.79 84.3 1.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.8 -50.25 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 C-N-CA 122.944 0.498 . . . . 0.0 110.194 171.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -159.33 -174.32 4.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.231 1.813 . . . . 0.0 106.26 165.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HG2' ' H ' ' A' ' 46' ' ' GLY . 26.2 tt0 -71.35 -137.39 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.18 1.392 . . . . 0.0 107.4 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.484 ' H ' ' HG2' ' A' ' 45' ' ' GLU . . . 51.87 116.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 128.104 2.764 . . . . 0.0 117.881 158.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.76 127.61 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 CA-C-N 119.709 1.755 . . . . 0.0 112.376 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.6 m -73.26 -28.24 62.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.999 -0.524 . . . . 0.0 112.11 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.83 -79.95 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.35 1.86 . . . . 0.0 110.389 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.55 170.17 19.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.018 0.927 . . . . 0.0 109.47 171.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -120.27 78.61 1.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.182 2.193 . . . . 0.0 110.161 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.92 164.75 4.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.689 1.596 . . . . 0.0 111.965 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.05 41.57 1.19 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.378 1.071 . . . . 0.0 110.026 -168.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.08 -45.97 89.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.301 1.04 . . . . 0.0 112.071 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 116.859 -1.543 . . . . 0.0 108.888 165.619 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -176.62 -78.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.546 2.338 . . . . 0.0 105.72 159.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 50.48 3.79 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 127.234 2.349 . . . . 0.0 112.911 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -144.29 -53.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.585 1.954 . . . . 0.0 109.299 163.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.27 -29.94 91.62 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.377 2.051 . . . . 0.0 114.199 166.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.95 102.15 9.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.004 1.274 . . . . 0.0 112.889 -172.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -126.31 -0.0 7.02 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.106 1.362 . . . . 0.0 112.763 163.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -75.91 165.72 50.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -165.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.99 167.25 20.28 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.225 1.95 . . . . 0.0 110.728 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp85 -85.46 43.83 1.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.621 -0.675 . . . . 0.0 110.639 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.03 24.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.901 1.68 . . . . 0.0 110.304 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.35 43.48 1.02 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.538 1.535 . . . . 0.0 111.652 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -78.23 70.65 4.62 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 120.603 -1.31 . . . . 0.0 107.89 170.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -52.96 130.52 33.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.4 1.08 . . . . 0.0 111.308 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.74 162.93 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 123.455 0.702 . . . . 0.0 111.746 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.0 135.29 45.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 111.422 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.01 163.86 23.5 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 158.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.2 p -42.28 -36.49 1.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 -164.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.1 -1.47 14.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 112.757 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.81 82.7 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 119.145 0.884 . . . . 0.0 112.175 -159.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -67.73 90.47 0.28 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.967 2.507 . . . . 0.0 109.75 -171.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.4 m -65.89 144.15 56.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.368 0.667 . . . . 0.0 111.832 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.18 158.39 39.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.473 2.709 . . . . 0.0 108.282 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 t -61.33 -28.49 69.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.818 1.247 . . . . 0.0 113.926 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -163.82 161.9 16.85 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 125.931 1.692 . . . . 0.0 108.376 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.81 -16.63 23.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 120.968 1.112 . . . . 0.0 111.87 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -64.85 -45.93 84.01 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.565 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.3 mtp -58.15 -41.6 84.1 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.979 0.809 . . . . 0.0 112.57 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 1.7 tt -55.76 -67.2 0.31 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 109.095 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -33.78 71.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.595 -0.69 . . . . 0.0 111.485 -172.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.9 t -53.32 -70.93 0.08 Allowed 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.239 1.416 . . . . 0.0 107.679 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.51 0.82 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 126.606 1.963 . . . . 0.0 111.851 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -49.86 -63.96 0.95 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.851 1.261 . . . . 0.0 110.979 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -15.07 63.46 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.663 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.48 -59.62 2.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.42 28.25 0.26 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.47 -1.183 . . . . 0.0 114.146 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.02 66.56 79.35 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 119.5 1.65 . . . . 0.0 109.737 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.58 -19.4 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.817 1.327 . . . . 0.0 112.402 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.56 -25.77 50.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.794 2.838 . . . . 0.0 113.904 176.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.446 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.5 tp -66.52 154.54 40.08 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 m -150.95 154.65 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.737 1.215 . . . . 0.0 110.182 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -75.08 86.56 2.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.55 -53.87 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.777 0.831 . . . . 0.0 109.788 166.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 15.1 t60 -164.66 -175.24 3.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.198 1.799 . . . . 0.0 108.503 175.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.6 ' H ' ' CG ' ' A' ' 44' ' ' HIS . 12.0 tt0 -86.0 -175.05 5.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.132 1.373 . . . . 0.0 108.045 158.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 45' ' ' GLU . . . 75.91 142.34 1.12 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.425 1.012 . . . . 0.0 112.12 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -83.24 146.86 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.177 1.918 . . . . 0.0 111.1 -171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.5 m -86.41 -36.86 18.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 168.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.24 139.93 58.04 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.525 1.13 . . . . 0.0 109.938 167.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -153.77 129.93 10.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -152.62 -67.65 0.16 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -173.37 171.01 4.09 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.316 2.246 . . . . 0.0 106.854 168.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -106.48 69.77 0.8 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.7 1.2 . . . . 0.0 110.38 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -65.73 157.92 28.89 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.055 0.542 . . . . 0.0 110.24 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 116.486 -1.721 . . . . 0.0 107.549 176.005 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.23 -79.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.521 1.928 . . . . 0.0 106.614 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.16 -27.23 41.17 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.636 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -44.08 78.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 116.902 -1.523 . . . . 0.0 114.557 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -68.47 -50.14 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.058 1.838 . . . . 0.0 111.562 166.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -90.7 76.32 6.47 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.856 1.207 . . . . 0.0 111.188 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.65 102.76 6.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 159.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.71 165.81 6.96 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.308 1.443 . . . . 0.0 109.253 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.43 159.09 32.73 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.124 1.883 . . . . 0.0 110.7 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -78.42 43.32 0.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.55 0.74 . . . . 0.0 110.488 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.48 126.15 27.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.593 1.957 . . . . 0.0 110.943 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.95 43.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.602 1.561 . . . . 0.0 111.511 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -83.53 62.76 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.496 -1.377 . . . . 0.0 109.913 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -53.69 140.28 29.8 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -165.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -146.45 176.65 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 125.424 1.49 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.7 t -125.5 146.19 49.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.435 1.016 . . . . 0.0 111.705 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.18 163.6 23.21 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.029 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 84.5 p -53.24 -14.46 0.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.114 1.766 . . . . 0.0 114.482 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.79 -15.24 58.22 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.212 2.205 . . . . 0.0 112.14 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.43 -9.73 40.28 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 124.856 1.217 . . . . 0.0 111.358 -163.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.52 114.9 15.76 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.561 1.945 . . . . 0.0 110.151 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -65.64 143.84 57.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.957 0.799 . . . . 0.0 109.536 166.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -121.26 147.4 45.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.323 1.849 . . . . 0.0 106.87 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 m -60.61 -23.43 64.71 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.555 0.742 . . . . 0.0 112.501 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -163.59 161.09 17.7 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.958 2.103 . . . . 0.0 107.95 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.3 -14.64 34.61 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.973 1.782 . . . . 0.0 112.201 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.64 -40.11 84.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.864 0.466 . . . . 0.0 110.986 173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 89.5 mtp -65.06 -39.72 93.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.013 0.824 . . . . 0.0 111.551 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.41 -63.66 1.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.073 0.949 . . . . 0.0 110.043 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.33 -32.4 71.2 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.668 -175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -69.07 0.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.02 -52.89 1.39 Allowed 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 126.47 1.908 . . . . 0.0 111.657 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -50.06 -63.09 1.22 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.385 1.874 . . . . 0.0 110.29 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -66.83 -25.91 66.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.331 1.052 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -57.43 5.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.282 0.633 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.11 21.31 0.11 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.565 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -125.62 62.22 40.52 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 119.589 1.694 . . . . 0.0 109.382 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -61.16 -18.3 57.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 121.45 1.554 . . . . 0.0 113.141 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -23.36 42.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.329 2.652 . . . . 0.0 113.625 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 tp -66.39 152.4 45.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.0 m -156.08 161.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.341 2.256 . . . . 0.0 108.87 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -75.73 80.81 2.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.24 -41.01 49.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 124.99 1.316 . . . . 0.0 111.147 172.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.36 143.04 18.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -84.63 55.23 3.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.478 1.132 . . . . 0.0 108.761 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.67 158.41 31.35 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.247 2.356 . . . . 0.0 108.488 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -82.15 153.47 16.53 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.835 2.357 . . . . 0.0 113.375 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 60.6 m -86.57 -53.07 5.18 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.377 1.871 . . . . 0.0 108.88 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.1 138.76 40.99 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.833 2.053 . . . . 0.0 110.093 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -153.6 176.04 12.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.842 1.257 . . . . 0.0 108.768 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 159.09 -46.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 128.909 2.884 . . . . 0.0 106.757 -159.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -75.42 115.56 15.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.692 1.597 . . . . 0.0 109.562 -164.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -130.75 75.74 1.68 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.9 -33.52 74.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.238 1.015 . . . . 0.0 111.407 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.9 t80 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 127.873 2.469 . . . . 0.0 105.984 170.437 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.469 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.1 133.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 162.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.16 -36.75 1.1 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.061 0.839 . . . . 0.0 113.552 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -50.3 72.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.401 1.08 . . . . 0.0 109.767 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.14 -36.08 6.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.628 2.218 . . . . 0.0 113.875 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -108.32 95.15 5.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.547 1.067 . . . . 0.0 110.232 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -119.91 5.51 10.91 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.025 1.33 . . . . 0.0 111.051 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.92 165.85 20.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 0.0 114.325 -167.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.92 167.98 10.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mtt85 -74.67 44.33 0.21 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.137 1.375 . . . . 0.0 111.448 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.78 120.31 12.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.716 1.207 . . . . 0.0 110.173 164.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.44 43.81 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.119 2.167 . . . . 0.0 111.709 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -78.7 67.86 4.54 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.782 -1.198 . . . . 0.0 108.213 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -57.59 133.66 55.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.741 1.609 . . . . 0.0 110.483 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.34 167.86 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.364 1.066 . . . . 0.0 111.158 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -106.15 137.69 43.65 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.229 1.012 . . . . 0.0 111.592 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.99 163.97 23.57 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 159.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -45.83 -34.27 3.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -168.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -0.04 6.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.475 1.11 . . . . 0.0 112.384 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.82 1.52 90.6 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 111.666 -159.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.86 100.48 4.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.836 1.654 . . . . 0.0 110.584 -166.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -66.1 143.61 57.21 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.858 -0.526 . . . . 0.0 111.355 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -122.27 153.62 38.65 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.87 2.468 . . . . 0.0 108.641 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -63.12 -28.42 70.05 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.462 1.505 . . . . 0.0 113.178 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -163.58 158.87 17.48 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.071 1.748 . . . . 0.0 110.126 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.63 -20.07 31.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.247 1.298 . . . . 0.0 111.496 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -66.1 -43.94 85.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.943 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtm -62.58 -35.54 79.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.6 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 3.7 tt -60.42 -66.05 0.59 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.213 0.915 . . . . 0.0 109.495 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -56.11 -36.49 68.25 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.337 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -68.93 0.13 Allowed 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.333 1.053 . . . . 0.0 108.945 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -37.94 -53.12 1.36 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.343 1.857 . . . . 0.0 110.784 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -51.54 -63.8 1.02 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.549 1.14 . . . . 0.0 110.523 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.36 -15.43 63.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.522 1.129 . . . . 0.0 112.742 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -78.27 -64.21 1.22 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.9 27.66 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.896 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -128.69 64.53 69.45 Favored Pre-proline 0 C--N 1.343 0.326 0 CA-C-N 119.141 1.471 . . . . 0.0 110.194 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -63.08 -16.65 55.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.97 1.382 . . . . 0.0 112.777 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.35 -25.99 42.16 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.179 2.192 . . . . 0.0 113.228 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.32 153.85 41.55 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -151.11 147.29 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.258 1.423 . . . . 0.0 107.72 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -76.9 86.2 3.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.92 -53.65 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.936 0.894 . . . . 0.0 110.401 168.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.65 177.21 5.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.274 1.43 . . . . 0.0 109.721 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 178.26 7.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.923 1.689 . . . . 0.0 107.713 166.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.76 142.03 1.05 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 119.039 0.836 . . . . 0.0 112.972 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -80.82 147.4 17.05 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.923 1.749 . . . . 0.0 111.119 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 m -85.59 -56.89 3.29 Favored 'General case' 0 CA--C 1.523 -0.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.021 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -61.49 145.96 50.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -78.51 163.55 25.47 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.327 0.584 . . . . 0.0 109.662 -171.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -92.77 98.61 11.51 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -59.82 163.36 4.55 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.81 0.814 . . . . 0.0 110.892 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -106.06 56.95 0.66 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.03 1.732 . . . . 0.0 109.83 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.72 -29.39 70.38 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 116.69 -1.624 . . . . 0.0 110.457 177.465 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -176.52 -71.08 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.311 1.844 . . . . 0.0 107.605 167.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.64 67.75 3.63 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.101 1.81 . . . . 0.0 110.727 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.6 -52.18 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.41 2.284 . . . . 0.0 107.556 169.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.77 -43.0 5.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.17 2.58 . . . . 0.0 114.521 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.11 93.59 5.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.809 1.64 . . . . 0.0 112.389 -169.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.11 2.43 9.83 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.063 1.745 . . . . 0.0 113.315 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.93 170.94 9.43 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -162.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.61 167.21 11.71 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.417 2.745 . . . . 0.0 111.474 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.43 45.73 0.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.388 -0.82 . . . . 0.0 111.24 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 119.5 9.9 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 165.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.06 42.94 0.27 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.018 2.527 . . . . 0.0 112.217 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.08 63.53 5.12 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.489 -1.382 . . . . 0.0 108.758 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.3 140.08 54.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.738 1.215 . . . . 0.0 113.419 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.2 160.19 13.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.84 135.25 35.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.702 1.601 . . . . 0.0 110.798 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.65 164.72 24.29 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 159.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 88.5 p -43.96 -38.26 3.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -169.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -0.24 7.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.671 1.188 . . . . 0.0 113.119 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.97 -5.36 85.31 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.821 0.737 . . . . 0.0 111.576 -165.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -71.7 99.98 2.24 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.599 2.359 . . . . 0.0 110.287 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.471 ' HG1' ' HB3' ' A' ' 49' ' ' ASP . 19.6 m -67.06 145.61 55.18 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.745 -0.597 . . . . 0.0 112.284 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -126.42 158.56 35.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.159 2.184 . . . . 0.0 108.876 171.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -62.75 -29.17 70.49 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.311 1.844 . . . . 0.0 114.178 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -163.71 155.02 14.25 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 109.148 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.33 -17.91 34.69 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.634 2.223 . . . . 0.0 110.736 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.1 t -62.61 -46.33 88.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.026 0.93 . . . . 0.0 110.06 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mtm -66.16 -31.81 72.87 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.233 -0.889 . . . . 0.0 112.823 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -60.98 -63.89 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.74 1.155 . . . . 0.0 109.72 171.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.86 -35.44 72.95 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.278 -176.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.13 -66.56 0.37 Allowed 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.53 -53.54 1.57 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 127.188 2.195 . . . . 0.0 110.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 43.4 tttm -50.85 -62.47 1.59 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.835 1.254 . . . . 0.0 109.746 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -18.82 65.41 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.379 1.049 . . . . 0.0 113.168 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -56.76 4.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 18.58 0.1 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.171 -1.35 . . . . 0.0 114.219 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.99 61.99 10.19 Favored Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.816 1.808 . . . . 0.0 108.515 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.98 -21.57 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 121.61 1.611 . . . . 0.0 112.847 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -29.67 67.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.338 2.255 . . . . 0.0 113.448 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.448 ' O ' ' HE2' ' A' ' 33' ' ' LYS . 7.1 tp -66.14 157.27 31.67 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.6 m -150.96 149.35 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 106.789 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -72.88 89.2 1.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -54.53 20.31 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 C-N-CA 124.58 1.152 . . . . 0.0 110.517 168.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.8 t60 174.97 170.87 0.27 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.357 2.663 . . . . 0.0 105.84 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -168.5 2.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.011 0.924 . . . . 0.0 109.077 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.83 131.74 2.04 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.1 128.09 8.85 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.929 1.865 . . . . 0.0 111.209 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 m -78.35 -56.71 4.23 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.188 0.449 . . . . 0.0 110.624 175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HB3' ' HG1' ' A' ' 22' ' ' THR . 4.0 t70 -72.23 169.79 15.42 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.378 1.471 . . . . 0.0 111.292 177.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.41 133.42 44.88 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 123.141 1.448 . . . . 0.0 112.808 -159.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -89.57 -62.6 1.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.579 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.13 59.74 0.54 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.164 2.586 . . . . 0.0 111.492 -167.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -71.67 68.15 0.59 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.599 2.359 . . . . 0.0 110.28 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -76.79 -28.72 55.74 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.924 1.689 . . . . 0.0 112.166 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.585 1.954 . . . . 0.0 107.544 170.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -166.5 159.2 14.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 145.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.55 -50.11 2.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.813 1.197 . . . . 0.0 115.341 162.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -63.77 -43.73 77.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.251 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.58 -61.92 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 CA-C-N 121.244 1.48 . . . . 0.0 110.384 159.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.3 m -92.36 74.07 5.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -158.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 130.31 25.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 158.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.95 167.21 0.77 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.207 1.803 . . . . 0.0 109.355 -174.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.1 156.73 51.48 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.018 1.145 . . . . 0.0 110.065 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -82.9 43.17 0.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.44 123.86 21.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.477 2.311 . . . . 0.0 109.886 166.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.73 54.03 2.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.443 1.897 . . . . 0.0 111.561 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -72.29 81.8 1.02 Allowed 'General case' 0 C--O 1.223 -0.311 0 O-C-N 120.726 -1.233 . . . . 0.0 107.877 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -65.98 86.22 0.09 Allowed 'General case' 0 C--O 1.221 -0.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.365 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.47 154.05 3.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 126.364 1.865 . . . . 0.0 114.123 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.7 t -86.11 127.66 34.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.65 -0.656 . . . . 0.0 109.371 167.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.5 163.19 26.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 158.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.3 p -33.79 -51.66 0.4 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.116 2.567 . . . . 0.0 117.399 -167.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 27.54 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 126.34 1.856 . . . . 0.0 110.945 -166.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.08 -1.4 8.56 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.547 1.546 . . . . 0.0 112.759 -165.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.55 89.2 2.18 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 129.885 3.274 . . . . 0.0 108.048 -166.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -65.87 143.71 57.27 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.713 -0.617 . . . . 0.0 109.55 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.77 151.96 47.53 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 127.121 2.168 . . . . 0.0 109.096 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -65.53 -18.68 65.51 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.706 1.603 . . . . 0.0 114.736 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -164.26 154.81 13.09 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 125.914 1.686 . . . . 0.0 109.597 166.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.93 -20.63 38.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.108 1.872 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.4 t -60.0 -58.2 9.57 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.172 168.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.5 mmm -61.12 -34.01 74.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.09 1.314 . . . . 0.0 112.928 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.413 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -54.76 -65.09 0.64 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.178 0.899 . . . . 0.0 109.242 166.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -28.08 69.68 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.991 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -63.23 1.37 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -42.93 -52.87 4.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.956 2.102 . . . . 0.0 111.62 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -48.42 -62.13 1.65 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.166 1.786 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -72.28 -16.43 61.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.489 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -67.89 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 171.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.11 22.86 0.68 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.288 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -129.3 56.87 26.44 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.208 1.504 . . . . 0.0 109.167 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -58.95 -21.6 58.91 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 CA-C-N 122.587 1.96 . . . . 0.0 113.012 -171.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.13 -34.15 77.4 Favored 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.001 4.12 . . . . 0.0 114.657 173.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.413 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 7.4 tp -65.63 153.84 40.49 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 125.437 1.495 . . . . 0.0 107.914 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.62 151.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 124.863 1.265 . . . . 0.0 109.212 169.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.67 85.83 3.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -34.98 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.395 1.478 . . . . 0.0 110.456 172.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 179.67 170.24 1.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.734 2.414 . . . . 0.0 107.319 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.72 177.5 7.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 158.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.08 139.67 0.88 Allowed Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.728 1.156 . . . . 0.0 111.68 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -85.52 152.57 10.39 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.555 2.837 . . . . 0.0 112.478 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 62.4 m -85.93 -32.21 21.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 166.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -66.43 165.6 14.01 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.341 1.456 . . . . 0.0 109.765 164.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -153.82 3.42 0.27 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.816 1.646 . . . . 0.0 110.604 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -79.17 -22.59 44.79 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.536 -1.353 . . . . 0.0 112.804 -173.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.23 133.53 41.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 112.228 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.73 55.66 0.9 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.373 1.869 . . . . 0.0 107.823 164.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -85.06 172.5 11.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.119 0.568 . . . . 0.0 110.166 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.864 1.665 . . . . 0.0 111.49 177.836 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -72.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.17 1.788 . . . . 0.0 107.446 160.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.84 51.82 4.36 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.872 2.177 . . . . 0.0 111.98 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.35 -53.49 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 127.102 2.161 . . . . 0.0 107.784 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.87 -42.32 46.31 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.125 1.217 . . . . 0.0 112.11 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.0 m -101.53 99.91 10.28 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.586 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.62 78.36 1.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 159.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -156.33 166.4 16.56 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.433 1.093 . . . . 0.0 110.79 -165.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.71 161.73 24.53 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.914 2.41 . . . . 0.0 112.212 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -75.06 44.47 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.923 1.289 . . . . 0.0 111.046 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 131.28 46.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.531 1.132 . . . . 0.0 110.643 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -85.98 43.07 1.02 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.997 2.119 . . . . 0.0 110.329 167.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -92.52 61.7 3.78 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.719 -1.238 . . . . 0.0 107.749 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -58.58 142.5 49.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -159.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.71 168.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.023 0.929 . . . . 0.0 112.186 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 t -114.12 136.51 52.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.13 163.34 22.09 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 158.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -52.87 -27.36 18.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -164.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -13.7 59.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.185 0.994 . . . . 0.0 112.216 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.76 -3.17 65.03 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -159.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.89 87.54 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.941 2.896 . . . . 0.0 107.846 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -66.53 143.5 57.02 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -125.1 155.7 39.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.212 2.205 . . . . 0.0 107.692 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 t -58.15 -29.6 65.7 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.866 0.866 . . . . 0.0 112.307 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -163.9 160.41 17.06 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.247 1.419 . . . . 0.0 108.509 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.84 -18.92 36.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.314 2.01 . . . . 0.0 111.632 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -67.54 -45.82 74.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.711 0.404 . . . . 0.0 110.524 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.4 mtp -62.66 -37.36 86.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.03 0.832 . . . . 0.0 111.573 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.478 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 4.0 tt -60.08 -66.62 0.49 Allowed 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.616 0.766 . . . . 0.0 109.879 170.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -32.68 66.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.852 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.68 -70.47 0.11 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.86 -52.94 0.94 Allowed 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 126.531 1.933 . . . . 0.0 111.993 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -48.69 -64.21 0.87 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.466 1.507 . . . . 0.0 110.7 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.99 -26.64 68.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.266 0.979 . . . . 0.0 112.338 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -59.7 2.73 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.11 21.27 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.524 -1.154 . . . . 0.0 113.946 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -130.16 54.09 13.56 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 119.434 1.617 . . . . 0.0 109.537 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -59.4 -22.34 65.39 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 CA-C-N 122.933 2.083 . . . . 0.0 113.074 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.3 -30.45 71.5 Favored 'General case' 0 CA--C 1.534 0.336 1 C-N-CA 132.616 4.366 . . . . 0.0 115.313 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.478 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 1.5 tp -65.37 158.8 25.6 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.838 1.255 . . . . 0.0 107.888 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.3 m -153.63 155.7 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.591 1.956 . . . . 0.0 108.072 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -75.81 88.07 2.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 164.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -48.86 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 122.583 0.353 . . . . 0.0 110.211 169.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.04 155.63 23.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.334 1.053 . . . . 0.0 108.223 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 170.32 15.71 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.94 156.2 0.07 OUTLIER Glycine 0 CA--C 1.544 1.847 0 O-C-N 121.006 -1.059 . . . . 0.0 112.13 -162.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -91.05 164.96 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 CA-C-N 119.263 1.532 . . . . 0.0 113.592 -164.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.9 m -85.79 -53.98 4.8 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.432 0.693 . . . . 0.0 109.169 167.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.28 134.25 44.16 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 123.112 0.565 . . . . 0.0 110.06 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -153.72 34.73 0.44 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.234 1.413 . . . . 0.0 107.263 166.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -129.47 92.44 3.35 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.843 1.257 . . . . 0.0 109.669 -165.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -173.16 167.73 4.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.602 2.361 . . . . 0.0 107.395 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -158.13 101.17 1.74 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -93.72 160.84 14.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.358 1.463 . . . . 0.0 110.794 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.251 1.174 0 C-N-CA 125.216 1.406 . . . . 0.0 111.594 -179.06 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -170.91 134.55 0.99 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.44 -41.39 1.15 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 115.849 1.1 . . . . 0.0 115.849 164.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.6 -47.04 83.42 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 119.701 1.75 . . . . 0.0 110.46 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -55.42 -43.27 59.92 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.321 2.014 . . . . 0.0 113.065 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -105.38 66.1 0.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.765 1.226 . . . . 0.0 111.992 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.14 -0.04 30.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.641 0.776 . . . . 0.0 112.061 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.04 165.3 17.26 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -159.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.45 164.18 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.908 2.405 . . . . 0.0 111.173 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -81.61 43.38 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.582 -0.699 . . . . 0.0 110.104 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.84 124.9 24.23 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.459 1.904 . . . . 0.0 110.846 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.92 43.55 0.93 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.419 1.088 . . . . 0.0 109.791 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.62 60.69 6.25 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.833 -1.167 . . . . 0.0 109.104 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.6 mmm-85 -53.07 140.2 26.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.247 1.819 . . . . 0.0 112.735 -162.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.99 156.63 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 123.898 0.879 . . . . 0.0 111.498 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.9 t -94.47 141.82 28.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.002 0.364 . . . . 0.0 110.774 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.88 166.29 24.81 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 160.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 96.0 p -49.65 -19.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -85.63 -8.32 58.31 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.323 1.42 . . . . 0.0 111.986 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.27 -9.65 69.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.06 -1.025 . . . . 0.0 110.85 -160.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -64.91 92.97 0.1 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 128.336 2.654 . . . . 0.0 110.934 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -66.06 144.06 56.95 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.549 0.74 . . . . 0.0 110.366 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -122.84 157.69 31.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.811 2.844 . . . . 0.0 108.625 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 m -62.64 -30.8 71.63 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.53 1.532 . . . . 0.0 113.909 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -163.81 163.46 15.88 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 127.497 2.319 . . . . 0.0 107.301 174.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.67 -16.36 30.13 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.31 1.34 . . . . 0.0 112.014 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -67.55 -46.84 71.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.654 170.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 mmm -59.43 -39.75 84.53 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.599 1.09 . . . . 0.0 111.024 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 2.1 tt -56.71 -69.44 0.15 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.994 0.918 . . . . 0.0 109.42 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -30.92 68.22 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.095 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -70.74 0.09 Allowed 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.3 -53.05 2.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.407 1.883 . . . . 0.0 112.191 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -46.64 -61.47 1.81 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.819 1.247 . . . . 0.0 110.716 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -21.18 64.6 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -79.74 -31.12 41.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.541 1.064 . . . . 0.0 110.721 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.73 21.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.993 -1.449 . . . . 0.0 114.824 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.7 64.77 70.38 Favored Pre-proline 0 C--O 1.224 -0.267 0 CA-C-N 120.004 1.902 . . . . 0.0 110.055 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.71 -17.49 59.24 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.222 1.472 . . . . 0.0 112.961 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.58 -26.26 41.36 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.935 2.494 . . . . 0.0 113.308 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 4.7 tp -66.37 152.01 45.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 m -150.06 153.22 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.391 0.676 . . . . 0.0 109.831 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -74.53 85.76 2.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -56.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.441 1.097 . . . . 0.0 110.62 164.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.76 -171.47 2.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.837 2.455 . . . . 0.0 106.426 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.74 -137.8 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.792 2.037 . . . . 0.0 107.194 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.98 122.76 0.01 OUTLIER Glycine 0 CA--C 1.543 1.788 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.55 144.0 35.25 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 119.992 1.896 . . . . 0.0 111.706 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 33.3 m -86.03 -31.94 21.72 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.652 0.381 . . . . 0.0 110.106 172.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.34 148.64 37.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.95 1.3 . . . . 0.0 112.478 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -156.46 95.43 1.57 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -163.8 117.92 1.53 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.99 155.4 16.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.845 0.831 . . . . 0.0 111.265 171.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -151.62 51.58 0.82 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -172.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -57.95 -63.66 1.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.99 1.716 . . . . 0.0 110.403 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 117.322 -1.323 . . . . 0.0 109.237 172.5 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.19 0.519 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -157.79 160.22 37.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 140.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.06 -50.99 2.76 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.43 1.014 . . . . 0.0 113.918 167.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -63.56 -45.34 83.06 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.109 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -57.21 -61.36 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.758 1.639 . . . . 0.0 111.099 166.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.45 59.1 5.32 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.402 -0.811 . . . . 0.0 112.122 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.88 -11.16 59.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.078 -0.389 . . . . 0.0 111.706 166.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.1 164.66 55.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.886 1.674 . . . . 0.0 113.928 -171.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.97 164.36 13.57 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.893 2.395 . . . . 0.0 111.727 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -79.59 43.9 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.499 1.12 . . . . 0.0 111.162 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.11 129.06 38.51 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.738 1.615 . . . . 0.0 110.332 170.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.95 43.84 1.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.481 1.513 . . . . 0.0 111.755 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.7 64.85 6.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.757 -1.214 . . . . 0.0 109.175 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -57.46 142.75 43.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -160.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.66 169.88 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 117.68 -1.152 . . . . 0.0 111.63 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -118.57 137.04 53.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.611 1.096 . . . . 0.0 111.907 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.26 164.72 28.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.2 p -36.21 -41.04 0.25 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.535 2.734 . . . . 0.0 115.929 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.67 -1.91 3.14 Favored 'General case' 0 N--CA 1.436 -1.165 1 C-N-CA 135.019 5.328 . . . . 0.0 111.939 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.91 -8.37 11.85 Favored Glycine 0 CA--C 1.539 1.559 0 CA-C-N 119.391 0.996 . . . . 0.0 112.025 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.47 95.89 0.23 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 130.487 3.515 . . . . 0.0 109.335 -170.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.2 m -66.45 143.7 56.95 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.072 0.463 . . . . 0.0 110.404 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -119.86 157.57 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 128.113 2.565 . . . . 0.0 107.512 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 m -59.16 -31.79 69.3 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.745 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -163.73 160.42 17.4 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 125.338 1.455 . . . . 0.0 108.779 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.01 -15.19 32.44 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.705 1.603 . . . . 0.0 111.399 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.33 -40.04 64.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 123.233 0.613 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.7 ttp -65.01 -44.84 87.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -54.77 -63.5 1.13 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.125 174.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.13 -31.51 70.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.994 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -68.48 0.18 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.68 -53.11 3.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 127.524 2.33 . . . . 0.0 111.856 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -45.37 -61.27 1.74 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.355 1.462 . . . . 0.0 110.722 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -66.01 -27.94 68.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 112.545 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.76 -26.22 40.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.211 0.204 . . . . 0.0 111.33 -173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 17.87 0.02 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.296 -1.28 . . . . 0.0 115.066 -177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -131.7 54.38 14.15 Favored Pre-proline 0 C--O 1.22 -0.456 0 CA-C-N 119.557 1.678 . . . . 0.0 109.099 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.2 -23.1 60.19 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 CA-C-N 122.545 1.945 . . . . 0.0 112.859 -170.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.24 -32.66 74.33 Favored 'General case' 0 CA--C 1.533 0.316 1 C-N-CA 132.882 4.473 . . . . 0.0 114.922 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 1.8 tp -65.37 157.79 28.32 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.959 1.303 . . . . 0.0 107.674 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -152.8 146.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 128.339 2.656 . . . . 0.0 107.676 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.97 83.69 5.84 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 m -53.64 -40.56 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.641 1.577 . . . . 0.0 109.625 -176.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -155.98 162.51 40.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 159.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.78 -179.74 5.58 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 163.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.11 149.22 0.09 OUTLIER Glycine 0 CA--C 1.544 1.874 0 O-C-N 120.796 -1.19 . . . . 0.0 112.534 -161.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.65 152.56 17.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.125 1.883 . . . . 0.0 111.7 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.1 m -86.64 -74.86 0.41 Allowed 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.716 0.769 . . . . 0.0 109.048 169.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -173.89 -175.72 1.1 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.722 2.809 . . . . 0.0 107.291 -162.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 163.43 -43.56 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.688 2.395 . . . . 0.0 111.492 158.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -127.19 111.22 13.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -53.96 127.01 24.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.757 1.623 . . . . 0.0 110.216 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -106.91 30.33 6.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.419 1.888 . . . . 0.0 111.77 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -69.88 162.51 27.82 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.888 0.875 . . . . 0.0 111.337 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.3 t80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.864 -1.541 . . . . 0.0 109.867 -175.121 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -163.29 165.4 24.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 153.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.58 9.86 82.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.243 0.925 . . . . 0.0 115.246 158.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.445 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.29 -44.02 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 126.961 2.104 . . . . 0.0 112.64 172.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 8.4 Cg_endo -56.43 -50.69 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.73 2.287 . . . . 0.0 112.457 163.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -95.23 107.99 20.11 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.74 0.816 . . . . 0.0 110.286 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -140.92 52.93 1.59 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.071 1.348 . . . . 0.0 108.071 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -144.77 163.43 33.51 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -161.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.57 166.84 13.59 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.255 2.637 . . . . 0.0 111.813 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -83.15 46.1 1.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.928 0.891 . . . . 0.0 109.734 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.88 123.08 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.117 0.967 . . . . 0.0 109.203 168.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.03 43.09 0.5 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.129 1.772 . . . . 0.0 111.975 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -78.6 76.71 5.1 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 169.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -61.59 141.3 57.86 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.686 -1.259 . . . . 0.0 110.957 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -150.18 164.98 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 124.71 1.204 . . . . 0.0 110.884 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -108.94 135.76 49.59 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.3 163.6 23.08 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 158.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.5 p -43.87 -39.1 3.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -165.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.15 2.09 5.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.489 1.041 . . . . 0.0 112.969 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.09 5.68 80.03 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 120.919 -1.113 . . . . 0.0 111.523 -161.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -71.79 90.21 1.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.119 2.968 . . . . 0.0 109.831 -169.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -65.92 143.89 57.13 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.076 0.853 . . . . 0.0 110.781 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.02 154.01 41.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 127.6 2.36 . . . . 0.0 107.831 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 p -66.06 -24.21 66.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.915 1.686 . . . . 0.0 114.106 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 14.3 p30 -164.01 156.31 14.88 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 126.714 2.006 . . . . 0.0 109.748 170.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.74 -17.03 37.9 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.939 1.759 . . . . 0.0 111.57 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.9 t -66.19 -48.19 71.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.518 168.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.8 mmm -58.09 -39.77 79.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.312 0.96 . . . . 0.0 111.565 175.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 2.7 tt -57.39 -67.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.124 0.97 . . . . 0.0 109.783 171.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 t -60.01 -29.28 68.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.987 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -71.36 0.11 Allowed 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.91 -52.99 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.409 1.884 . . . . 0.0 111.932 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 42.9 tttm -48.08 -64.16 0.87 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.818 1.247 . . . . 0.0 110.893 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -65.55 -20.17 66.22 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 124.005 0.815 . . . . 0.0 112.763 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -74.63 -62.69 1.44 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.54 0.3 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.822 -174.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -128.69 63.08 64.05 Favored Pre-proline 0 C--O 1.221 -0.409 0 CA-C-N 119.193 1.497 . . . . 0.0 109.604 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.11 -19.08 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.206 1.466 . . . . 0.0 112.744 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.67 -22.82 43.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.202 2.601 . . . . 0.0 113.557 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 6.0 tp -66.52 153.91 41.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -150.9 152.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.174 1.39 . . . . 0.0 108.59 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -75.34 83.9 2.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 166.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.52 -54.45 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.69 168.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.23 -170.44 2.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.809 2.043 . . . . 0.0 107.502 174.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -137.3 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.06 1.744 . . . . 0.0 106.881 167.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.32 118.25 0.01 OUTLIER Glycine 0 CA--C 1.539 1.57 0 C-N-CA 127.555 2.502 . . . . 0.0 118.664 158.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.7 137.65 30.41 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.189 1.926 . . . . 0.0 111.908 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.0 m -85.92 -64.74 1.1 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.75 131.08 47.7 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.636 0.774 . . . . 0.0 111.247 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -153.73 159.52 42.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.773 2.029 . . . . 0.0 108.11 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -163.85 -30.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.336 1.454 . . . . 0.0 109.521 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -54.01 147.38 12.62 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 129.664 3.186 . . . . 0.0 112.125 163.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.21 44.18 0.42 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.304 1.841 . . . . 0.0 109.376 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -70.78 165.88 22.16 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.777 -0.577 . . . . 0.0 110.171 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.0 p90 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.815 -173.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 p90 . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 122.233 1.016 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -169.0 162.57 11.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 143.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.92 -64.65 1.92 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.56 1.552 . . . . 0.0 112.087 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.33 80.57 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-O 116.364 -1.779 . . . . 0.0 115.108 -172.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -50.0 -26.61 14.72 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 122.072 1.776 . . . . 0.0 113.35 168.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.6 m -105.01 22.01 16.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.127 1.771 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.85 73.66 0.1 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.47 1.108 . . . . 0.0 109.524 170.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.09 167.93 11.77 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.416 1.886 . . . . 0.0 109.905 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.8 157.33 24.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.598 2.199 . . . . 0.0 110.936 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -79.06 43.7 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.492 -0.755 . . . . 0.0 110.233 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.07 140.84 58.28 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.417 1.487 . . . . 0.0 110.786 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.61 43.82 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.898 1.679 . . . . 0.0 110.497 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -89.58 46.13 1.34 Allowed 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.332 -1.48 . . . . 0.0 110.509 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -49.01 145.78 3.8 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.575 1.95 . . . . 0.0 115.262 -164.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 m -148.53 174.31 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.237 1.415 . . . . 0.0 110.606 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -116.53 137.09 52.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 0.794 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.58 163.55 22.75 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.216 0.898 . . . . 0.0 112.059 161.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.9 p -54.64 -17.73 3.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 118.653 2.835 . . . . 0.0 118.653 -168.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -9.32 59.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.354 0.662 . . . . 0.0 111.724 171.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.7 -3.93 65.75 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.739 1.161 . . . . 0.0 111.043 -171.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.755 ' ND2' ' HH ' ' A' ' 23' ' ' TYR . 4.9 p30 -71.14 113.91 8.66 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 127.487 2.315 . . . . 0.0 109.902 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -66.15 144.77 56.45 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 122.207 -0.308 . . . . 0.0 110.424 167.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.755 ' HH ' ' ND2' ' A' ' 21' ' ' ASN . 64.1 m-85 -122.53 150.33 42.71 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.946 2.098 . . . . 0.0 107.156 173.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -60.64 -27.31 67.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.399 1.08 . . . . 0.0 113.498 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -163.79 163.43 15.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.673 2.389 . . . . 0.0 107.028 174.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.99 -17.1 32.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.042 1.161 . . . . 0.0 112.065 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 -40.32 93.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.487 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.4 mmm -66.15 -40.87 90.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.751 1.159 . . . . 0.0 111.86 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.456 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 2.3 tt -59.25 -65.24 0.7 Allowed 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.453 0.701 . . . . 0.0 109.163 171.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -31.5 70.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.797 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.9 t -52.77 -69.01 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.39 -53.06 3.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.516 1.526 . . . . 0.0 111.589 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -50.57 -63.71 1.04 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.034 1.734 . . . . 0.0 110.914 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -62.31 -26.75 68.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.814 1.646 . . . . 0.0 112.221 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -63.32 1.2 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.0 20.27 0.29 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.179 -1.345 . . . . 0.0 114.479 -173.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -124.95 63.84 41.45 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 119.859 1.83 . . . . 0.0 110.139 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.59 -16.06 45.67 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 CA-C-N 121.506 1.574 . . . . 0.0 113.392 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -22.97 33.73 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.28 2.632 . . . . 0.0 113.508 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.456 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.47 150.59 48.72 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 174.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.6 m -153.63 159.77 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.712 1.605 . . . . 0.0 108.784 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.44 82.07 1.44 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.72 -42.17 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -157.24 140.3 15.33 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.554 1.141 . . . . 0.0 108.627 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.12 37.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.111 1.365 . . . . 0.0 112.697 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.15 159.99 27.75 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.73 148.95 29.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.234 1.956 . . . . 0.0 111.632 -167.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m -86.14 -71.28 0.55 Allowed 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.273 1.029 . . . . 0.0 108.54 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -173.31 162.75 4.43 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 127.06 2.144 . . . . 0.0 107.967 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -170.35 155.46 5.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.881 2.472 . . . . 0.0 107.04 164.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -139.97 33.33 1.96 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -173.28 -175.26 1.14 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.836 2.455 . . . . 0.0 106.243 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -141.4 80.43 1.73 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 163.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -55.3 164.08 1.03 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.104 0.961 . . . . 0.0 110.465 164.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.9 p90 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.407 1.883 . . . . 0.0 107.827 -177.075 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -176.44 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.415 1.886 . . . . 0.0 108.319 151.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.8 61.96 3.97 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.66 2.076 . . . . 0.0 111.023 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.92 -54.93 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 126.964 2.106 . . . . 0.0 107.463 170.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.01 -49.97 7.13 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 120.337 1.156 . . . . 0.0 111.705 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -91.42 87.24 6.35 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.804 0.729 . . . . 0.0 109.242 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -141.2 48.59 1.67 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.584 1.154 . . . . 0.0 108.406 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.64 164.85 38.41 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -163.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -82.86 168.48 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.068 2.512 . . . . 0.0 112.169 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -85.15 44.31 1.08 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.01 0.924 . . . . 0.0 110.968 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.33 135.01 56.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 109.663 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.99 43.37 1.04 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.453 2.301 . . . . 0.0 114.131 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -78.45 82.25 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 120.709 -1.244 . . . . 0.0 107.649 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.48 120.05 9.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 119.569 -1.957 . . . . 0.0 107.588 172.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -138.36 155.29 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -107.64 136.81 46.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.782 0.719 . . . . 0.0 110.319 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.54 163.81 24.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.1 p -34.23 -41.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.131 2.972 . . . . 0.0 116.184 -172.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 0.04 5.16 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.436 4.694 . . . . 0.0 111.75 -172.39 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.38 -4.81 39.49 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.373 0.987 . . . . 0.0 111.65 -165.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -76.49 106.12 7.94 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 127.229 2.211 . . . . 0.0 110.632 -170.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -66.24 144.29 56.71 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.453 0.57 . . . . 0.0 111.302 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -124.28 152.06 43.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.772 2.429 . . . . 0.0 107.041 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.477 1.111 . . . . 0.0 113.838 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -163.91 156.52 15.27 Favored Pre-proline 0 C--N 1.343 0.303 0 C-N-CA 126.958 2.103 . . . . 0.0 109.331 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.45 -18.65 43.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.412 2.075 . . . . 0.0 111.274 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -66.46 -42.52 87.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.69 -0.672 . . . . 0.0 111.005 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 86.4 mtp -61.61 -41.6 97.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.549 1.068 . . . . 0.0 112.031 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.86 -64.93 0.71 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.73 171.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.39 -30.04 70.3 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.843 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.15 -69.63 0.13 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.18 -53.04 2.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.284 1.833 . . . . 0.0 111.053 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -48.06 -62.51 1.44 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.597 1.559 . . . . 0.0 110.632 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -18.14 63.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.227 -0.892 . . . . 0.0 112.799 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.97 -51.34 9.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.942 0.792 . . . . 0.0 108.885 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.9 22.51 0.11 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.153 -1.359 . . . . 0.0 114.641 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -129.57 61.3 56.91 Favored Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 120.015 1.908 . . . . 0.0 110.338 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.04 -24.64 66.82 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.814 1.676 . . . . 0.0 112.703 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.16 -30.44 68.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 131.163 3.785 . . . . 0.0 115.042 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 tp -66.33 155.27 37.76 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.3 m -153.76 153.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.067 1.747 . . . . 0.0 109.788 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -74.86 83.37 2.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 m -57.37 -38.27 61.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 122.775 0.43 . . . . 0.0 110.378 169.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -162.89 138.38 6.89 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.652 1.181 . . . . 0.0 109.502 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.18 68.25 10.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.452 1.024 . . . . 0.0 108.805 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.99 157.46 20.2 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.51 153.99 13.81 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.965 1.776 . . . . 0.0 112.76 -159.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m -86.58 -49.39 7.58 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.875 1.27 . . . . 0.0 107.761 167.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.12 83.63 2.96 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.994 2.118 . . . . 0.0 110.341 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -166.53 -177.4 3.96 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.048 2.139 . . . . 0.0 107.174 171.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -143.24 -40.18 0.31 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.93 0.787 . . . . 0.0 113.013 -175.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -173.76 173.39 3.32 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.207 2.203 . . . . 0.0 107.231 -167.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.38 54.35 1.84 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 160.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -143.43 124.0 14.04 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.375 -0.828 . . . . 0.0 110.202 -158.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.108 0 CA-C-O 116.678 -1.63 . . . . 0.0 109.677 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.93 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.669 2.388 . . . . 0.0 105.873 166.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.88 -26.49 68.99 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.277 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.3 -48.49 82.54 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 119.593 1.697 . . . . 0.0 111.072 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.67 -65.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.388 2.059 . . . . 0.0 113.09 161.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.8 m -88.64 74.65 8.39 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 112.639 -158.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.91 8.89 6.84 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.866 1.266 . . . . 0.0 112.528 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.44 164.63 59.62 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 120.844 -1.16 . . . . 0.0 113.089 -175.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 169.18 20.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.882 2.388 . . . . 0.0 111.95 -174.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -75.17 43.73 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.539 1.536 . . . . 0.0 111.04 171.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 114.01 4.96 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 124.888 1.275 . . . . 0.0 108.888 168.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.7 101.86 5.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -148.47 79.86 1.44 Allowed 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -59.43 132.15 53.11 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.391 -0.818 . . . . 0.0 110.004 -170.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.98 167.38 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 123.507 0.723 . . . . 0.0 111.527 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.8 t -115.55 134.29 55.21 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.132 0.973 . . . . 0.0 110.887 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.24 164.96 23.7 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.983 1.277 . . . . 0.0 110.631 164.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -41.54 -40.37 1.83 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -164.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.78 0.03 4.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.589 1.556 . . . . 0.0 112.799 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.13 -0.71 88.43 Favored Glycine 0 CA--C 1.541 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 112.073 -159.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.02 94.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.959 2.104 . . . . 0.0 110.174 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.9 m -66.19 143.59 57.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -130.96 153.65 48.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.464 3.106 . . . . 0.0 110.254 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 m -45.62 -40.15 8.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 130.67 3.588 . . . . 0.0 116.157 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -163.76 158.73 17.02 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.603 1.961 . . . . 0.0 108.941 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.54 -19.82 27.84 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.519 1.479 . . . . 0.0 111.674 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.65 -46.84 88.81 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -63.35 -32.56 74.02 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 1.1 tt -61.67 -61.1 2.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 119.382 0.992 . . . . 0.0 109.022 172.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -60.5 -32.91 71.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.815 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -62.06 2.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.83 -52.99 6.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.903 2.081 . . . . 0.0 111.556 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 41.5 tttm -50.18 -60.96 2.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.381 1.073 . . . . 0.0 109.762 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 -17.14 63.56 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 124.259 0.974 . . . . 0.0 112.512 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -79.54 -44.55 20.94 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.811 0.732 . . . . 0.0 110.532 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.33 17.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.105 -1.386 . . . . 0.0 114.121 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -120.4 63.71 10.14 Favored Pre-proline 0 C--O 1.22 -0.485 0 CA-C-N 119.797 1.799 . . . . 0.0 109.38 -177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -60.22 -22.44 70.42 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.122 1.881 . . . . 0.0 112.988 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.44 -26.12 55.12 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 128.122 2.569 . . . . 0.0 113.441 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.05 154.53 39.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m -150.8 148.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -75.13 85.25 2.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.19 -58.99 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.46 1.104 . . . . 0.0 109.893 167.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.38 -173.26 1.42 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.361 1.464 . . . . 0.0 109.243 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -177.15 6.32 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.968 2.107 . . . . 0.0 109.929 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.14 141.96 1.14 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 119.248 0.931 . . . . 0.0 113.909 171.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -82.88 145.9 12.8 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.113 1.876 . . . . 0.0 111.756 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m -86.48 -34.83 19.93 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 172.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.24 140.17 54.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -85.08 67.11 10.07 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.588 0.709 . . . . 0.0 109.776 -165.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -100.32 -84.87 0.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.247 1.419 . . . . 0.0 110.432 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.71 166.34 4.5 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 128.77 2.828 . . . . 0.0 105.524 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -147.05 65.73 1.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.543 0.737 . . . . 0.0 109.064 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -144.35 -171.54 3.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.019 2.128 . . . . 0.0 109.162 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--O 1.256 1.397 0 CA-C-O 116.854 -1.546 . . . . 0.0 110.863 -174.033 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -176.68 -65.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.122 0.969 . . . . 0.0 110.514 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.26 -14.62 44.33 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.766 2.127 . . . . 0.0 114.674 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -55.04 3.88 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.325 2.25 . . . . 0.0 110.925 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.29 -53.79 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.929 2.42 . . . . 0.0 110.724 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.5 m -87.65 124.38 33.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 120.34 1.427 . . . . 0.0 108.94 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.14 29.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.468 1.507 . . . . 0.0 110.922 -173.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 164.98 13.59 Favored Pre-proline 0 C--O 1.236 0.355 0 O-C-N 121.677 -0.639 . . . . 0.0 111.043 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.69 172.92 13.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.268 1.979 . . . . 0.0 109.688 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -78.12 46.32 0.59 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.96 1.304 . . . . 0.0 110.373 171.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.64 123.89 20.9 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.29 49.71 1.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.113 1.365 . . . . 0.0 109.638 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -80.18 58.96 3.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -48.06 122.92 5.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.852 1.205 . . . . 0.0 111.329 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.0 m -134.23 178.15 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 C-N-CA 124.571 1.148 . . . . 0.0 111.153 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.6 144.11 51.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.76 171.05 31.34 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.18 -24.58 11.16 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 175.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -84.24 0.08 50.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.419 1.888 . . . . 0.0 112.516 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -7.55 36.96 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.823 -1.173 . . . . 0.0 111.859 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.58 107.34 1.37 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.182 1.393 . . . . 0.0 107.447 -176.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -66.27 146.25 54.81 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -123.9 139.94 53.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.796 2.039 . . . . 0.0 106.488 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.6 t -45.45 -32.08 2.01 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.997 2.119 . . . . 0.0 112.206 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -163.56 154.7 14.2 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.555 2.342 . . . . 0.0 111.135 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -74.91 -24.4 13.05 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 111.159 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -28.01 69.26 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.023 -0.423 . . . . 0.0 112.049 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -36.03 60.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.76 170.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.405 ' HG ' ' CD1' ' A' ' 40' ' ' LEU . 8.8 tt -56.43 -67.34 0.31 Allowed 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -50.27 -37.33 35.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.556 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -71.78 0.06 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 175.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.9 -51.11 4.42 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.099 2.16 . . . . 0.0 110.872 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -66.29 0.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -15.17 60.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -67.31 0.61 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.751 0.82 . . . . 0.0 108.86 178.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.75 39.97 0.25 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 126.489 1.995 . . . . 0.0 110.162 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -138.08 59.78 20.11 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.888 1.344 . . . . 0.0 111.341 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.92 -8.66 14.31 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.047 1.831 . . . . 0.0 112.764 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -90.5 -24.52 20.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.011 2.125 . . . . 0.0 113.769 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.405 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 3.1 tp -66.4 150.32 49.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.6 m -149.2 152.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -78.24 83.63 4.49 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -57.12 -46.15 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.861 0.865 . . . . 0.0 111.534 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -164.47 157.01 16.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 125.177 1.391 . . . . 0.0 109.084 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -87.68 54.99 3.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.964 2.906 . . . . 0.0 110.54 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.73 150.13 21.61 Favored Glycine 0 C--O 1.226 -0.358 0 O-C-N 119.836 -1.79 . . . . 0.0 109.041 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.2 146.62 28.7 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.235 1.956 . . . . 0.0 111.599 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m -86.44 -65.55 1.0 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.714 1.206 . . . . 0.0 110.502 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.97 -76.86 0.06 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.679 1.592 . . . . 0.0 111.368 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.93 176.68 4.14 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.401 1.48 . . . . 0.0 110.255 173.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -152.25 76.73 1.18 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.22 154.99 3.97 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.781 0.8 . . . . 0.0 110.449 172.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.72 46.98 0.72 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.91 161.12 30.57 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.624 0.769 . . . . 0.0 110.577 172.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.9 p90 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 116.713 -1.613 . . . . 0.0 108.399 -178.411 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.455 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -176.13 133.75 0.25 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.14 -31.07 0.95 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.097 1.332 . . . . 0.0 114.701 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -67.08 -56.27 13.84 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.726 1.263 . . . . 0.0 111.024 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.23 -48.42 0.62 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.238 1.959 . . . . 0.0 112.299 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.04 125.41 41.46 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.469 0.708 . . . . 0.0 109.654 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 8' ' ' CYS . 1.8 mt-10 -154.47 -24.33 0.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.981 1.712 . . . . 0.0 110.93 172.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.407 ' H ' ' H ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -49.61 158.35 0.84 Allowed Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 125.972 1.709 . . . . 0.0 114.753 -179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.13 169.35 22.75 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 121.928 1.752 . . . . 0.0 111.179 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -80.29 43.65 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.075 0.95 . . . . 0.0 110.044 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.24 19.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.501 1.52 . . . . 0.0 109.247 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 42.79 0.33 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 111.08 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -84.93 63.26 7.98 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 121.149 -0.969 . . . . 0.0 108.698 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -55.77 134.9 51.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.108 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.34 -178.27 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 125.151 1.381 . . . . 0.0 111.516 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -125.21 137.34 54.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.512 1.125 . . . . 0.0 110.564 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.91 168.78 26.36 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 165.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.518 ' HA ' HG11 ' A' ' 43' ' ' VAL . 17.4 p -50.69 -31.3 15.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -171.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.02 0.0 5.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.25 66.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.359 0.981 . . . . 0.0 111.624 -163.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.09 110.82 9.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.337 1.455 . . . . 0.0 109.553 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -65.84 143.95 57.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.969 0.414 . . . . 0.0 110.366 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -119.4 145.39 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.368 2.267 . . . . 0.0 108.225 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -58.33 -29.22 65.77 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.344 1.057 . . . . 0.0 113.002 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 18.9 p30 -163.89 155.96 14.8 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 125.208 1.403 . . . . 0.0 109.78 173.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 68.6 Cg_endo -70.27 -16.37 35.4 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.486 2.124 . . . . 0.0 111.023 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.162 -0.336 . . . . 0.0 110.953 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.8 mtm -66.08 -31.73 72.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.656 172.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.918 ' HG ' HD11 ' A' ' 40' ' ' LEU . 7.7 tt -59.6 -68.26 0.3 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.397 0.998 . . . . 0.0 109.38 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -51.98 -39.27 59.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.824 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -68.49 0.17 Allowed 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.76 1.95 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 126.592 1.957 . . . . 0.0 110.506 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -51.04 -63.44 1.13 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.926 0.89 . . . . 0.0 110.647 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.6 -16.87 64.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.69 1.196 . . . . 0.0 112.727 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -77.87 -66.18 0.87 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.51 23.74 0.36 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.896 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -127.33 60.67 44.55 Favored Pre-proline 0 C--O 1.222 -0.392 0 CA-C-N 119.618 1.709 . . . . 0.0 109.835 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -61.23 -17.73 54.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.657 1.571 . . . . 0.0 113.166 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -26.36 45.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.399 2.28 . . . . 0.0 113.333 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.918 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.04 153.38 42.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.593 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.5 m -150.88 149.42 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -72.55 85.67 1.16 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -56.5 -47.16 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.563 0.745 . . . . 0.0 109.747 172.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 166.12 151.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.862 2.865 . . . . 0.0 106.957 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -68.34 -173.26 0.4 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.844 2.058 . . . . 0.0 111.388 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.71 142.1 0.79 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.08 143.68 18.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.225 1.513 . . . . 0.0 110.475 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 119.274 -0.394 . . . . 0.0 110.85 177.197 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.39 -89.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.269 1.028 . . . . 0.0 109.667 156.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.19 76.24 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.112 -0.993 . . . . 0.0 112.555 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -43.98 79.63 Favored Pre-proline 0 C--N 1.34 0.161 0 CA-C-O 117.217 -1.373 . . . . 0.0 114.378 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.83 -51.41 0.48 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.538 2.159 . . . . 0.0 111.928 159.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.42 70.16 8.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.027 1.285 . . . . 0.0 113.081 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -83.92 -14.09 51.87 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.38 162.42 61.22 Favored Pre-proline 0 C--O 1.236 0.373 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -158.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.83 165.47 28.52 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.934 2.423 . . . . 0.0 110.783 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.81 43.56 1.0 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.386 0.674 . . . . 0.0 109.381 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.33 122.56 17.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.124 1.77 . . . . 0.0 110.498 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.89 43.77 0.36 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.56 1.944 . . . . 0.0 111.246 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -92.36 58.01 3.13 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 120.5 -1.375 . . . . 0.0 108.751 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -53.65 147.42 11.39 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.345 1.858 . . . . 0.0 113.207 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -149.14 153.75 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.024 0.929 . . . . 0.0 111.751 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 t -86.44 133.88 33.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 110.473 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.16 164.15 23.46 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 158.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.1 p -51.28 -25.12 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -168.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 0.01 11.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 112.385 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.58 50.17 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.838 -1.163 . . . . 0.0 110.692 -158.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -66.71 96.99 0.43 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 131.347 3.859 . . . . 0.0 110.974 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -66.13 144.39 56.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.756 0.422 . . . . 0.0 111.344 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -123.81 153.3 41.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.776 2.03 . . . . 0.0 107.809 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -65.97 -21.56 66.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 10.8 p30 -163.76 159.99 17.3 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.215 1.806 . . . . 0.0 108.883 168.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 46.0 Cg_endo -66.75 -20.13 52.72 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.877 . . . . 0.0 110.996 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -68.89 -45.57 70.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.224 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -37.57 87.24 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.623 1.101 . . . . 0.0 111.311 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.9 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.1 tt -56.7 -66.74 0.39 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.222 1.009 . . . . 0.0 109.964 168.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -32.16 70.71 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.536 -0.727 . . . . 0.0 111.327 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.7 -68.5 0.18 Allowed 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.03 -52.85 1.82 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.052 1.741 . . . . 0.0 111.525 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 42.9 tttm -48.18 -61.75 1.83 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.193 1.397 . . . . 0.0 110.544 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -67.92 -21.16 65.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -48.9 16.18 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.74 25.4 0.1 OUTLIER Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.234 -1.315 . . . . 0.0 114.887 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -130.35 63.65 70.05 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 120.014 1.907 . . . . 0.0 109.789 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -61.33 -19.99 66.36 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.446 1.552 . . . . 0.0 112.664 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -23.92 46.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.513 2.725 . . . . 0.0 113.494 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -66.49 154.67 39.69 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.647 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.8 m -150.66 150.6 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 124.901 1.28 . . . . 0.0 108.753 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -71.77 84.88 0.92 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.41 -53.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.303 0.641 . . . . 0.0 110.112 166.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -169.98 175.63 5.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.224 1.809 . . . . 0.0 110.148 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.21 171.93 10.28 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.88 2.472 . . . . 0.0 108.239 164.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.5 138.43 0.85 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 127.373 2.416 . . . . 0.0 112.216 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.18 142.42 21.58 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 110.834 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.123 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 p90 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -176.7 -86.56 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.709 2.003 . . . . 0.0 107.597 141.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.22 -15.82 80.5 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.19 0.9 . . . . 0.0 113.637 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -50.02 65.79 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 119.317 1.558 . . . . 0.0 111.923 171.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -60.7 -51.89 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.291 1.327 . . . . 0.0 112.261 160.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.1 m -89.29 71.7 8.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.473 1.033 . . . . 0.0 112.323 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -116.85 84.15 2.09 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.11 165.24 19.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 123.282 0.633 . . . . 0.0 111.307 -172.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 165.07 20.73 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.251 2.634 . . . . 0.0 111.357 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.55 43.3 0.47 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.878 0.871 . . . . 0.0 111.067 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.0 128.32 35.59 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.899 1.279 . . . . 0.0 111.066 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.03 43.26 1.04 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.648 1.579 . . . . 0.0 110.674 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.454 ' O ' HG13 ' A' ' 15' ' ' VAL . 11.5 m170 -83.42 64.59 7.92 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 120.597 -1.314 . . . . 0.0 107.975 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -55.84 134.74 52.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.699 1.136 . . . . 0.0 111.721 -167.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 13' ' ' HIS . 14.1 m -135.68 169.68 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 110.443 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -123.9 143.17 50.53 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.4 1.0 . . . . 0.0 110.933 175.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.18 166.5 28.46 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.573 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.1 p -34.35 -40.86 0.1 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.278 2.631 . . . . 0.0 115.562 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.85 0.05 10.05 Favored 'General case' 0 N--CA 1.436 -1.16 1 C-N-CA 132.919 4.487 . . . . 0.0 111.654 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.2 -4.32 33.42 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.969 0.804 . . . . 0.0 112.086 -166.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.76 102.96 4.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.98 2.512 . . . . 0.0 110.163 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -66.37 143.56 57.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.219 0.463 . . . . 0.0 111.54 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -123.93 155.95 37.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.117 2.967 . . . . 0.0 108.499 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.1 t -63.88 -28.79 70.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -163.87 160.65 17.14 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.918 1.687 . . . . 0.0 107.637 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.37 -14.9 28.2 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 120.744 0.963 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.01 -44.68 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 118.101 0.409 . . . . 0.0 110.596 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mmm -59.0 -46.36 88.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.009 0.924 . . . . 0.0 110.515 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.78 -62.22 1.84 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.111 1.365 . . . . 0.0 110.876 173.211 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -35.56 77.18 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.713 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.38 -68.32 0.18 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 171.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.81 -52.75 1.72 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.872 2.069 . . . . 0.0 112.104 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 42.2 tttm -48.53 -59.11 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.731 1.612 . . . . 0.0 110.323 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -71.0 -23.97 62.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.576 0.75 . . . . 0.0 112.64 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -75.88 -38.65 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.514 0.726 . . . . 0.0 110.718 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.2 18.91 0.03 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.057 -1.413 . . . . 0.0 115.488 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 16.4 t-20 -128.79 62.42 61.1 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 120.327 2.063 . . . . 0.0 110.073 -176.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.23 -25.34 71.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.979 1.786 . . . . 0.0 112.786 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.06 -32.66 74.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 131.273 3.829 . . . . 0.0 114.304 175.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.661 HD12 ' H ' ' A' ' 41' ' ' VAL . 3.8 tp -66.2 157.54 31.13 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 109.183 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.661 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.4 m -152.47 149.79 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 126.516 1.926 . . . . 0.0 109.74 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.77 83.96 1.64 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 164.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -54.1 -46.29 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.743 0.817 . . . . 0.0 108.946 174.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -161.22 178.78 8.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -83.36 178.83 7.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 159.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.01 144.14 1.38 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -172.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.45 158.64 25.74 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.868 1.712 . . . . 0.0 110.853 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.6 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 64.6 m . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 162.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -176.81 -81.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.94 1.696 . . . . 0.0 107.113 140.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.25 -39.38 44.15 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 119.2 -0.778 . . . . 0.0 112.222 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -43.51 77.81 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 116.682 -1.628 . . . . 0.0 115.127 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 18.5 Cg_endo -56.11 -28.24 69.15 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 122.266 1.845 . . . . 0.0 112.228 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -105.25 29.15 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.769 1.628 . . . . 0.0 111.915 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -56.78 -27.67 60.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.57 163.42 3.73 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.129 2.572 . . . . 0.0 114.997 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.21 162.24 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.376 2.051 . . . . 0.0 110.912 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 43.15 0.97 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.633 -0.667 . . . . 0.0 110.236 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.43 127.69 33.27 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.093 2.157 . . . . 0.0 110.89 172.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.18 43.54 0.63 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.556 1.542 . . . . 0.0 112.019 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -82.78 55.92 3.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.458 -1.401 . . . . 0.0 109.959 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -54.65 144.26 22.37 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.61 1.564 . . . . 0.0 114.881 -161.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 26' ' ' PRO . 4.2 m -146.36 162.16 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.726 0.81 . . . . 0.0 111.844 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.6 t -101.43 130.77 47.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.279 0.632 . . . . 0.0 112.0 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.08 163.39 23.23 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 158.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.474 ' HA ' HG11 ' A' ' 43' ' ' VAL . 88.5 p -34.03 -57.56 0.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 118.237 2.68 . . . . 0.0 118.237 -161.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.71 42.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.219 -162.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.36 42.44 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 123.758 0.694 . . . . 0.0 112.617 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.18 75.51 2.33 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.824 3.249 . . . . 0.0 108.946 -159.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.0 m -66.31 143.74 57.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.662 -0.649 . . . . 0.0 110.225 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.02 155.42 46.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.597 2.359 . . . . 0.0 108.562 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -59.85 -25.45 65.03 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.434 1.494 . . . . 0.0 114.047 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 11.8 p30 -163.55 162.66 17.01 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.806 2.043 . . . . 0.0 107.675 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HA ' HG21 ' A' ' 15' ' ' VAL . 39.8 Cg_endo -66.83 -21.82 50.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.185 1.257 . . . . 0.0 111.368 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.01 -37.84 84.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.599 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 mmm -68.85 -35.68 77.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.792 1.178 . . . . 0.0 111.704 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.937 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.1 tt -61.9 -63.99 1.08 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.38 -32.64 70.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.777 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 2.1 t -51.4 -71.44 0.06 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.02 -52.9 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.431 1.893 . . . . 0.0 111.317 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 44.9 tttm -48.66 -63.96 0.94 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.844 1.657 . . . . 0.0 110.466 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -73.15 -18.4 61.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.54 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -73.55 -55.08 6.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.97 0.508 . . . . 0.0 110.131 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.08 16.49 0.09 OUTLIER Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.818 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 12.5 t-20 -126.76 57.77 24.06 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.693 1.746 . . . . 0.0 108.646 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.22 -22.85 66.78 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 122.48 1.921 . . . . 0.0 112.724 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.07 -31.89 73.24 Favored 'General case' 0 CA--C 1.533 0.312 1 C-N-CA 132.415 4.286 . . . . 0.0 114.873 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.937 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -65.69 156.59 32.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.188 1.395 . . . . 0.0 108.542 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.659 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.4 m -152.36 155.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.853 1.661 . . . . 0.0 109.431 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -73.84 87.01 1.75 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 163.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.93 -48.51 63.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 123.165 0.586 . . . . 0.0 110.491 167.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -162.73 164.37 26.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.135 1.774 . . . . 0.0 107.534 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -84.26 166.01 17.85 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 166.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.83 150.18 2.81 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 111.357 -170.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -83.23 157.55 14.94 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.659 -166.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.0 m . . . . . 0 C--N 1.342 0.241 0 CA-C-O 119.31 -0.376 . . . . 0.0 110.656 165.26 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 p90 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.96 -68.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.978 . . . . 0.0 105.965 166.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.9 -17.87 42.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.849 1.214 . . . . 0.0 115.289 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -64.91 -52.02 52.69 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 119.011 1.406 . . . . 0.0 111.81 165.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.46 -58.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.015 3.143 . . . . 0.0 112.629 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.89 96.79 10.34 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.953 1.706 . . . . 0.0 111.082 -167.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.84 0.02 2.16 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 125.007 1.442 . . . . 0.0 113.947 -175.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 163.9 62.59 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.354 1.462 . . . . 0.0 113.884 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.52 165.18 31.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.595 2.197 . . . . 0.0 110.69 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.36 47.51 0.09 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.83 1.252 . . . . 0.0 112.066 167.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.84 118.73 10.1 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.146 165.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -77.55 42.44 0.36 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.407 1.883 . . . . 0.0 111.473 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 15' ' ' VAL . 6.2 m80 -79.58 64.89 4.58 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.67 137.61 57.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.657 1.572 . . . . 0.0 111.55 -168.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 13' ' ' HIS . 2.8 m -141.54 167.32 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.89 0.876 . . . . 0.0 112.097 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 t -105.53 141.56 36.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.071 0.948 . . . . 0.0 110.719 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.39 166.14 24.1 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.892 1.234 . . . . 0.0 111.217 159.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.55 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -37.9 -40.35 0.45 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.385 2.274 . . . . 0.0 115.665 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.47 16.5 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 110.314 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.77 65.47 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.219 -165.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -68.68 92.62 0.48 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.46 1.504 . . . . 0.0 109.354 -163.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -65.9 143.46 57.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -126.54 155.02 43.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.827 2.051 . . . . 0.0 108.707 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.1 p -65.46 -27.88 68.82 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.688 1.195 . . . . 0.0 113.212 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -163.41 152.63 12.42 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 127.326 2.25 . . . . 0.0 108.957 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.86 -23.65 22.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.118 1.212 . . . . 0.0 110.92 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -56.76 -44.47 81.81 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 111.105 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.31 70.14 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.896 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.6 tt -64.46 -65.86 0.62 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 t -52.39 -29.47 24.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.445 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -62.05 -60.74 3.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.094 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' N ' ' SG ' ' A' ' 31' ' ' CYS . . . -42.35 -51.9 4.72 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.992 2.117 . . . . 0.0 110.206 175.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 tttm -50.95 -63.2 1.2 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.339 1.024 . . . . 0.0 110.562 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.73 -14.0 62.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.518 1.127 . . . . 0.0 113.943 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -58.23 3.26 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.75 34.14 0.14 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.591 -1.116 . . . . 0.0 113.09 -173.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -134.85 62.1 51.29 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 119.271 1.535 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.0 -13.44 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 CA-C-N 121.058 1.414 . . . . 0.0 114.027 -172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.66 -27.01 37.25 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.503 2.721 . . . . 0.0 112.735 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.896 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.9 tp -66.39 153.56 42.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.62 ' H ' HD12 ' A' ' 40' ' ' LEU . 35.2 m -147.74 144.05 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -74.38 87.28 2.03 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.7 OUTLIER -58.73 -50.67 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.44 1.496 . . . . 0.0 108.885 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -179.39 -171.52 0.2 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.51 3.124 . . . . 0.0 107.574 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -164.82 1.05 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.81 2.444 . . . . 0.0 108.604 166.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 123.15 0.19 Allowed Glycine 0 CA--C 1.544 1.895 0 C-N-CA 124.862 1.22 . . . . 0.0 113.975 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.16 135.23 13.54 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 120.823 2.311 . . . . 0.0 112.312 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.534 0.337 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.444 178.422 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.22 -54.9 0.01 OUTLIER 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.18 0.992 . . . . 0.0 111.448 170.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.75 67.0 1.12 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 127.017 2.246 . . . . 0.0 109.39 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -176.62 -55.87 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.259 1.824 . . . . 0.0 109.851 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' CA ' ' A' ' 31' ' ' CYS . 28.2 Cg_endo -72.74 -58.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.733 1.622 . . . . 0.0 110.004 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.17 133.83 35.53 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 176.57 34.41 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 O-C-N 125.967 2.042 . . . . 0.0 111.726 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.7 165.78 12.72 Favored Pre-proline 0 C--O 1.233 0.234 0 O-C-N 121.293 -0.88 . . . . 0.0 112.28 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.48 172.38 14.34 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.233 1.956 . . . . 0.0 109.709 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -77.01 44.26 0.39 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.661 1.584 . . . . 0.0 110.722 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 120.31 11.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.77 1.228 . . . . 0.0 110.046 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.49 54.49 2.36 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.802 1.641 . . . . 0.0 110.54 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.613 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.5 m80 -91.04 61.3 4.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 48.4 mmm-85 -46.2 100.37 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 13' ' ' HIS . 34.8 m -99.52 178.81 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 124.932 1.293 . . . . 0.0 112.299 174.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 4.1 t -115.97 135.33 54.07 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.457 1.503 . . . . 0.0 109.025 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.75 173.07 41.38 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -55.58 -32.1 62.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.21 -0.03 30.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.914 1.286 . . . . 0.0 110.567 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.93 -0.82 61.16 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.67 1.129 . . . . 0.0 111.991 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.97 115.32 11.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 26.2 m -65.79 150.14 49.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.77 136.02 53.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -37.17 -37.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.777 2.031 . . . . 0.0 113.241 170.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -163.69 155.79 15.0 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 128.072 2.549 . . . . 0.0 111.361 -176.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.3 -24.87 16.19 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.471 2.781 . . . . 0.0 110.292 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.74 -30.04 69.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.3 mtp -74.61 -41.51 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.002 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.79 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.6 tt -51.26 -70.03 0.1 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 t -50.24 -38.07 38.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.741 0.416 . . . . 0.0 111.804 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.442 ' CA ' ' HB2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -51.49 -72.18 0.05 Allowed 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -35.91 -55.85 0.73 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 127.679 2.392 . . . . 0.0 109.79 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.52 -66.03 0.43 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.481 -1.69 . . . . 0.0 114.054 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.87 63.24 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 124.584 1.177 . . . . 0.0 111.249 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -78.33 0.11 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.399 1.48 . . . . 0.0 107.778 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.43 48.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 127.078 2.275 . . . . 0.0 109.503 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -148.03 59.99 4.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 117.891 0.845 . . . . 0.0 111.753 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.83 -10.56 17.62 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 122.967 2.445 . . . . 0.0 113.612 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.55 -28.93 21.67 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 127.0 2.12 . . . . 0.0 113.709 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.79 HD11 ' HG ' ' A' ' 29' ' ' LEU . 2.4 tp -65.59 154.2 39.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.56 ' H ' HD12 ' A' ' 40' ' ' LEU . 18.1 m -146.89 145.33 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -73.42 82.83 1.45 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -55.5 -49.75 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.669 172.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 174.78 176.94 0.15 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.009 2.124 . . . . 0.0 109.032 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -174.85 5.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.009 2.124 . . . . 0.0 110.522 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.34 134.37 0.53 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.37 1.462 . . . . 0.0 112.909 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.9 145.52 36.2 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.532 2.166 . . . . 0.0 111.372 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.457 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.461 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.69 174.97 14.22 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 102.989 -2.967 . . . . 0.0 102.989 139.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.15 -70.22 2.82 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.768 1.175 . . . . 0.0 112.041 166.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -43.97 83.86 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 116.553 -1.689 . . . . 0.0 114.739 -173.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 31.8 Cg_endo -57.5 -22.32 50.35 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.652 1.568 . . . . 0.0 113.206 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.75 46.55 1.82 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.684 1.594 . . . . 0.0 112.309 -167.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -29.73 70.38 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.692 -1.255 . . . . 0.0 112.018 168.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.06 157.14 54.19 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 126.436 1.894 . . . . 0.0 115.513 -163.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.59 164.64 30.16 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.015 2.477 . . . . 0.0 110.572 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.72 43.52 0.84 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.599 -0.688 . . . . 0.0 109.994 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.13 132.73 49.17 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.382 1.873 . . . . 0.0 110.578 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.85 43.62 1.05 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.953 1.701 . . . . 0.0 110.82 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -87.96 63.93 7.59 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.248 -1.533 . . . . 0.0 108.761 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -60.11 146.96 41.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.894 1.278 . . . . 0.0 113.344 -160.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 m -147.36 158.41 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.499 1.12 . . . . 0.0 111.819 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -91.55 136.51 33.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.666 0.786 . . . . 0.0 110.967 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.79 163.97 23.8 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 159.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.501 ' HA ' HG11 ' A' ' 43' ' ' VAL . 82.1 p -47.15 -32.61 4.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.109 2.164 . . . . 0.0 116.17 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.65 -7.27 25.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.844 1.658 . . . . 0.0 113.019 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.78 -9.67 50.58 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.359 0.98 . . . . 0.0 111.046 -158.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.7 96.5 0.28 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.133 2.573 . . . . 0.0 108.921 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -66.63 144.33 56.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 110.504 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -123.71 145.12 49.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.843 1.657 . . . . 0.0 107.389 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.423 ' H ' ' CE ' ' A' ' 28' ' ' MET . 10.0 m -62.69 -16.25 56.35 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -176.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.46 158.5 17.5 Favored Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 108.607 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.38 -15.77 31.17 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.785 1.657 . . . . 0.0 111.99 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -72.82 -40.23 65.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.423 ' CE ' ' H ' ' A' ' 24' ' ' SER . 19.0 ttp -61.87 -45.33 94.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.916 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.22 -63.55 1.12 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.991 174.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -34.44 74.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.226 -174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 2.9 t -50.31 -69.02 0.12 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 124.806 1.243 . . . . 0.0 108.616 169.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.09 -52.63 2.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.099 2.16 . . . . 0.0 111.884 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -49.13 -61.61 1.98 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.869 1.668 . . . . 0.0 110.586 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 123.957 0.786 . . . . 0.0 112.512 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -77.68 -46.6 21.45 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.002 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.5 18.82 0.09 OUTLIER Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.312 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -133.48 65.45 71.94 Favored Pre-proline 0 C--O 1.223 -0.338 0 CA-C-N 119.932 1.866 . . . . 0.0 110.25 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -61.55 -20.07 67.22 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.482 1.565 . . . . 0.0 112.615 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -22.14 47.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.654 2.782 . . . . 0.0 113.774 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.916 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.9 tp -66.48 152.15 45.76 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.614 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.3 m -151.52 155.98 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.773 1.629 . . . . 0.0 108.801 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -73.79 84.3 1.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.8 -50.25 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 C-N-CA 122.944 0.498 . . . . 0.0 110.194 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -159.33 -174.32 4.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.231 1.813 . . . . 0.0 106.26 165.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 46' ' ' GLY . 26.2 tt0 -71.35 -137.39 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.18 1.392 . . . . 0.0 107.4 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.472 ' H ' ' HG2' ' A' ' 45' ' ' GLU . . . 51.87 116.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 128.104 2.764 . . . . 0.0 117.881 158.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.76 127.61 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 CA-C-N 119.709 1.755 . . . . 0.0 112.376 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.6 m . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 118.999 -0.524 . . . . 0.0 112.11 173.719 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.463 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -176.62 -78.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.546 2.338 . . . . 0.0 105.72 159.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 50.48 3.79 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 127.234 2.349 . . . . 0.0 112.911 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 2.9 t-20 -144.29 -53.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.585 1.954 . . . . 0.0 109.299 163.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 11.3 Cg_endo -59.27 -29.94 91.62 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.377 2.051 . . . . 0.0 114.199 166.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.95 102.15 9.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.004 1.274 . . . . 0.0 112.889 -172.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -126.31 -0.0 7.02 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.106 1.362 . . . . 0.0 112.763 163.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -75.91 165.72 50.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -165.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.99 167.25 20.28 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.225 1.95 . . . . 0.0 110.728 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp85 -85.46 43.83 1.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.621 -0.675 . . . . 0.0 110.639 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.03 24.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.901 1.68 . . . . 0.0 110.304 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.35 43.48 1.02 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.538 1.535 . . . . 0.0 111.652 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.484 ' O ' HG13 ' A' ' 15' ' ' VAL . 34.5 m170 -78.23 70.65 4.62 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 120.603 -1.31 . . . . 0.0 107.89 170.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -52.96 130.52 33.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.4 1.08 . . . . 0.0 111.308 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 13' ' ' HIS . 4.1 m -135.74 162.93 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 123.455 0.702 . . . . 0.0 111.746 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.0 135.29 45.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 111.422 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.01 163.86 23.5 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 158.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.521 ' HA ' HG11 ' A' ' 43' ' ' VAL . 89.2 p -42.28 -36.49 1.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 -164.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . 82.0 m-20 -72.1 -1.47 14.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 112.757 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.81 82.7 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 119.145 0.884 . . . . 0.0 112.175 -159.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 45.8 t-20 -67.73 90.47 0.28 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.967 2.507 . . . . 0.0 109.75 -171.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 83.4 m -65.89 144.15 56.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.368 0.667 . . . . 0.0 111.832 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.18 158.39 39.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.473 2.709 . . . . 0.0 108.282 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 t -61.33 -28.49 69.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.818 1.247 . . . . 0.0 113.926 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 12.9 p30 -163.82 161.9 16.85 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 125.931 1.692 . . . . 0.0 108.376 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.9 Cg_endo -73.81 -16.63 23.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 120.968 1.112 . . . . 0.0 111.87 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -64.85 -45.93 84.01 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.565 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.3 mtp -58.15 -41.6 84.1 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.979 0.809 . . . . 0.0 112.57 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.904 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.7 tt -55.76 -67.2 0.31 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 109.095 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -33.78 71.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.595 -0.69 . . . . 0.0 111.485 -172.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.9 t -53.32 -70.93 0.08 Allowed 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.239 1.416 . . . . 0.0 107.679 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.51 0.82 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 126.606 1.963 . . . . 0.0 111.851 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -49.86 -63.96 0.95 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.851 1.261 . . . . 0.0 110.979 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -15.07 63.46 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.663 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -80.48 -59.62 2.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.42 28.25 0.26 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.47 -1.183 . . . . 0.0 114.146 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.02 66.56 79.35 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 119.5 1.65 . . . . 0.0 109.737 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.58 -19.4 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.817 1.327 . . . . 0.0 112.402 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.56 -25.77 50.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.794 2.838 . . . . 0.0 113.904 176.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.904 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.5 tp -66.52 154.54 40.08 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.689 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.1 m -150.95 154.65 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.737 1.215 . . . . 0.0 110.182 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.408 HE22 ' HB3' ' A' ' 26' ' ' PRO . 30.1 tp60 -75.08 86.56 2.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -56.55 -53.87 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.777 0.831 . . . . 0.0 109.788 166.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -164.66 -175.24 3.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.198 1.799 . . . . 0.0 108.503 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -86.0 -175.05 5.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.132 1.373 . . . . 0.0 108.045 158.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.91 142.34 1.12 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.425 1.012 . . . . 0.0 112.12 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -83.24 146.86 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.177 1.918 . . . . 0.0 111.1 -171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 168.823 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.23 -79.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.521 1.928 . . . . 0.0 106.614 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.16 -27.23 41.17 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.636 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -44.08 78.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 116.902 -1.523 . . . . 0.0 114.557 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -68.47 -50.14 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.058 1.838 . . . . 0.0 111.562 166.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -90.7 76.32 6.47 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.856 1.207 . . . . 0.0 111.188 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.65 102.76 6.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 159.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.71 165.81 6.96 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.308 1.443 . . . . 0.0 109.253 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.43 159.09 32.73 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.124 1.883 . . . . 0.0 110.7 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -78.42 43.32 0.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.55 0.74 . . . . 0.0 110.488 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.48 126.15 27.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.593 1.957 . . . . 0.0 110.943 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.95 43.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.602 1.561 . . . . 0.0 111.511 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -83.53 62.76 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.496 -1.377 . . . . 0.0 109.913 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -53.69 140.28 29.8 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -165.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -146.45 176.65 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 125.424 1.49 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 42.7 t -125.5 146.19 49.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.435 1.016 . . . . 0.0 111.705 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.18 163.6 23.21 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.029 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.428 ' HB3' HG13 ' A' ' 43' ' ' VAL . 84.5 p -53.24 -14.46 0.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.114 1.766 . . . . 0.0 114.482 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.79 -15.24 58.22 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.212 2.205 . . . . 0.0 112.14 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.43 -9.73 40.28 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 124.856 1.217 . . . . 0.0 111.358 -163.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.52 114.9 15.76 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.561 1.945 . . . . 0.0 110.151 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -65.64 143.84 57.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.957 0.799 . . . . 0.0 109.536 166.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -121.26 147.4 45.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.323 1.849 . . . . 0.0 106.87 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 m -60.61 -23.43 64.71 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.555 0.742 . . . . 0.0 112.501 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -163.59 161.09 17.7 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.958 2.103 . . . . 0.0 107.95 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.3 -14.64 34.61 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.973 1.782 . . . . 0.0 112.201 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.64 -40.11 84.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.864 0.466 . . . . 0.0 110.986 173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 89.5 mtp -65.06 -39.72 93.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.013 0.824 . . . . 0.0 111.551 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -58.41 -63.66 1.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.073 0.949 . . . . 0.0 110.043 171.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.45 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -60.33 -32.4 71.2 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.668 -175.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -69.07 0.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.02 -52.89 1.39 Allowed 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 126.47 1.908 . . . . 0.0 111.657 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -50.06 -63.09 1.22 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.385 1.874 . . . . 0.0 110.29 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -66.83 -25.91 66.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.331 1.052 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -69.57 -57.43 5.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.282 0.633 . . . . 0.0 109.529 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.11 21.31 0.11 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.565 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -125.62 62.22 40.52 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 119.589 1.694 . . . . 0.0 109.382 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -61.16 -18.3 57.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 121.45 1.554 . . . . 0.0 113.141 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -23.36 42.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.329 2.652 . . . . 0.0 113.625 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.684 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.5 tp -66.39 152.4 45.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.539 ' H ' HD12 ' A' ' 40' ' ' LEU . 29.0 m -156.08 161.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.341 2.256 . . . . 0.0 108.87 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -75.73 80.81 2.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 18' ' ' SER . 0.3 OUTLIER -54.24 -41.01 49.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 124.99 1.316 . . . . 0.0 111.147 172.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.36 143.04 18.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -84.63 55.23 3.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.478 1.132 . . . . 0.0 108.761 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.67 158.41 31.35 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.247 2.356 . . . . 0.0 108.488 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -82.15 153.47 16.53 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.835 2.357 . . . . 0.0 113.375 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 60.6 m . . . . . 0 CA--C 1.529 0.152 0 C-N-CA 126.377 1.871 . . . . 0.0 108.88 169.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.616 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.1 133.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 162.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.16 -36.75 1.1 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.061 0.839 . . . . 0.0 113.552 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -50.3 72.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.401 1.08 . . . . 0.0 109.767 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.14 -36.08 6.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.628 2.218 . . . . 0.0 113.875 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -108.32 95.15 5.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.547 1.067 . . . . 0.0 110.232 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -119.91 5.51 10.91 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.025 1.33 . . . . 0.0 111.051 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.92 165.85 20.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 0.0 114.325 -167.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.92 167.98 10.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mtt85 -74.67 44.33 0.21 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.137 1.375 . . . . 0.0 111.448 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.78 120.31 12.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.716 1.207 . . . . 0.0 110.173 164.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.44 43.81 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.119 2.167 . . . . 0.0 111.709 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.479 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.2 m-70 -78.7 67.86 4.54 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.782 -1.198 . . . . 0.0 108.213 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -57.59 133.66 55.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.741 1.609 . . . . 0.0 110.483 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 13' ' ' HIS . 17.9 m -135.34 167.86 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.364 1.066 . . . . 0.0 111.158 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -106.15 137.69 43.65 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.229 1.012 . . . . 0.0 111.592 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.99 163.97 23.57 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 159.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.451 ' HA ' HG11 ' A' ' 43' ' ' VAL . 60.6 p -45.83 -34.27 3.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -168.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -0.04 6.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.475 1.11 . . . . 0.0 112.384 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.82 1.52 90.6 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 111.666 -159.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.86 100.48 4.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.836 1.654 . . . . 0.0 110.584 -166.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -66.1 143.61 57.21 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.858 -0.526 . . . . 0.0 111.355 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -122.27 153.62 38.65 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.87 2.468 . . . . 0.0 108.641 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -63.12 -28.42 70.05 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.462 1.505 . . . . 0.0 113.178 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 18.3 p30 -163.58 158.87 17.48 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.071 1.748 . . . . 0.0 110.126 173.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.4 Cg_endo -70.63 -20.07 31.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.247 1.298 . . . . 0.0 111.496 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -66.1 -43.94 85.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.943 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtm -62.58 -35.54 79.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.6 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.913 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.7 tt -60.42 -66.05 0.59 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.213 0.915 . . . . 0.0 109.495 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -56.11 -36.49 68.25 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.337 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -68.93 0.13 Allowed 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.333 1.053 . . . . 0.0 108.945 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -37.94 -53.12 1.36 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.343 1.857 . . . . 0.0 110.784 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -51.54 -63.8 1.02 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.549 1.14 . . . . 0.0 110.523 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.36 -15.43 63.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.522 1.129 . . . . 0.0 112.742 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -78.27 -64.21 1.22 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.9 27.66 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.896 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -128.69 64.53 69.45 Favored Pre-proline 0 C--N 1.343 0.326 0 CA-C-N 119.141 1.471 . . . . 0.0 110.194 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -63.08 -16.65 55.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.97 1.382 . . . . 0.0 112.777 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.35 -25.99 42.16 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.179 2.192 . . . . 0.0 113.228 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.913 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.32 153.85 41.55 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.667 ' H ' HD12 ' A' ' 40' ' ' LEU . 31.6 m -151.11 147.29 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.258 1.423 . . . . 0.0 107.72 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -76.9 86.2 3.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.92 -53.65 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.936 0.894 . . . . 0.0 110.401 168.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.65 177.21 5.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.274 1.43 . . . . 0.0 109.721 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 178.26 7.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.923 1.689 . . . . 0.0 107.713 166.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.76 142.03 1.05 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 119.039 0.836 . . . . 0.0 112.972 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -80.82 147.4 17.05 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.923 1.749 . . . . 0.0 111.119 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.523 -0.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.021 171.607 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -176.52 -71.08 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.311 1.844 . . . . 0.0 107.605 167.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.64 67.75 3.63 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.101 1.81 . . . . 0.0 110.727 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.6 -52.18 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.41 2.284 . . . . 0.0 107.556 169.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.77 -43.0 5.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.17 2.58 . . . . 0.0 114.521 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.11 93.59 5.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.809 1.64 . . . . 0.0 112.389 -169.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.11 2.43 9.83 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.063 1.745 . . . . 0.0 113.315 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.93 170.94 9.43 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -162.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.61 167.21 11.71 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.417 2.745 . . . . 0.0 111.474 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.43 45.73 0.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.388 -0.82 . . . . 0.0 111.24 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 119.5 9.9 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 165.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.06 42.94 0.27 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.018 2.527 . . . . 0.0 112.217 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.08 63.53 5.12 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.489 -1.382 . . . . 0.0 108.758 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.3 140.08 54.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.738 1.215 . . . . 0.0 113.419 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.2 160.19 13.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.84 135.25 35.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.702 1.601 . . . . 0.0 110.798 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.65 164.72 24.29 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 159.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' HG11 ' A' ' 43' ' ' VAL . 88.5 p -43.96 -38.26 3.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -169.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -0.24 7.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.671 1.188 . . . . 0.0 113.119 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.97 -5.36 85.31 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.821 0.737 . . . . 0.0 111.576 -165.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -71.7 99.98 2.24 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.599 2.359 . . . . 0.0 110.287 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -67.06 145.61 55.18 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.745 -0.597 . . . . 0.0 112.284 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -126.42 158.56 35.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.159 2.184 . . . . 0.0 108.876 171.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -62.75 -29.17 70.49 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.311 1.844 . . . . 0.0 114.178 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -163.71 155.02 14.25 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 109.148 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.33 -17.91 34.69 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.634 2.223 . . . . 0.0 110.736 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.1 t -62.61 -46.33 88.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.026 0.93 . . . . 0.0 110.06 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mtm -66.16 -31.81 72.87 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.233 -0.889 . . . . 0.0 112.823 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.887 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -60.98 -63.89 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.74 1.155 . . . . 0.0 109.72 171.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.86 -35.44 72.95 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.278 -176.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.13 -66.56 0.37 Allowed 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.53 -53.54 1.57 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 127.188 2.195 . . . . 0.0 110.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 43.4 tttm -50.85 -62.47 1.59 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.835 1.254 . . . . 0.0 109.746 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -18.82 65.41 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.379 1.049 . . . . 0.0 113.168 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -56.76 4.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 18.58 0.1 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.171 -1.35 . . . . 0.0 114.219 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.99 61.99 10.19 Favored Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.816 1.808 . . . . 0.0 108.515 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.98 -21.57 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 121.61 1.611 . . . . 0.0 112.847 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -29.67 67.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.338 2.255 . . . . 0.0 113.448 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.887 HD11 ' HG ' ' A' ' 29' ' ' LEU . 7.1 tp -66.14 157.27 31.67 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.687 ' H ' HD12 ' A' ' 40' ' ' LEU . 29.6 m -150.96 149.35 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 106.789 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -72.88 89.2 1.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -54.18 -54.53 20.31 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 C-N-CA 124.58 1.152 . . . . 0.0 110.517 168.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.8 t60 174.97 170.87 0.27 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.357 2.663 . . . . 0.0 105.84 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -168.5 2.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.011 0.924 . . . . 0.0 109.077 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.83 131.74 2.04 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.1 128.09 8.85 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.929 1.865 . . . . 0.0 111.209 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.47 0.565 0 CA-C-N 118.188 0.449 . . . . 0.0 110.624 175.217 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -166.5 159.2 14.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 145.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.55 -50.11 2.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.813 1.197 . . . . 0.0 115.341 162.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -63.77 -43.73 77.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.251 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.58 -61.92 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 CA-C-N 121.244 1.48 . . . . 0.0 110.384 159.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.3 m -92.36 74.07 5.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -158.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 130.31 25.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 158.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.95 167.21 0.77 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.207 1.803 . . . . 0.0 109.355 -174.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.1 156.73 51.48 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.018 1.145 . . . . 0.0 110.065 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -82.9 43.17 0.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.44 123.86 21.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.477 2.311 . . . . 0.0 109.886 166.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.73 54.03 2.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.443 1.897 . . . . 0.0 111.561 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -72.29 81.8 1.02 Allowed 'General case' 0 C--O 1.223 -0.311 0 O-C-N 120.726 -1.233 . . . . 0.0 107.877 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -65.98 86.22 0.09 Allowed 'General case' 0 C--O 1.221 -0.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.365 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.47 154.05 3.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 126.364 1.865 . . . . 0.0 114.123 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 35.7 t -86.11 127.66 34.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.65 -0.656 . . . . 0.0 109.371 167.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.5 163.19 26.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 158.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.418 ' HA ' HG11 ' A' ' 43' ' ' VAL . 71.3 p -33.79 -51.66 0.4 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.116 2.567 . . . . 0.0 117.399 -167.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 27.54 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 126.34 1.856 . . . . 0.0 110.945 -166.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.08 -1.4 8.56 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.547 1.546 . . . . 0.0 112.759 -165.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.55 89.2 2.18 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 129.885 3.274 . . . . 0.0 108.048 -166.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -65.87 143.71 57.27 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.713 -0.617 . . . . 0.0 109.55 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.77 151.96 47.53 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 127.121 2.168 . . . . 0.0 109.096 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -65.53 -18.68 65.51 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.706 1.603 . . . . 0.0 114.736 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -164.26 154.81 13.09 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 125.914 1.686 . . . . 0.0 109.597 166.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.93 -20.63 38.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.108 1.872 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.4 t -60.0 -58.2 9.57 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.172 168.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.5 mmm -61.12 -34.01 74.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.09 1.314 . . . . 0.0 112.928 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.945 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -54.76 -65.09 0.64 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.178 0.899 . . . . 0.0 109.242 166.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -28.08 69.68 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.991 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -63.23 1.37 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -42.93 -52.87 4.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.956 2.102 . . . . 0.0 111.62 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 40.2 tttm -48.42 -62.13 1.65 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.166 1.786 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -72.28 -16.43 61.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.489 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -67.89 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 171.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.11 22.86 0.68 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.288 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 9.5 t-20 -129.3 56.87 26.44 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.208 1.504 . . . . 0.0 109.167 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -58.95 -21.6 58.91 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 CA-C-N 122.587 1.96 . . . . 0.0 113.012 -171.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.13 -34.15 77.4 Favored 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.001 4.12 . . . . 0.0 114.657 173.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.945 HD11 ' HG ' ' A' ' 29' ' ' LEU . 7.4 tp -65.63 153.84 40.49 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 125.437 1.495 . . . . 0.0 107.914 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.486 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.7 m -149.62 151.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 124.863 1.265 . . . . 0.0 109.212 169.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.67 85.83 3.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.61 -34.98 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.395 1.478 . . . . 0.0 110.456 172.581 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 179.67 170.24 1.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.734 2.414 . . . . 0.0 107.319 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.72 177.5 7.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 158.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.08 139.67 0.88 Allowed Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.728 1.156 . . . . 0.0 111.68 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -85.52 152.57 10.39 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.555 2.837 . . . . 0.0 112.478 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 62.4 m . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 166.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -72.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.17 1.788 . . . . 0.0 107.446 160.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.84 51.82 4.36 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.872 2.177 . . . . 0.0 111.98 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.35 -53.49 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 127.102 2.161 . . . . 0.0 107.784 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.87 -42.32 46.31 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.125 1.217 . . . . 0.0 112.11 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.0 m -101.53 99.91 10.28 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.586 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.62 78.36 1.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 159.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -156.33 166.4 16.56 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.433 1.093 . . . . 0.0 110.79 -165.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.71 161.73 24.53 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.914 2.41 . . . . 0.0 112.212 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -75.06 44.47 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.923 1.289 . . . . 0.0 111.046 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 131.28 46.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.531 1.132 . . . . 0.0 110.643 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -85.98 43.07 1.02 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.997 2.119 . . . . 0.0 110.329 167.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -92.52 61.7 3.78 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.719 -1.238 . . . . 0.0 107.749 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -58.58 142.5 49.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -159.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.71 168.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.023 0.929 . . . . 0.0 112.186 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 t -114.12 136.51 52.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.13 163.34 22.09 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 158.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -52.87 -27.36 18.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -164.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -13.7 59.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.185 0.994 . . . . 0.0 112.216 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.76 -3.17 65.03 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -159.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.89 87.54 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.941 2.896 . . . . 0.0 107.846 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -66.53 143.5 57.02 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -125.1 155.7 39.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.212 2.205 . . . . 0.0 107.692 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 t -58.15 -29.6 65.7 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.866 0.866 . . . . 0.0 112.307 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -163.9 160.41 17.06 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.247 1.419 . . . . 0.0 108.509 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.84 -18.92 36.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.314 2.01 . . . . 0.0 111.632 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -67.54 -45.82 74.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.711 0.404 . . . . 0.0 110.524 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.4 mtp -62.66 -37.36 86.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.03 0.832 . . . . 0.0 111.573 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.958 ' HG ' HD11 ' A' ' 40' ' ' LEU . 4.0 tt -60.08 -66.62 0.49 Allowed 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.616 0.766 . . . . 0.0 109.879 170.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -32.68 66.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.852 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.68 -70.47 0.11 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.86 -52.94 0.94 Allowed 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 126.531 1.933 . . . . 0.0 111.993 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -48.69 -64.21 0.87 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.466 1.507 . . . . 0.0 110.7 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.99 -26.64 68.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.266 0.979 . . . . 0.0 112.338 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -70.23 -59.7 2.73 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.11 21.27 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.524 -1.154 . . . . 0.0 113.946 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -130.16 54.09 13.56 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 119.434 1.617 . . . . 0.0 109.537 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -59.4 -22.34 65.39 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 CA-C-N 122.933 2.083 . . . . 0.0 113.074 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.3 -30.45 71.5 Favored 'General case' 0 CA--C 1.534 0.336 1 C-N-CA 132.616 4.366 . . . . 0.0 115.313 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.958 HD11 ' HG ' ' A' ' 29' ' ' LEU . 1.5 tp -65.37 158.8 25.6 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.838 1.255 . . . . 0.0 107.888 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.68 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.3 m -153.63 155.7 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.591 1.956 . . . . 0.0 108.072 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -75.81 88.07 2.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 164.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -48.86 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 122.583 0.353 . . . . 0.0 110.211 169.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.04 155.63 23.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.334 1.053 . . . . 0.0 108.223 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 170.32 15.71 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.94 156.2 0.07 OUTLIER Glycine 0 CA--C 1.544 1.847 0 O-C-N 121.006 -1.059 . . . . 0.0 112.13 -162.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -91.05 164.96 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 CA-C-N 119.263 1.532 . . . . 0.0 113.592 -164.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.9 m . . . . . 0 C--N 1.341 0.209 0 C-N-CA 123.432 0.693 . . . . 0.0 109.169 167.79 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.478 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -170.91 134.55 0.99 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.44 -41.39 1.15 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 115.849 1.1 . . . . 0.0 115.849 164.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.6 -47.04 83.42 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 119.701 1.75 . . . . 0.0 110.46 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -55.42 -43.27 59.92 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.321 2.014 . . . . 0.0 113.065 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -105.38 66.1 0.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.765 1.226 . . . . 0.0 111.992 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.14 -0.04 30.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.641 0.776 . . . . 0.0 112.061 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.04 165.3 17.26 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -159.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.45 164.18 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.908 2.405 . . . . 0.0 111.173 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -81.61 43.38 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.582 -0.699 . . . . 0.0 110.104 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.84 124.9 24.23 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.459 1.904 . . . . 0.0 110.846 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.92 43.55 0.93 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.419 1.088 . . . . 0.0 109.791 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.62 60.69 6.25 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.833 -1.167 . . . . 0.0 109.104 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.6 mmm-85 -53.07 140.2 26.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.247 1.819 . . . . 0.0 112.735 -162.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.99 156.63 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 123.898 0.879 . . . . 0.0 111.498 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 52.9 t -94.47 141.82 28.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.002 0.364 . . . . 0.0 110.774 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.88 166.29 24.81 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 160.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.464 ' HA ' HG11 ' A' ' 43' ' ' VAL . 96.0 p -49.65 -19.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -176.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -85.63 -8.32 58.31 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.323 1.42 . . . . 0.0 111.986 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.27 -9.65 69.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.06 -1.025 . . . . 0.0 110.85 -160.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -64.91 92.97 0.1 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 128.336 2.654 . . . . 0.0 110.934 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -66.06 144.06 56.95 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.549 0.74 . . . . 0.0 110.366 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -122.84 157.69 31.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.811 2.844 . . . . 0.0 108.625 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 m -62.64 -30.8 71.63 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.53 1.532 . . . . 0.0 113.909 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 10.5 p30 -163.81 163.46 15.88 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 127.497 2.319 . . . . 0.0 107.301 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.2 Cg_endo -71.67 -16.36 30.13 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.31 1.34 . . . . 0.0 112.014 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -67.55 -46.84 71.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.654 170.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 mmm -59.43 -39.75 84.53 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.599 1.09 . . . . 0.0 111.024 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.1 tt -56.71 -69.44 0.15 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.994 0.918 . . . . 0.0 109.42 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -30.92 68.22 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.095 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -70.74 0.09 Allowed 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.3 -53.05 2.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.407 1.883 . . . . 0.0 112.191 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -46.64 -61.47 1.81 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.819 1.247 . . . . 0.0 110.716 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -21.18 64.6 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 8.5 tt0 -79.74 -31.12 41.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.541 1.064 . . . . 0.0 110.721 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.73 21.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.993 -1.449 . . . . 0.0 114.824 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.7 64.77 70.38 Favored Pre-proline 0 C--O 1.224 -0.267 0 CA-C-N 120.004 1.902 . . . . 0.0 110.055 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.71 -17.49 59.24 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.222 1.472 . . . . 0.0 112.961 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.58 -26.26 41.36 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.935 2.494 . . . . 0.0 113.308 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.928 HD11 ' HG ' ' A' ' 29' ' ' LEU . 4.7 tp -66.37 152.01 45.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.598 ' H ' HD12 ' A' ' 40' ' ' LEU . 31.0 m -150.06 153.22 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.391 0.676 . . . . 0.0 109.831 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -74.53 85.76 2.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -53.7 -56.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.441 1.097 . . . . 0.0 110.62 164.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.76 -171.47 2.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.837 2.455 . . . . 0.0 106.426 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.74 -137.8 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.792 2.037 . . . . 0.0 107.194 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.98 122.76 0.01 OUTLIER Glycine 0 CA--C 1.543 1.788 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.55 144.0 35.25 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 119.992 1.896 . . . . 0.0 111.706 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.408 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 33.3 m . . . . . 0 C--N 1.339 0.142 0 C-N-CA 122.652 0.381 . . . . 0.0 110.106 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.19 0.519 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -157.79 160.22 37.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 140.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.06 -50.99 2.76 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.43 1.014 . . . . 0.0 113.918 167.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -63.56 -45.34 83.06 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.109 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -57.21 -61.36 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.758 1.639 . . . . 0.0 111.099 166.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.45 59.1 5.32 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.402 -0.811 . . . . 0.0 112.122 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.88 -11.16 59.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.078 -0.389 . . . . 0.0 111.706 166.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.1 164.66 55.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.886 1.674 . . . . 0.0 113.928 -171.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.97 164.36 13.57 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.893 2.395 . . . . 0.0 111.727 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -79.59 43.9 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.499 1.12 . . . . 0.0 111.162 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.11 129.06 38.51 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.738 1.615 . . . . 0.0 110.332 170.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.95 43.84 1.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.481 1.513 . . . . 0.0 111.755 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.7 64.85 6.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.757 -1.214 . . . . 0.0 109.175 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -57.46 142.75 43.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -160.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.66 169.88 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 117.68 -1.152 . . . . 0.0 111.63 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 0.4 OUTLIER -118.57 137.04 53.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.611 1.096 . . . . 0.0 111.907 178.573 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.26 164.72 28.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.58 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.2 p -36.21 -41.04 0.25 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.535 2.734 . . . . 0.0 115.929 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.67 -1.91 3.14 Favored 'General case' 0 N--CA 1.436 -1.165 1 C-N-CA 135.019 5.328 . . . . 0.0 111.939 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.91 -8.37 11.85 Favored Glycine 0 CA--C 1.539 1.559 0 CA-C-N 119.391 0.996 . . . . 0.0 112.025 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.47 95.89 0.23 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 130.487 3.515 . . . . 0.0 109.335 -170.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.2 m -66.45 143.7 56.95 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.072 0.463 . . . . 0.0 110.404 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -119.86 157.57 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 128.113 2.565 . . . . 0.0 107.512 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 m -59.16 -31.79 69.3 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.745 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -163.73 160.42 17.4 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 125.338 1.455 . . . . 0.0 108.779 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.01 -15.19 32.44 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.705 1.603 . . . . 0.0 111.399 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.33 -40.04 64.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 123.233 0.613 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.7 ttp -65.01 -44.84 87.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -54.77 -63.5 1.13 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.125 174.507 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.13 -31.51 70.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.994 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -68.48 0.18 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.68 -53.11 3.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 127.524 2.33 . . . . 0.0 111.856 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -45.37 -61.27 1.74 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.355 1.462 . . . . 0.0 110.722 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -66.01 -27.94 68.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 112.545 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.76 -26.22 40.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.211 0.204 . . . . 0.0 111.33 -173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 17.87 0.02 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.296 -1.28 . . . . 0.0 115.066 -177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -131.7 54.38 14.15 Favored Pre-proline 0 C--O 1.22 -0.456 0 CA-C-N 119.557 1.678 . . . . 0.0 109.099 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.2 -23.1 60.19 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 CA-C-N 122.545 1.945 . . . . 0.0 112.859 -170.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.24 -32.66 74.33 Favored 'General case' 0 CA--C 1.533 0.316 1 C-N-CA 132.882 4.473 . . . . 0.0 114.922 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.928 HD11 ' HG ' ' A' ' 29' ' ' LEU . 1.8 tp -65.37 157.79 28.32 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.959 1.303 . . . . 0.0 107.674 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.6 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.0 m -152.8 146.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 128.339 2.656 . . . . 0.0 107.676 173.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.97 83.69 5.84 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 41' ' ' VAL . 1.4 m -53.64 -40.56 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.641 1.577 . . . . 0.0 109.625 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -155.98 162.51 40.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 159.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.78 -179.74 5.58 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 163.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.11 149.22 0.09 OUTLIER Glycine 0 CA--C 1.544 1.874 0 O-C-N 120.796 -1.19 . . . . 0.0 112.534 -161.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.65 152.56 17.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.125 1.883 . . . . 0.0 111.7 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.552 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 59.1 m . . . . . 0 C--N 1.339 0.119 0 CA-C-O 121.716 0.769 . . . . 0.0 109.048 169.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -163.29 165.4 24.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 153.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.58 9.86 82.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.243 0.925 . . . . 0.0 115.246 158.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.613 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.29 -44.02 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 126.961 2.104 . . . . 0.0 112.64 172.555 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 8.4 Cg_endo -56.43 -50.69 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.73 2.287 . . . . 0.0 112.457 163.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -95.23 107.99 20.11 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.74 0.816 . . . . 0.0 110.286 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -140.92 52.93 1.59 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.071 1.348 . . . . 0.0 108.071 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -144.77 163.43 33.51 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -161.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.57 166.84 13.59 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.255 2.637 . . . . 0.0 111.813 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -83.15 46.1 1.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.928 0.891 . . . . 0.0 109.734 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.88 123.08 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.117 0.967 . . . . 0.0 109.203 168.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.03 43.09 0.5 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.129 1.772 . . . . 0.0 111.975 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -78.6 76.71 5.1 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 169.495 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -61.59 141.3 57.86 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.686 -1.259 . . . . 0.0 110.957 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -150.18 164.98 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 124.71 1.204 . . . . 0.0 110.884 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -108.94 135.76 49.59 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.3 163.6 23.08 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 158.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.448 ' HA ' HG11 ' A' ' 43' ' ' VAL . 82.5 p -43.87 -39.1 3.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -165.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.15 2.09 5.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.489 1.041 . . . . 0.0 112.969 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.09 5.68 80.03 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 120.919 -1.113 . . . . 0.0 111.523 -161.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -71.79 90.21 1.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.119 2.968 . . . . 0.0 109.831 -169.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -65.92 143.89 57.13 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.076 0.853 . . . . 0.0 110.781 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.02 154.01 41.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 127.6 2.36 . . . . 0.0 107.831 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 p -66.06 -24.21 66.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.915 1.686 . . . . 0.0 114.106 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 14.3 p30 -164.01 156.31 14.88 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 126.714 2.006 . . . . 0.0 109.748 170.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB3' HE22 ' A' ' 42' ' ' GLN . 55.7 Cg_endo -69.74 -17.03 37.9 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.939 1.759 . . . . 0.0 111.57 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.9 t -66.19 -48.19 71.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.518 168.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.8 mmm -58.09 -39.77 79.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.312 0.96 . . . . 0.0 111.565 175.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.922 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.7 tt -57.39 -67.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.124 0.97 . . . . 0.0 109.783 171.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 t -60.01 -29.28 68.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.987 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -71.36 0.11 Allowed 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.91 -52.99 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.409 1.884 . . . . 0.0 111.932 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -48.08 -64.16 0.87 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.818 1.247 . . . . 0.0 110.893 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -65.55 -20.17 66.22 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 124.005 0.815 . . . . 0.0 112.763 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -74.63 -62.69 1.44 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.54 0.3 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.822 -174.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -128.69 63.08 64.05 Favored Pre-proline 0 C--O 1.221 -0.409 0 CA-C-N 119.193 1.497 . . . . 0.0 109.604 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.11 -19.08 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.206 1.466 . . . . 0.0 112.744 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.67 -22.82 43.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.202 2.601 . . . . 0.0 113.557 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.922 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.0 tp -66.52 153.91 41.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.653 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.9 m -150.9 152.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.174 1.39 . . . . 0.0 108.59 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.416 HE22 ' HB3' ' A' ' 26' ' ' PRO . 40.6 tp60 -75.34 83.9 2.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 166.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.52 -54.45 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.69 168.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.23 -170.44 2.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.809 2.043 . . . . 0.0 107.502 174.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -137.3 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.06 1.744 . . . . 0.0 106.881 167.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.32 118.25 0.01 OUTLIER Glycine 0 CA--C 1.539 1.57 0 C-N-CA 127.555 2.502 . . . . 0.0 118.664 158.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.7 137.65 30.41 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.189 1.926 . . . . 0.0 111.908 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.115 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 p90 . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 122.233 1.016 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -169.0 162.57 11.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 143.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.92 -64.65 1.92 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.56 1.552 . . . . 0.0 112.087 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.33 80.57 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-O 116.364 -1.779 . . . . 0.0 115.108 -172.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 15.7 Cg_endo -50.0 -26.61 14.72 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 122.072 1.776 . . . . 0.0 113.35 168.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.6 m -105.01 22.01 16.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.127 1.771 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.85 73.66 0.1 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.47 1.108 . . . . 0.0 109.524 170.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.09 167.93 11.77 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.416 1.886 . . . . 0.0 109.905 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.8 157.33 24.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.598 2.199 . . . . 0.0 110.936 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -79.06 43.7 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.492 -0.755 . . . . 0.0 110.233 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.07 140.84 58.28 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.417 1.487 . . . . 0.0 110.786 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.61 43.82 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.898 1.679 . . . . 0.0 110.497 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -89.58 46.13 1.34 Allowed 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.332 -1.48 . . . . 0.0 110.509 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -49.01 145.78 3.8 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.575 1.95 . . . . 0.0 115.262 -164.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 m -148.53 174.31 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.237 1.415 . . . . 0.0 110.606 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -116.53 137.09 52.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 0.794 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.58 163.55 22.75 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.216 0.898 . . . . 0.0 112.059 161.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.45 ' HA ' HG11 ' A' ' 43' ' ' VAL . 80.9 p -54.64 -17.73 3.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 118.653 2.835 . . . . 0.0 118.653 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -9.32 59.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.354 0.662 . . . . 0.0 111.724 171.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.7 -3.93 65.75 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.739 1.161 . . . . 0.0 111.043 -171.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.14 113.91 8.66 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 127.487 2.315 . . . . 0.0 109.902 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -66.15 144.77 56.45 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 122.207 -0.308 . . . . 0.0 110.424 167.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -122.53 150.33 42.71 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.946 2.098 . . . . 0.0 107.156 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -60.64 -27.31 67.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.399 1.08 . . . . 0.0 113.498 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -163.79 163.43 15.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.673 2.389 . . . . 0.0 107.028 174.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.99 -17.1 32.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.042 1.161 . . . . 0.0 112.065 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 -40.32 93.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.487 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.4 mmm -66.15 -40.87 90.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.751 1.159 . . . . 0.0 111.86 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.97 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.3 tt -59.25 -65.24 0.7 Allowed 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.453 0.701 . . . . 0.0 109.163 171.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -31.5 70.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.797 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 3.9 t -52.77 -69.01 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.39 -53.06 3.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.516 1.526 . . . . 0.0 111.589 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -50.57 -63.71 1.04 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.034 1.734 . . . . 0.0 110.914 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -62.31 -26.75 68.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.814 1.646 . . . . 0.0 112.221 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -63.32 1.2 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.0 20.27 0.29 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.179 -1.345 . . . . 0.0 114.479 -173.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -124.95 63.84 41.45 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 119.859 1.83 . . . . 0.0 110.139 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.59 -16.06 45.67 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 CA-C-N 121.506 1.574 . . . . 0.0 113.392 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -22.97 33.73 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.28 2.632 . . . . 0.0 113.508 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.97 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.47 150.59 48.72 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 174.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.596 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.6 m -153.63 159.77 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.712 1.605 . . . . 0.0 108.784 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.44 82.07 1.44 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.4 m -59.72 -42.17 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 170.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -157.24 140.3 15.33 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.554 1.141 . . . . 0.0 108.627 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.12 37.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.111 1.365 . . . . 0.0 112.697 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.15 159.99 27.75 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.73 148.95 29.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.234 1.956 . . . . 0.0 111.632 -167.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m . . . . . 0 CA--C 1.517 -0.317 0 C-N-CA 124.273 1.029 . . . . 0.0 108.54 174.456 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -176.44 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.415 1.886 . . . . 0.0 108.319 151.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.8 61.96 3.97 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.66 2.076 . . . . 0.0 111.023 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.92 -54.93 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 126.964 2.106 . . . . 0.0 107.463 170.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.01 -49.97 7.13 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 120.337 1.156 . . . . 0.0 111.705 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -91.42 87.24 6.35 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.804 0.729 . . . . 0.0 109.242 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -141.2 48.59 1.67 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.584 1.154 . . . . 0.0 108.406 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.64 164.85 38.41 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -163.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -82.86 168.48 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.068 2.512 . . . . 0.0 112.169 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -85.15 44.31 1.08 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.01 0.924 . . . . 0.0 110.968 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.33 135.01 56.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 109.663 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.99 43.37 1.04 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.453 2.301 . . . . 0.0 114.131 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -78.45 82.25 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 120.709 -1.244 . . . . 0.0 107.649 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.48 120.05 9.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 119.569 -1.957 . . . . 0.0 107.588 172.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -138.36 155.29 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -107.64 136.81 46.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.782 0.719 . . . . 0.0 110.319 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.54 163.81 24.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.498 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.1 p -34.23 -41.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.131 2.972 . . . . 0.0 116.184 -172.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 0.04 5.16 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.436 4.694 . . . . 0.0 111.75 -172.39 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.38 -4.81 39.49 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.373 0.987 . . . . 0.0 111.65 -165.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -76.49 106.12 7.94 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 127.229 2.211 . . . . 0.0 110.632 -170.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -66.24 144.29 56.71 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.453 0.57 . . . . 0.0 111.302 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -124.28 152.06 43.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.772 2.429 . . . . 0.0 107.041 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.477 1.111 . . . . 0.0 113.838 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -163.91 156.52 15.27 Favored Pre-proline 0 C--N 1.343 0.303 0 C-N-CA 126.958 2.103 . . . . 0.0 109.331 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.45 -18.65 43.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.412 2.075 . . . . 0.0 111.274 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -66.46 -42.52 87.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.69 -0.672 . . . . 0.0 111.005 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 86.4 mtp -61.61 -41.6 97.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.549 1.068 . . . . 0.0 112.031 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.735 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.86 -64.93 0.71 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.73 171.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.498 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -61.39 -30.04 70.3 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.843 -173.596 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.15 -69.63 0.13 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.18 -53.04 2.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.284 1.833 . . . . 0.0 111.053 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -48.06 -62.51 1.44 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.597 1.559 . . . . 0.0 110.632 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -18.14 63.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.227 -0.892 . . . . 0.0 112.799 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -79.97 -51.34 9.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.942 0.792 . . . . 0.0 108.885 -177.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.9 22.51 0.11 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.153 -1.359 . . . . 0.0 114.641 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -129.57 61.3 56.91 Favored Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 120.015 1.908 . . . . 0.0 110.338 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.04 -24.64 66.82 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.814 1.676 . . . . 0.0 112.703 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.16 -30.44 68.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 131.163 3.785 . . . . 0.0 115.042 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.735 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tp -66.33 155.27 37.76 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.588 ' H ' HD12 ' A' ' 40' ' ' LEU . 26.3 m -153.76 153.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.067 1.747 . . . . 0.0 109.788 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -74.86 83.37 2.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.8 m -57.37 -38.27 61.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 122.775 0.43 . . . . 0.0 110.378 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -162.89 138.38 6.89 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.652 1.181 . . . . 0.0 109.502 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.18 68.25 10.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.452 1.024 . . . . 0.0 108.805 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.99 157.46 20.2 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.51 153.99 13.81 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.965 1.776 . . . . 0.0 112.76 -159.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m . . . . . 0 CA--C 1.528 0.117 0 C-N-CA 124.875 1.27 . . . . 0.0 107.761 167.673 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.93 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.669 2.388 . . . . 0.0 105.873 166.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.88 -26.49 68.99 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.277 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.3 -48.49 82.54 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 119.593 1.697 . . . . 0.0 111.072 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.67 -65.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.388 2.059 . . . . 0.0 113.09 161.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.8 m -88.64 74.65 8.39 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 112.639 -158.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.91 8.89 6.84 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.866 1.266 . . . . 0.0 112.528 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.44 164.63 59.62 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 120.844 -1.16 . . . . 0.0 113.089 -175.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 169.18 20.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.882 2.388 . . . . 0.0 111.95 -174.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -75.17 43.73 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.539 1.536 . . . . 0.0 111.04 171.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 114.01 4.96 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 124.888 1.275 . . . . 0.0 108.888 168.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.7 101.86 5.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -148.47 79.86 1.44 Allowed 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.51 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 15.4 mmm180 -59.43 132.15 53.11 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.391 -0.818 . . . . 0.0 110.004 -170.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.98 167.38 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 123.507 0.723 . . . . 0.0 111.527 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.8 t -115.55 134.29 55.21 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.132 0.973 . . . . 0.0 110.887 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.24 164.96 23.7 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.983 1.277 . . . . 0.0 110.631 164.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.419 ' HA ' HG11 ' A' ' 43' ' ' VAL . 4.9 p -41.54 -40.37 1.83 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -164.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.78 0.03 4.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.589 1.556 . . . . 0.0 112.799 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.13 -0.71 88.43 Favored Glycine 0 CA--C 1.541 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 112.073 -159.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.02 94.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.959 2.104 . . . . 0.0 110.174 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.9 m -66.19 143.59 57.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -130.96 153.65 48.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.464 3.106 . . . . 0.0 110.254 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 7.1 m -45.62 -40.15 8.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 130.67 3.588 . . . . 0.0 116.157 172.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -163.76 158.73 17.02 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.603 1.961 . . . . 0.0 108.941 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.54 -19.82 27.84 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.519 1.479 . . . . 0.0 111.674 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.65 -46.84 88.81 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -63.35 -32.56 74.02 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.915 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.1 tt -61.67 -61.1 2.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 119.382 0.992 . . . . 0.0 109.022 172.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -60.5 -32.91 71.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.815 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -62.06 2.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.83 -52.99 6.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.903 2.081 . . . . 0.0 111.556 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 41.5 tttm -50.18 -60.96 2.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.381 1.073 . . . . 0.0 109.762 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 -17.14 63.56 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 124.259 0.974 . . . . 0.0 112.512 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -79.54 -44.55 20.94 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.811 0.732 . . . . 0.0 110.532 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.33 17.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.105 -1.386 . . . . 0.0 114.121 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -120.4 63.71 10.14 Favored Pre-proline 0 C--O 1.22 -0.485 0 CA-C-N 119.797 1.799 . . . . 0.0 109.38 -177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -60.22 -22.44 70.42 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.122 1.881 . . . . 0.0 112.988 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.44 -26.12 55.12 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 128.122 2.569 . . . . 0.0 113.441 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.915 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.05 154.53 39.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.655 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.1 m -150.8 148.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -75.13 85.25 2.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -54.19 -58.99 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.46 1.104 . . . . 0.0 109.893 167.422 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.38 -173.26 1.42 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.361 1.464 . . . . 0.0 109.243 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -177.15 6.32 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.968 2.107 . . . . 0.0 109.929 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.14 141.96 1.14 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 119.248 0.931 . . . . 0.0 113.909 171.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -82.88 145.9 12.8 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.113 1.876 . . . . 0.0 111.756 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.338 0.067 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 172.558 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PHE . . . . . 0.468 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -176.68 -65.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.122 0.969 . . . . 0.0 110.514 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.26 -14.62 44.33 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.766 2.127 . . . . 0.0 114.674 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -55.04 3.88 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.325 2.25 . . . . 0.0 110.925 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB2' ' CA ' ' A' ' 31' ' ' CYS . 37.5 Cg_endo -71.29 -53.79 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.929 2.42 . . . . 0.0 110.724 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.5 m -87.65 124.38 33.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 120.34 1.427 . . . . 0.0 108.94 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.14 29.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.468 1.507 . . . . 0.0 110.922 -173.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 164.98 13.59 Favored Pre-proline 0 C--O 1.236 0.355 0 O-C-N 121.677 -0.639 . . . . 0.0 111.043 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.69 172.92 13.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.268 1.979 . . . . 0.0 109.688 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -78.12 46.32 0.59 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.96 1.304 . . . . 0.0 110.373 171.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.64 123.89 20.9 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.29 49.71 1.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.113 1.365 . . . . 0.0 109.638 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.659 ' O ' HG13 ' A' ' 15' ' ' VAL . 10.2 m170 -80.18 58.96 3.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -48.06 122.92 5.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.852 1.205 . . . . 0.0 111.329 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 13' ' ' HIS . 23.0 m -134.23 178.15 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 C-N-CA 124.571 1.148 . . . . 0.0 111.153 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.6 144.11 51.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.76 171.05 31.34 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -53.18 -24.58 11.16 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 175.323 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -84.24 0.08 50.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.419 1.888 . . . . 0.0 112.516 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -7.55 36.96 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.823 -1.173 . . . . 0.0 111.859 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.58 107.34 1.37 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.182 1.393 . . . . 0.0 107.447 -176.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 7.4 m -66.27 146.25 54.81 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.466 ' CD2' HD12 ' A' ' 29' ' ' LEU . 60.1 m-85 -123.9 139.94 53.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.796 2.039 . . . . 0.0 106.488 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.6 t -45.45 -32.08 2.01 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.997 2.119 . . . . 0.0 112.206 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -163.56 154.7 14.2 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.555 2.342 . . . . 0.0 111.135 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -74.91 -24.4 13.05 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 111.159 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -28.01 69.26 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.023 -0.423 . . . . 0.0 112.049 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -36.03 60.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.76 170.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.856 ' HG ' HD11 ' A' ' 40' ' ' LEU . 8.8 tt -56.43 -67.34 0.31 Allowed 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -50.27 -37.33 35.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.556 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' CA ' ' HB2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -52.09 -71.78 0.06 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 175.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.9 -51.11 4.42 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.099 2.16 . . . . 0.0 110.872 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -66.29 0.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -15.17 60.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -73.86 -67.31 0.61 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.751 0.82 . . . . 0.0 108.86 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.75 39.97 0.25 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 126.489 1.995 . . . . 0.0 110.162 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -138.08 59.78 20.11 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.888 1.344 . . . . 0.0 111.341 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.92 -8.66 14.31 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.047 1.831 . . . . 0.0 112.764 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -90.5 -24.52 20.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.011 2.125 . . . . 0.0 113.769 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.856 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tp -66.4 150.32 49.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.487 ' H ' HD12 ' A' ' 40' ' ' LEU . 9.6 m -149.2 152.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -78.24 83.63 4.49 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.7 m -57.12 -46.15 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.861 0.865 . . . . 0.0 111.534 170.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -164.47 157.01 16.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 125.177 1.391 . . . . 0.0 109.084 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -87.68 54.99 3.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.964 2.906 . . . . 0.0 110.54 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.73 150.13 21.61 Favored Glycine 0 C--O 1.226 -0.358 0 O-C-N 119.836 -1.79 . . . . 0.0 109.041 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.2 146.62 28.7 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.235 1.956 . . . . 0.0 111.599 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 124.714 1.206 . . . . 0.0 110.502 179.426 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.455 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -176.13 133.75 0.25 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.14 -31.07 0.95 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.097 1.332 . . . . 0.0 114.701 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -67.08 -56.27 13.84 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.726 1.263 . . . . 0.0 111.024 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.23 -48.42 0.62 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.238 1.959 . . . . 0.0 112.299 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.04 125.41 41.46 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.469 0.708 . . . . 0.0 109.654 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 8' ' ' CYS . 1.8 mt-10 -154.47 -24.33 0.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.981 1.712 . . . . 0.0 110.93 172.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' H ' ' H ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -49.61 158.35 0.84 Allowed Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 125.972 1.709 . . . . 0.0 114.753 -179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.13 169.35 22.75 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 121.928 1.752 . . . . 0.0 111.179 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -80.29 43.65 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.075 0.95 . . . . 0.0 110.044 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.24 19.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.501 1.52 . . . . 0.0 109.247 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 42.79 0.33 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 111.08 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -84.93 63.26 7.98 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 121.149 -0.969 . . . . 0.0 108.698 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -55.77 134.9 51.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.108 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.34 -178.27 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 125.151 1.381 . . . . 0.0 111.516 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -125.21 137.34 54.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.512 1.125 . . . . 0.0 110.564 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.91 168.78 26.36 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 165.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.518 ' HA ' HG11 ' A' ' 43' ' ' VAL . 17.4 p -50.69 -31.3 15.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -171.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.02 0.0 5.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.25 66.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.359 0.981 . . . . 0.0 111.624 -163.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.09 110.82 9.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.337 1.455 . . . . 0.0 109.553 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -65.84 143.95 57.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.969 0.414 . . . . 0.0 110.366 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -119.4 145.39 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.368 2.267 . . . . 0.0 108.225 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -58.33 -29.22 65.77 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.344 1.057 . . . . 0.0 113.002 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 18.9 p30 -163.89 155.96 14.8 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 125.208 1.403 . . . . 0.0 109.78 173.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 68.6 Cg_endo -70.27 -16.37 35.4 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.486 2.124 . . . . 0.0 111.023 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.162 -0.336 . . . . 0.0 110.953 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.8 mtm -66.08 -31.73 72.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.656 172.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.918 ' HG ' HD11 ' A' ' 40' ' ' LEU . 7.7 tt -59.6 -68.26 0.3 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.397 0.998 . . . . 0.0 109.38 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -51.98 -39.27 59.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.824 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -68.49 0.17 Allowed 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.76 1.95 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 126.592 1.957 . . . . 0.0 110.506 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -51.04 -63.44 1.13 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.926 0.89 . . . . 0.0 110.647 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.6 -16.87 64.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.69 1.196 . . . . 0.0 112.727 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -77.87 -66.18 0.87 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.51 23.74 0.36 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.896 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -127.33 60.67 44.55 Favored Pre-proline 0 C--O 1.222 -0.392 0 CA-C-N 119.618 1.709 . . . . 0.0 109.835 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -61.23 -17.73 54.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.657 1.571 . . . . 0.0 113.166 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -26.36 45.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.399 2.28 . . . . 0.0 113.333 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.918 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.04 153.38 42.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.593 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.5 m -150.88 149.42 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -72.55 85.67 1.16 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -56.5 -47.16 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.563 0.745 . . . . 0.0 109.747 172.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 166.12 151.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.862 2.865 . . . . 0.0 106.957 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -68.34 -173.26 0.4 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.844 2.058 . . . . 0.0 111.388 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.71 142.1 0.79 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.08 143.68 18.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.225 1.513 . . . . 0.0 110.475 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.61 -43.27 14.59 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 119.274 -0.394 . . . . 0.0 110.85 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -65.23 159.48 23.61 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.411 0.684 . . . . 0.0 109.717 171.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -57.96 -64.43 0.91 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.897 1.679 . . . . 0.0 109.903 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -167.45 34.51 0.03 OUTLIER 'General case' 0 C--N 1.343 0.304 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -173.28 -167.54 0.41 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 118.978 -2.326 . . . . 0.0 106.954 -164.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -153.39 45.98 0.65 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.123 1.328 . . . . 0.0 110.565 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -169.65 157.08 6.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.95 1.3 . . . . 0.0 108.591 -164.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.31 1.444 . . . . 0.0 110.125 -179.386 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.39 -89.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.269 1.028 . . . . 0.0 109.667 156.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.19 76.24 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.112 -0.993 . . . . 0.0 112.555 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -43.98 79.63 Favored Pre-proline 0 C--N 1.34 0.161 0 CA-C-O 117.217 -1.373 . . . . 0.0 114.378 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.83 -51.41 0.48 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.538 2.159 . . . . 0.0 111.928 159.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.42 70.16 8.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.027 1.285 . . . . 0.0 113.081 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -83.92 -14.09 51.87 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.38 162.42 61.22 Favored Pre-proline 0 C--O 1.236 0.373 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -158.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.83 165.47 28.52 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.934 2.423 . . . . 0.0 110.783 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.81 43.56 1.0 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.386 0.674 . . . . 0.0 109.381 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.33 122.56 17.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.124 1.77 . . . . 0.0 110.498 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.89 43.77 0.36 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.56 1.944 . . . . 0.0 111.246 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -92.36 58.01 3.13 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 120.5 -1.375 . . . . 0.0 108.751 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -53.65 147.42 11.39 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.345 1.858 . . . . 0.0 113.207 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -149.14 153.75 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.024 0.929 . . . . 0.0 111.751 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 t -86.44 133.88 33.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 110.473 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.16 164.15 23.46 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 158.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.1 p -51.28 -25.12 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -168.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 0.01 11.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 112.385 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.58 50.17 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.838 -1.163 . . . . 0.0 110.692 -158.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -66.71 96.99 0.43 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 131.347 3.859 . . . . 0.0 110.974 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -66.13 144.39 56.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.756 0.422 . . . . 0.0 111.344 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -123.81 153.3 41.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.776 2.03 . . . . 0.0 107.809 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -65.97 -21.56 66.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 10.8 p30 -163.76 159.99 17.3 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.215 1.806 . . . . 0.0 108.883 168.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 46.0 Cg_endo -66.75 -20.13 52.72 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.877 . . . . 0.0 110.996 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -68.89 -45.57 70.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.224 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -37.57 87.24 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.623 1.101 . . . . 0.0 111.311 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.9 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.1 tt -56.7 -66.74 0.39 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.222 1.009 . . . . 0.0 109.964 168.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -32.16 70.71 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.536 -0.727 . . . . 0.0 111.327 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.7 -68.5 0.18 Allowed 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.03 -52.85 1.82 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.052 1.741 . . . . 0.0 111.525 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 42.9 tttm -48.18 -61.75 1.83 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.193 1.397 . . . . 0.0 110.544 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -67.92 -21.16 65.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -48.9 16.18 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.74 25.4 0.1 OUTLIER Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.234 -1.315 . . . . 0.0 114.887 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -130.35 63.65 70.05 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 120.014 1.907 . . . . 0.0 109.789 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -61.33 -19.99 66.36 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.446 1.552 . . . . 0.0 112.664 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -23.92 46.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.513 2.725 . . . . 0.0 113.494 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -66.49 154.67 39.69 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.647 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.8 m -150.66 150.6 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 124.901 1.28 . . . . 0.0 108.753 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -71.77 84.88 0.92 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.41 -53.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.303 0.641 . . . . 0.0 110.112 166.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -169.98 175.63 5.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.224 1.809 . . . . 0.0 110.148 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.21 171.93 10.28 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.88 2.472 . . . . 0.0 108.239 164.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.5 138.43 0.85 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 127.373 2.416 . . . . 0.0 112.216 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.18 142.42 21.58 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 110.834 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 m -83.47 -77.47 0.25 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -173.86 165.45 4.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.934 2.493 . . . . 0.0 107.514 -168.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.289 83.7 tt0 162.78 -72.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 128.479 2.712 . . . . 0.0 109.7 158.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -144.3 83.83 1.74 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.651 1.581 . . . . 0.0 107.905 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.19 146.4 23.46 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.808 0.843 . . . . 0.0 111.841 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -161.71 53.41 0.25 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.246 1.418 . . . . 0.0 109.534 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -81.37 171.65 14.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.359 1.064 . . . . 0.0 111.143 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 116.058 -1.925 . . . . 0.0 108.467 168.513 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 p90 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -176.7 -86.56 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.709 2.003 . . . . 0.0 107.597 141.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.22 -15.82 80.5 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.19 0.9 . . . . 0.0 113.637 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -50.02 65.79 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 119.317 1.558 . . . . 0.0 111.923 171.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -60.7 -51.89 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.291 1.327 . . . . 0.0 112.261 160.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.1 m -89.29 71.7 8.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.473 1.033 . . . . 0.0 112.323 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -116.85 84.15 2.09 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.11 165.24 19.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 123.282 0.633 . . . . 0.0 111.307 -172.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 165.07 20.73 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.251 2.634 . . . . 0.0 111.357 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.55 43.3 0.47 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.878 0.871 . . . . 0.0 111.067 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.0 128.32 35.59 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.899 1.279 . . . . 0.0 111.066 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.03 43.26 1.04 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.648 1.579 . . . . 0.0 110.674 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.454 ' O ' HG13 ' A' ' 15' ' ' VAL . 11.5 m170 -83.42 64.59 7.92 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 120.597 -1.314 . . . . 0.0 107.975 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -55.84 134.74 52.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.699 1.136 . . . . 0.0 111.721 -167.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 13' ' ' HIS . 14.1 m -135.68 169.68 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 110.443 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -123.9 143.17 50.53 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.4 1.0 . . . . 0.0 110.933 175.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.18 166.5 28.46 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.573 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.1 p -34.35 -40.86 0.1 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.278 2.631 . . . . 0.0 115.562 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.85 0.05 10.05 Favored 'General case' 0 N--CA 1.436 -1.16 1 C-N-CA 132.919 4.487 . . . . 0.0 111.654 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.2 -4.32 33.42 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.969 0.804 . . . . 0.0 112.086 -166.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.76 102.96 4.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.98 2.512 . . . . 0.0 110.163 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -66.37 143.56 57.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.219 0.463 . . . . 0.0 111.54 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -123.93 155.95 37.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.117 2.967 . . . . 0.0 108.499 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.1 t -63.88 -28.79 70.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -163.87 160.65 17.14 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.918 1.687 . . . . 0.0 107.637 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.37 -14.9 28.2 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 120.744 0.963 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.01 -44.68 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 118.101 0.409 . . . . 0.0 110.596 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mmm -59.0 -46.36 88.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.009 0.924 . . . . 0.0 110.515 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.78 -62.22 1.84 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.111 1.365 . . . . 0.0 110.876 173.211 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -35.56 77.18 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.713 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.38 -68.32 0.18 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 171.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.81 -52.75 1.72 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.872 2.069 . . . . 0.0 112.104 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 42.2 tttm -48.53 -59.11 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.731 1.612 . . . . 0.0 110.323 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -71.0 -23.97 62.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.576 0.75 . . . . 0.0 112.64 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -75.88 -38.65 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.514 0.726 . . . . 0.0 110.718 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.2 18.91 0.03 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.057 -1.413 . . . . 0.0 115.488 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 16.4 t-20 -128.79 62.42 61.1 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 120.327 2.063 . . . . 0.0 110.073 -176.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.23 -25.34 71.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.979 1.786 . . . . 0.0 112.786 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.06 -32.66 74.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 131.273 3.829 . . . . 0.0 114.304 175.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.661 HD12 ' H ' ' A' ' 41' ' ' VAL . 3.8 tp -66.2 157.54 31.13 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 109.183 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.661 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.4 m -152.47 149.79 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 126.516 1.926 . . . . 0.0 109.74 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.77 83.96 1.64 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 164.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -54.1 -46.29 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.743 0.817 . . . . 0.0 108.946 174.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -161.22 178.78 8.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -83.36 178.83 7.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 159.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.01 144.14 1.38 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -172.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.45 158.64 25.74 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.868 1.712 . . . . 0.0 110.853 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.6 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 64.6 m -86.49 -91.05 0.1 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 162.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.23 -157.25 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.093 1.357 . . . . 0.0 108.876 174.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.27 -89.61 0.11 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.285 1.434 . . . . 0.0 108.377 164.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.88 -54.26 0.16 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.163 2.585 . . . . 0.0 108.47 169.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -173.6 157.07 3.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.558 2.343 . . . . 0.0 108.126 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -106.94 83.37 1.82 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.495 1.518 . . . . 0.0 111.12 171.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -70.14 170.67 11.06 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.785 0.721 . . . . 0.0 111.461 167.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.608 -1.187 . . . . 0.0 112.227 -176.178 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -176.81 -81.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.94 1.696 . . . . 0.0 107.113 140.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.25 -39.38 44.15 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 119.2 -0.778 . . . . 0.0 112.222 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -43.51 77.81 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 116.682 -1.628 . . . . 0.0 115.127 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 18.5 Cg_endo -56.11 -28.24 69.15 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 122.266 1.845 . . . . 0.0 112.228 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -105.25 29.15 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.769 1.628 . . . . 0.0 111.915 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -56.78 -27.67 60.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.57 163.42 3.73 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.129 2.572 . . . . 0.0 114.997 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.21 162.24 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.376 2.051 . . . . 0.0 110.912 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 43.15 0.97 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.633 -0.667 . . . . 0.0 110.236 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.43 127.69 33.27 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.093 2.157 . . . . 0.0 110.89 172.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.18 43.54 0.63 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.556 1.542 . . . . 0.0 112.019 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -82.78 55.92 3.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.458 -1.401 . . . . 0.0 109.959 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -54.65 144.26 22.37 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.61 1.564 . . . . 0.0 114.881 -161.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 26' ' ' PRO . 4.2 m -146.36 162.16 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.726 0.81 . . . . 0.0 111.844 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.6 t -101.43 130.77 47.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.279 0.632 . . . . 0.0 112.0 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.08 163.39 23.23 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 158.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.474 ' HA ' HG11 ' A' ' 43' ' ' VAL . 88.5 p -34.03 -57.56 0.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 118.237 2.68 . . . . 0.0 118.237 -161.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.71 42.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.219 -162.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.36 42.44 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 123.758 0.694 . . . . 0.0 112.617 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.18 75.51 2.33 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.824 3.249 . . . . 0.0 108.946 -159.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.0 m -66.31 143.74 57.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.662 -0.649 . . . . 0.0 110.225 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.02 155.42 46.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.597 2.359 . . . . 0.0 108.562 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -59.85 -25.45 65.03 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.434 1.494 . . . . 0.0 114.047 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 11.8 p30 -163.55 162.66 17.01 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.806 2.043 . . . . 0.0 107.675 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HA ' HG21 ' A' ' 15' ' ' VAL . 39.8 Cg_endo -66.83 -21.82 50.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.185 1.257 . . . . 0.0 111.368 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.01 -37.84 84.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.599 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 mmm -68.85 -35.68 77.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.792 1.178 . . . . 0.0 111.704 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.937 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.1 tt -61.9 -63.99 1.08 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.38 -32.64 70.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.777 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 2.1 t -51.4 -71.44 0.06 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.02 -52.9 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.431 1.893 . . . . 0.0 111.317 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 44.9 tttm -48.66 -63.96 0.94 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.844 1.657 . . . . 0.0 110.466 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -73.15 -18.4 61.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.54 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -73.55 -55.08 6.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.97 0.508 . . . . 0.0 110.131 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.08 16.49 0.09 OUTLIER Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.818 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 12.5 t-20 -126.76 57.77 24.06 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.693 1.746 . . . . 0.0 108.646 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.22 -22.85 66.78 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 122.48 1.921 . . . . 0.0 112.724 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.07 -31.89 73.24 Favored 'General case' 0 CA--C 1.533 0.312 1 C-N-CA 132.415 4.286 . . . . 0.0 114.873 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.937 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -65.69 156.59 32.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.188 1.395 . . . . 0.0 108.542 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.659 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.4 m -152.36 155.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.853 1.661 . . . . 0.0 109.431 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -73.84 87.01 1.75 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 163.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.93 -48.51 63.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 123.165 0.586 . . . . 0.0 110.491 167.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -162.73 164.37 26.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.135 1.774 . . . . 0.0 107.534 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -84.26 166.01 17.85 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 166.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.83 150.18 2.81 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 111.357 -170.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -83.23 157.55 14.94 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.659 -166.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.42 -38.76 18.31 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 119.31 -0.376 . . . . 0.0 110.656 165.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.56 128.79 37.62 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 168.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -153.77 148.5 26.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 164.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -151.85 -47.42 0.11 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.253 1.421 . . . . 0.0 109.1 -173.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.57 164.7 4.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.236 2.215 . . . . 0.0 107.563 163.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -145.5 38.37 1.13 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.341 1.456 . . . . 0.0 109.056 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.02 -48.15 74.93 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.798 0.839 . . . . 0.0 111.517 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 125.481 1.513 . . . . 0.0 109.429 165.554 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 p90 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.96 -68.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.978 . . . . 0.0 105.965 166.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.9 -17.87 42.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.849 1.214 . . . . 0.0 115.289 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -64.91 -52.02 52.69 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 119.011 1.406 . . . . 0.0 111.81 165.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.46 -58.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.015 3.143 . . . . 0.0 112.629 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.89 96.79 10.34 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.953 1.706 . . . . 0.0 111.082 -167.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.84 0.02 2.16 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 125.007 1.442 . . . . 0.0 113.947 -175.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 163.9 62.59 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.354 1.462 . . . . 0.0 113.884 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.52 165.18 31.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.595 2.197 . . . . 0.0 110.69 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.36 47.51 0.09 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.83 1.252 . . . . 0.0 112.066 167.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.84 118.73 10.1 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.146 165.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -77.55 42.44 0.36 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.407 1.883 . . . . 0.0 111.473 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 15' ' ' VAL . 6.2 m80 -79.58 64.89 4.58 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.67 137.61 57.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.657 1.572 . . . . 0.0 111.55 -168.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 13' ' ' HIS . 2.8 m -141.54 167.32 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.89 0.876 . . . . 0.0 112.097 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 t -105.53 141.56 36.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.071 0.948 . . . . 0.0 110.719 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.39 166.14 24.1 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.892 1.234 . . . . 0.0 111.217 159.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.55 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -37.9 -40.35 0.45 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.385 2.274 . . . . 0.0 115.665 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.47 16.5 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 110.314 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.77 65.47 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.219 -165.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -68.68 92.62 0.48 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.46 1.504 . . . . 0.0 109.354 -163.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -65.9 143.46 57.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -126.54 155.02 43.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.827 2.051 . . . . 0.0 108.707 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.1 p -65.46 -27.88 68.82 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.688 1.195 . . . . 0.0 113.212 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -163.41 152.63 12.42 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 127.326 2.25 . . . . 0.0 108.957 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.86 -23.65 22.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.118 1.212 . . . . 0.0 110.92 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -56.76 -44.47 81.81 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 111.105 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.31 70.14 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.896 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.6 tt -64.46 -65.86 0.62 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 t -52.39 -29.47 24.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.445 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -62.05 -60.74 3.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.094 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' N ' ' SG ' ' A' ' 31' ' ' CYS . . . -42.35 -51.9 4.72 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.992 2.117 . . . . 0.0 110.206 175.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 tttm -50.95 -63.2 1.2 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.339 1.024 . . . . 0.0 110.562 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.73 -14.0 62.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.518 1.127 . . . . 0.0 113.943 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -58.23 3.26 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.75 34.14 0.14 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.591 -1.116 . . . . 0.0 113.09 -173.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -134.85 62.1 51.29 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 119.271 1.535 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.0 -13.44 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 CA-C-N 121.058 1.414 . . . . 0.0 114.027 -172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.66 -27.01 37.25 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.503 2.721 . . . . 0.0 112.735 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.896 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.9 tp -66.39 153.56 42.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.62 ' H ' HD12 ' A' ' 40' ' ' LEU . 35.2 m -147.74 144.05 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -74.38 87.28 2.03 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.7 OUTLIER -58.73 -50.67 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.44 1.496 . . . . 0.0 108.885 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -179.39 -171.52 0.2 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.51 3.124 . . . . 0.0 107.574 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -164.82 1.05 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.81 2.444 . . . . 0.0 108.604 166.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 123.15 0.19 Allowed Glycine 0 CA--C 1.544 1.895 0 C-N-CA 124.862 1.22 . . . . 0.0 113.975 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.16 135.23 13.54 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 120.823 2.311 . . . . 0.0 112.312 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m -76.02 -43.02 46.13 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.444 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -74.84 125.44 28.81 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.304 1.041 . . . . 0.0 109.522 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.14 88.13 1.23 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.06 83.43 0.65 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.81 2.044 . . . . 0.0 109.098 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -58.22 111.92 1.37 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.464 1.906 . . . . 0.0 110.213 167.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -104.28 47.06 0.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.917 1.687 . . . . 0.0 109.443 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.53 174.68 12.67 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 166.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.195 1.398 . . . . 0.0 112.118 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.22 -54.9 0.01 OUTLIER 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.18 0.992 . . . . 0.0 111.448 170.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.75 67.0 1.12 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 127.017 2.246 . . . . 0.0 109.39 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -176.62 -55.87 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.259 1.824 . . . . 0.0 109.851 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' CA ' ' A' ' 31' ' ' CYS . 28.2 Cg_endo -72.74 -58.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.733 1.622 . . . . 0.0 110.004 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.17 133.83 35.53 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 176.57 34.41 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 O-C-N 125.967 2.042 . . . . 0.0 111.726 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.7 165.78 12.72 Favored Pre-proline 0 C--O 1.233 0.234 0 O-C-N 121.293 -0.88 . . . . 0.0 112.28 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.48 172.38 14.34 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.233 1.956 . . . . 0.0 109.709 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -77.01 44.26 0.39 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.661 1.584 . . . . 0.0 110.722 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 120.31 11.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.77 1.228 . . . . 0.0 110.046 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.49 54.49 2.36 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.802 1.641 . . . . 0.0 110.54 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.613 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.5 m80 -91.04 61.3 4.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 48.4 mmm-85 -46.2 100.37 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 13' ' ' HIS . 34.8 m -99.52 178.81 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 124.932 1.293 . . . . 0.0 112.299 174.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 4.1 t -115.97 135.33 54.07 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.457 1.503 . . . . 0.0 109.025 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.75 173.07 41.38 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -55.58 -32.1 62.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.21 -0.03 30.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.914 1.286 . . . . 0.0 110.567 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.93 -0.82 61.16 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.67 1.129 . . . . 0.0 111.991 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.97 115.32 11.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 26.2 m -65.79 150.14 49.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.77 136.02 53.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -37.17 -37.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.777 2.031 . . . . 0.0 113.241 170.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -163.69 155.79 15.0 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 128.072 2.549 . . . . 0.0 111.361 -176.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.3 -24.87 16.19 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.471 2.781 . . . . 0.0 110.292 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.74 -30.04 69.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.3 mtp -74.61 -41.51 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.002 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.79 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.6 tt -51.26 -70.03 0.1 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 t -50.24 -38.07 38.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.741 0.416 . . . . 0.0 111.804 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.442 ' CA ' ' HB2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -51.49 -72.18 0.05 Allowed 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -35.91 -55.85 0.73 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 127.679 2.392 . . . . 0.0 109.79 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.52 -66.03 0.43 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.481 -1.69 . . . . 0.0 114.054 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.87 63.24 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 124.584 1.177 . . . . 0.0 111.249 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -78.33 0.11 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.399 1.48 . . . . 0.0 107.778 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.43 48.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 127.078 2.275 . . . . 0.0 109.503 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -148.03 59.99 4.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 117.891 0.845 . . . . 0.0 111.753 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.83 -10.56 17.62 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 122.967 2.445 . . . . 0.0 113.612 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.55 -28.93 21.67 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 127.0 2.12 . . . . 0.0 113.709 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.79 HD11 ' HG ' ' A' ' 29' ' ' LEU . 2.4 tp -65.59 154.2 39.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.56 ' H ' HD12 ' A' ' 40' ' ' LEU . 18.1 m -146.89 145.33 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -73.42 82.83 1.45 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -55.5 -49.75 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.669 172.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 174.78 176.94 0.15 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.009 2.124 . . . . 0.0 109.032 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -174.85 5.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.009 2.124 . . . . 0.0 110.522 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.34 134.37 0.53 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.37 1.462 . . . . 0.0 112.909 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.9 145.52 36.2 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.532 2.166 . . . . 0.0 111.372 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.457 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -86.53 -99.99 0.07 Allowed 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 178.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -178.67 135.92 0.14 Allowed 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 125.317 1.636 . . . . 0.0 108.419 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.99 -176.75 6.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.997 1.319 . . . . 0.0 110.674 173.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.32 52.62 2.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.482 1.513 . . . . 0.0 109.928 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -174.26 152.46 1.81 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.612 0.765 . . . . 0.0 110.022 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -135.51 75.17 1.55 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.033 0.933 . . . . 0.0 108.653 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.94 157.48 20.13 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.89 0.476 . . . . 0.0 110.353 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.254 1.325 0 CA-C-O 117.437 -1.268 . . . . 0.0 109.436 -179.675 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.461 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.69 174.97 14.22 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 102.989 -2.967 . . . . 0.0 102.989 139.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.15 -70.22 2.82 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.768 1.175 . . . . 0.0 112.041 166.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -43.97 83.86 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 116.553 -1.689 . . . . 0.0 114.739 -173.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 31.8 Cg_endo -57.5 -22.32 50.35 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.652 1.568 . . . . 0.0 113.206 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.75 46.55 1.82 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.684 1.594 . . . . 0.0 112.309 -167.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -29.73 70.38 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.692 -1.255 . . . . 0.0 112.018 168.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.06 157.14 54.19 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 126.436 1.894 . . . . 0.0 115.513 -163.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.59 164.64 30.16 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.015 2.477 . . . . 0.0 110.572 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.72 43.52 0.84 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.599 -0.688 . . . . 0.0 109.994 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.13 132.73 49.17 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.382 1.873 . . . . 0.0 110.578 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.85 43.62 1.05 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.953 1.701 . . . . 0.0 110.82 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -87.96 63.93 7.59 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.248 -1.533 . . . . 0.0 108.761 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -60.11 146.96 41.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.894 1.278 . . . . 0.0 113.344 -160.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 m -147.36 158.41 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.499 1.12 . . . . 0.0 111.819 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -91.55 136.51 33.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.666 0.786 . . . . 0.0 110.967 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.79 163.97 23.8 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 159.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.501 ' HA ' HG11 ' A' ' 43' ' ' VAL . 82.1 p -47.15 -32.61 4.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.109 2.164 . . . . 0.0 116.17 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.65 -7.27 25.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.844 1.658 . . . . 0.0 113.019 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.78 -9.67 50.58 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.359 0.98 . . . . 0.0 111.046 -158.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.7 96.5 0.28 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.133 2.573 . . . . 0.0 108.921 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -66.63 144.33 56.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 110.504 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -123.71 145.12 49.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.843 1.657 . . . . 0.0 107.389 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.423 ' H ' ' CE ' ' A' ' 28' ' ' MET . 10.0 m -62.69 -16.25 56.35 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -176.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.46 158.5 17.5 Favored Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 108.607 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.38 -15.77 31.17 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.785 1.657 . . . . 0.0 111.99 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -72.82 -40.23 65.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.423 ' CE ' ' H ' ' A' ' 24' ' ' SER . 19.0 ttp -61.87 -45.33 94.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.916 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.22 -63.55 1.12 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.991 174.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -34.44 74.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.226 -174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 2.9 t -50.31 -69.02 0.12 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 124.806 1.243 . . . . 0.0 108.616 169.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.09 -52.63 2.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.099 2.16 . . . . 0.0 111.884 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -49.13 -61.61 1.98 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.869 1.668 . . . . 0.0 110.586 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 123.957 0.786 . . . . 0.0 112.512 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -77.68 -46.6 21.45 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.002 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.5 18.82 0.09 OUTLIER Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.312 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -133.48 65.45 71.94 Favored Pre-proline 0 C--O 1.223 -0.338 0 CA-C-N 119.932 1.866 . . . . 0.0 110.25 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -61.55 -20.07 67.22 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.482 1.565 . . . . 0.0 112.615 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -22.14 47.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.654 2.782 . . . . 0.0 113.774 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.916 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.9 tp -66.48 152.15 45.76 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.614 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.3 m -151.52 155.98 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.773 1.629 . . . . 0.0 108.801 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -73.79 84.3 1.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.8 -50.25 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 C-N-CA 122.944 0.498 . . . . 0.0 110.194 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -159.33 -174.32 4.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.231 1.813 . . . . 0.0 106.26 165.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 46' ' ' GLY . 26.2 tt0 -71.35 -137.39 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.18 1.392 . . . . 0.0 107.4 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.472 ' H ' ' HG2' ' A' ' 45' ' ' GLU . . . 51.87 116.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 128.104 2.764 . . . . 0.0 117.881 158.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.76 127.61 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 CA-C-N 119.709 1.755 . . . . 0.0 112.376 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.6 m -73.26 -28.24 62.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.999 -0.524 . . . . 0.0 112.11 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.83 -79.95 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.35 1.86 . . . . 0.0 110.389 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.55 170.17 19.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.018 0.927 . . . . 0.0 109.47 171.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -120.27 78.61 1.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.182 2.193 . . . . 0.0 110.161 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.92 164.75 4.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.689 1.596 . . . . 0.0 111.965 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.05 41.57 1.19 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.378 1.071 . . . . 0.0 110.026 -168.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.08 -45.97 89.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.301 1.04 . . . . 0.0 112.071 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 116.859 -1.543 . . . . 0.0 108.888 165.619 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.463 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -176.62 -78.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.546 2.338 . . . . 0.0 105.72 159.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 50.48 3.79 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 127.234 2.349 . . . . 0.0 112.911 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 2.9 t-20 -144.29 -53.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.585 1.954 . . . . 0.0 109.299 163.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 11.3 Cg_endo -59.27 -29.94 91.62 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.377 2.051 . . . . 0.0 114.199 166.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.95 102.15 9.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.004 1.274 . . . . 0.0 112.889 -172.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -126.31 -0.0 7.02 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.106 1.362 . . . . 0.0 112.763 163.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -75.91 165.72 50.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -165.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.99 167.25 20.28 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.225 1.95 . . . . 0.0 110.728 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp85 -85.46 43.83 1.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.621 -0.675 . . . . 0.0 110.639 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.03 24.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.901 1.68 . . . . 0.0 110.304 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.35 43.48 1.02 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.538 1.535 . . . . 0.0 111.652 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.484 ' O ' HG13 ' A' ' 15' ' ' VAL . 34.5 m170 -78.23 70.65 4.62 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 120.603 -1.31 . . . . 0.0 107.89 170.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -52.96 130.52 33.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.4 1.08 . . . . 0.0 111.308 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 13' ' ' HIS . 4.1 m -135.74 162.93 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 123.455 0.702 . . . . 0.0 111.746 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.0 135.29 45.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 111.422 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.01 163.86 23.5 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 158.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.521 ' HA ' HG11 ' A' ' 43' ' ' VAL . 89.2 p -42.28 -36.49 1.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 -164.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . 82.0 m-20 -72.1 -1.47 14.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 112.757 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.81 82.7 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 119.145 0.884 . . . . 0.0 112.175 -159.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 45.8 t-20 -67.73 90.47 0.28 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.967 2.507 . . . . 0.0 109.75 -171.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 83.4 m -65.89 144.15 56.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.368 0.667 . . . . 0.0 111.832 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.18 158.39 39.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.473 2.709 . . . . 0.0 108.282 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 t -61.33 -28.49 69.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.818 1.247 . . . . 0.0 113.926 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 12.9 p30 -163.82 161.9 16.85 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 125.931 1.692 . . . . 0.0 108.376 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.9 Cg_endo -73.81 -16.63 23.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 120.968 1.112 . . . . 0.0 111.87 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -64.85 -45.93 84.01 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.565 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.3 mtp -58.15 -41.6 84.1 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.979 0.809 . . . . 0.0 112.57 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.904 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.7 tt -55.76 -67.2 0.31 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 109.095 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -33.78 71.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.595 -0.69 . . . . 0.0 111.485 -172.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.9 t -53.32 -70.93 0.08 Allowed 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.239 1.416 . . . . 0.0 107.679 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.51 0.82 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 126.606 1.963 . . . . 0.0 111.851 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -49.86 -63.96 0.95 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.851 1.261 . . . . 0.0 110.979 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -15.07 63.46 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.663 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -80.48 -59.62 2.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.42 28.25 0.26 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.47 -1.183 . . . . 0.0 114.146 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.02 66.56 79.35 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 119.5 1.65 . . . . 0.0 109.737 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.58 -19.4 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.817 1.327 . . . . 0.0 112.402 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.56 -25.77 50.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.794 2.838 . . . . 0.0 113.904 176.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.904 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.5 tp -66.52 154.54 40.08 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.689 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.1 m -150.95 154.65 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.737 1.215 . . . . 0.0 110.182 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.408 HE22 ' HB3' ' A' ' 26' ' ' PRO . 30.1 tp60 -75.08 86.56 2.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -56.55 -53.87 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.777 0.831 . . . . 0.0 109.788 166.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -164.66 -175.24 3.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.198 1.799 . . . . 0.0 108.503 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -86.0 -175.05 5.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.132 1.373 . . . . 0.0 108.045 158.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.91 142.34 1.12 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.425 1.012 . . . . 0.0 112.12 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -83.24 146.86 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.177 1.918 . . . . 0.0 111.1 -171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.5 m -86.41 -36.86 18.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 168.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.24 139.93 58.04 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.525 1.13 . . . . 0.0 109.938 167.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -153.77 129.93 10.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -152.62 -67.65 0.16 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -173.37 171.01 4.09 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.316 2.246 . . . . 0.0 106.854 168.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -106.48 69.77 0.8 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.7 1.2 . . . . 0.0 110.38 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -65.73 157.92 28.89 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.055 0.542 . . . . 0.0 110.24 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 116.486 -1.721 . . . . 0.0 107.549 176.005 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.23 -79.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.521 1.928 . . . . 0.0 106.614 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.16 -27.23 41.17 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.636 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -44.08 78.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 116.902 -1.523 . . . . 0.0 114.557 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -68.47 -50.14 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.058 1.838 . . . . 0.0 111.562 166.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -90.7 76.32 6.47 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.856 1.207 . . . . 0.0 111.188 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.65 102.76 6.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 159.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.71 165.81 6.96 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.308 1.443 . . . . 0.0 109.253 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.43 159.09 32.73 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.124 1.883 . . . . 0.0 110.7 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -78.42 43.32 0.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.55 0.74 . . . . 0.0 110.488 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.48 126.15 27.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.593 1.957 . . . . 0.0 110.943 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.95 43.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.602 1.561 . . . . 0.0 111.511 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -83.53 62.76 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.496 -1.377 . . . . 0.0 109.913 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -53.69 140.28 29.8 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -165.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -146.45 176.65 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 125.424 1.49 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 42.7 t -125.5 146.19 49.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.435 1.016 . . . . 0.0 111.705 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.18 163.6 23.21 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.029 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.428 ' HB3' HG13 ' A' ' 43' ' ' VAL . 84.5 p -53.24 -14.46 0.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.114 1.766 . . . . 0.0 114.482 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.79 -15.24 58.22 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.212 2.205 . . . . 0.0 112.14 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.43 -9.73 40.28 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 124.856 1.217 . . . . 0.0 111.358 -163.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.52 114.9 15.76 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.561 1.945 . . . . 0.0 110.151 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -65.64 143.84 57.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.957 0.799 . . . . 0.0 109.536 166.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -121.26 147.4 45.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.323 1.849 . . . . 0.0 106.87 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 m -60.61 -23.43 64.71 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.555 0.742 . . . . 0.0 112.501 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -163.59 161.09 17.7 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.958 2.103 . . . . 0.0 107.95 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.3 -14.64 34.61 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.973 1.782 . . . . 0.0 112.201 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.64 -40.11 84.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.864 0.466 . . . . 0.0 110.986 173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 89.5 mtp -65.06 -39.72 93.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.013 0.824 . . . . 0.0 111.551 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -58.41 -63.66 1.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.073 0.949 . . . . 0.0 110.043 171.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.45 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -60.33 -32.4 71.2 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.668 -175.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -69.07 0.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.02 -52.89 1.39 Allowed 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 126.47 1.908 . . . . 0.0 111.657 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -50.06 -63.09 1.22 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.385 1.874 . . . . 0.0 110.29 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -66.83 -25.91 66.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.331 1.052 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -69.57 -57.43 5.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.282 0.633 . . . . 0.0 109.529 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.11 21.31 0.11 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.565 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -125.62 62.22 40.52 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 119.589 1.694 . . . . 0.0 109.382 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -61.16 -18.3 57.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 121.45 1.554 . . . . 0.0 113.141 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -23.36 42.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.329 2.652 . . . . 0.0 113.625 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.684 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.5 tp -66.39 152.4 45.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.539 ' H ' HD12 ' A' ' 40' ' ' LEU . 29.0 m -156.08 161.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.341 2.256 . . . . 0.0 108.87 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -75.73 80.81 2.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 18' ' ' SER . 0.3 OUTLIER -54.24 -41.01 49.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 124.99 1.316 . . . . 0.0 111.147 172.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.36 143.04 18.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -84.63 55.23 3.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.478 1.132 . . . . 0.0 108.761 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.67 158.41 31.35 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.247 2.356 . . . . 0.0 108.488 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -82.15 153.47 16.53 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.835 2.357 . . . . 0.0 113.375 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 60.6 m -86.57 -53.07 5.18 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.377 1.871 . . . . 0.0 108.88 169.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.1 138.76 40.99 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.833 2.053 . . . . 0.0 110.093 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -153.6 176.04 12.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.842 1.257 . . . . 0.0 108.768 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 159.09 -46.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 128.909 2.884 . . . . 0.0 106.757 -159.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -75.42 115.56 15.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.692 1.597 . . . . 0.0 109.562 -164.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -130.75 75.74 1.68 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.9 -33.52 74.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.238 1.015 . . . . 0.0 111.407 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.9 t80 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 127.873 2.469 . . . . 0.0 105.984 170.437 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.616 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.1 133.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 162.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.16 -36.75 1.1 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.061 0.839 . . . . 0.0 113.552 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -50.3 72.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.401 1.08 . . . . 0.0 109.767 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.14 -36.08 6.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.628 2.218 . . . . 0.0 113.875 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -108.32 95.15 5.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.547 1.067 . . . . 0.0 110.232 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -119.91 5.51 10.91 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.025 1.33 . . . . 0.0 111.051 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.92 165.85 20.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 0.0 114.325 -167.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.92 167.98 10.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mtt85 -74.67 44.33 0.21 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.137 1.375 . . . . 0.0 111.448 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.78 120.31 12.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.716 1.207 . . . . 0.0 110.173 164.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.44 43.81 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.119 2.167 . . . . 0.0 111.709 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.479 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.2 m-70 -78.7 67.86 4.54 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.782 -1.198 . . . . 0.0 108.213 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -57.59 133.66 55.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.741 1.609 . . . . 0.0 110.483 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 13' ' ' HIS . 17.9 m -135.34 167.86 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.364 1.066 . . . . 0.0 111.158 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -106.15 137.69 43.65 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.229 1.012 . . . . 0.0 111.592 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.99 163.97 23.57 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 159.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.451 ' HA ' HG11 ' A' ' 43' ' ' VAL . 60.6 p -45.83 -34.27 3.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -168.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -0.04 6.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.475 1.11 . . . . 0.0 112.384 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.82 1.52 90.6 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 111.666 -159.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.86 100.48 4.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.836 1.654 . . . . 0.0 110.584 -166.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -66.1 143.61 57.21 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.858 -0.526 . . . . 0.0 111.355 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -122.27 153.62 38.65 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.87 2.468 . . . . 0.0 108.641 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -63.12 -28.42 70.05 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.462 1.505 . . . . 0.0 113.178 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 18.3 p30 -163.58 158.87 17.48 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.071 1.748 . . . . 0.0 110.126 173.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.4 Cg_endo -70.63 -20.07 31.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.247 1.298 . . . . 0.0 111.496 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -66.1 -43.94 85.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.943 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtm -62.58 -35.54 79.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.6 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.913 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.7 tt -60.42 -66.05 0.59 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.213 0.915 . . . . 0.0 109.495 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -56.11 -36.49 68.25 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.337 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -68.93 0.13 Allowed 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.333 1.053 . . . . 0.0 108.945 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -37.94 -53.12 1.36 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.343 1.857 . . . . 0.0 110.784 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -51.54 -63.8 1.02 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.549 1.14 . . . . 0.0 110.523 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.36 -15.43 63.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.522 1.129 . . . . 0.0 112.742 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -78.27 -64.21 1.22 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.9 27.66 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.896 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -128.69 64.53 69.45 Favored Pre-proline 0 C--N 1.343 0.326 0 CA-C-N 119.141 1.471 . . . . 0.0 110.194 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -63.08 -16.65 55.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.97 1.382 . . . . 0.0 112.777 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.35 -25.99 42.16 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.179 2.192 . . . . 0.0 113.228 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.913 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.32 153.85 41.55 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.667 ' H ' HD12 ' A' ' 40' ' ' LEU . 31.6 m -151.11 147.29 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.258 1.423 . . . . 0.0 107.72 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -76.9 86.2 3.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.92 -53.65 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.936 0.894 . . . . 0.0 110.401 168.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.65 177.21 5.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.274 1.43 . . . . 0.0 109.721 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 178.26 7.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.923 1.689 . . . . 0.0 107.713 166.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.76 142.03 1.05 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 119.039 0.836 . . . . 0.0 112.972 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -80.82 147.4 17.05 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.923 1.749 . . . . 0.0 111.119 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 m -85.59 -56.89 3.29 Favored 'General case' 0 CA--C 1.523 -0.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.021 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -61.49 145.96 50.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -78.51 163.55 25.47 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.327 0.584 . . . . 0.0 109.662 -171.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -92.77 98.61 11.51 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -59.82 163.36 4.55 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.81 0.814 . . . . 0.0 110.892 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -106.06 56.95 0.66 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.03 1.732 . . . . 0.0 109.83 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.72 -29.39 70.38 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 116.69 -1.624 . . . . 0.0 110.457 177.465 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -176.52 -71.08 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.311 1.844 . . . . 0.0 107.605 167.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.64 67.75 3.63 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.101 1.81 . . . . 0.0 110.727 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.6 -52.18 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.41 2.284 . . . . 0.0 107.556 169.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.77 -43.0 5.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.17 2.58 . . . . 0.0 114.521 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.11 93.59 5.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.809 1.64 . . . . 0.0 112.389 -169.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.11 2.43 9.83 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.063 1.745 . . . . 0.0 113.315 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.93 170.94 9.43 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -162.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.61 167.21 11.71 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.417 2.745 . . . . 0.0 111.474 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.43 45.73 0.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.388 -0.82 . . . . 0.0 111.24 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 119.5 9.9 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 165.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.06 42.94 0.27 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.018 2.527 . . . . 0.0 112.217 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.08 63.53 5.12 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.489 -1.382 . . . . 0.0 108.758 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.3 140.08 54.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.738 1.215 . . . . 0.0 113.419 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.2 160.19 13.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.84 135.25 35.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.702 1.601 . . . . 0.0 110.798 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.65 164.72 24.29 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 159.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' HG11 ' A' ' 43' ' ' VAL . 88.5 p -43.96 -38.26 3.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -169.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -0.24 7.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.671 1.188 . . . . 0.0 113.119 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.97 -5.36 85.31 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.821 0.737 . . . . 0.0 111.576 -165.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -71.7 99.98 2.24 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.599 2.359 . . . . 0.0 110.287 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -67.06 145.61 55.18 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.745 -0.597 . . . . 0.0 112.284 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -126.42 158.56 35.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.159 2.184 . . . . 0.0 108.876 171.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -62.75 -29.17 70.49 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.311 1.844 . . . . 0.0 114.178 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -163.71 155.02 14.25 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 109.148 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.33 -17.91 34.69 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.634 2.223 . . . . 0.0 110.736 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.1 t -62.61 -46.33 88.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.026 0.93 . . . . 0.0 110.06 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mtm -66.16 -31.81 72.87 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.233 -0.889 . . . . 0.0 112.823 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.887 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -60.98 -63.89 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.74 1.155 . . . . 0.0 109.72 171.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.86 -35.44 72.95 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.278 -176.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.13 -66.56 0.37 Allowed 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.53 -53.54 1.57 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 127.188 2.195 . . . . 0.0 110.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 43.4 tttm -50.85 -62.47 1.59 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.835 1.254 . . . . 0.0 109.746 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -18.82 65.41 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.379 1.049 . . . . 0.0 113.168 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -56.76 4.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 18.58 0.1 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.171 -1.35 . . . . 0.0 114.219 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.99 61.99 10.19 Favored Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.816 1.808 . . . . 0.0 108.515 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.98 -21.57 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 121.61 1.611 . . . . 0.0 112.847 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -29.67 67.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.338 2.255 . . . . 0.0 113.448 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.887 HD11 ' HG ' ' A' ' 29' ' ' LEU . 7.1 tp -66.14 157.27 31.67 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.687 ' H ' HD12 ' A' ' 40' ' ' LEU . 29.6 m -150.96 149.35 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 106.789 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -72.88 89.2 1.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -54.18 -54.53 20.31 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 C-N-CA 124.58 1.152 . . . . 0.0 110.517 168.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.8 t60 174.97 170.87 0.27 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.357 2.663 . . . . 0.0 105.84 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -168.5 2.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.011 0.924 . . . . 0.0 109.077 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.83 131.74 2.04 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.1 128.09 8.85 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.929 1.865 . . . . 0.0 111.209 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 m -78.35 -56.71 4.23 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.188 0.449 . . . . 0.0 110.624 175.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -72.23 169.79 15.42 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.378 1.471 . . . . 0.0 111.292 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.41 133.42 44.88 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 123.141 1.448 . . . . 0.0 112.808 -159.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -89.57 -62.6 1.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.579 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.13 59.74 0.54 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.164 2.586 . . . . 0.0 111.492 -167.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -71.67 68.15 0.59 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.599 2.359 . . . . 0.0 110.28 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -76.79 -28.72 55.74 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.924 1.689 . . . . 0.0 112.166 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.585 1.954 . . . . 0.0 107.544 170.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -166.5 159.2 14.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 145.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.55 -50.11 2.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.813 1.197 . . . . 0.0 115.341 162.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -63.77 -43.73 77.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.251 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.58 -61.92 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 CA-C-N 121.244 1.48 . . . . 0.0 110.384 159.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.3 m -92.36 74.07 5.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -158.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 130.31 25.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 158.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.95 167.21 0.77 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.207 1.803 . . . . 0.0 109.355 -174.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.1 156.73 51.48 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.018 1.145 . . . . 0.0 110.065 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -82.9 43.17 0.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.44 123.86 21.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.477 2.311 . . . . 0.0 109.886 166.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.73 54.03 2.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.443 1.897 . . . . 0.0 111.561 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -72.29 81.8 1.02 Allowed 'General case' 0 C--O 1.223 -0.311 0 O-C-N 120.726 -1.233 . . . . 0.0 107.877 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -65.98 86.22 0.09 Allowed 'General case' 0 C--O 1.221 -0.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.365 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.47 154.05 3.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 126.364 1.865 . . . . 0.0 114.123 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 35.7 t -86.11 127.66 34.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.65 -0.656 . . . . 0.0 109.371 167.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.5 163.19 26.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 158.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.418 ' HA ' HG11 ' A' ' 43' ' ' VAL . 71.3 p -33.79 -51.66 0.4 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.116 2.567 . . . . 0.0 117.399 -167.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 27.54 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 126.34 1.856 . . . . 0.0 110.945 -166.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.08 -1.4 8.56 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.547 1.546 . . . . 0.0 112.759 -165.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.55 89.2 2.18 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 129.885 3.274 . . . . 0.0 108.048 -166.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -65.87 143.71 57.27 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.713 -0.617 . . . . 0.0 109.55 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.77 151.96 47.53 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 127.121 2.168 . . . . 0.0 109.096 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -65.53 -18.68 65.51 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.706 1.603 . . . . 0.0 114.736 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -164.26 154.81 13.09 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 125.914 1.686 . . . . 0.0 109.597 166.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.93 -20.63 38.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.108 1.872 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.4 t -60.0 -58.2 9.57 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.172 168.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.5 mmm -61.12 -34.01 74.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.09 1.314 . . . . 0.0 112.928 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.945 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -54.76 -65.09 0.64 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.178 0.899 . . . . 0.0 109.242 166.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -28.08 69.68 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.991 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -63.23 1.37 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -42.93 -52.87 4.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.956 2.102 . . . . 0.0 111.62 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 40.2 tttm -48.42 -62.13 1.65 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.166 1.786 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -72.28 -16.43 61.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.489 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -67.89 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 171.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.11 22.86 0.68 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.288 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 9.5 t-20 -129.3 56.87 26.44 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.208 1.504 . . . . 0.0 109.167 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -58.95 -21.6 58.91 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 CA-C-N 122.587 1.96 . . . . 0.0 113.012 -171.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.13 -34.15 77.4 Favored 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.001 4.12 . . . . 0.0 114.657 173.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.945 HD11 ' HG ' ' A' ' 29' ' ' LEU . 7.4 tp -65.63 153.84 40.49 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 125.437 1.495 . . . . 0.0 107.914 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.486 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.7 m -149.62 151.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 124.863 1.265 . . . . 0.0 109.212 169.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.67 85.83 3.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.61 -34.98 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.395 1.478 . . . . 0.0 110.456 172.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 179.67 170.24 1.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.734 2.414 . . . . 0.0 107.319 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.72 177.5 7.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 158.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.08 139.67 0.88 Allowed Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.728 1.156 . . . . 0.0 111.68 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -85.52 152.57 10.39 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.555 2.837 . . . . 0.0 112.478 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.422 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 62.4 m -85.93 -32.21 21.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 166.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -66.43 165.6 14.01 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.341 1.456 . . . . 0.0 109.765 164.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -153.82 3.42 0.27 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.816 1.646 . . . . 0.0 110.604 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -79.17 -22.59 44.79 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.536 -1.353 . . . . 0.0 112.804 -173.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.23 133.53 41.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 112.228 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.73 55.66 0.9 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.373 1.869 . . . . 0.0 107.823 164.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -85.06 172.5 11.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.119 0.568 . . . . 0.0 110.166 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.864 1.665 . . . . 0.0 111.49 177.836 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -72.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.17 1.788 . . . . 0.0 107.446 160.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.84 51.82 4.36 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.872 2.177 . . . . 0.0 111.98 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.35 -53.49 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 127.102 2.161 . . . . 0.0 107.784 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.87 -42.32 46.31 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.125 1.217 . . . . 0.0 112.11 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.0 m -101.53 99.91 10.28 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.586 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.62 78.36 1.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 159.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -156.33 166.4 16.56 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.433 1.093 . . . . 0.0 110.79 -165.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.71 161.73 24.53 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.914 2.41 . . . . 0.0 112.212 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -75.06 44.47 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.923 1.289 . . . . 0.0 111.046 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 131.28 46.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.531 1.132 . . . . 0.0 110.643 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -85.98 43.07 1.02 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.997 2.119 . . . . 0.0 110.329 167.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -92.52 61.7 3.78 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.719 -1.238 . . . . 0.0 107.749 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -58.58 142.5 49.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -159.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.71 168.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.023 0.929 . . . . 0.0 112.186 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 t -114.12 136.51 52.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.13 163.34 22.09 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 158.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -52.87 -27.36 18.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -164.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -13.7 59.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.185 0.994 . . . . 0.0 112.216 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.76 -3.17 65.03 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -159.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.89 87.54 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.941 2.896 . . . . 0.0 107.846 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -66.53 143.5 57.02 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -125.1 155.7 39.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.212 2.205 . . . . 0.0 107.692 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 t -58.15 -29.6 65.7 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.866 0.866 . . . . 0.0 112.307 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -163.9 160.41 17.06 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.247 1.419 . . . . 0.0 108.509 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.84 -18.92 36.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.314 2.01 . . . . 0.0 111.632 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -67.54 -45.82 74.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.711 0.404 . . . . 0.0 110.524 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.4 mtp -62.66 -37.36 86.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.03 0.832 . . . . 0.0 111.573 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.958 ' HG ' HD11 ' A' ' 40' ' ' LEU . 4.0 tt -60.08 -66.62 0.49 Allowed 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.616 0.766 . . . . 0.0 109.879 170.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -32.68 66.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.852 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.68 -70.47 0.11 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.86 -52.94 0.94 Allowed 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 126.531 1.933 . . . . 0.0 111.993 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -48.69 -64.21 0.87 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.466 1.507 . . . . 0.0 110.7 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.99 -26.64 68.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.266 0.979 . . . . 0.0 112.338 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -70.23 -59.7 2.73 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.11 21.27 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.524 -1.154 . . . . 0.0 113.946 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -130.16 54.09 13.56 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 119.434 1.617 . . . . 0.0 109.537 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -59.4 -22.34 65.39 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 CA-C-N 122.933 2.083 . . . . 0.0 113.074 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.3 -30.45 71.5 Favored 'General case' 0 CA--C 1.534 0.336 1 C-N-CA 132.616 4.366 . . . . 0.0 115.313 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.958 HD11 ' HG ' ' A' ' 29' ' ' LEU . 1.5 tp -65.37 158.8 25.6 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.838 1.255 . . . . 0.0 107.888 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.68 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.3 m -153.63 155.7 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.591 1.956 . . . . 0.0 108.072 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -75.81 88.07 2.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 164.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -48.86 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 122.583 0.353 . . . . 0.0 110.211 169.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.04 155.63 23.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.334 1.053 . . . . 0.0 108.223 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 170.32 15.71 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.94 156.2 0.07 OUTLIER Glycine 0 CA--C 1.544 1.847 0 O-C-N 121.006 -1.059 . . . . 0.0 112.13 -162.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -91.05 164.96 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 CA-C-N 119.263 1.532 . . . . 0.0 113.592 -164.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.9 m -85.79 -53.98 4.8 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.432 0.693 . . . . 0.0 109.169 167.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.28 134.25 44.16 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 123.112 0.565 . . . . 0.0 110.06 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -153.72 34.73 0.44 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.234 1.413 . . . . 0.0 107.263 166.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -129.47 92.44 3.35 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.843 1.257 . . . . 0.0 109.669 -165.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -173.16 167.73 4.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.602 2.361 . . . . 0.0 107.395 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -158.13 101.17 1.74 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -93.72 160.84 14.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.358 1.463 . . . . 0.0 110.794 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.251 1.174 0 C-N-CA 125.216 1.406 . . . . 0.0 111.594 -179.06 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.478 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -170.91 134.55 0.99 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.44 -41.39 1.15 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 115.849 1.1 . . . . 0.0 115.849 164.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.6 -47.04 83.42 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 119.701 1.75 . . . . 0.0 110.46 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -55.42 -43.27 59.92 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.321 2.014 . . . . 0.0 113.065 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -105.38 66.1 0.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.765 1.226 . . . . 0.0 111.992 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.14 -0.04 30.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.641 0.776 . . . . 0.0 112.061 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.04 165.3 17.26 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -159.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.45 164.18 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.908 2.405 . . . . 0.0 111.173 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -81.61 43.38 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.582 -0.699 . . . . 0.0 110.104 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.84 124.9 24.23 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.459 1.904 . . . . 0.0 110.846 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.92 43.55 0.93 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.419 1.088 . . . . 0.0 109.791 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.62 60.69 6.25 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.833 -1.167 . . . . 0.0 109.104 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.6 mmm-85 -53.07 140.2 26.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.247 1.819 . . . . 0.0 112.735 -162.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.99 156.63 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 123.898 0.879 . . . . 0.0 111.498 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 52.9 t -94.47 141.82 28.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.002 0.364 . . . . 0.0 110.774 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.88 166.29 24.81 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 160.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.464 ' HA ' HG11 ' A' ' 43' ' ' VAL . 96.0 p -49.65 -19.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -176.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -85.63 -8.32 58.31 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.323 1.42 . . . . 0.0 111.986 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.27 -9.65 69.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.06 -1.025 . . . . 0.0 110.85 -160.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -64.91 92.97 0.1 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 128.336 2.654 . . . . 0.0 110.934 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -66.06 144.06 56.95 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.549 0.74 . . . . 0.0 110.366 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -122.84 157.69 31.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.811 2.844 . . . . 0.0 108.625 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 m -62.64 -30.8 71.63 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.53 1.532 . . . . 0.0 113.909 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 10.5 p30 -163.81 163.46 15.88 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 127.497 2.319 . . . . 0.0 107.301 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.2 Cg_endo -71.67 -16.36 30.13 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.31 1.34 . . . . 0.0 112.014 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -67.55 -46.84 71.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.654 170.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 mmm -59.43 -39.75 84.53 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.599 1.09 . . . . 0.0 111.024 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.1 tt -56.71 -69.44 0.15 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.994 0.918 . . . . 0.0 109.42 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -30.92 68.22 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.095 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -70.74 0.09 Allowed 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.3 -53.05 2.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.407 1.883 . . . . 0.0 112.191 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -46.64 -61.47 1.81 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.819 1.247 . . . . 0.0 110.716 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -21.18 64.6 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 8.5 tt0 -79.74 -31.12 41.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.541 1.064 . . . . 0.0 110.721 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.73 21.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.993 -1.449 . . . . 0.0 114.824 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.7 64.77 70.38 Favored Pre-proline 0 C--O 1.224 -0.267 0 CA-C-N 120.004 1.902 . . . . 0.0 110.055 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.71 -17.49 59.24 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.222 1.472 . . . . 0.0 112.961 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.58 -26.26 41.36 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.935 2.494 . . . . 0.0 113.308 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.928 HD11 ' HG ' ' A' ' 29' ' ' LEU . 4.7 tp -66.37 152.01 45.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.598 ' H ' HD12 ' A' ' 40' ' ' LEU . 31.0 m -150.06 153.22 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.391 0.676 . . . . 0.0 109.831 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -74.53 85.76 2.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -53.7 -56.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.441 1.097 . . . . 0.0 110.62 164.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.76 -171.47 2.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.837 2.455 . . . . 0.0 106.426 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.74 -137.8 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.792 2.037 . . . . 0.0 107.194 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.98 122.76 0.01 OUTLIER Glycine 0 CA--C 1.543 1.788 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.55 144.0 35.25 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 119.992 1.896 . . . . 0.0 111.706 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.408 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 33.3 m -86.03 -31.94 21.72 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.652 0.381 . . . . 0.0 110.106 172.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.34 148.64 37.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.95 1.3 . . . . 0.0 112.478 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -156.46 95.43 1.57 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -163.8 117.92 1.53 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.99 155.4 16.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.845 0.831 . . . . 0.0 111.265 171.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -151.62 51.58 0.82 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -172.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -57.95 -63.66 1.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.99 1.716 . . . . 0.0 110.403 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 117.322 -1.323 . . . . 0.0 109.237 172.5 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.19 0.519 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -157.79 160.22 37.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 140.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.06 -50.99 2.76 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.43 1.014 . . . . 0.0 113.918 167.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -63.56 -45.34 83.06 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.109 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -57.21 -61.36 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.758 1.639 . . . . 0.0 111.099 166.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.45 59.1 5.32 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.402 -0.811 . . . . 0.0 112.122 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.88 -11.16 59.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.078 -0.389 . . . . 0.0 111.706 166.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.1 164.66 55.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.886 1.674 . . . . 0.0 113.928 -171.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.97 164.36 13.57 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.893 2.395 . . . . 0.0 111.727 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -79.59 43.9 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.499 1.12 . . . . 0.0 111.162 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.11 129.06 38.51 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.738 1.615 . . . . 0.0 110.332 170.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.95 43.84 1.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.481 1.513 . . . . 0.0 111.755 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.7 64.85 6.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.757 -1.214 . . . . 0.0 109.175 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -57.46 142.75 43.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -160.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.66 169.88 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 117.68 -1.152 . . . . 0.0 111.63 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 0.4 OUTLIER -118.57 137.04 53.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.611 1.096 . . . . 0.0 111.907 178.573 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.26 164.72 28.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.58 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.2 p -36.21 -41.04 0.25 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.535 2.734 . . . . 0.0 115.929 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.67 -1.91 3.14 Favored 'General case' 0 N--CA 1.436 -1.165 1 C-N-CA 135.019 5.328 . . . . 0.0 111.939 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.91 -8.37 11.85 Favored Glycine 0 CA--C 1.539 1.559 0 CA-C-N 119.391 0.996 . . . . 0.0 112.025 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.47 95.89 0.23 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 130.487 3.515 . . . . 0.0 109.335 -170.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.2 m -66.45 143.7 56.95 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.072 0.463 . . . . 0.0 110.404 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -119.86 157.57 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 128.113 2.565 . . . . 0.0 107.512 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 m -59.16 -31.79 69.3 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.745 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -163.73 160.42 17.4 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 125.338 1.455 . . . . 0.0 108.779 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.01 -15.19 32.44 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.705 1.603 . . . . 0.0 111.399 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.33 -40.04 64.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 123.233 0.613 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.7 ttp -65.01 -44.84 87.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -54.77 -63.5 1.13 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.125 174.507 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.13 -31.51 70.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.994 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -68.48 0.18 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.68 -53.11 3.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 127.524 2.33 . . . . 0.0 111.856 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -45.37 -61.27 1.74 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.355 1.462 . . . . 0.0 110.722 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -66.01 -27.94 68.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 112.545 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.76 -26.22 40.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.211 0.204 . . . . 0.0 111.33 -173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 17.87 0.02 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.296 -1.28 . . . . 0.0 115.066 -177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -131.7 54.38 14.15 Favored Pre-proline 0 C--O 1.22 -0.456 0 CA-C-N 119.557 1.678 . . . . 0.0 109.099 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.2 -23.1 60.19 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 CA-C-N 122.545 1.945 . . . . 0.0 112.859 -170.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.24 -32.66 74.33 Favored 'General case' 0 CA--C 1.533 0.316 1 C-N-CA 132.882 4.473 . . . . 0.0 114.922 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.928 HD11 ' HG ' ' A' ' 29' ' ' LEU . 1.8 tp -65.37 157.79 28.32 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.959 1.303 . . . . 0.0 107.674 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.6 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.0 m -152.8 146.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 128.339 2.656 . . . . 0.0 107.676 173.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.97 83.69 5.84 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 41' ' ' VAL . 1.4 m -53.64 -40.56 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.641 1.577 . . . . 0.0 109.625 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -155.98 162.51 40.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 159.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.78 -179.74 5.58 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 163.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.11 149.22 0.09 OUTLIER Glycine 0 CA--C 1.544 1.874 0 O-C-N 120.796 -1.19 . . . . 0.0 112.534 -161.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.65 152.56 17.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.125 1.883 . . . . 0.0 111.7 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.552 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 59.1 m -86.64 -74.86 0.41 Allowed 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.716 0.769 . . . . 0.0 109.048 169.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -173.89 -175.72 1.1 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.722 2.809 . . . . 0.0 107.291 -162.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 163.43 -43.56 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.688 2.395 . . . . 0.0 111.492 158.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -127.19 111.22 13.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -53.96 127.01 24.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.757 1.623 . . . . 0.0 110.216 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -106.91 30.33 6.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.419 1.888 . . . . 0.0 111.77 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -69.88 162.51 27.82 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.888 0.875 . . . . 0.0 111.337 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.3 t80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.864 -1.541 . . . . 0.0 109.867 -175.121 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -163.29 165.4 24.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 153.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.58 9.86 82.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.243 0.925 . . . . 0.0 115.246 158.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.613 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.29 -44.02 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 126.961 2.104 . . . . 0.0 112.64 172.555 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 8.4 Cg_endo -56.43 -50.69 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.73 2.287 . . . . 0.0 112.457 163.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -95.23 107.99 20.11 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.74 0.816 . . . . 0.0 110.286 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -140.92 52.93 1.59 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.071 1.348 . . . . 0.0 108.071 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -144.77 163.43 33.51 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -161.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.57 166.84 13.59 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.255 2.637 . . . . 0.0 111.813 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -83.15 46.1 1.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.928 0.891 . . . . 0.0 109.734 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.88 123.08 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.117 0.967 . . . . 0.0 109.203 168.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.03 43.09 0.5 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.129 1.772 . . . . 0.0 111.975 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -78.6 76.71 5.1 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 169.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -61.59 141.3 57.86 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.686 -1.259 . . . . 0.0 110.957 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -150.18 164.98 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 124.71 1.204 . . . . 0.0 110.884 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -108.94 135.76 49.59 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.3 163.6 23.08 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 158.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.448 ' HA ' HG11 ' A' ' 43' ' ' VAL . 82.5 p -43.87 -39.1 3.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -165.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.15 2.09 5.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.489 1.041 . . . . 0.0 112.969 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.09 5.68 80.03 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 120.919 -1.113 . . . . 0.0 111.523 -161.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -71.79 90.21 1.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.119 2.968 . . . . 0.0 109.831 -169.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -65.92 143.89 57.13 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.076 0.853 . . . . 0.0 110.781 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.02 154.01 41.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 127.6 2.36 . . . . 0.0 107.831 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 p -66.06 -24.21 66.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.915 1.686 . . . . 0.0 114.106 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 14.3 p30 -164.01 156.31 14.88 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 126.714 2.006 . . . . 0.0 109.748 170.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB3' HE22 ' A' ' 42' ' ' GLN . 55.7 Cg_endo -69.74 -17.03 37.9 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.939 1.759 . . . . 0.0 111.57 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.9 t -66.19 -48.19 71.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.518 168.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.8 mmm -58.09 -39.77 79.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.312 0.96 . . . . 0.0 111.565 175.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.922 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.7 tt -57.39 -67.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.124 0.97 . . . . 0.0 109.783 171.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 t -60.01 -29.28 68.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.987 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -71.36 0.11 Allowed 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.91 -52.99 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.409 1.884 . . . . 0.0 111.932 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -48.08 -64.16 0.87 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.818 1.247 . . . . 0.0 110.893 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -65.55 -20.17 66.22 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 124.005 0.815 . . . . 0.0 112.763 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -74.63 -62.69 1.44 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.54 0.3 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.822 -174.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -128.69 63.08 64.05 Favored Pre-proline 0 C--O 1.221 -0.409 0 CA-C-N 119.193 1.497 . . . . 0.0 109.604 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.11 -19.08 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.206 1.466 . . . . 0.0 112.744 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.67 -22.82 43.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.202 2.601 . . . . 0.0 113.557 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.922 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.0 tp -66.52 153.91 41.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.653 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.9 m -150.9 152.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.174 1.39 . . . . 0.0 108.59 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.416 HE22 ' HB3' ' A' ' 26' ' ' PRO . 40.6 tp60 -75.34 83.9 2.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 166.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.52 -54.45 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.69 168.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.23 -170.44 2.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.809 2.043 . . . . 0.0 107.502 174.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -137.3 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.06 1.744 . . . . 0.0 106.881 167.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.32 118.25 0.01 OUTLIER Glycine 0 CA--C 1.539 1.57 0 C-N-CA 127.555 2.502 . . . . 0.0 118.664 158.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.7 137.65 30.41 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.189 1.926 . . . . 0.0 111.908 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.0 m -85.92 -64.74 1.1 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.75 131.08 47.7 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.636 0.774 . . . . 0.0 111.247 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -153.73 159.52 42.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.773 2.029 . . . . 0.0 108.11 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -163.85 -30.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.336 1.454 . . . . 0.0 109.521 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -54.01 147.38 12.62 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 129.664 3.186 . . . . 0.0 112.125 163.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.21 44.18 0.42 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.304 1.841 . . . . 0.0 109.376 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -70.78 165.88 22.16 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.777 -0.577 . . . . 0.0 110.171 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.0 p90 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.815 -173.837 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 p90 . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 122.233 1.016 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -169.0 162.57 11.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 143.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.92 -64.65 1.92 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.56 1.552 . . . . 0.0 112.087 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.33 80.57 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-O 116.364 -1.779 . . . . 0.0 115.108 -172.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 15.7 Cg_endo -50.0 -26.61 14.72 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 122.072 1.776 . . . . 0.0 113.35 168.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.6 m -105.01 22.01 16.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.127 1.771 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.85 73.66 0.1 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.47 1.108 . . . . 0.0 109.524 170.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.09 167.93 11.77 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.416 1.886 . . . . 0.0 109.905 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.8 157.33 24.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.598 2.199 . . . . 0.0 110.936 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -79.06 43.7 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.492 -0.755 . . . . 0.0 110.233 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.07 140.84 58.28 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.417 1.487 . . . . 0.0 110.786 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.61 43.82 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.898 1.679 . . . . 0.0 110.497 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -89.58 46.13 1.34 Allowed 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.332 -1.48 . . . . 0.0 110.509 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -49.01 145.78 3.8 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.575 1.95 . . . . 0.0 115.262 -164.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 m -148.53 174.31 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.237 1.415 . . . . 0.0 110.606 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -116.53 137.09 52.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 0.794 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.58 163.55 22.75 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.216 0.898 . . . . 0.0 112.059 161.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.45 ' HA ' HG11 ' A' ' 43' ' ' VAL . 80.9 p -54.64 -17.73 3.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 118.653 2.835 . . . . 0.0 118.653 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -9.32 59.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.354 0.662 . . . . 0.0 111.724 171.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.7 -3.93 65.75 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.739 1.161 . . . . 0.0 111.043 -171.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.14 113.91 8.66 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 127.487 2.315 . . . . 0.0 109.902 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -66.15 144.77 56.45 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 122.207 -0.308 . . . . 0.0 110.424 167.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -122.53 150.33 42.71 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.946 2.098 . . . . 0.0 107.156 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -60.64 -27.31 67.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.399 1.08 . . . . 0.0 113.498 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -163.79 163.43 15.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.673 2.389 . . . . 0.0 107.028 174.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.99 -17.1 32.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.042 1.161 . . . . 0.0 112.065 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 -40.32 93.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.487 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.4 mmm -66.15 -40.87 90.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.751 1.159 . . . . 0.0 111.86 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.97 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.3 tt -59.25 -65.24 0.7 Allowed 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.453 0.701 . . . . 0.0 109.163 171.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -31.5 70.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.797 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 3.9 t -52.77 -69.01 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.39 -53.06 3.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.516 1.526 . . . . 0.0 111.589 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -50.57 -63.71 1.04 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.034 1.734 . . . . 0.0 110.914 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -62.31 -26.75 68.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.814 1.646 . . . . 0.0 112.221 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -63.32 1.2 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.0 20.27 0.29 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.179 -1.345 . . . . 0.0 114.479 -173.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -124.95 63.84 41.45 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 119.859 1.83 . . . . 0.0 110.139 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.59 -16.06 45.67 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 CA-C-N 121.506 1.574 . . . . 0.0 113.392 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -22.97 33.73 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.28 2.632 . . . . 0.0 113.508 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.97 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.47 150.59 48.72 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 174.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.596 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.6 m -153.63 159.77 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.712 1.605 . . . . 0.0 108.784 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.44 82.07 1.44 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.4 m -59.72 -42.17 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 170.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -157.24 140.3 15.33 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.554 1.141 . . . . 0.0 108.627 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.12 37.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.111 1.365 . . . . 0.0 112.697 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.15 159.99 27.75 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.73 148.95 29.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.234 1.956 . . . . 0.0 111.632 -167.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m -86.14 -71.28 0.55 Allowed 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.273 1.029 . . . . 0.0 108.54 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -173.31 162.75 4.43 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 127.06 2.144 . . . . 0.0 107.967 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -170.35 155.46 5.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.881 2.472 . . . . 0.0 107.04 164.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -139.97 33.33 1.96 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -173.28 -175.26 1.14 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.836 2.455 . . . . 0.0 106.243 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -141.4 80.43 1.73 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 163.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -55.3 164.08 1.03 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.104 0.961 . . . . 0.0 110.465 164.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.9 p90 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.407 1.883 . . . . 0.0 107.827 -177.075 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -176.44 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.415 1.886 . . . . 0.0 108.319 151.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.8 61.96 3.97 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.66 2.076 . . . . 0.0 111.023 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.92 -54.93 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 126.964 2.106 . . . . 0.0 107.463 170.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.01 -49.97 7.13 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 120.337 1.156 . . . . 0.0 111.705 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -91.42 87.24 6.35 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.804 0.729 . . . . 0.0 109.242 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -141.2 48.59 1.67 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.584 1.154 . . . . 0.0 108.406 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.64 164.85 38.41 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -163.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -82.86 168.48 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.068 2.512 . . . . 0.0 112.169 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -85.15 44.31 1.08 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.01 0.924 . . . . 0.0 110.968 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.33 135.01 56.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 109.663 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.99 43.37 1.04 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.453 2.301 . . . . 0.0 114.131 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -78.45 82.25 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 120.709 -1.244 . . . . 0.0 107.649 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.48 120.05 9.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 119.569 -1.957 . . . . 0.0 107.588 172.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -138.36 155.29 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -107.64 136.81 46.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.782 0.719 . . . . 0.0 110.319 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.54 163.81 24.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.498 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.1 p -34.23 -41.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.131 2.972 . . . . 0.0 116.184 -172.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 0.04 5.16 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.436 4.694 . . . . 0.0 111.75 -172.39 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.38 -4.81 39.49 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.373 0.987 . . . . 0.0 111.65 -165.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -76.49 106.12 7.94 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 127.229 2.211 . . . . 0.0 110.632 -170.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -66.24 144.29 56.71 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.453 0.57 . . . . 0.0 111.302 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -124.28 152.06 43.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.772 2.429 . . . . 0.0 107.041 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.477 1.111 . . . . 0.0 113.838 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -163.91 156.52 15.27 Favored Pre-proline 0 C--N 1.343 0.303 0 C-N-CA 126.958 2.103 . . . . 0.0 109.331 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.45 -18.65 43.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.412 2.075 . . . . 0.0 111.274 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -66.46 -42.52 87.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.69 -0.672 . . . . 0.0 111.005 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 86.4 mtp -61.61 -41.6 97.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.549 1.068 . . . . 0.0 112.031 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.735 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.86 -64.93 0.71 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.73 171.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.498 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -61.39 -30.04 70.3 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.843 -173.596 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.15 -69.63 0.13 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.18 -53.04 2.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.284 1.833 . . . . 0.0 111.053 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -48.06 -62.51 1.44 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.597 1.559 . . . . 0.0 110.632 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -18.14 63.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.227 -0.892 . . . . 0.0 112.799 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -79.97 -51.34 9.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.942 0.792 . . . . 0.0 108.885 -177.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.9 22.51 0.11 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.153 -1.359 . . . . 0.0 114.641 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -129.57 61.3 56.91 Favored Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 120.015 1.908 . . . . 0.0 110.338 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.04 -24.64 66.82 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.814 1.676 . . . . 0.0 112.703 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.16 -30.44 68.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 131.163 3.785 . . . . 0.0 115.042 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.735 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tp -66.33 155.27 37.76 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.588 ' H ' HD12 ' A' ' 40' ' ' LEU . 26.3 m -153.76 153.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.067 1.747 . . . . 0.0 109.788 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -74.86 83.37 2.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.8 m -57.37 -38.27 61.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 122.775 0.43 . . . . 0.0 110.378 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -162.89 138.38 6.89 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.652 1.181 . . . . 0.0 109.502 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.18 68.25 10.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.452 1.024 . . . . 0.0 108.805 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.99 157.46 20.2 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.51 153.99 13.81 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.965 1.776 . . . . 0.0 112.76 -159.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m -86.58 -49.39 7.58 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.875 1.27 . . . . 0.0 107.761 167.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.12 83.63 2.96 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.994 2.118 . . . . 0.0 110.341 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -166.53 -177.4 3.96 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.048 2.139 . . . . 0.0 107.174 171.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -143.24 -40.18 0.31 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.93 0.787 . . . . 0.0 113.013 -175.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -173.76 173.39 3.32 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.207 2.203 . . . . 0.0 107.231 -167.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.38 54.35 1.84 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 160.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -143.43 124.0 14.04 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.375 -0.828 . . . . 0.0 110.202 -158.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.108 0 CA-C-O 116.678 -1.63 . . . . 0.0 109.677 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.93 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.669 2.388 . . . . 0.0 105.873 166.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.88 -26.49 68.99 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.277 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.3 -48.49 82.54 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 119.593 1.697 . . . . 0.0 111.072 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.67 -65.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.388 2.059 . . . . 0.0 113.09 161.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.8 m -88.64 74.65 8.39 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 112.639 -158.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.91 8.89 6.84 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.866 1.266 . . . . 0.0 112.528 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.44 164.63 59.62 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 120.844 -1.16 . . . . 0.0 113.089 -175.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 169.18 20.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.882 2.388 . . . . 0.0 111.95 -174.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -75.17 43.73 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.539 1.536 . . . . 0.0 111.04 171.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 114.01 4.96 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 124.888 1.275 . . . . 0.0 108.888 168.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.7 101.86 5.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -148.47 79.86 1.44 Allowed 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.51 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 15.4 mmm180 -59.43 132.15 53.11 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.391 -0.818 . . . . 0.0 110.004 -170.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.98 167.38 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 123.507 0.723 . . . . 0.0 111.527 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.8 t -115.55 134.29 55.21 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.132 0.973 . . . . 0.0 110.887 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.24 164.96 23.7 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.983 1.277 . . . . 0.0 110.631 164.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.419 ' HA ' HG11 ' A' ' 43' ' ' VAL . 4.9 p -41.54 -40.37 1.83 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -164.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.78 0.03 4.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.589 1.556 . . . . 0.0 112.799 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.13 -0.71 88.43 Favored Glycine 0 CA--C 1.541 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 112.073 -159.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.02 94.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.959 2.104 . . . . 0.0 110.174 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.9 m -66.19 143.59 57.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -130.96 153.65 48.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.464 3.106 . . . . 0.0 110.254 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 7.1 m -45.62 -40.15 8.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 130.67 3.588 . . . . 0.0 116.157 172.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -163.76 158.73 17.02 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.603 1.961 . . . . 0.0 108.941 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.54 -19.82 27.84 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.519 1.479 . . . . 0.0 111.674 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.65 -46.84 88.81 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -63.35 -32.56 74.02 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.915 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.1 tt -61.67 -61.1 2.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 119.382 0.992 . . . . 0.0 109.022 172.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -60.5 -32.91 71.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.815 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -62.06 2.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.83 -52.99 6.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.903 2.081 . . . . 0.0 111.556 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 41.5 tttm -50.18 -60.96 2.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.381 1.073 . . . . 0.0 109.762 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 -17.14 63.56 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 124.259 0.974 . . . . 0.0 112.512 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -79.54 -44.55 20.94 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.811 0.732 . . . . 0.0 110.532 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.33 17.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.105 -1.386 . . . . 0.0 114.121 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -120.4 63.71 10.14 Favored Pre-proline 0 C--O 1.22 -0.485 0 CA-C-N 119.797 1.799 . . . . 0.0 109.38 -177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -60.22 -22.44 70.42 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.122 1.881 . . . . 0.0 112.988 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.44 -26.12 55.12 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 128.122 2.569 . . . . 0.0 113.441 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.915 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.05 154.53 39.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.655 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.1 m -150.8 148.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -75.13 85.25 2.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -54.19 -58.99 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.46 1.104 . . . . 0.0 109.893 167.422 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.38 -173.26 1.42 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.361 1.464 . . . . 0.0 109.243 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -177.15 6.32 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.968 2.107 . . . . 0.0 109.929 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.14 141.96 1.14 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 119.248 0.931 . . . . 0.0 113.909 171.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -82.88 145.9 12.8 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.113 1.876 . . . . 0.0 111.756 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m -86.48 -34.83 19.93 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 172.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.24 140.17 54.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -85.08 67.11 10.07 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.588 0.709 . . . . 0.0 109.776 -165.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -100.32 -84.87 0.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.247 1.419 . . . . 0.0 110.432 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.71 166.34 4.5 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 128.77 2.828 . . . . 0.0 105.524 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -147.05 65.73 1.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.543 0.737 . . . . 0.0 109.064 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -144.35 -171.54 3.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.019 2.128 . . . . 0.0 109.162 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--O 1.256 1.397 0 CA-C-O 116.854 -1.546 . . . . 0.0 110.863 -174.033 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.468 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -176.68 -65.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.122 0.969 . . . . 0.0 110.514 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.26 -14.62 44.33 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.766 2.127 . . . . 0.0 114.674 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -55.04 3.88 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.325 2.25 . . . . 0.0 110.925 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB2' ' CA ' ' A' ' 31' ' ' CYS . 37.5 Cg_endo -71.29 -53.79 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.929 2.42 . . . . 0.0 110.724 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.5 m -87.65 124.38 33.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 120.34 1.427 . . . . 0.0 108.94 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.14 29.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.468 1.507 . . . . 0.0 110.922 -173.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 164.98 13.59 Favored Pre-proline 0 C--O 1.236 0.355 0 O-C-N 121.677 -0.639 . . . . 0.0 111.043 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.69 172.92 13.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.268 1.979 . . . . 0.0 109.688 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -78.12 46.32 0.59 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.96 1.304 . . . . 0.0 110.373 171.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.64 123.89 20.9 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.29 49.71 1.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.113 1.365 . . . . 0.0 109.638 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.659 ' O ' HG13 ' A' ' 15' ' ' VAL . 10.2 m170 -80.18 58.96 3.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -48.06 122.92 5.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.852 1.205 . . . . 0.0 111.329 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 13' ' ' HIS . 23.0 m -134.23 178.15 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 C-N-CA 124.571 1.148 . . . . 0.0 111.153 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.6 144.11 51.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.76 171.05 31.34 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -53.18 -24.58 11.16 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 175.323 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -84.24 0.08 50.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.419 1.888 . . . . 0.0 112.516 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -7.55 36.96 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.823 -1.173 . . . . 0.0 111.859 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.58 107.34 1.37 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.182 1.393 . . . . 0.0 107.447 -176.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 7.4 m -66.27 146.25 54.81 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.466 ' CD2' HD12 ' A' ' 29' ' ' LEU . 60.1 m-85 -123.9 139.94 53.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.796 2.039 . . . . 0.0 106.488 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.6 t -45.45 -32.08 2.01 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.997 2.119 . . . . 0.0 112.206 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -163.56 154.7 14.2 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.555 2.342 . . . . 0.0 111.135 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -74.91 -24.4 13.05 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 111.159 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -28.01 69.26 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.023 -0.423 . . . . 0.0 112.049 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -36.03 60.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.76 170.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.856 ' HG ' HD11 ' A' ' 40' ' ' LEU . 8.8 tt -56.43 -67.34 0.31 Allowed 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -50.27 -37.33 35.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.556 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' CA ' ' HB2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -52.09 -71.78 0.06 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 175.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.9 -51.11 4.42 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.099 2.16 . . . . 0.0 110.872 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -66.29 0.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -15.17 60.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -73.86 -67.31 0.61 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.751 0.82 . . . . 0.0 108.86 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.75 39.97 0.25 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 126.489 1.995 . . . . 0.0 110.162 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -138.08 59.78 20.11 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.888 1.344 . . . . 0.0 111.341 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.92 -8.66 14.31 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.047 1.831 . . . . 0.0 112.764 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -90.5 -24.52 20.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.011 2.125 . . . . 0.0 113.769 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.856 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tp -66.4 150.32 49.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.487 ' H ' HD12 ' A' ' 40' ' ' LEU . 9.6 m -149.2 152.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -78.24 83.63 4.49 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.7 m -57.12 -46.15 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.861 0.865 . . . . 0.0 111.534 170.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -164.47 157.01 16.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 125.177 1.391 . . . . 0.0 109.084 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -87.68 54.99 3.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.964 2.906 . . . . 0.0 110.54 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.73 150.13 21.61 Favored Glycine 0 C--O 1.226 -0.358 0 O-C-N 119.836 -1.79 . . . . 0.0 109.041 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.2 146.62 28.7 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.235 1.956 . . . . 0.0 111.599 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m -86.44 -65.55 1.0 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.714 1.206 . . . . 0.0 110.502 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.97 -76.86 0.06 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.679 1.592 . . . . 0.0 111.368 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.93 176.68 4.14 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.401 1.48 . . . . 0.0 110.255 173.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -152.25 76.73 1.18 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.22 154.99 3.97 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.781 0.8 . . . . 0.0 110.449 172.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.72 46.98 0.72 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.91 161.12 30.57 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.624 0.769 . . . . 0.0 110.577 172.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.9 p90 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 116.713 -1.613 . . . . 0.0 108.399 -178.411 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.455 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -176.13 133.75 0.25 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.14 -31.07 0.95 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.097 1.332 . . . . 0.0 114.701 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -67.08 -56.27 13.84 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.726 1.263 . . . . 0.0 111.024 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.23 -48.42 0.62 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.238 1.959 . . . . 0.0 112.299 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.04 125.41 41.46 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.469 0.708 . . . . 0.0 109.654 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 8' ' ' CYS . 1.8 mt-10 -154.47 -24.33 0.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.981 1.712 . . . . 0.0 110.93 172.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.407 ' H ' ' H ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -49.61 158.35 0.84 Allowed Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 125.972 1.709 . . . . 0.0 114.753 -179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.13 169.35 22.75 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 121.928 1.752 . . . . 0.0 111.179 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -80.29 43.65 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.075 0.95 . . . . 0.0 110.044 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.24 19.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.501 1.52 . . . . 0.0 109.247 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 42.79 0.33 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 111.08 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -84.93 63.26 7.98 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 121.149 -0.969 . . . . 0.0 108.698 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -55.77 134.9 51.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.108 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.34 -178.27 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 125.151 1.381 . . . . 0.0 111.516 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -125.21 137.34 54.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.512 1.125 . . . . 0.0 110.564 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.91 168.78 26.36 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 165.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.518 ' HA ' HG11 ' A' ' 43' ' ' VAL . 17.4 p -50.69 -31.3 15.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -171.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.02 0.0 5.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.25 66.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.359 0.981 . . . . 0.0 111.624 -163.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.09 110.82 9.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.337 1.455 . . . . 0.0 109.553 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -65.84 143.95 57.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.969 0.414 . . . . 0.0 110.366 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -119.4 145.39 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.368 2.267 . . . . 0.0 108.225 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -58.33 -29.22 65.77 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.344 1.057 . . . . 0.0 113.002 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 18.9 p30 -163.89 155.96 14.8 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 125.208 1.403 . . . . 0.0 109.78 173.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 68.6 Cg_endo -70.27 -16.37 35.4 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.486 2.124 . . . . 0.0 111.023 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.162 -0.336 . . . . 0.0 110.953 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.8 mtm -66.08 -31.73 72.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.656 172.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.918 ' HG ' HD11 ' A' ' 40' ' ' LEU . 7.7 tt -59.6 -68.26 0.3 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.397 0.998 . . . . 0.0 109.38 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -51.98 -39.27 59.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.824 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -68.49 0.17 Allowed 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.76 1.95 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 126.592 1.957 . . . . 0.0 110.506 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -51.04 -63.44 1.13 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.926 0.89 . . . . 0.0 110.647 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.6 -16.87 64.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.69 1.196 . . . . 0.0 112.727 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -77.87 -66.18 0.87 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.51 23.74 0.36 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.896 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -127.33 60.67 44.55 Favored Pre-proline 0 C--O 1.222 -0.392 0 CA-C-N 119.618 1.709 . . . . 0.0 109.835 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -61.23 -17.73 54.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.657 1.571 . . . . 0.0 113.166 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -26.36 45.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.399 2.28 . . . . 0.0 113.333 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.918 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.04 153.38 42.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.593 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.5 m -150.88 149.42 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -72.55 85.67 1.16 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -56.5 -47.16 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.563 0.745 . . . . 0.0 109.747 172.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 166.12 151.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.862 2.865 . . . . 0.0 106.957 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -68.34 -173.26 0.4 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.844 2.058 . . . . 0.0 111.388 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.71 142.1 0.79 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.08 143.68 18.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.225 1.513 . . . . 0.0 110.475 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 119.274 -0.394 . . . . 0.0 110.85 177.197 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.39 -89.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.269 1.028 . . . . 0.0 109.667 156.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.19 76.24 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.112 -0.993 . . . . 0.0 112.555 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -43.98 79.63 Favored Pre-proline 0 C--N 1.34 0.161 0 CA-C-O 117.217 -1.373 . . . . 0.0 114.378 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.83 -51.41 0.48 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.538 2.159 . . . . 0.0 111.928 159.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.42 70.16 8.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.027 1.285 . . . . 0.0 113.081 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -83.92 -14.09 51.87 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.38 162.42 61.22 Favored Pre-proline 0 C--O 1.236 0.373 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -158.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.83 165.47 28.52 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.934 2.423 . . . . 0.0 110.783 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.81 43.56 1.0 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.386 0.674 . . . . 0.0 109.381 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.33 122.56 17.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.124 1.77 . . . . 0.0 110.498 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.89 43.77 0.36 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.56 1.944 . . . . 0.0 111.246 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -92.36 58.01 3.13 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 120.5 -1.375 . . . . 0.0 108.751 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -53.65 147.42 11.39 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.345 1.858 . . . . 0.0 113.207 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -149.14 153.75 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.024 0.929 . . . . 0.0 111.751 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 t -86.44 133.88 33.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 110.473 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.16 164.15 23.46 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 158.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.1 p -51.28 -25.12 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -168.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 0.01 11.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 112.385 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.58 50.17 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.838 -1.163 . . . . 0.0 110.692 -158.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -66.71 96.99 0.43 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 131.347 3.859 . . . . 0.0 110.974 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -66.13 144.39 56.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.756 0.422 . . . . 0.0 111.344 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -123.81 153.3 41.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.776 2.03 . . . . 0.0 107.809 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -65.97 -21.56 66.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 10.8 p30 -163.76 159.99 17.3 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.215 1.806 . . . . 0.0 108.883 168.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 46.0 Cg_endo -66.75 -20.13 52.72 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.877 . . . . 0.0 110.996 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -68.89 -45.57 70.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.224 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -37.57 87.24 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.623 1.101 . . . . 0.0 111.311 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.9 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.1 tt -56.7 -66.74 0.39 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.222 1.009 . . . . 0.0 109.964 168.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -32.16 70.71 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.536 -0.727 . . . . 0.0 111.327 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.7 -68.5 0.18 Allowed 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.03 -52.85 1.82 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.052 1.741 . . . . 0.0 111.525 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 42.9 tttm -48.18 -61.75 1.83 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.193 1.397 . . . . 0.0 110.544 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -67.92 -21.16 65.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -48.9 16.18 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.74 25.4 0.1 OUTLIER Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.234 -1.315 . . . . 0.0 114.887 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -130.35 63.65 70.05 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 120.014 1.907 . . . . 0.0 109.789 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -61.33 -19.99 66.36 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.446 1.552 . . . . 0.0 112.664 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -23.92 46.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.513 2.725 . . . . 0.0 113.494 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -66.49 154.67 39.69 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.647 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.8 m -150.66 150.6 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 124.901 1.28 . . . . 0.0 108.753 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -71.77 84.88 0.92 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.41 -53.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.303 0.641 . . . . 0.0 110.112 166.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -169.98 175.63 5.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.224 1.809 . . . . 0.0 110.148 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.21 171.93 10.28 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.88 2.472 . . . . 0.0 108.239 164.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.5 138.43 0.85 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 127.373 2.416 . . . . 0.0 112.216 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.18 142.42 21.58 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 110.834 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.123 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 p90 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -176.7 -86.56 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.709 2.003 . . . . 0.0 107.597 141.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.22 -15.82 80.5 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.19 0.9 . . . . 0.0 113.637 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -50.02 65.79 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 119.317 1.558 . . . . 0.0 111.923 171.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -60.7 -51.89 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.291 1.327 . . . . 0.0 112.261 160.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.1 m -89.29 71.7 8.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.473 1.033 . . . . 0.0 112.323 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -116.85 84.15 2.09 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.11 165.24 19.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 123.282 0.633 . . . . 0.0 111.307 -172.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 165.07 20.73 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.251 2.634 . . . . 0.0 111.357 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.55 43.3 0.47 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.878 0.871 . . . . 0.0 111.067 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.0 128.32 35.59 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.899 1.279 . . . . 0.0 111.066 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.03 43.26 1.04 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.648 1.579 . . . . 0.0 110.674 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.454 ' O ' HG13 ' A' ' 15' ' ' VAL . 11.5 m170 -83.42 64.59 7.92 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 120.597 -1.314 . . . . 0.0 107.975 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -55.84 134.74 52.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.699 1.136 . . . . 0.0 111.721 -167.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 13' ' ' HIS . 14.1 m -135.68 169.68 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 110.443 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -123.9 143.17 50.53 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.4 1.0 . . . . 0.0 110.933 175.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.18 166.5 28.46 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.573 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.1 p -34.35 -40.86 0.1 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.278 2.631 . . . . 0.0 115.562 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.85 0.05 10.05 Favored 'General case' 0 N--CA 1.436 -1.16 1 C-N-CA 132.919 4.487 . . . . 0.0 111.654 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.2 -4.32 33.42 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.969 0.804 . . . . 0.0 112.086 -166.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.76 102.96 4.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.98 2.512 . . . . 0.0 110.163 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -66.37 143.56 57.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.219 0.463 . . . . 0.0 111.54 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -123.93 155.95 37.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.117 2.967 . . . . 0.0 108.499 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.1 t -63.88 -28.79 70.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -163.87 160.65 17.14 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.918 1.687 . . . . 0.0 107.637 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.37 -14.9 28.2 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 120.744 0.963 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.01 -44.68 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 118.101 0.409 . . . . 0.0 110.596 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mmm -59.0 -46.36 88.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.009 0.924 . . . . 0.0 110.515 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.78 -62.22 1.84 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.111 1.365 . . . . 0.0 110.876 173.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -35.56 77.18 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.713 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.38 -68.32 0.18 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 171.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.81 -52.75 1.72 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.872 2.069 . . . . 0.0 112.104 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 42.2 tttm -48.53 -59.11 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.731 1.612 . . . . 0.0 110.323 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -71.0 -23.97 62.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.576 0.75 . . . . 0.0 112.64 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -75.88 -38.65 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.514 0.726 . . . . 0.0 110.718 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.2 18.91 0.03 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.057 -1.413 . . . . 0.0 115.488 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 16.4 t-20 -128.79 62.42 61.1 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 120.327 2.063 . . . . 0.0 110.073 -176.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.23 -25.34 71.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.979 1.786 . . . . 0.0 112.786 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.06 -32.66 74.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 131.273 3.829 . . . . 0.0 114.304 175.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.661 HD12 ' H ' ' A' ' 41' ' ' VAL . 3.8 tp -66.2 157.54 31.13 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 109.183 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.661 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.4 m -152.47 149.79 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 126.516 1.926 . . . . 0.0 109.74 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.77 83.96 1.64 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 164.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -54.1 -46.29 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.743 0.817 . . . . 0.0 108.946 174.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -161.22 178.78 8.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -83.36 178.83 7.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 159.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.01 144.14 1.38 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -172.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.45 158.64 25.74 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.868 1.712 . . . . 0.0 110.853 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.6 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 64.6 m . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 162.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -176.81 -81.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.94 1.696 . . . . 0.0 107.113 140.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.25 -39.38 44.15 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 119.2 -0.778 . . . . 0.0 112.222 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -43.51 77.81 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 116.682 -1.628 . . . . 0.0 115.127 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 18.5 Cg_endo -56.11 -28.24 69.15 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 122.266 1.845 . . . . 0.0 112.228 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -105.25 29.15 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.769 1.628 . . . . 0.0 111.915 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -56.78 -27.67 60.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.57 163.42 3.73 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.129 2.572 . . . . 0.0 114.997 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.21 162.24 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.376 2.051 . . . . 0.0 110.912 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 43.15 0.97 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.633 -0.667 . . . . 0.0 110.236 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.43 127.69 33.27 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.093 2.157 . . . . 0.0 110.89 172.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.18 43.54 0.63 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.556 1.542 . . . . 0.0 112.019 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -82.78 55.92 3.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.458 -1.401 . . . . 0.0 109.959 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -54.65 144.26 22.37 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.61 1.564 . . . . 0.0 114.881 -161.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 26' ' ' PRO . 4.2 m -146.36 162.16 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.726 0.81 . . . . 0.0 111.844 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.6 t -101.43 130.77 47.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.279 0.632 . . . . 0.0 112.0 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.08 163.39 23.23 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 158.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.474 ' HA ' HG11 ' A' ' 43' ' ' VAL . 88.5 p -34.03 -57.56 0.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 118.237 2.68 . . . . 0.0 118.237 -161.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.71 42.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.219 -162.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.36 42.44 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 123.758 0.694 . . . . 0.0 112.617 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.18 75.51 2.33 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.824 3.249 . . . . 0.0 108.946 -159.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.0 m -66.31 143.74 57.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.662 -0.649 . . . . 0.0 110.225 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.02 155.42 46.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.597 2.359 . . . . 0.0 108.562 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -59.85 -25.45 65.03 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.434 1.494 . . . . 0.0 114.047 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 11.8 p30 -163.55 162.66 17.01 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.806 2.043 . . . . 0.0 107.675 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HA ' HG21 ' A' ' 15' ' ' VAL . 39.8 Cg_endo -66.83 -21.82 50.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.185 1.257 . . . . 0.0 111.368 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.01 -37.84 84.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.599 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 mmm -68.85 -35.68 77.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.792 1.178 . . . . 0.0 111.704 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.937 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.1 tt -61.9 -63.99 1.08 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.38 -32.64 70.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.777 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 2.1 t -51.4 -71.44 0.06 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.02 -52.9 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.431 1.893 . . . . 0.0 111.317 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 44.9 tttm -48.66 -63.96 0.94 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.844 1.657 . . . . 0.0 110.466 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -73.15 -18.4 61.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.54 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -73.55 -55.08 6.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.97 0.508 . . . . 0.0 110.131 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.08 16.49 0.09 OUTLIER Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.818 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 12.5 t-20 -126.76 57.77 24.06 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.693 1.746 . . . . 0.0 108.646 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.22 -22.85 66.78 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 122.48 1.921 . . . . 0.0 112.724 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.07 -31.89 73.24 Favored 'General case' 0 CA--C 1.533 0.312 1 C-N-CA 132.415 4.286 . . . . 0.0 114.873 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.937 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -65.69 156.59 32.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.188 1.395 . . . . 0.0 108.542 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.659 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.4 m -152.36 155.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.853 1.661 . . . . 0.0 109.431 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -73.84 87.01 1.75 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 163.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.93 -48.51 63.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 123.165 0.586 . . . . 0.0 110.491 167.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -162.73 164.37 26.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.135 1.774 . . . . 0.0 107.534 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -84.26 166.01 17.85 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 166.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.83 150.18 2.81 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 111.357 -170.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -83.23 157.55 14.94 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.659 -166.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.0 m . . . . . 0 C--N 1.342 0.241 0 CA-C-O 119.31 -0.376 . . . . 0.0 110.656 165.26 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 p90 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.96 -68.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.978 . . . . 0.0 105.965 166.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.9 -17.87 42.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.849 1.214 . . . . 0.0 115.289 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -64.91 -52.02 52.69 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 119.011 1.406 . . . . 0.0 111.81 165.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.46 -58.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.015 3.143 . . . . 0.0 112.629 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.89 96.79 10.34 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.953 1.706 . . . . 0.0 111.082 -167.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.84 0.02 2.16 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 125.007 1.442 . . . . 0.0 113.947 -175.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 163.9 62.59 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.354 1.462 . . . . 0.0 113.884 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.52 165.18 31.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.595 2.197 . . . . 0.0 110.69 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.36 47.51 0.09 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.83 1.252 . . . . 0.0 112.066 167.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.84 118.73 10.1 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.146 165.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -77.55 42.44 0.36 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.407 1.883 . . . . 0.0 111.473 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 15' ' ' VAL . 6.2 m80 -79.58 64.89 4.58 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.67 137.61 57.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.657 1.572 . . . . 0.0 111.55 -168.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 13' ' ' HIS . 2.8 m -141.54 167.32 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.89 0.876 . . . . 0.0 112.097 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 t -105.53 141.56 36.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.071 0.948 . . . . 0.0 110.719 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.39 166.14 24.1 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.892 1.234 . . . . 0.0 111.217 159.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.55 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -37.9 -40.35 0.45 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.385 2.274 . . . . 0.0 115.665 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.47 16.5 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 110.314 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.77 65.47 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.219 -165.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -68.68 92.62 0.48 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.46 1.504 . . . . 0.0 109.354 -163.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -65.9 143.46 57.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -126.54 155.02 43.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.827 2.051 . . . . 0.0 108.707 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.1 p -65.46 -27.88 68.82 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.688 1.195 . . . . 0.0 113.212 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -163.41 152.63 12.42 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 127.326 2.25 . . . . 0.0 108.957 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.86 -23.65 22.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.118 1.212 . . . . 0.0 110.92 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -56.76 -44.47 81.81 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 111.105 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.31 70.14 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.896 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.6 tt -64.46 -65.86 0.62 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 t -52.39 -29.47 24.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.445 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -62.05 -60.74 3.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' N ' ' SG ' ' A' ' 31' ' ' CYS . . . -42.35 -51.9 4.72 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.992 2.117 . . . . 0.0 110.206 175.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 tttm -50.95 -63.2 1.2 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.339 1.024 . . . . 0.0 110.562 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.73 -14.0 62.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.518 1.127 . . . . 0.0 113.943 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -58.23 3.26 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.75 34.14 0.14 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.591 -1.116 . . . . 0.0 113.09 -173.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -134.85 62.1 51.29 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 119.271 1.535 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.0 -13.44 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 CA-C-N 121.058 1.414 . . . . 0.0 114.027 -172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.66 -27.01 37.25 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.503 2.721 . . . . 0.0 112.735 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.896 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.9 tp -66.39 153.56 42.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.62 ' H ' HD12 ' A' ' 40' ' ' LEU . 35.2 m -147.74 144.05 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -74.38 87.28 2.03 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.7 OUTLIER -58.73 -50.67 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.44 1.496 . . . . 0.0 108.885 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -179.39 -171.52 0.2 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.51 3.124 . . . . 0.0 107.574 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -164.82 1.05 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.81 2.444 . . . . 0.0 108.604 166.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 123.15 0.19 Allowed Glycine 0 CA--C 1.544 1.895 0 C-N-CA 124.862 1.22 . . . . 0.0 113.975 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.16 135.23 13.54 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 120.823 2.311 . . . . 0.0 112.312 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.534 0.337 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.444 178.422 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.22 -54.9 0.01 OUTLIER 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.18 0.992 . . . . 0.0 111.448 170.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.75 67.0 1.12 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 127.017 2.246 . . . . 0.0 109.39 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -176.62 -55.87 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.259 1.824 . . . . 0.0 109.851 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' CA ' ' A' ' 31' ' ' CYS . 28.2 Cg_endo -72.74 -58.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.733 1.622 . . . . 0.0 110.004 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.17 133.83 35.53 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 176.57 34.41 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 O-C-N 125.967 2.042 . . . . 0.0 111.726 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.7 165.78 12.72 Favored Pre-proline 0 C--O 1.233 0.234 0 O-C-N 121.293 -0.88 . . . . 0.0 112.28 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.48 172.38 14.34 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.233 1.956 . . . . 0.0 109.709 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -77.01 44.26 0.39 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.661 1.584 . . . . 0.0 110.722 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 120.31 11.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.77 1.228 . . . . 0.0 110.046 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.49 54.49 2.36 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.802 1.641 . . . . 0.0 110.54 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.613 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.5 m80 -91.04 61.3 4.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 48.4 mmm-85 -46.2 100.37 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 13' ' ' HIS . 34.8 m -99.52 178.81 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 124.932 1.293 . . . . 0.0 112.299 174.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 4.1 t -115.97 135.33 54.07 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.457 1.503 . . . . 0.0 109.025 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.75 173.07 41.38 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -55.58 -32.1 62.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.21 -0.03 30.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.914 1.286 . . . . 0.0 110.567 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.93 -0.82 61.16 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.67 1.129 . . . . 0.0 111.991 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.97 115.32 11.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 26.2 m -65.79 150.14 49.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.77 136.02 53.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -37.17 -37.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.777 2.031 . . . . 0.0 113.241 170.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -163.69 155.79 15.0 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 128.072 2.549 . . . . 0.0 111.361 -176.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.3 -24.87 16.19 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.471 2.781 . . . . 0.0 110.292 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.74 -30.04 69.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.3 mtp -74.61 -41.51 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.002 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.79 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.6 tt -51.26 -70.03 0.1 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 t -50.24 -38.07 38.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.741 0.416 . . . . 0.0 111.804 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.442 ' CA ' ' HB2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -51.49 -72.18 0.05 Allowed 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -35.91 -55.85 0.73 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 127.679 2.392 . . . . 0.0 109.79 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.52 -66.03 0.43 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.481 -1.69 . . . . 0.0 114.054 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.87 63.24 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 124.584 1.177 . . . . 0.0 111.249 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -78.33 0.11 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.399 1.48 . . . . 0.0 107.778 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.43 48.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 127.078 2.275 . . . . 0.0 109.503 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -148.03 59.99 4.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 117.891 0.845 . . . . 0.0 111.753 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.83 -10.56 17.62 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 122.967 2.445 . . . . 0.0 113.612 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.55 -28.93 21.67 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 127.0 2.12 . . . . 0.0 113.709 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.79 HD11 ' HG ' ' A' ' 29' ' ' LEU . 2.4 tp -65.59 154.2 39.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.56 ' H ' HD12 ' A' ' 40' ' ' LEU . 18.1 m -146.89 145.33 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -73.42 82.83 1.45 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -55.5 -49.75 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.669 172.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 174.78 176.94 0.15 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.009 2.124 . . . . 0.0 109.032 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -174.85 5.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.009 2.124 . . . . 0.0 110.522 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.34 134.37 0.53 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.37 1.462 . . . . 0.0 112.909 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.9 145.52 36.2 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.532 2.166 . . . . 0.0 111.372 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.457 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.461 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.69 174.97 14.22 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 102.989 -2.967 . . . . 0.0 102.989 139.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.15 -70.22 2.82 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.768 1.175 . . . . 0.0 112.041 166.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -43.97 83.86 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 116.553 -1.689 . . . . 0.0 114.739 -173.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 31.8 Cg_endo -57.5 -22.32 50.35 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.652 1.568 . . . . 0.0 113.206 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.75 46.55 1.82 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.684 1.594 . . . . 0.0 112.309 -167.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -29.73 70.38 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.692 -1.255 . . . . 0.0 112.018 168.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.06 157.14 54.19 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 126.436 1.894 . . . . 0.0 115.513 -163.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.59 164.64 30.16 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.015 2.477 . . . . 0.0 110.572 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.72 43.52 0.84 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.599 -0.688 . . . . 0.0 109.994 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.13 132.73 49.17 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.382 1.873 . . . . 0.0 110.578 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.85 43.62 1.05 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.953 1.701 . . . . 0.0 110.82 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -87.96 63.93 7.59 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.248 -1.533 . . . . 0.0 108.761 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -60.11 146.96 41.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.894 1.278 . . . . 0.0 113.344 -160.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 m -147.36 158.41 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.499 1.12 . . . . 0.0 111.819 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -91.55 136.51 33.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.666 0.786 . . . . 0.0 110.967 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.79 163.97 23.8 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 159.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.501 ' HA ' HG11 ' A' ' 43' ' ' VAL . 82.1 p -47.15 -32.61 4.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.109 2.164 . . . . 0.0 116.17 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.65 -7.27 25.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.844 1.658 . . . . 0.0 113.019 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.78 -9.67 50.58 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.359 0.98 . . . . 0.0 111.046 -158.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.7 96.5 0.28 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.133 2.573 . . . . 0.0 108.921 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -66.63 144.33 56.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 110.504 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -123.71 145.12 49.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.843 1.657 . . . . 0.0 107.389 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.423 ' H ' ' CE ' ' A' ' 28' ' ' MET . 10.0 m -62.69 -16.25 56.35 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -176.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.46 158.5 17.5 Favored Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 108.607 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.38 -15.77 31.17 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.785 1.657 . . . . 0.0 111.99 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -72.82 -40.23 65.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.423 ' CE ' ' H ' ' A' ' 24' ' ' SER . 19.0 ttp -61.87 -45.33 94.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.916 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.22 -63.55 1.12 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.991 174.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -34.44 74.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.226 -174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 2.9 t -50.31 -69.02 0.12 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 124.806 1.243 . . . . 0.0 108.616 169.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.09 -52.63 2.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.099 2.16 . . . . 0.0 111.884 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -49.13 -61.61 1.98 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.869 1.668 . . . . 0.0 110.586 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 123.957 0.786 . . . . 0.0 112.512 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -77.68 -46.6 21.45 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.5 18.82 0.09 OUTLIER Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.312 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -133.48 65.45 71.94 Favored Pre-proline 0 C--O 1.223 -0.338 0 CA-C-N 119.932 1.866 . . . . 0.0 110.25 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -61.55 -20.07 67.22 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.482 1.565 . . . . 0.0 112.615 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -22.14 47.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.654 2.782 . . . . 0.0 113.774 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.916 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.9 tp -66.48 152.15 45.76 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.614 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.3 m -151.52 155.98 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.773 1.629 . . . . 0.0 108.801 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -73.79 84.3 1.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.8 -50.25 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 C-N-CA 122.944 0.498 . . . . 0.0 110.194 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -159.33 -174.32 4.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.231 1.813 . . . . 0.0 106.26 165.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 46' ' ' GLY . 26.2 tt0 -71.35 -137.39 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.18 1.392 . . . . 0.0 107.4 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.472 ' H ' ' HG2' ' A' ' 45' ' ' GLU . . . 51.87 116.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 128.104 2.764 . . . . 0.0 117.881 158.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.76 127.61 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 CA-C-N 119.709 1.755 . . . . 0.0 112.376 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.6 m . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 118.999 -0.524 . . . . 0.0 112.11 173.719 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.463 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -176.62 -78.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.546 2.338 . . . . 0.0 105.72 159.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 50.48 3.79 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 127.234 2.349 . . . . 0.0 112.911 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 2.9 t-20 -144.29 -53.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.585 1.954 . . . . 0.0 109.299 163.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 11.3 Cg_endo -59.27 -29.94 91.62 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.377 2.051 . . . . 0.0 114.199 166.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.95 102.15 9.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.004 1.274 . . . . 0.0 112.889 -172.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -126.31 -0.0 7.02 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.106 1.362 . . . . 0.0 112.763 163.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -75.91 165.72 50.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -165.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.99 167.25 20.28 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.225 1.95 . . . . 0.0 110.728 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp85 -85.46 43.83 1.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.621 -0.675 . . . . 0.0 110.639 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.03 24.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.901 1.68 . . . . 0.0 110.304 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.35 43.48 1.02 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.538 1.535 . . . . 0.0 111.652 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.484 ' O ' HG13 ' A' ' 15' ' ' VAL . 34.5 m170 -78.23 70.65 4.62 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 120.603 -1.31 . . . . 0.0 107.89 170.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -52.96 130.52 33.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.4 1.08 . . . . 0.0 111.308 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 13' ' ' HIS . 4.1 m -135.74 162.93 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 123.455 0.702 . . . . 0.0 111.746 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.0 135.29 45.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 111.422 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.01 163.86 23.5 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 158.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.521 ' HA ' HG11 ' A' ' 43' ' ' VAL . 89.2 p -42.28 -36.49 1.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 -164.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . 82.0 m-20 -72.1 -1.47 14.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 112.757 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.81 82.7 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 119.145 0.884 . . . . 0.0 112.175 -159.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 45.8 t-20 -67.73 90.47 0.28 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.967 2.507 . . . . 0.0 109.75 -171.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 83.4 m -65.89 144.15 56.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.368 0.667 . . . . 0.0 111.832 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.18 158.39 39.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.473 2.709 . . . . 0.0 108.282 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 t -61.33 -28.49 69.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.818 1.247 . . . . 0.0 113.926 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 12.9 p30 -163.82 161.9 16.85 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 125.931 1.692 . . . . 0.0 108.376 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.9 Cg_endo -73.81 -16.63 23.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 120.968 1.112 . . . . 0.0 111.87 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -64.85 -45.93 84.01 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.565 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.3 mtp -58.15 -41.6 84.1 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.979 0.809 . . . . 0.0 112.57 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.904 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.7 tt -55.76 -67.2 0.31 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 109.095 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -33.78 71.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.595 -0.69 . . . . 0.0 111.485 -172.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.9 t -53.32 -70.93 0.08 Allowed 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.239 1.416 . . . . 0.0 107.679 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.51 0.82 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 126.606 1.963 . . . . 0.0 111.851 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -49.86 -63.96 0.95 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.851 1.261 . . . . 0.0 110.979 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -15.07 63.46 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.663 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -80.48 -59.62 2.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.42 28.25 0.26 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.47 -1.183 . . . . 0.0 114.146 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.02 66.56 79.35 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 119.5 1.65 . . . . 0.0 109.737 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.58 -19.4 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.817 1.327 . . . . 0.0 112.402 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.56 -25.77 50.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.794 2.838 . . . . 0.0 113.904 176.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.904 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.5 tp -66.52 154.54 40.08 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.689 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.1 m -150.95 154.65 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.737 1.215 . . . . 0.0 110.182 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.408 HE22 ' HB3' ' A' ' 26' ' ' PRO . 30.1 tp60 -75.08 86.56 2.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -56.55 -53.87 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.777 0.831 . . . . 0.0 109.788 166.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -164.66 -175.24 3.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.198 1.799 . . . . 0.0 108.503 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -86.0 -175.05 5.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.132 1.373 . . . . 0.0 108.045 158.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.91 142.34 1.12 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.425 1.012 . . . . 0.0 112.12 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -83.24 146.86 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.177 1.918 . . . . 0.0 111.1 -171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 168.823 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.23 -79.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.521 1.928 . . . . 0.0 106.614 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.16 -27.23 41.17 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.636 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -44.08 78.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 116.902 -1.523 . . . . 0.0 114.557 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -68.47 -50.14 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.058 1.838 . . . . 0.0 111.562 166.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -90.7 76.32 6.47 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.856 1.207 . . . . 0.0 111.188 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.65 102.76 6.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 159.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.71 165.81 6.96 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.308 1.443 . . . . 0.0 109.253 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.43 159.09 32.73 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.124 1.883 . . . . 0.0 110.7 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -78.42 43.32 0.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.55 0.74 . . . . 0.0 110.488 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.48 126.15 27.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.593 1.957 . . . . 0.0 110.943 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.95 43.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.602 1.561 . . . . 0.0 111.511 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -83.53 62.76 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.496 -1.377 . . . . 0.0 109.913 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -53.69 140.28 29.8 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -165.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -146.45 176.65 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 125.424 1.49 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 42.7 t -125.5 146.19 49.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.435 1.016 . . . . 0.0 111.705 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.18 163.6 23.21 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.029 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.428 ' HB3' HG13 ' A' ' 43' ' ' VAL . 84.5 p -53.24 -14.46 0.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.114 1.766 . . . . 0.0 114.482 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.79 -15.24 58.22 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.212 2.205 . . . . 0.0 112.14 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.43 -9.73 40.28 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 124.856 1.217 . . . . 0.0 111.358 -163.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.52 114.9 15.76 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.561 1.945 . . . . 0.0 110.151 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -65.64 143.84 57.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.957 0.799 . . . . 0.0 109.536 166.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -121.26 147.4 45.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.323 1.849 . . . . 0.0 106.87 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 m -60.61 -23.43 64.71 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.555 0.742 . . . . 0.0 112.501 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -163.59 161.09 17.7 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.958 2.103 . . . . 0.0 107.95 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.3 -14.64 34.61 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.973 1.782 . . . . 0.0 112.201 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.64 -40.11 84.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.864 0.466 . . . . 0.0 110.986 173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 89.5 mtp -65.06 -39.72 93.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.013 0.824 . . . . 0.0 111.551 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -58.41 -63.66 1.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.073 0.949 . . . . 0.0 110.043 171.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.45 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -60.33 -32.4 71.2 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.668 -175.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -69.07 0.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.02 -52.89 1.39 Allowed 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 126.47 1.908 . . . . 0.0 111.657 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -50.06 -63.09 1.22 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.385 1.874 . . . . 0.0 110.29 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -66.83 -25.91 66.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.331 1.052 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -69.57 -57.43 5.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.282 0.633 . . . . 0.0 109.529 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.11 21.31 0.11 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.565 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -125.62 62.22 40.52 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 119.589 1.694 . . . . 0.0 109.382 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -61.16 -18.3 57.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 121.45 1.554 . . . . 0.0 113.141 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -23.36 42.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.329 2.652 . . . . 0.0 113.625 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.684 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.5 tp -66.39 152.4 45.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.539 ' H ' HD12 ' A' ' 40' ' ' LEU . 29.0 m -156.08 161.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.341 2.256 . . . . 0.0 108.87 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -75.73 80.81 2.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 18' ' ' SER . 0.3 OUTLIER -54.24 -41.01 49.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 124.99 1.316 . . . . 0.0 111.147 172.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.36 143.04 18.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -84.63 55.23 3.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.478 1.132 . . . . 0.0 108.761 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.67 158.41 31.35 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.247 2.356 . . . . 0.0 108.488 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -82.15 153.47 16.53 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.835 2.357 . . . . 0.0 113.375 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 60.6 m . . . . . 0 CA--C 1.529 0.152 0 C-N-CA 126.377 1.871 . . . . 0.0 108.88 169.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.616 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.1 133.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 162.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.16 -36.75 1.1 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.061 0.839 . . . . 0.0 113.552 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -50.3 72.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.401 1.08 . . . . 0.0 109.767 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.14 -36.08 6.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.628 2.218 . . . . 0.0 113.875 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -108.32 95.15 5.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.547 1.067 . . . . 0.0 110.232 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -119.91 5.51 10.91 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.025 1.33 . . . . 0.0 111.051 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.92 165.85 20.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 0.0 114.325 -167.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.92 167.98 10.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mtt85 -74.67 44.33 0.21 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.137 1.375 . . . . 0.0 111.448 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.78 120.31 12.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.716 1.207 . . . . 0.0 110.173 164.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.44 43.81 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.119 2.167 . . . . 0.0 111.709 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.479 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.2 m-70 -78.7 67.86 4.54 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.782 -1.198 . . . . 0.0 108.213 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -57.59 133.66 55.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.741 1.609 . . . . 0.0 110.483 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 13' ' ' HIS . 17.9 m -135.34 167.86 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.364 1.066 . . . . 0.0 111.158 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -106.15 137.69 43.65 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.229 1.012 . . . . 0.0 111.592 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.99 163.97 23.57 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 159.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.451 ' HA ' HG11 ' A' ' 43' ' ' VAL . 60.6 p -45.83 -34.27 3.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -168.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -0.04 6.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.475 1.11 . . . . 0.0 112.384 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.82 1.52 90.6 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 111.666 -159.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.86 100.48 4.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.836 1.654 . . . . 0.0 110.584 -166.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -66.1 143.61 57.21 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.858 -0.526 . . . . 0.0 111.355 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -122.27 153.62 38.65 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.87 2.468 . . . . 0.0 108.641 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -63.12 -28.42 70.05 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.462 1.505 . . . . 0.0 113.178 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 18.3 p30 -163.58 158.87 17.48 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.071 1.748 . . . . 0.0 110.126 173.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.4 Cg_endo -70.63 -20.07 31.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.247 1.298 . . . . 0.0 111.496 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -66.1 -43.94 85.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.943 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtm -62.58 -35.54 79.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.6 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.913 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.7 tt -60.42 -66.05 0.59 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.213 0.915 . . . . 0.0 109.495 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -56.11 -36.49 68.25 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.337 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -68.93 0.13 Allowed 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.333 1.053 . . . . 0.0 108.945 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -37.94 -53.12 1.36 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.343 1.857 . . . . 0.0 110.784 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -51.54 -63.8 1.02 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.549 1.14 . . . . 0.0 110.523 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.36 -15.43 63.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.522 1.129 . . . . 0.0 112.742 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -78.27 -64.21 1.22 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.9 27.66 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.896 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -128.69 64.53 69.45 Favored Pre-proline 0 C--N 1.343 0.326 0 CA-C-N 119.141 1.471 . . . . 0.0 110.194 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -63.08 -16.65 55.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.97 1.382 . . . . 0.0 112.777 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.35 -25.99 42.16 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.179 2.192 . . . . 0.0 113.228 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.913 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.32 153.85 41.55 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.667 ' H ' HD12 ' A' ' 40' ' ' LEU . 31.6 m -151.11 147.29 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.258 1.423 . . . . 0.0 107.72 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -76.9 86.2 3.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.92 -53.65 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.936 0.894 . . . . 0.0 110.401 168.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.65 177.21 5.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.274 1.43 . . . . 0.0 109.721 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 178.26 7.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.923 1.689 . . . . 0.0 107.713 166.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.76 142.03 1.05 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 119.039 0.836 . . . . 0.0 112.972 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -80.82 147.4 17.05 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.923 1.749 . . . . 0.0 111.119 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.523 -0.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.021 171.607 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -176.52 -71.08 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.311 1.844 . . . . 0.0 107.605 167.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.64 67.75 3.63 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.101 1.81 . . . . 0.0 110.727 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.6 -52.18 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.41 2.284 . . . . 0.0 107.556 169.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.77 -43.0 5.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.17 2.58 . . . . 0.0 114.521 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.11 93.59 5.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.809 1.64 . . . . 0.0 112.389 -169.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.11 2.43 9.83 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.063 1.745 . . . . 0.0 113.315 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.93 170.94 9.43 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -162.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.61 167.21 11.71 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.417 2.745 . . . . 0.0 111.474 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.43 45.73 0.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.388 -0.82 . . . . 0.0 111.24 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 119.5 9.9 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 165.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.06 42.94 0.27 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.018 2.527 . . . . 0.0 112.217 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.08 63.53 5.12 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.489 -1.382 . . . . 0.0 108.758 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.3 140.08 54.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.738 1.215 . . . . 0.0 113.419 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.2 160.19 13.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.84 135.25 35.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.702 1.601 . . . . 0.0 110.798 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.65 164.72 24.29 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 159.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' HG11 ' A' ' 43' ' ' VAL . 88.5 p -43.96 -38.26 3.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -169.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -0.24 7.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.671 1.188 . . . . 0.0 113.119 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.97 -5.36 85.31 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.821 0.737 . . . . 0.0 111.576 -165.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -71.7 99.98 2.24 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.599 2.359 . . . . 0.0 110.287 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -67.06 145.61 55.18 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.745 -0.597 . . . . 0.0 112.284 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -126.42 158.56 35.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.159 2.184 . . . . 0.0 108.876 171.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -62.75 -29.17 70.49 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.311 1.844 . . . . 0.0 114.178 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -163.71 155.02 14.25 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 109.148 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.33 -17.91 34.69 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.634 2.223 . . . . 0.0 110.736 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.1 t -62.61 -46.33 88.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.026 0.93 . . . . 0.0 110.06 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mtm -66.16 -31.81 72.87 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.233 -0.889 . . . . 0.0 112.823 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.887 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -60.98 -63.89 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.74 1.155 . . . . 0.0 109.72 171.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.86 -35.44 72.95 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.278 -176.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.13 -66.56 0.37 Allowed 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.53 -53.54 1.57 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 127.188 2.195 . . . . 0.0 110.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 43.4 tttm -50.85 -62.47 1.59 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.835 1.254 . . . . 0.0 109.746 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -18.82 65.41 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.379 1.049 . . . . 0.0 113.168 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -56.76 4.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 18.58 0.1 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.171 -1.35 . . . . 0.0 114.219 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.99 61.99 10.19 Favored Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.816 1.808 . . . . 0.0 108.515 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.98 -21.57 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 121.61 1.611 . . . . 0.0 112.847 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -29.67 67.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.338 2.255 . . . . 0.0 113.448 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.887 HD11 ' HG ' ' A' ' 29' ' ' LEU . 7.1 tp -66.14 157.27 31.67 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.687 ' H ' HD12 ' A' ' 40' ' ' LEU . 29.6 m -150.96 149.35 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 106.789 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -72.88 89.2 1.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -54.18 -54.53 20.31 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 C-N-CA 124.58 1.152 . . . . 0.0 110.517 168.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.8 t60 174.97 170.87 0.27 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.357 2.663 . . . . 0.0 105.84 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -168.5 2.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.011 0.924 . . . . 0.0 109.077 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.83 131.74 2.04 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.1 128.09 8.85 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.929 1.865 . . . . 0.0 111.209 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.47 0.565 0 CA-C-N 118.188 0.449 . . . . 0.0 110.624 175.217 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -166.5 159.2 14.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 145.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.55 -50.11 2.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.813 1.197 . . . . 0.0 115.341 162.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -63.77 -43.73 77.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.251 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.58 -61.92 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 CA-C-N 121.244 1.48 . . . . 0.0 110.384 159.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.3 m -92.36 74.07 5.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -158.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 130.31 25.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 158.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.95 167.21 0.77 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.207 1.803 . . . . 0.0 109.355 -174.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.1 156.73 51.48 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.018 1.145 . . . . 0.0 110.065 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -82.9 43.17 0.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.44 123.86 21.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.477 2.311 . . . . 0.0 109.886 166.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.73 54.03 2.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.443 1.897 . . . . 0.0 111.561 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -72.29 81.8 1.02 Allowed 'General case' 0 C--O 1.223 -0.311 0 O-C-N 120.726 -1.233 . . . . 0.0 107.877 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -65.98 86.22 0.09 Allowed 'General case' 0 C--O 1.221 -0.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.365 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.47 154.05 3.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 126.364 1.865 . . . . 0.0 114.123 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 35.7 t -86.11 127.66 34.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.65 -0.656 . . . . 0.0 109.371 167.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.5 163.19 26.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 158.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.418 ' HA ' HG11 ' A' ' 43' ' ' VAL . 71.3 p -33.79 -51.66 0.4 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.116 2.567 . . . . 0.0 117.399 -167.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 27.54 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 126.34 1.856 . . . . 0.0 110.945 -166.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.08 -1.4 8.56 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.547 1.546 . . . . 0.0 112.759 -165.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.55 89.2 2.18 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 129.885 3.274 . . . . 0.0 108.048 -166.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -65.87 143.71 57.27 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.713 -0.617 . . . . 0.0 109.55 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.77 151.96 47.53 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 127.121 2.168 . . . . 0.0 109.096 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -65.53 -18.68 65.51 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.706 1.603 . . . . 0.0 114.736 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -164.26 154.81 13.09 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 125.914 1.686 . . . . 0.0 109.597 166.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.93 -20.63 38.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.108 1.872 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.4 t -60.0 -58.2 9.57 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.172 168.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.5 mmm -61.12 -34.01 74.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.09 1.314 . . . . 0.0 112.928 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.945 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -54.76 -65.09 0.64 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.178 0.899 . . . . 0.0 109.242 166.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -28.08 69.68 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.991 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -63.23 1.37 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -42.93 -52.87 4.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.956 2.102 . . . . 0.0 111.62 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 40.2 tttm -48.42 -62.13 1.65 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.166 1.786 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -72.28 -16.43 61.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.489 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -67.89 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 171.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.11 22.86 0.68 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.288 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 9.5 t-20 -129.3 56.87 26.44 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.208 1.504 . . . . 0.0 109.167 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -58.95 -21.6 58.91 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 CA-C-N 122.587 1.96 . . . . 0.0 113.012 -171.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.13 -34.15 77.4 Favored 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.001 4.12 . . . . 0.0 114.657 173.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.945 HD11 ' HG ' ' A' ' 29' ' ' LEU . 7.4 tp -65.63 153.84 40.49 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 125.437 1.495 . . . . 0.0 107.914 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.486 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.7 m -149.62 151.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 124.863 1.265 . . . . 0.0 109.212 169.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.67 85.83 3.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.61 -34.98 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.395 1.478 . . . . 0.0 110.456 172.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 179.67 170.24 1.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.734 2.414 . . . . 0.0 107.319 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.72 177.5 7.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 158.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.08 139.67 0.88 Allowed Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.728 1.156 . . . . 0.0 111.68 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -85.52 152.57 10.39 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.555 2.837 . . . . 0.0 112.478 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 62.4 m . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 166.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -72.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.17 1.788 . . . . 0.0 107.446 160.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.84 51.82 4.36 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.872 2.177 . . . . 0.0 111.98 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.35 -53.49 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 127.102 2.161 . . . . 0.0 107.784 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.87 -42.32 46.31 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.125 1.217 . . . . 0.0 112.11 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.0 m -101.53 99.91 10.28 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.586 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.62 78.36 1.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 159.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -156.33 166.4 16.56 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.433 1.093 . . . . 0.0 110.79 -165.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.71 161.73 24.53 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.914 2.41 . . . . 0.0 112.212 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -75.06 44.47 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.923 1.289 . . . . 0.0 111.046 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 131.28 46.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.531 1.132 . . . . 0.0 110.643 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -85.98 43.07 1.02 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.997 2.119 . . . . 0.0 110.329 167.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -92.52 61.7 3.78 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.719 -1.238 . . . . 0.0 107.749 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -58.58 142.5 49.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -159.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.71 168.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.023 0.929 . . . . 0.0 112.186 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 t -114.12 136.51 52.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.13 163.34 22.09 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 158.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -52.87 -27.36 18.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -164.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -13.7 59.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.185 0.994 . . . . 0.0 112.216 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.76 -3.17 65.03 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -159.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.89 87.54 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.941 2.896 . . . . 0.0 107.846 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -66.53 143.5 57.02 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -125.1 155.7 39.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.212 2.205 . . . . 0.0 107.692 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 t -58.15 -29.6 65.7 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.866 0.866 . . . . 0.0 112.307 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -163.9 160.41 17.06 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.247 1.419 . . . . 0.0 108.509 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.84 -18.92 36.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.314 2.01 . . . . 0.0 111.632 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -67.54 -45.82 74.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.711 0.404 . . . . 0.0 110.524 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.4 mtp -62.66 -37.36 86.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.03 0.832 . . . . 0.0 111.573 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.958 ' HG ' HD11 ' A' ' 40' ' ' LEU . 4.0 tt -60.08 -66.62 0.49 Allowed 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.616 0.766 . . . . 0.0 109.879 170.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -32.68 66.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.852 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.68 -70.47 0.11 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.86 -52.94 0.94 Allowed 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 126.531 1.933 . . . . 0.0 111.993 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -48.69 -64.21 0.87 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.466 1.507 . . . . 0.0 110.7 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.99 -26.64 68.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.266 0.979 . . . . 0.0 112.338 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -70.23 -59.7 2.73 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.11 21.27 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.524 -1.154 . . . . 0.0 113.946 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -130.16 54.09 13.56 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 119.434 1.617 . . . . 0.0 109.537 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -59.4 -22.34 65.39 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 CA-C-N 122.933 2.083 . . . . 0.0 113.074 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.3 -30.45 71.5 Favored 'General case' 0 CA--C 1.534 0.336 1 C-N-CA 132.616 4.366 . . . . 0.0 115.313 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.958 HD11 ' HG ' ' A' ' 29' ' ' LEU . 1.5 tp -65.37 158.8 25.6 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.838 1.255 . . . . 0.0 107.888 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.68 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.3 m -153.63 155.7 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.591 1.956 . . . . 0.0 108.072 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -75.81 88.07 2.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 164.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -48.86 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 122.583 0.353 . . . . 0.0 110.211 169.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.04 155.63 23.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.334 1.053 . . . . 0.0 108.223 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 170.32 15.71 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.94 156.2 0.07 OUTLIER Glycine 0 CA--C 1.544 1.847 0 O-C-N 121.006 -1.059 . . . . 0.0 112.13 -162.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -91.05 164.96 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 CA-C-N 119.263 1.532 . . . . 0.0 113.592 -164.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.9 m . . . . . 0 C--N 1.341 0.209 0 C-N-CA 123.432 0.693 . . . . 0.0 109.169 167.79 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.478 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -170.91 134.55 0.99 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.44 -41.39 1.15 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 115.849 1.1 . . . . 0.0 115.849 164.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.6 -47.04 83.42 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 119.701 1.75 . . . . 0.0 110.46 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -55.42 -43.27 59.92 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.321 2.014 . . . . 0.0 113.065 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -105.38 66.1 0.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.765 1.226 . . . . 0.0 111.992 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.14 -0.04 30.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.641 0.776 . . . . 0.0 112.061 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.04 165.3 17.26 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -159.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.45 164.18 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.908 2.405 . . . . 0.0 111.173 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -81.61 43.38 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.582 -0.699 . . . . 0.0 110.104 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.84 124.9 24.23 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.459 1.904 . . . . 0.0 110.846 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.92 43.55 0.93 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.419 1.088 . . . . 0.0 109.791 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.62 60.69 6.25 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.833 -1.167 . . . . 0.0 109.104 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.6 mmm-85 -53.07 140.2 26.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.247 1.819 . . . . 0.0 112.735 -162.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.99 156.63 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 123.898 0.879 . . . . 0.0 111.498 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 52.9 t -94.47 141.82 28.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.002 0.364 . . . . 0.0 110.774 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.88 166.29 24.81 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 160.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.464 ' HA ' HG11 ' A' ' 43' ' ' VAL . 96.0 p -49.65 -19.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -176.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -85.63 -8.32 58.31 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.323 1.42 . . . . 0.0 111.986 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.27 -9.65 69.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.06 -1.025 . . . . 0.0 110.85 -160.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -64.91 92.97 0.1 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 128.336 2.654 . . . . 0.0 110.934 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -66.06 144.06 56.95 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.549 0.74 . . . . 0.0 110.366 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -122.84 157.69 31.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.811 2.844 . . . . 0.0 108.625 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 m -62.64 -30.8 71.63 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.53 1.532 . . . . 0.0 113.909 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 10.5 p30 -163.81 163.46 15.88 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 127.497 2.319 . . . . 0.0 107.301 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.2 Cg_endo -71.67 -16.36 30.13 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.31 1.34 . . . . 0.0 112.014 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -67.55 -46.84 71.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.654 170.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 mmm -59.43 -39.75 84.53 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.599 1.09 . . . . 0.0 111.024 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.1 tt -56.71 -69.44 0.15 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.994 0.918 . . . . 0.0 109.42 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -30.92 68.22 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.095 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -70.74 0.09 Allowed 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.3 -53.05 2.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.407 1.883 . . . . 0.0 112.191 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -46.64 -61.47 1.81 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.819 1.247 . . . . 0.0 110.716 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -21.18 64.6 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 8.5 tt0 -79.74 -31.12 41.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.541 1.064 . . . . 0.0 110.721 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.73 21.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.993 -1.449 . . . . 0.0 114.824 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.7 64.77 70.38 Favored Pre-proline 0 C--O 1.224 -0.267 0 CA-C-N 120.004 1.902 . . . . 0.0 110.055 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.71 -17.49 59.24 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.222 1.472 . . . . 0.0 112.961 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.58 -26.26 41.36 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.935 2.494 . . . . 0.0 113.308 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.928 HD11 ' HG ' ' A' ' 29' ' ' LEU . 4.7 tp -66.37 152.01 45.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.598 ' H ' HD12 ' A' ' 40' ' ' LEU . 31.0 m -150.06 153.22 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.391 0.676 . . . . 0.0 109.831 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -74.53 85.76 2.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -53.7 -56.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.441 1.097 . . . . 0.0 110.62 164.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.76 -171.47 2.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.837 2.455 . . . . 0.0 106.426 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.74 -137.8 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.792 2.037 . . . . 0.0 107.194 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.98 122.76 0.01 OUTLIER Glycine 0 CA--C 1.543 1.788 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.55 144.0 35.25 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 119.992 1.896 . . . . 0.0 111.706 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.408 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 33.3 m . . . . . 0 C--N 1.339 0.142 0 C-N-CA 122.652 0.381 . . . . 0.0 110.106 172.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.19 0.519 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -157.79 160.22 37.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 140.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.06 -50.99 2.76 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.43 1.014 . . . . 0.0 113.918 167.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -63.56 -45.34 83.06 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.109 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -57.21 -61.36 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.758 1.639 . . . . 0.0 111.099 166.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.45 59.1 5.32 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.402 -0.811 . . . . 0.0 112.122 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.88 -11.16 59.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.078 -0.389 . . . . 0.0 111.706 166.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.1 164.66 55.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.886 1.674 . . . . 0.0 113.928 -171.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.97 164.36 13.57 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.893 2.395 . . . . 0.0 111.727 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -79.59 43.9 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.499 1.12 . . . . 0.0 111.162 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.11 129.06 38.51 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.738 1.615 . . . . 0.0 110.332 170.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.95 43.84 1.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.481 1.513 . . . . 0.0 111.755 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.7 64.85 6.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.757 -1.214 . . . . 0.0 109.175 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -57.46 142.75 43.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -160.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.66 169.88 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 117.68 -1.152 . . . . 0.0 111.63 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 0.4 OUTLIER -118.57 137.04 53.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.611 1.096 . . . . 0.0 111.907 178.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.26 164.72 28.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.58 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.2 p -36.21 -41.04 0.25 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.535 2.734 . . . . 0.0 115.929 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.67 -1.91 3.14 Favored 'General case' 0 N--CA 1.436 -1.165 1 C-N-CA 135.019 5.328 . . . . 0.0 111.939 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.91 -8.37 11.85 Favored Glycine 0 CA--C 1.539 1.559 0 CA-C-N 119.391 0.996 . . . . 0.0 112.025 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.47 95.89 0.23 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 130.487 3.515 . . . . 0.0 109.335 -170.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.2 m -66.45 143.7 56.95 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.072 0.463 . . . . 0.0 110.404 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -119.86 157.57 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 128.113 2.565 . . . . 0.0 107.512 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 m -59.16 -31.79 69.3 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.745 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -163.73 160.42 17.4 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 125.338 1.455 . . . . 0.0 108.779 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.01 -15.19 32.44 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.705 1.603 . . . . 0.0 111.399 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.33 -40.04 64.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 123.233 0.613 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.7 ttp -65.01 -44.84 87.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -54.77 -63.5 1.13 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.125 174.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.13 -31.51 70.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.994 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -68.48 0.18 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.68 -53.11 3.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 127.524 2.33 . . . . 0.0 111.856 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -45.37 -61.27 1.74 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.355 1.462 . . . . 0.0 110.722 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -66.01 -27.94 68.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 112.545 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.76 -26.22 40.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.211 0.204 . . . . 0.0 111.33 -173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 17.87 0.02 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.296 -1.28 . . . . 0.0 115.066 -177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -131.7 54.38 14.15 Favored Pre-proline 0 C--O 1.22 -0.456 0 CA-C-N 119.557 1.678 . . . . 0.0 109.099 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.2 -23.1 60.19 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 CA-C-N 122.545 1.945 . . . . 0.0 112.859 -170.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.24 -32.66 74.33 Favored 'General case' 0 CA--C 1.533 0.316 1 C-N-CA 132.882 4.473 . . . . 0.0 114.922 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.928 HD11 ' HG ' ' A' ' 29' ' ' LEU . 1.8 tp -65.37 157.79 28.32 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.959 1.303 . . . . 0.0 107.674 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.6 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.0 m -152.8 146.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 128.339 2.656 . . . . 0.0 107.676 173.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.97 83.69 5.84 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 41' ' ' VAL . 1.4 m -53.64 -40.56 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.641 1.577 . . . . 0.0 109.625 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -155.98 162.51 40.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 159.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.78 -179.74 5.58 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 163.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.11 149.22 0.09 OUTLIER Glycine 0 CA--C 1.544 1.874 0 O-C-N 120.796 -1.19 . . . . 0.0 112.534 -161.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.65 152.56 17.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.125 1.883 . . . . 0.0 111.7 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.552 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 59.1 m . . . . . 0 C--N 1.339 0.119 0 CA-C-O 121.716 0.769 . . . . 0.0 109.048 169.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -163.29 165.4 24.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 153.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.58 9.86 82.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.243 0.925 . . . . 0.0 115.246 158.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.613 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.29 -44.02 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 126.961 2.104 . . . . 0.0 112.64 172.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 8.4 Cg_endo -56.43 -50.69 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.73 2.287 . . . . 0.0 112.457 163.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -95.23 107.99 20.11 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.74 0.816 . . . . 0.0 110.286 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -140.92 52.93 1.59 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.071 1.348 . . . . 0.0 108.071 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -144.77 163.43 33.51 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -161.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.57 166.84 13.59 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.255 2.637 . . . . 0.0 111.813 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -83.15 46.1 1.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.928 0.891 . . . . 0.0 109.734 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.88 123.08 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.117 0.967 . . . . 0.0 109.203 168.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.03 43.09 0.5 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.129 1.772 . . . . 0.0 111.975 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -78.6 76.71 5.1 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 169.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -61.59 141.3 57.86 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.686 -1.259 . . . . 0.0 110.957 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -150.18 164.98 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 124.71 1.204 . . . . 0.0 110.884 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -108.94 135.76 49.59 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.3 163.6 23.08 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 158.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.448 ' HA ' HG11 ' A' ' 43' ' ' VAL . 82.5 p -43.87 -39.1 3.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -165.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.15 2.09 5.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.489 1.041 . . . . 0.0 112.969 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.09 5.68 80.03 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 120.919 -1.113 . . . . 0.0 111.523 -161.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -71.79 90.21 1.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.119 2.968 . . . . 0.0 109.831 -169.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -65.92 143.89 57.13 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.076 0.853 . . . . 0.0 110.781 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.02 154.01 41.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 127.6 2.36 . . . . 0.0 107.831 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 p -66.06 -24.21 66.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.915 1.686 . . . . 0.0 114.106 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 14.3 p30 -164.01 156.31 14.88 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 126.714 2.006 . . . . 0.0 109.748 170.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB3' HE22 ' A' ' 42' ' ' GLN . 55.7 Cg_endo -69.74 -17.03 37.9 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.939 1.759 . . . . 0.0 111.57 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.9 t -66.19 -48.19 71.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.518 168.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.8 mmm -58.09 -39.77 79.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.312 0.96 . . . . 0.0 111.565 175.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.922 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.7 tt -57.39 -67.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.124 0.97 . . . . 0.0 109.783 171.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 t -60.01 -29.28 68.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.987 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -71.36 0.11 Allowed 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.91 -52.99 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.409 1.884 . . . . 0.0 111.932 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -48.08 -64.16 0.87 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.818 1.247 . . . . 0.0 110.893 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -65.55 -20.17 66.22 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 124.005 0.815 . . . . 0.0 112.763 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -74.63 -62.69 1.44 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.54 0.3 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.822 -174.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -128.69 63.08 64.05 Favored Pre-proline 0 C--O 1.221 -0.409 0 CA-C-N 119.193 1.497 . . . . 0.0 109.604 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.11 -19.08 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.206 1.466 . . . . 0.0 112.744 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.67 -22.82 43.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.202 2.601 . . . . 0.0 113.557 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.922 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.0 tp -66.52 153.91 41.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.653 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.9 m -150.9 152.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.174 1.39 . . . . 0.0 108.59 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.416 HE22 ' HB3' ' A' ' 26' ' ' PRO . 40.6 tp60 -75.34 83.9 2.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 166.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.52 -54.45 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.69 168.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.23 -170.44 2.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.809 2.043 . . . . 0.0 107.502 174.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -137.3 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.06 1.744 . . . . 0.0 106.881 167.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.32 118.25 0.01 OUTLIER Glycine 0 CA--C 1.539 1.57 0 C-N-CA 127.555 2.502 . . . . 0.0 118.664 158.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.7 137.65 30.41 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.189 1.926 . . . . 0.0 111.908 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.529 0.16 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.115 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 p90 . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 122.233 1.016 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -169.0 162.57 11.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 143.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.92 -64.65 1.92 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.56 1.552 . . . . 0.0 112.087 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.33 80.57 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-O 116.364 -1.779 . . . . 0.0 115.108 -172.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 15.7 Cg_endo -50.0 -26.61 14.72 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 122.072 1.776 . . . . 0.0 113.35 168.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.6 m -105.01 22.01 16.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.127 1.771 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.85 73.66 0.1 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.47 1.108 . . . . 0.0 109.524 170.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.09 167.93 11.77 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.416 1.886 . . . . 0.0 109.905 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.8 157.33 24.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.598 2.199 . . . . 0.0 110.936 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -79.06 43.7 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.492 -0.755 . . . . 0.0 110.233 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.07 140.84 58.28 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.417 1.487 . . . . 0.0 110.786 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.61 43.82 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.898 1.679 . . . . 0.0 110.497 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -89.58 46.13 1.34 Allowed 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.332 -1.48 . . . . 0.0 110.509 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -49.01 145.78 3.8 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.575 1.95 . . . . 0.0 115.262 -164.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 m -148.53 174.31 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.237 1.415 . . . . 0.0 110.606 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -116.53 137.09 52.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 0.794 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.58 163.55 22.75 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.216 0.898 . . . . 0.0 112.059 161.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.45 ' HA ' HG11 ' A' ' 43' ' ' VAL . 80.9 p -54.64 -17.73 3.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 118.653 2.835 . . . . 0.0 118.653 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -9.32 59.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.354 0.662 . . . . 0.0 111.724 171.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.7 -3.93 65.75 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.739 1.161 . . . . 0.0 111.043 -171.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.14 113.91 8.66 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 127.487 2.315 . . . . 0.0 109.902 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -66.15 144.77 56.45 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 122.207 -0.308 . . . . 0.0 110.424 167.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -122.53 150.33 42.71 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.946 2.098 . . . . 0.0 107.156 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -60.64 -27.31 67.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.399 1.08 . . . . 0.0 113.498 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -163.79 163.43 15.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.673 2.389 . . . . 0.0 107.028 174.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.99 -17.1 32.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.042 1.161 . . . . 0.0 112.065 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 -40.32 93.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.487 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.4 mmm -66.15 -40.87 90.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.751 1.159 . . . . 0.0 111.86 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.97 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.3 tt -59.25 -65.24 0.7 Allowed 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.453 0.701 . . . . 0.0 109.163 171.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -31.5 70.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.797 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 3.9 t -52.77 -69.01 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.39 -53.06 3.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.516 1.526 . . . . 0.0 111.589 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -50.57 -63.71 1.04 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.034 1.734 . . . . 0.0 110.914 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -62.31 -26.75 68.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.814 1.646 . . . . 0.0 112.221 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -63.32 1.2 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.0 20.27 0.29 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.179 -1.345 . . . . 0.0 114.479 -173.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -124.95 63.84 41.45 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 119.859 1.83 . . . . 0.0 110.139 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.59 -16.06 45.67 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 CA-C-N 121.506 1.574 . . . . 0.0 113.392 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -22.97 33.73 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.28 2.632 . . . . 0.0 113.508 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.97 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.47 150.59 48.72 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 174.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.596 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.6 m -153.63 159.77 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.712 1.605 . . . . 0.0 108.784 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.44 82.07 1.44 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.4 m -59.72 -42.17 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 170.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -157.24 140.3 15.33 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.554 1.141 . . . . 0.0 108.627 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.12 37.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.111 1.365 . . . . 0.0 112.697 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.15 159.99 27.75 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.73 148.95 29.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.234 1.956 . . . . 0.0 111.632 -167.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m . . . . . 0 CA--C 1.517 -0.317 0 C-N-CA 124.273 1.029 . . . . 0.0 108.54 174.456 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -176.44 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.415 1.886 . . . . 0.0 108.319 151.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.8 61.96 3.97 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.66 2.076 . . . . 0.0 111.023 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.92 -54.93 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 126.964 2.106 . . . . 0.0 107.463 170.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.01 -49.97 7.13 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 120.337 1.156 . . . . 0.0 111.705 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -91.42 87.24 6.35 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.804 0.729 . . . . 0.0 109.242 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -141.2 48.59 1.67 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.584 1.154 . . . . 0.0 108.406 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.64 164.85 38.41 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -163.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -82.86 168.48 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.068 2.512 . . . . 0.0 112.169 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -85.15 44.31 1.08 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.01 0.924 . . . . 0.0 110.968 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.33 135.01 56.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 109.663 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.99 43.37 1.04 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.453 2.301 . . . . 0.0 114.131 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -78.45 82.25 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 120.709 -1.244 . . . . 0.0 107.649 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.48 120.05 9.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 119.569 -1.957 . . . . 0.0 107.588 172.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -138.36 155.29 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -107.64 136.81 46.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.782 0.719 . . . . 0.0 110.319 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.54 163.81 24.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.498 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.1 p -34.23 -41.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.131 2.972 . . . . 0.0 116.184 -172.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 0.04 5.16 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.436 4.694 . . . . 0.0 111.75 -172.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.38 -4.81 39.49 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.373 0.987 . . . . 0.0 111.65 -165.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -76.49 106.12 7.94 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 127.229 2.211 . . . . 0.0 110.632 -170.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -66.24 144.29 56.71 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.453 0.57 . . . . 0.0 111.302 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -124.28 152.06 43.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.772 2.429 . . . . 0.0 107.041 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.477 1.111 . . . . 0.0 113.838 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -163.91 156.52 15.27 Favored Pre-proline 0 C--N 1.343 0.303 0 C-N-CA 126.958 2.103 . . . . 0.0 109.331 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.45 -18.65 43.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.412 2.075 . . . . 0.0 111.274 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -66.46 -42.52 87.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.69 -0.672 . . . . 0.0 111.005 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 86.4 mtp -61.61 -41.6 97.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.549 1.068 . . . . 0.0 112.031 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.735 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.86 -64.93 0.71 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.73 171.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.498 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -61.39 -30.04 70.3 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.843 -173.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.15 -69.63 0.13 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.18 -53.04 2.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.284 1.833 . . . . 0.0 111.053 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -48.06 -62.51 1.44 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.597 1.559 . . . . 0.0 110.632 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -18.14 63.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.227 -0.892 . . . . 0.0 112.799 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -79.97 -51.34 9.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.942 0.792 . . . . 0.0 108.885 -177.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.9 22.51 0.11 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.153 -1.359 . . . . 0.0 114.641 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -129.57 61.3 56.91 Favored Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 120.015 1.908 . . . . 0.0 110.338 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.04 -24.64 66.82 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.814 1.676 . . . . 0.0 112.703 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.16 -30.44 68.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 131.163 3.785 . . . . 0.0 115.042 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.735 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tp -66.33 155.27 37.76 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.588 ' H ' HD12 ' A' ' 40' ' ' LEU . 26.3 m -153.76 153.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.067 1.747 . . . . 0.0 109.788 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -74.86 83.37 2.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.8 m -57.37 -38.27 61.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 122.775 0.43 . . . . 0.0 110.378 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -162.89 138.38 6.89 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.652 1.181 . . . . 0.0 109.502 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.18 68.25 10.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.452 1.024 . . . . 0.0 108.805 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.99 157.46 20.2 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.51 153.99 13.81 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.965 1.776 . . . . 0.0 112.76 -159.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m . . . . . 0 CA--C 1.528 0.117 0 C-N-CA 124.875 1.27 . . . . 0.0 107.761 167.673 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.93 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.669 2.388 . . . . 0.0 105.873 166.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.88 -26.49 68.99 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.277 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.3 -48.49 82.54 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 119.593 1.697 . . . . 0.0 111.072 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.67 -65.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.388 2.059 . . . . 0.0 113.09 161.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.8 m -88.64 74.65 8.39 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 112.639 -158.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.91 8.89 6.84 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.866 1.266 . . . . 0.0 112.528 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.44 164.63 59.62 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 120.844 -1.16 . . . . 0.0 113.089 -175.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 169.18 20.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.882 2.388 . . . . 0.0 111.95 -174.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -75.17 43.73 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.539 1.536 . . . . 0.0 111.04 171.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 114.01 4.96 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 124.888 1.275 . . . . 0.0 108.888 168.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.7 101.86 5.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -148.47 79.86 1.44 Allowed 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.51 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 15.4 mmm180 -59.43 132.15 53.11 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.391 -0.818 . . . . 0.0 110.004 -170.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.98 167.38 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 123.507 0.723 . . . . 0.0 111.527 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.8 t -115.55 134.29 55.21 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.132 0.973 . . . . 0.0 110.887 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.24 164.96 23.7 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.983 1.277 . . . . 0.0 110.631 164.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.419 ' HA ' HG11 ' A' ' 43' ' ' VAL . 4.9 p -41.54 -40.37 1.83 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -164.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.78 0.03 4.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.589 1.556 . . . . 0.0 112.799 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.13 -0.71 88.43 Favored Glycine 0 CA--C 1.541 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 112.073 -159.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.02 94.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.959 2.104 . . . . 0.0 110.174 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.9 m -66.19 143.59 57.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -130.96 153.65 48.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.464 3.106 . . . . 0.0 110.254 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 7.1 m -45.62 -40.15 8.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 130.67 3.588 . . . . 0.0 116.157 172.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -163.76 158.73 17.02 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.603 1.961 . . . . 0.0 108.941 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.54 -19.82 27.84 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.519 1.479 . . . . 0.0 111.674 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.65 -46.84 88.81 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -63.35 -32.56 74.02 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.915 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.1 tt -61.67 -61.1 2.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 119.382 0.992 . . . . 0.0 109.022 172.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -60.5 -32.91 71.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.815 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -62.06 2.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.83 -52.99 6.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.903 2.081 . . . . 0.0 111.556 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 41.5 tttm -50.18 -60.96 2.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.381 1.073 . . . . 0.0 109.762 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 -17.14 63.56 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 124.259 0.974 . . . . 0.0 112.512 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -79.54 -44.55 20.94 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.811 0.732 . . . . 0.0 110.532 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.33 17.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.105 -1.386 . . . . 0.0 114.121 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -120.4 63.71 10.14 Favored Pre-proline 0 C--O 1.22 -0.485 0 CA-C-N 119.797 1.799 . . . . 0.0 109.38 -177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -60.22 -22.44 70.42 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.122 1.881 . . . . 0.0 112.988 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.44 -26.12 55.12 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 128.122 2.569 . . . . 0.0 113.441 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.915 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.05 154.53 39.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.655 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.1 m -150.8 148.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -75.13 85.25 2.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -54.19 -58.99 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.46 1.104 . . . . 0.0 109.893 167.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.38 -173.26 1.42 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.361 1.464 . . . . 0.0 109.243 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -177.15 6.32 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.968 2.107 . . . . 0.0 109.929 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.14 141.96 1.14 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 119.248 0.931 . . . . 0.0 113.909 171.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -82.88 145.9 12.8 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.113 1.876 . . . . 0.0 111.756 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.338 0.067 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 172.558 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PHE . . . . . 0.468 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -176.68 -65.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.122 0.969 . . . . 0.0 110.514 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.26 -14.62 44.33 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.766 2.127 . . . . 0.0 114.674 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -55.04 3.88 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.325 2.25 . . . . 0.0 110.925 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB2' ' CA ' ' A' ' 31' ' ' CYS . 37.5 Cg_endo -71.29 -53.79 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.929 2.42 . . . . 0.0 110.724 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.5 m -87.65 124.38 33.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 120.34 1.427 . . . . 0.0 108.94 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.14 29.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.468 1.507 . . . . 0.0 110.922 -173.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 164.98 13.59 Favored Pre-proline 0 C--O 1.236 0.355 0 O-C-N 121.677 -0.639 . . . . 0.0 111.043 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.69 172.92 13.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.268 1.979 . . . . 0.0 109.688 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -78.12 46.32 0.59 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.96 1.304 . . . . 0.0 110.373 171.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.64 123.89 20.9 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.29 49.71 1.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.113 1.365 . . . . 0.0 109.638 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.659 ' O ' HG13 ' A' ' 15' ' ' VAL . 10.2 m170 -80.18 58.96 3.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -48.06 122.92 5.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.852 1.205 . . . . 0.0 111.329 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 13' ' ' HIS . 23.0 m -134.23 178.15 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 C-N-CA 124.571 1.148 . . . . 0.0 111.153 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.6 144.11 51.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.76 171.05 31.34 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -53.18 -24.58 11.16 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 175.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -84.24 0.08 50.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.419 1.888 . . . . 0.0 112.516 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -7.55 36.96 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.823 -1.173 . . . . 0.0 111.859 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.58 107.34 1.37 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.182 1.393 . . . . 0.0 107.447 -176.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 7.4 m -66.27 146.25 54.81 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.466 ' CD2' HD12 ' A' ' 29' ' ' LEU . 60.1 m-85 -123.9 139.94 53.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.796 2.039 . . . . 0.0 106.488 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.6 t -45.45 -32.08 2.01 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.997 2.119 . . . . 0.0 112.206 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -163.56 154.7 14.2 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.555 2.342 . . . . 0.0 111.135 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -74.91 -24.4 13.05 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 111.159 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -28.01 69.26 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.023 -0.423 . . . . 0.0 112.049 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -36.03 60.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.76 170.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.856 ' HG ' HD11 ' A' ' 40' ' ' LEU . 8.8 tt -56.43 -67.34 0.31 Allowed 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -50.27 -37.33 35.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.556 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' CA ' ' HB2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -52.09 -71.78 0.06 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 175.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.9 -51.11 4.42 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.099 2.16 . . . . 0.0 110.872 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -66.29 0.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -15.17 60.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -73.86 -67.31 0.61 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.751 0.82 . . . . 0.0 108.86 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.75 39.97 0.25 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 126.489 1.995 . . . . 0.0 110.162 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -138.08 59.78 20.11 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.888 1.344 . . . . 0.0 111.341 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.92 -8.66 14.31 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.047 1.831 . . . . 0.0 112.764 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -90.5 -24.52 20.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.011 2.125 . . . . 0.0 113.769 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.856 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tp -66.4 150.32 49.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.487 ' H ' HD12 ' A' ' 40' ' ' LEU . 9.6 m -149.2 152.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -78.24 83.63 4.49 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.7 m -57.12 -46.15 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.861 0.865 . . . . 0.0 111.534 170.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -164.47 157.01 16.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 125.177 1.391 . . . . 0.0 109.084 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -87.68 54.99 3.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.964 2.906 . . . . 0.0 110.54 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.73 150.13 21.61 Favored Glycine 0 C--O 1.226 -0.358 0 O-C-N 119.836 -1.79 . . . . 0.0 109.041 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.2 146.62 28.7 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.235 1.956 . . . . 0.0 111.599 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 124.714 1.206 . . . . 0.0 110.502 179.426 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.455 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -176.13 133.75 0.25 Allowed 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.14 -31.07 0.95 Allowed Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.097 1.332 . . . . 0.0 114.701 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -67.08 -56.27 13.84 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 118.726 1.263 . . . . 0.0 111.024 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.23 -48.42 0.62 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.238 1.959 . . . . 0.0 112.299 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.04 125.41 41.46 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.469 0.708 . . . . 0.0 109.654 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' H ' ' H ' ' A' ' 8' ' ' CYS . 1.8 mt-10 -154.47 -24.33 0.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.981 1.712 . . . . 0.0 110.93 172.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' H ' ' H ' ' A' ' 7' ' ' GLU . 0.9 OUTLIER -49.61 158.35 0.84 Allowed Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 125.972 1.709 . . . . 0.0 114.753 -179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.13 169.35 22.75 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 121.928 1.752 . . . . 0.0 111.179 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -80.29 43.65 0.64 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.075 0.95 . . . . 0.0 110.044 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.48 123.24 19.13 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.501 1.52 . . . . 0.0 109.247 171.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.96 42.79 0.33 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 111.08 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -84.93 63.26 7.98 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 121.149 -0.969 . . . . 0.0 108.698 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -55.77 134.9 51.89 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.333 0.653 . . . . 0.0 112.108 -169.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.0 m -139.34 -178.27 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 125.151 1.381 . . . . 0.0 111.516 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -125.21 137.34 54.12 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.512 1.125 . . . . 0.0 110.564 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.91 168.78 26.36 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 165.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.518 ' HA ' HG11 ' A' ' 43' ' ' VAL . 17.4 p -50.69 -31.3 15.97 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -171.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -69.02 0.0 5.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.649 1.18 . . . . 0.0 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.25 66.38 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.359 0.981 . . . . 0.0 111.624 -163.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.09 110.82 9.72 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.337 1.455 . . . . 0.0 109.553 -171.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -65.84 143.95 57.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.969 0.414 . . . . 0.0 110.366 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -119.4 145.39 46.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.368 2.267 . . . . 0.0 108.225 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -58.33 -29.22 65.77 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.344 1.057 . . . . 0.0 113.002 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 18.9 p30 -163.89 155.96 14.8 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 125.208 1.403 . . . . 0.0 109.78 173.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 68.6 Cg_endo -70.27 -16.37 35.4 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.486 2.124 . . . . 0.0 111.023 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -41.37 76.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 122.162 -0.336 . . . . 0.0 110.953 175.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.8 mtm -66.08 -31.73 72.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.656 172.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.918 ' HG ' HD11 ' A' ' 40' ' ' LEU . 7.7 tt -59.6 -68.26 0.3 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.397 0.998 . . . . 0.0 109.38 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -51.98 -39.27 59.09 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.824 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -68.49 0.17 Allowed 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.22 -52.76 1.95 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 126.592 1.957 . . . . 0.0 110.506 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -51.04 -63.44 1.13 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.926 0.89 . . . . 0.0 110.647 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.6 -16.87 64.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.69 1.196 . . . . 0.0 112.727 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -77.87 -66.18 0.87 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.51 23.74 0.36 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.896 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -127.33 60.67 44.55 Favored Pre-proline 0 C--O 1.222 -0.392 0 CA-C-N 119.618 1.709 . . . . 0.0 109.835 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -61.23 -17.73 54.39 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 121.657 1.571 . . . . 0.0 113.166 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -26.36 45.03 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.399 2.28 . . . . 0.0 113.333 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.918 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.04 153.38 42.39 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.593 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.5 m -150.88 149.42 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -72.55 85.67 1.16 Allowed 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -56.5 -47.16 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.563 0.745 . . . . 0.0 109.747 172.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 166.12 151.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 128.862 2.865 . . . . 0.0 106.957 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 pm0 -68.34 -173.26 0.4 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.844 2.058 . . . . 0.0 111.388 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.71 142.1 0.79 Allowed Glycine 0 CA--C 1.536 1.385 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.08 143.68 18.06 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 CA-C-N 119.225 1.513 . . . . 0.0 110.475 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.61 -43.27 14.59 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 119.274 -0.394 . . . . 0.0 110.85 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -65.23 159.48 23.61 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.411 0.684 . . . . 0.0 109.717 171.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -57.96 -64.43 0.91 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.897 1.679 . . . . 0.0 109.903 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -167.45 34.51 0.03 OUTLIER 'General case' 0 C--N 1.343 0.304 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -173.28 -167.54 0.41 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 118.978 -2.326 . . . . 0.0 106.954 -164.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -153.39 45.98 0.65 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.123 1.328 . . . . 0.0 110.565 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -169.65 157.08 6.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.95 1.3 . . . . 0.0 108.591 -164.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 C--O 1.247 0.929 0 C-N-CA 125.31 1.444 . . . . 0.0 110.125 -179.386 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.39 -89.88 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.269 1.028 . . . . 0.0 109.667 156.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.58 -16.19 76.24 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.112 -0.993 . . . . 0.0 112.555 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -43.98 79.63 Favored Pre-proline 0 C--N 1.34 0.161 0 CA-C-O 117.217 -1.373 . . . . 0.0 114.378 171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.83 -51.41 0.48 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.538 2.159 . . . . 0.0 111.928 159.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.42 70.16 8.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.027 1.285 . . . . 0.0 113.081 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -83.92 -14.09 51.87 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.38 162.42 61.22 Favored Pre-proline 0 C--O 1.236 0.373 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -158.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.83 165.47 28.52 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.934 2.423 . . . . 0.0 110.783 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.81 43.56 1.0 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.386 0.674 . . . . 0.0 109.381 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.33 122.56 17.77 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.124 1.77 . . . . 0.0 110.498 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.89 43.77 0.36 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.56 1.944 . . . . 0.0 111.246 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -92.36 58.01 3.13 Favored 'General case' 0 C--O 1.222 -0.362 0 O-C-N 120.5 -1.375 . . . . 0.0 108.751 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -53.65 147.42 11.39 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.345 1.858 . . . . 0.0 113.207 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -149.14 153.75 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.024 0.929 . . . . 0.0 111.751 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 t -86.44 133.88 33.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.195 0.598 . . . . 0.0 110.473 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.16 164.15 23.46 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 158.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.1 p -51.28 -25.12 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -168.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 0.01 11.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.283 1.033 . . . . 0.0 112.385 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.58 50.17 Favored Glycine 0 CA--C 1.538 1.51 0 O-C-N 120.838 -1.163 . . . . 0.0 110.692 -158.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -66.71 96.99 0.43 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 131.347 3.859 . . . . 0.0 110.974 -171.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -66.13 144.39 56.71 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.756 0.422 . . . . 0.0 111.344 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -123.81 153.3 41.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.776 2.03 . . . . 0.0 107.809 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -65.97 -21.56 66.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.43 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 10.8 p30 -163.76 159.99 17.3 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.215 1.806 . . . . 0.0 108.883 168.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 46.0 Cg_endo -66.75 -20.13 52.72 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.877 . . . . 0.0 110.996 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -68.89 -45.57 70.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.224 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -62.8 -37.57 87.24 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.623 1.101 . . . . 0.0 111.311 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.9 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.1 tt -56.7 -66.74 0.39 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.222 1.009 . . . . 0.0 109.964 168.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.1 -32.16 70.71 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.536 -0.727 . . . . 0.0 111.327 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.7 -68.5 0.18 Allowed 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -39.03 -52.85 1.82 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 126.052 1.741 . . . . 0.0 111.525 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 42.9 tttm -48.18 -61.75 1.83 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.193 1.397 . . . . 0.0 110.544 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -67.92 -21.16 65.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -48.9 16.18 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.74 25.4 0.1 OUTLIER Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.234 -1.315 . . . . 0.0 114.887 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -130.35 63.65 70.05 Favored Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 120.014 1.907 . . . . 0.0 109.789 -178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -61.33 -19.99 66.36 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.446 1.552 . . . . 0.0 112.664 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -23.92 46.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.513 2.725 . . . . 0.0 113.494 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -66.49 154.67 39.69 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.647 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.8 m -150.66 150.6 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 124.901 1.28 . . . . 0.0 108.753 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 -71.77 84.88 0.92 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 165.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.41 -53.12 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 123.303 0.641 . . . . 0.0 110.112 166.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -169.98 175.63 5.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.224 1.809 . . . . 0.0 110.148 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.21 171.93 10.28 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.88 2.472 . . . . 0.0 108.239 164.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.5 138.43 0.85 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 127.373 2.416 . . . . 0.0 112.216 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -77.18 142.42 21.58 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.192 2.595 . . . . 0.0 110.834 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 m -83.47 -77.47 0.25 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -173.86 165.45 4.35 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.934 2.493 . . . . 0.0 107.514 -168.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.289 83.7 tt0 162.78 -72.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 128.479 2.712 . . . . 0.0 109.7 158.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -144.3 83.83 1.74 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.651 1.581 . . . . 0.0 107.905 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.19 146.4 23.46 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.808 0.843 . . . . 0.0 111.841 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -161.71 53.41 0.25 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.246 1.418 . . . . 0.0 109.534 -175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -81.37 171.65 14.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.359 1.064 . . . . 0.0 111.143 169.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 116.058 -1.925 . . . . 0.0 108.467 168.513 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.2 p90 . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -176.7 -86.56 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.709 2.003 . . . . 0.0 107.597 141.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.22 -15.82 80.5 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.19 0.9 . . . . 0.0 113.637 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 -50.02 65.79 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 119.317 1.558 . . . . 0.0 111.923 171.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -60.7 -51.89 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.291 1.327 . . . . 0.0 112.261 160.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.1 m -89.29 71.7 8.17 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.473 1.033 . . . . 0.0 112.323 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -116.85 84.15 2.09 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 165.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.11 165.24 19.24 Favored Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 123.282 0.633 . . . . 0.0 111.307 -172.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 165.07 20.73 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.251 2.634 . . . . 0.0 111.357 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -78.55 43.3 0.47 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.878 0.871 . . . . 0.0 111.067 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.0 128.32 35.59 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.899 1.279 . . . . 0.0 111.066 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.03 43.26 1.04 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.648 1.579 . . . . 0.0 110.674 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.454 ' O ' HG13 ' A' ' 15' ' ' VAL . 11.5 m170 -83.42 64.59 7.92 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 120.597 -1.314 . . . . 0.0 107.975 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -55.84 134.74 52.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.699 1.136 . . . . 0.0 111.721 -167.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 13' ' ' HIS . 14.1 m -135.68 169.68 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 110.443 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -123.9 143.17 50.53 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.4 1.0 . . . . 0.0 110.933 175.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.18 166.5 28.46 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.573 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.1 p -34.35 -40.86 0.1 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.278 2.631 . . . . 0.0 115.562 -177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.85 0.05 10.05 Favored 'General case' 0 N--CA 1.436 -1.16 1 C-N-CA 132.919 4.487 . . . . 0.0 111.654 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.2 -4.32 33.42 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.969 0.804 . . . . 0.0 112.086 -166.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -74.76 102.96 4.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.98 2.512 . . . . 0.0 110.163 -170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 m -66.37 143.56 57.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 118.219 0.463 . . . . 0.0 111.54 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -123.93 155.95 37.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.117 2.967 . . . . 0.0 108.499 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.1 t -63.88 -28.79 70.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -163.87 160.65 17.14 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 125.918 1.687 . . . . 0.0 107.637 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.37 -14.9 28.2 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 120.744 0.963 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.3 t -65.01 -44.68 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 118.101 0.409 . . . . 0.0 110.596 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mmm -59.0 -46.36 88.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.009 0.924 . . . . 0.0 110.515 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -55.78 -62.22 1.84 Allowed 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 125.111 1.365 . . . . 0.0 110.876 173.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -35.56 77.18 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.713 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.38 -68.32 0.18 Allowed 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 171.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.81 -52.75 1.72 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.872 2.069 . . . . 0.0 112.104 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 42.2 tttm -48.53 -59.11 3.76 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.731 1.612 . . . . 0.0 110.323 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -71.0 -23.97 62.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.576 0.75 . . . . 0.0 112.64 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -75.88 -38.65 57.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.514 0.726 . . . . 0.0 110.718 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.2 18.91 0.03 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.057 -1.413 . . . . 0.0 115.488 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 16.4 t-20 -128.79 62.42 61.1 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 120.327 2.063 . . . . 0.0 110.073 -176.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -58.23 -25.34 71.59 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 121.979 1.786 . . . . 0.0 112.786 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.06 -32.66 74.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 131.273 3.829 . . . . 0.0 114.304 175.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.661 HD12 ' H ' ' A' ' 41' ' ' VAL . 3.8 tp -66.2 157.54 31.13 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 109.183 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.661 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.4 m -152.47 149.79 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 C-N-CA 126.516 1.926 . . . . 0.0 109.74 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.77 83.96 1.64 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 164.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -54.1 -46.29 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.743 0.817 . . . . 0.0 108.946 174.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -161.22 178.78 8.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -83.36 178.83 7.87 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 159.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.01 144.14 1.38 Allowed Glycine 0 CA--C 1.535 1.289 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -172.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.45 158.64 25.74 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.868 1.712 . . . . 0.0 110.853 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.6 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 64.6 m -86.49 -91.05 0.1 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 162.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.23 -157.25 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.093 1.357 . . . . 0.0 108.876 174.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.27 -89.61 0.11 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.285 1.434 . . . . 0.0 108.377 164.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.88 -54.26 0.16 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.163 2.585 . . . . 0.0 108.47 169.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -173.6 157.07 3.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.558 2.343 . . . . 0.0 108.126 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -106.94 83.37 1.82 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.495 1.518 . . . . 0.0 111.12 171.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -70.14 170.67 11.06 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.785 0.721 . . . . 0.0 111.461 167.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.608 -1.187 . . . . 0.0 112.227 -176.178 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 13.2 p90 . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -176.81 -81.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.94 1.696 . . . . 0.0 107.113 140.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.25 -39.38 44.15 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-O 119.2 -0.778 . . . . 0.0 112.222 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -43.51 77.81 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 116.682 -1.628 . . . . 0.0 115.127 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 18.5 Cg_endo -56.11 -28.24 69.15 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 122.266 1.845 . . . . 0.0 112.228 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 m -105.25 29.15 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.769 1.628 . . . . 0.0 111.915 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -56.78 -27.67 60.05 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.14 0.976 . . . . 0.0 111.502 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -57.57 163.42 3.73 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 128.129 2.572 . . . . 0.0 114.997 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.21 162.24 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.376 2.051 . . . . 0.0 110.912 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 43.15 0.97 Allowed 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.633 -0.667 . . . . 0.0 110.236 173.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.43 127.69 33.27 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.093 2.157 . . . . 0.0 110.89 172.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.18 43.54 0.63 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.556 1.542 . . . . 0.0 112.019 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -82.78 55.92 3.21 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 120.458 -1.401 . . . . 0.0 109.959 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -54.65 144.26 22.37 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.61 1.564 . . . . 0.0 114.881 -161.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 26' ' ' PRO . 4.2 m -146.36 162.16 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 123.726 0.81 . . . . 0.0 111.844 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.6 t -101.43 130.77 47.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.279 0.632 . . . . 0.0 112.0 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.08 163.39 23.23 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 158.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.474 ' HA ' HG11 ' A' ' 43' ' ' VAL . 88.5 p -34.03 -57.56 0.47 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 118.237 2.68 . . . . 0.0 118.237 -161.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.71 42.14 0.9 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.37 1.068 . . . . 0.0 110.219 -162.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.37 5.36 42.44 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 123.758 0.694 . . . . 0.0 112.617 -168.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.18 75.51 2.33 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 129.824 3.249 . . . . 0.0 108.946 -159.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.0 m -66.31 143.74 57.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.662 -0.649 . . . . 0.0 110.225 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -130.02 155.42 46.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 127.597 2.359 . . . . 0.0 108.562 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -59.85 -25.45 65.03 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.434 1.494 . . . . 0.0 114.047 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 11.8 p30 -163.55 162.66 17.01 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.806 2.043 . . . . 0.0 107.675 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HA ' HG21 ' A' ' 15' ' ' VAL . 39.8 Cg_endo -66.83 -21.82 50.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 121.185 1.257 . . . . 0.0 111.368 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.01 -37.84 84.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.79 -0.624 . . . . 0.0 111.599 172.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 mmm -68.85 -35.68 77.24 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.792 1.178 . . . . 0.0 111.704 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.937 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.1 tt -61.9 -63.99 1.08 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.38 -32.64 70.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.777 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 2.1 t -51.4 -71.44 0.06 Allowed 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 171.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.02 -52.9 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.431 1.893 . . . . 0.0 111.317 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 44.9 tttm -48.66 -63.96 0.94 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.844 1.657 . . . . 0.0 110.466 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -73.15 -18.4 61.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.54 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -73.55 -55.08 6.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.97 0.508 . . . . 0.0 110.131 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.08 16.49 0.09 OUTLIER Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.818 -172.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 12.5 t-20 -126.76 57.77 24.06 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 119.693 1.746 . . . . 0.0 108.646 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.22 -22.85 66.78 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 CA-C-N 122.48 1.921 . . . . 0.0 112.724 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.07 -31.89 73.24 Favored 'General case' 0 CA--C 1.533 0.312 1 C-N-CA 132.415 4.286 . . . . 0.0 114.873 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.937 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.0 tp -65.69 156.59 32.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.188 1.395 . . . . 0.0 108.542 -177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.659 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.4 m -152.36 155.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.853 1.661 . . . . 0.0 109.431 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -73.84 87.01 1.75 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 163.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.93 -48.51 63.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 C-N-CA 123.165 0.586 . . . . 0.0 110.491 167.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -162.73 164.37 26.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.135 1.774 . . . . 0.0 107.534 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -84.26 166.01 17.85 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 166.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.83 150.18 2.81 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 111.357 -170.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -83.23 157.55 14.94 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.659 -166.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.42 -38.76 18.31 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-O 119.31 -0.376 . . . . 0.0 110.656 165.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -62.56 128.79 37.62 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 168.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -153.77 148.5 26.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 164.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -151.85 -47.42 0.11 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.253 1.421 . . . . 0.0 109.1 -173.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.57 164.7 4.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.236 2.215 . . . . 0.0 107.563 163.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -145.5 38.37 1.13 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.341 1.456 . . . . 0.0 109.056 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.02 -48.15 74.93 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.798 0.839 . . . . 0.0 111.517 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 125.481 1.513 . . . . 0.0 109.429 165.554 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 p90 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.96 -68.31 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.978 . . . . 0.0 105.965 166.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.9 -17.87 42.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.849 1.214 . . . . 0.0 115.289 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -64.91 -52.02 52.69 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-N 119.011 1.406 . . . . 0.0 111.81 165.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.46 -58.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.015 3.143 . . . . 0.0 112.629 170.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.89 96.79 10.34 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.953 1.706 . . . . 0.0 111.082 -167.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.84 0.02 2.16 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 125.007 1.442 . . . . 0.0 113.947 -175.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 163.9 62.59 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.354 1.462 . . . . 0.0 113.884 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.52 165.18 31.05 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.595 2.197 . . . . 0.0 110.69 -177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.36 47.51 0.09 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.83 1.252 . . . . 0.0 112.066 167.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.84 118.73 10.1 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.146 165.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -77.55 42.44 0.36 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.407 1.883 . . . . 0.0 111.473 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.437 ' O ' HG13 ' A' ' 15' ' ' VAL . 6.2 m80 -79.58 64.89 4.58 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.67 137.61 57.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.657 1.572 . . . . 0.0 111.55 -168.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 13' ' ' HIS . 2.8 m -141.54 167.32 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.89 0.876 . . . . 0.0 112.097 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 t -105.53 141.56 36.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.071 0.948 . . . . 0.0 110.719 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.39 166.14 24.1 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.892 1.234 . . . . 0.0 111.217 159.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.55 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -37.9 -40.35 0.45 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.385 2.274 . . . . 0.0 115.665 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.47 16.5 7.52 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.502 1.121 . . . . 0.0 110.314 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.42 -2.77 65.47 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.219 -165.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -68.68 92.62 0.48 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.46 1.504 . . . . 0.0 109.354 -163.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -65.9 143.46 57.41 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -126.54 155.02 43.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.827 2.051 . . . . 0.0 108.707 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.1 p -65.46 -27.88 68.82 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.688 1.195 . . . . 0.0 113.212 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -163.41 152.63 12.42 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 127.326 2.25 . . . . 0.0 108.957 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.86 -23.65 22.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.118 1.212 . . . . 0.0 110.92 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -56.76 -44.47 81.81 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.33 1.452 . . . . 0.0 111.105 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.31 70.14 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.896 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.6 tt -64.46 -65.86 0.62 Allowed 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 t -52.39 -29.47 24.26 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.445 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -62.05 -60.74 3.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' N ' ' SG ' ' A' ' 31' ' ' CYS . . . -42.35 -51.9 4.72 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.992 2.117 . . . . 0.0 110.206 175.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.0 tttm -50.95 -63.2 1.2 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 124.339 1.024 . . . . 0.0 110.562 -177.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.73 -14.0 62.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.518 1.127 . . . . 0.0 113.943 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -58.23 3.26 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.75 34.14 0.14 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 118.591 -1.116 . . . . 0.0 113.09 -173.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -134.85 62.1 51.29 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 119.271 1.535 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.0 -13.44 39.86 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 CA-C-N 121.058 1.414 . . . . 0.0 114.027 -172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.66 -27.01 37.25 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.503 2.721 . . . . 0.0 112.735 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.896 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.9 tp -66.39 153.56 42.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.62 ' H ' HD12 ' A' ' 40' ' ' LEU . 35.2 m -147.74 144.05 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -74.38 87.28 2.03 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 169.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.7 OUTLIER -58.73 -50.67 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.44 1.496 . . . . 0.0 108.885 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -179.39 -171.52 0.2 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 129.51 3.124 . . . . 0.0 107.574 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -164.82 1.05 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.81 2.444 . . . . 0.0 108.604 166.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 123.15 0.19 Allowed Glycine 0 CA--C 1.544 1.895 0 C-N-CA 124.862 1.22 . . . . 0.0 113.975 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.16 135.23 13.54 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 120.823 2.311 . . . . 0.0 112.312 -171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m -76.02 -43.02 46.13 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.444 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -74.84 125.44 28.81 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.304 1.041 . . . . 0.0 109.522 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -154.14 88.13 1.23 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.06 83.43 0.65 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.81 2.044 . . . . 0.0 109.098 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -58.22 111.92 1.37 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.464 1.906 . . . . 0.0 110.213 167.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -104.28 47.06 0.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.917 1.687 . . . . 0.0 109.443 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.53 174.68 12.67 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 166.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.39 0 C-N-CA 125.195 1.398 . . . . 0.0 112.118 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.22 -54.9 0.01 OUTLIER 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.18 0.992 . . . . 0.0 111.448 170.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.75 67.0 1.12 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 127.017 2.246 . . . . 0.0 109.39 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -176.62 -55.87 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.259 1.824 . . . . 0.0 109.851 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' CA ' ' A' ' 31' ' ' CYS . 28.2 Cg_endo -72.74 -58.2 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.733 1.622 . . . . 0.0 110.004 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.17 133.83 35.53 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 176.57 34.41 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 O-C-N 125.967 2.042 . . . . 0.0 111.726 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.7 165.78 12.72 Favored Pre-proline 0 C--O 1.233 0.234 0 O-C-N 121.293 -0.88 . . . . 0.0 112.28 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.48 172.38 14.34 Favored 'Trans proline' 0 N--CA 1.441 -1.577 0 C-N-CA 122.233 1.956 . . . . 0.0 109.709 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -77.01 44.26 0.39 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 125.661 1.584 . . . . 0.0 110.722 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.78 120.31 11.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 124.77 1.228 . . . . 0.0 110.046 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.49 54.49 2.36 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.802 1.641 . . . . 0.0 110.54 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.613 ' O ' HG13 ' A' ' 15' ' ' VAL . 1.5 m80 -91.04 61.3 4.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 48.4 mmm-85 -46.2 100.37 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 13' ' ' HIS . 34.8 m -99.52 178.81 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 C-N-CA 124.932 1.293 . . . . 0.0 112.299 174.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 4.1 t -115.97 135.33 54.07 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.457 1.503 . . . . 0.0 109.025 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.75 173.07 41.38 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 171.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.568 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -55.58 -32.1 62.76 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.21 -0.03 30.39 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.914 1.286 . . . . 0.0 110.567 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.93 -0.82 61.16 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.67 1.129 . . . . 0.0 111.991 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.97 115.32 11.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 26.2 m -65.79 150.14 49.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.77 136.02 53.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -37.17 -37.48 0.17 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.777 2.031 . . . . 0.0 113.241 170.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -163.69 155.79 15.0 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 128.072 2.549 . . . . 0.0 111.361 -176.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.3 -24.87 16.19 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.471 2.781 . . . . 0.0 110.292 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.74 -30.04 69.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 175.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.3 mtp -74.61 -41.51 60.29 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 118.207 -0.902 . . . . 0.0 113.002 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.79 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.6 tt -51.26 -70.03 0.1 Allowed 'General case' 0 C--N 1.345 0.392 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 t -50.24 -38.07 38.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.741 0.416 . . . . 0.0 111.804 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.442 ' CA ' ' HB2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -51.49 -72.18 0.05 Allowed 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 175.388 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -35.91 -55.85 0.73 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 127.679 2.392 . . . . 0.0 109.79 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.52 -66.03 0.43 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.481 -1.69 . . . . 0.0 114.054 175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.87 63.24 Favored 'General case' 0 C--N 1.343 0.326 0 O-C-N 124.584 1.177 . . . . 0.0 111.249 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -78.33 0.11 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.399 1.48 . . . . 0.0 107.778 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.43 48.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 127.078 2.275 . . . . 0.0 109.503 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -148.03 59.99 4.92 Favored Pre-proline 0 N--CA 1.469 0.524 0 CA-C-N 117.891 0.845 . . . . 0.0 111.753 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.83 -10.56 17.62 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 122.967 2.445 . . . . 0.0 113.612 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.55 -28.93 21.67 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 127.0 2.12 . . . . 0.0 113.709 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.79 HD11 ' HG ' ' A' ' 29' ' ' LEU . 2.4 tp -65.59 154.2 39.4 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.56 ' H ' HD12 ' A' ' 40' ' ' LEU . 18.1 m -146.89 145.33 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -73.42 82.83 1.45 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -55.5 -49.75 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.669 172.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 174.78 176.94 0.15 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.009 2.124 . . . . 0.0 109.032 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -174.85 5.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 127.009 2.124 . . . . 0.0 110.522 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.34 134.37 0.53 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.37 1.462 . . . . 0.0 112.909 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -73.9 145.52 36.2 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 CA-C-N 120.532 2.166 . . . . 0.0 111.372 -173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.457 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -86.53 -99.99 0.07 Allowed 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 178.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -178.67 135.92 0.14 Allowed 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 125.317 1.636 . . . . 0.0 108.419 -175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.99 -176.75 6.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.997 1.319 . . . . 0.0 110.674 173.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.32 52.62 2.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.482 1.513 . . . . 0.0 109.928 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -174.26 152.46 1.81 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.612 0.765 . . . . 0.0 110.022 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -135.51 75.17 1.55 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.033 0.933 . . . . 0.0 108.653 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.94 157.48 20.13 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 122.89 0.476 . . . . 0.0 110.353 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.254 1.325 0 CA-C-O 117.437 -1.268 . . . . 0.0 109.436 -179.675 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.461 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.69 174.97 14.22 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 102.989 -2.967 . . . . 0.0 102.989 139.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.15 -70.22 2.82 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.768 1.175 . . . . 0.0 112.041 166.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -43.97 83.86 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 116.553 -1.689 . . . . 0.0 114.739 -173.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 31.8 Cg_endo -57.5 -22.32 50.35 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.652 1.568 . . . . 0.0 113.206 169.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.5 m -118.75 46.55 1.82 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.684 1.594 . . . . 0.0 112.309 -167.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -29.73 70.38 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.692 -1.255 . . . . 0.0 112.018 168.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.06 157.14 54.19 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 126.436 1.894 . . . . 0.0 115.513 -163.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.59 164.64 30.16 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.015 2.477 . . . . 0.0 110.572 -174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.72 43.52 0.84 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.599 -0.688 . . . . 0.0 109.994 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.13 132.73 49.17 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.382 1.873 . . . . 0.0 110.578 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.85 43.62 1.05 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.953 1.701 . . . . 0.0 110.82 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -87.96 63.93 7.59 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.248 -1.533 . . . . 0.0 108.761 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -60.11 146.96 41.23 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.894 1.278 . . . . 0.0 113.344 -160.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 m -147.36 158.41 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.499 1.12 . . . . 0.0 111.819 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -91.55 136.51 33.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.666 0.786 . . . . 0.0 110.967 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.79 163.97 23.8 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 159.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.501 ' HA ' HG11 ' A' ' 43' ' ' VAL . 82.1 p -47.15 -32.61 4.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.109 2.164 . . . . 0.0 116.17 -175.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -67.65 -7.27 25.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.844 1.658 . . . . 0.0 113.019 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.78 -9.67 50.58 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.359 0.98 . . . . 0.0 111.046 -158.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.7 96.5 0.28 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.133 2.573 . . . . 0.0 108.921 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.0 m -66.63 144.33 56.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 110.504 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -123.71 145.12 49.23 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.843 1.657 . . . . 0.0 107.389 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.423 ' H ' ' CE ' ' A' ' 28' ' ' MET . 10.0 m -62.69 -16.25 56.35 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -176.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.46 158.5 17.5 Favored Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 108.607 170.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.38 -15.77 31.17 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.785 1.657 . . . . 0.0 111.99 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 t -72.82 -40.23 65.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.423 ' CE ' ' H ' ' A' ' 24' ' ' SER . 19.0 ttp -61.87 -45.33 94.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.327 1.051 . . . . 0.0 109.466 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.916 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -55.22 -63.55 1.12 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.991 174.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -34.44 74.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.226 -174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 2.9 t -50.31 -69.02 0.12 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 124.806 1.243 . . . . 0.0 108.616 169.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.09 -52.63 2.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 127.099 2.16 . . . . 0.0 111.884 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -49.13 -61.61 1.98 Allowed 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.869 1.668 . . . . 0.0 110.586 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -66.81 -24.64 66.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 123.957 0.786 . . . . 0.0 112.512 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -77.68 -46.6 21.45 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.5 18.82 0.09 OUTLIER Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.351 -1.25 . . . . 0.0 115.312 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -133.48 65.45 71.94 Favored Pre-proline 0 C--O 1.223 -0.338 0 CA-C-N 119.932 1.866 . . . . 0.0 110.25 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -61.55 -20.07 67.22 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 CA-C-N 121.482 1.565 . . . . 0.0 112.615 -176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -22.14 47.53 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.654 2.782 . . . . 0.0 113.774 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.916 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.9 tp -66.48 152.15 45.76 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 170.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.614 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.3 m -151.52 155.98 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.773 1.629 . . . . 0.0 108.801 174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -73.79 84.3 1.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.8 -50.25 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 C-N-CA 122.944 0.498 . . . . 0.0 110.194 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -159.33 -174.32 4.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.231 1.813 . . . . 0.0 106.26 165.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 46' ' ' GLY . 26.2 tt0 -71.35 -137.39 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.18 1.392 . . . . 0.0 107.4 167.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.472 ' H ' ' HG2' ' A' ' 45' ' ' GLU . . . 51.87 116.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.532 0 C-N-CA 128.104 2.764 . . . . 0.0 117.881 158.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.76 127.61 14.03 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 CA-C-N 119.709 1.755 . . . . 0.0 112.376 -169.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.6 m -73.26 -28.24 62.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.999 -0.524 . . . . 0.0 112.11 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.83 -79.95 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.35 1.86 . . . . 0.0 110.389 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.55 170.17 19.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.018 0.927 . . . . 0.0 109.47 171.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -120.27 78.61 1.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.182 2.193 . . . . 0.0 110.161 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.92 164.75 4.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.689 1.596 . . . . 0.0 111.965 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.05 41.57 1.19 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.378 1.071 . . . . 0.0 110.026 -168.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -63.08 -45.97 89.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.301 1.04 . . . . 0.0 112.071 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 116.859 -1.543 . . . . 0.0 108.888 165.619 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.463 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -176.62 -78.15 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.546 2.338 . . . . 0.0 105.72 159.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 50.48 3.79 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 127.234 2.349 . . . . 0.0 112.911 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 2.9 t-20 -144.29 -53.63 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 126.585 1.954 . . . . 0.0 109.299 163.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 11.3 Cg_endo -59.27 -29.94 91.62 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.377 2.051 . . . . 0.0 114.199 166.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.95 102.15 9.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.004 1.274 . . . . 0.0 112.889 -172.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -126.31 -0.0 7.02 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.106 1.362 . . . . 0.0 112.763 163.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -75.91 165.72 50.95 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -165.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.99 167.25 20.28 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.225 1.95 . . . . 0.0 110.728 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.4 mtp85 -85.46 43.83 1.05 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.621 -0.675 . . . . 0.0 110.639 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 125.03 24.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 125.901 1.68 . . . . 0.0 110.304 171.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.35 43.48 1.02 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.538 1.535 . . . . 0.0 111.652 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.484 ' O ' HG13 ' A' ' 15' ' ' VAL . 34.5 m170 -78.23 70.65 4.62 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 120.603 -1.31 . . . . 0.0 107.89 170.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -52.96 130.52 33.86 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.4 1.08 . . . . 0.0 111.308 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 13' ' ' HIS . 4.1 m -135.74 162.93 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 123.455 0.702 . . . . 0.0 111.746 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.2 t -104.0 135.29 45.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 111.422 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.01 163.86 23.5 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 158.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.521 ' HA ' HG11 ' A' ' 43' ' ' VAL . 89.2 p -42.28 -36.49 1.25 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 118.198 2.666 . . . . 0.0 118.198 -164.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 21' ' ' ASN . 82.0 m-20 -72.1 -1.47 14.98 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.467 1.507 . . . . 0.0 112.757 -177.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.22 -6.81 82.7 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 119.145 0.884 . . . . 0.0 112.175 -159.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 19' ' ' ASP . 45.8 t-20 -67.73 90.47 0.28 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 127.967 2.507 . . . . 0.0 109.75 -171.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 83.4 m -65.89 144.15 56.99 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 123.368 0.667 . . . . 0.0 111.832 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.18 158.39 39.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.473 2.709 . . . . 0.0 108.282 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.7 t -61.33 -28.49 69.25 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.818 1.247 . . . . 0.0 113.926 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 12.9 p30 -163.82 161.9 16.85 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 125.931 1.692 . . . . 0.0 108.376 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.9 Cg_endo -73.81 -16.63 23.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 120.968 1.112 . . . . 0.0 111.87 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -64.85 -45.93 84.01 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 118.729 -0.653 . . . . 0.0 110.565 171.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.3 mtp -58.15 -41.6 84.1 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.979 0.809 . . . . 0.0 112.57 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.904 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.7 tt -55.76 -67.2 0.31 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 109.095 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -33.78 71.81 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.595 -0.69 . . . . 0.0 111.485 -172.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 2.9 t -53.32 -70.93 0.08 Allowed 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.239 1.416 . . . . 0.0 107.679 171.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.51 0.82 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 126.606 1.963 . . . . 0.0 111.851 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -49.86 -63.96 0.95 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.851 1.261 . . . . 0.0 110.979 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -15.07 63.46 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.663 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -80.48 -59.62 2.63 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.42 28.25 0.26 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.47 -1.183 . . . . 0.0 114.146 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.02 66.56 79.35 Favored Pre-proline 0 C--O 1.223 -0.328 0 CA-C-N 119.5 1.65 . . . . 0.0 109.737 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.58 -19.4 64.68 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.817 1.327 . . . . 0.0 112.402 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.56 -25.77 50.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.794 2.838 . . . . 0.0 113.904 176.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.904 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.5 tp -66.52 154.54 40.08 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.689 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.1 m -150.95 154.65 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 124.737 1.215 . . . . 0.0 110.182 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.408 HE22 ' HB3' ' A' ' 26' ' ' PRO . 30.1 tp60 -75.08 86.56 2.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 166.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -56.55 -53.87 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.777 0.831 . . . . 0.0 109.788 166.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -164.66 -175.24 3.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.198 1.799 . . . . 0.0 108.503 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -86.0 -175.05 5.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.132 1.373 . . . . 0.0 108.045 158.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.91 142.34 1.12 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.425 1.012 . . . . 0.0 112.12 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -83.24 146.86 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.177 1.918 . . . . 0.0 111.1 -171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.5 m -86.41 -36.86 18.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 168.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.24 139.93 58.04 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.525 1.13 . . . . 0.0 109.938 167.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -153.77 129.93 10.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -152.62 -67.65 0.16 Allowed 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -173.37 171.01 4.09 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.316 2.246 . . . . 0.0 106.854 168.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -106.48 69.77 0.8 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.7 1.2 . . . . 0.0 110.38 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -65.73 157.92 28.89 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.055 0.542 . . . . 0.0 110.24 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 116.486 -1.721 . . . . 0.0 107.549 176.005 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.494 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.23 -79.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.521 1.928 . . . . 0.0 106.614 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.16 -27.23 41.17 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.636 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -44.08 78.18 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 116.902 -1.523 . . . . 0.0 114.557 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -68.47 -50.14 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.058 1.838 . . . . 0.0 111.562 166.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -90.7 76.32 6.47 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.856 1.207 . . . . 0.0 111.188 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.65 102.76 6.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 159.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.71 165.81 6.96 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.308 1.443 . . . . 0.0 109.253 -174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.43 159.09 32.73 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.124 1.883 . . . . 0.0 110.7 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -78.42 43.32 0.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.55 0.74 . . . . 0.0 110.488 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.48 126.15 27.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.593 1.957 . . . . 0.0 110.943 173.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.95 43.39 1.04 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.602 1.561 . . . . 0.0 111.511 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -83.53 62.76 6.99 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.496 -1.377 . . . . 0.0 109.913 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -53.69 140.28 29.8 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -165.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -146.45 176.65 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 125.424 1.49 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 42.7 t -125.5 146.19 49.76 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.435 1.016 . . . . 0.0 111.705 174.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.18 163.6 23.21 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.029 165.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.428 ' HB3' HG13 ' A' ' 43' ' ' VAL . 84.5 p -53.24 -14.46 0.7 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.114 1.766 . . . . 0.0 114.482 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.79 -15.24 58.22 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.212 2.205 . . . . 0.0 112.14 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.43 -9.73 40.28 Favored Glycine 0 C--N 1.348 1.2 0 C-N-CA 124.856 1.217 . . . . 0.0 111.358 -163.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -76.52 114.9 15.76 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 126.561 1.945 . . . . 0.0 110.151 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 m -65.64 143.84 57.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.957 0.799 . . . . 0.0 109.536 166.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -121.26 147.4 45.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.323 1.849 . . . . 0.0 106.87 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 m -60.61 -23.43 64.71 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.555 0.742 . . . . 0.0 112.501 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -163.59 161.09 17.7 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.958 2.103 . . . . 0.0 107.95 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.3 -14.64 34.61 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.973 1.782 . . . . 0.0 112.201 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.64 -40.11 84.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.864 0.466 . . . . 0.0 110.986 173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 89.5 mtp -65.06 -39.72 93.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.013 0.824 . . . . 0.0 111.551 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -58.41 -63.66 1.2 Allowed 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.073 0.949 . . . . 0.0 110.043 171.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.45 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -60.33 -32.4 71.2 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.668 -175.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 -69.07 0.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.02 -52.89 1.39 Allowed 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 126.47 1.908 . . . . 0.0 111.657 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -50.06 -63.09 1.22 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.385 1.874 . . . . 0.0 110.29 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -66.83 -25.91 66.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.331 1.052 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -69.57 -57.43 5.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.282 0.633 . . . . 0.0 109.529 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.11 21.31 0.11 Allowed Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.565 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -125.62 62.22 40.52 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 119.589 1.694 . . . . 0.0 109.382 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -61.16 -18.3 57.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 121.45 1.554 . . . . 0.0 113.141 -174.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -23.36 42.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.329 2.652 . . . . 0.0 113.625 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.684 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.5 tp -66.39 152.4 45.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.539 ' H ' HD12 ' A' ' 40' ' ' LEU . 29.0 m -156.08 161.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.341 2.256 . . . . 0.0 108.87 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -75.73 80.81 2.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 170.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 18' ' ' SER . 0.3 OUTLIER -54.24 -41.01 49.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 124.99 1.316 . . . . 0.0 111.147 172.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.36 143.04 18.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -84.63 55.23 3.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.478 1.132 . . . . 0.0 108.761 171.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.67 158.41 31.35 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.247 2.356 . . . . 0.0 108.488 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -82.15 153.47 16.53 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.835 2.357 . . . . 0.0 113.375 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 60.6 m -86.57 -53.07 5.18 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.377 1.871 . . . . 0.0 108.88 169.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.1 138.76 40.99 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.833 2.053 . . . . 0.0 110.093 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -153.6 176.04 12.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.842 1.257 . . . . 0.0 108.768 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 159.09 -46.4 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 128.909 2.884 . . . . 0.0 106.757 -159.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -75.42 115.56 15.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.692 1.597 . . . . 0.0 109.562 -164.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -130.75 75.74 1.68 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.9 -33.52 74.88 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.238 1.015 . . . . 0.0 111.407 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.9 t80 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 127.873 2.469 . . . . 0.0 105.984 170.437 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.616 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.1 133.0 0.25 Allowed 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 162.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.16 -36.75 1.1 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.061 0.839 . . . . 0.0 113.552 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -50.3 72.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.401 1.08 . . . . 0.0 109.767 171.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.14 -36.08 6.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.628 2.218 . . . . 0.0 113.875 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -108.32 95.15 5.47 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.547 1.067 . . . . 0.0 110.232 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -119.91 5.51 10.91 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.025 1.33 . . . . 0.0 111.051 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.92 165.85 20.73 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 0.0 114.325 -167.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -84.92 167.98 10.91 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.495 2.13 . . . . 0.0 111.684 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.1 mtt85 -74.67 44.33 0.21 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.137 1.375 . . . . 0.0 111.448 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.78 120.31 12.79 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.716 1.207 . . . . 0.0 110.173 164.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -78.44 43.81 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.119 2.167 . . . . 0.0 111.709 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.479 ' O ' HG13 ' A' ' 15' ' ' VAL . 2.2 m-70 -78.7 67.86 4.54 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.782 -1.198 . . . . 0.0 108.213 174.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -57.59 133.66 55.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.741 1.609 . . . . 0.0 110.483 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 13' ' ' HIS . 17.9 m -135.34 167.86 24.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.364 1.066 . . . . 0.0 111.158 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -106.15 137.69 43.65 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.229 1.012 . . . . 0.0 111.592 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.99 163.97 23.57 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 159.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.451 ' HA ' HG11 ' A' ' 43' ' ' VAL . 60.6 p -45.83 -34.27 3.66 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -168.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.06 -0.04 6.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.475 1.11 . . . . 0.0 112.384 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.82 1.52 90.6 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 111.666 -159.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.86 100.48 4.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.836 1.654 . . . . 0.0 110.584 -166.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -66.1 143.61 57.21 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.858 -0.526 . . . . 0.0 111.355 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -122.27 153.62 38.65 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.87 2.468 . . . . 0.0 108.641 172.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -63.12 -28.42 70.05 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.462 1.505 . . . . 0.0 113.178 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 18.3 p30 -163.58 158.87 17.48 Favored Pre-proline 0 C--O 1.237 0.402 0 C-N-CA 126.071 1.748 . . . . 0.0 110.126 173.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.4 Cg_endo -70.63 -20.07 31.18 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.247 1.298 . . . . 0.0 111.496 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.7 t -66.1 -43.94 85.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.943 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtm -62.58 -35.54 79.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.6 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.913 ' HG ' HD11 ' A' ' 40' ' ' LEU . 3.7 tt -60.42 -66.05 0.59 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.213 0.915 . . . . 0.0 109.495 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -56.11 -36.49 68.25 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.337 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -51.59 -68.93 0.13 Allowed 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 124.333 1.053 . . . . 0.0 108.945 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -37.94 -53.12 1.36 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.343 1.857 . . . . 0.0 110.784 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -51.54 -63.8 1.02 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.549 1.14 . . . . 0.0 110.523 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.36 -15.43 63.27 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.522 1.129 . . . . 0.0 112.742 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -78.27 -64.21 1.22 Allowed 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.9 27.66 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.896 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -128.69 64.53 69.45 Favored Pre-proline 0 C--N 1.343 0.326 0 CA-C-N 119.141 1.471 . . . . 0.0 110.194 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -63.08 -16.65 55.75 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 120.97 1.382 . . . . 0.0 112.777 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.35 -25.99 42.16 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.179 2.192 . . . . 0.0 113.228 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.913 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.6 tp -66.32 153.85 41.55 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.667 ' H ' HD12 ' A' ' 40' ' ' LEU . 31.6 m -151.11 147.29 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.258 1.423 . . . . 0.0 107.72 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -76.9 86.2 3.46 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.92 -53.65 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.936 0.894 . . . . 0.0 110.401 168.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.65 177.21 5.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.274 1.43 . . . . 0.0 109.721 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.92 178.26 7.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.923 1.689 . . . . 0.0 107.713 166.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.76 142.03 1.05 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 119.039 0.836 . . . . 0.0 112.972 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -80.82 147.4 17.05 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.923 1.749 . . . . 0.0 111.119 -174.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.6 m -85.59 -56.89 3.29 Favored 'General case' 0 CA--C 1.523 -0.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.021 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -61.49 145.96 50.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -78.51 163.55 25.47 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.327 0.584 . . . . 0.0 109.662 -171.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -92.77 98.61 11.51 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -59.82 163.36 4.55 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.81 0.814 . . . . 0.0 110.892 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -106.06 56.95 0.66 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.03 1.732 . . . . 0.0 109.83 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.72 -29.39 70.38 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -171.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 116.69 -1.624 . . . . 0.0 110.457 177.465 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -176.52 -71.08 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.311 1.844 . . . . 0.0 107.605 167.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.64 67.75 3.63 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 126.101 1.81 . . . . 0.0 110.727 -175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.6 -52.18 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.41 2.284 . . . . 0.0 107.556 169.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.77 -43.0 5.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.17 2.58 . . . . 0.0 114.521 169.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.11 93.59 5.31 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 120.809 1.64 . . . . 0.0 112.389 -169.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.11 2.43 9.83 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.063 1.745 . . . . 0.0 113.315 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.93 170.94 9.43 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -162.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.61 167.21 11.71 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.417 2.745 . . . . 0.0 111.474 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.43 45.73 0.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.388 -0.82 . . . . 0.0 111.24 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 119.5 9.9 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 121.286 -0.884 . . . . 0.0 109.635 165.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.06 42.94 0.27 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.018 2.527 . . . . 0.0 112.217 177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -91.08 63.53 5.12 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.489 -1.382 . . . . 0.0 108.758 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -58.3 140.08 54.0 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.738 1.215 . . . . 0.0 113.419 -165.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.2 160.19 13.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.84 135.25 35.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.702 1.601 . . . . 0.0 110.798 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.65 164.72 24.29 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 159.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' HG11 ' A' ' 43' ' ' VAL . 88.5 p -43.96 -38.26 3.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -169.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -0.24 7.25 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.671 1.188 . . . . 0.0 113.119 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.97 -5.36 85.31 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.821 0.737 . . . . 0.0 111.576 -165.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -71.7 99.98 2.24 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.599 2.359 . . . . 0.0 110.287 -170.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -67.06 145.61 55.18 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.745 -0.597 . . . . 0.0 112.284 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -126.42 158.56 35.68 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.159 2.184 . . . . 0.0 108.876 171.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.3 m -62.75 -29.17 70.49 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.311 1.844 . . . . 0.0 114.178 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -163.71 155.02 14.25 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 125.187 1.395 . . . . 0.0 109.148 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.33 -17.91 34.69 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.634 2.223 . . . . 0.0 110.736 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.1 t -62.61 -46.33 88.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.026 0.93 . . . . 0.0 110.06 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 mtm -66.16 -31.81 72.87 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.233 -0.889 . . . . 0.0 112.823 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.887 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -60.98 -63.89 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.74 1.155 . . . . 0.0 109.72 171.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.86 -35.44 72.95 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.278 -176.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.13 -66.56 0.37 Allowed 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -38.53 -53.54 1.57 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 127.188 2.195 . . . . 0.0 110.492 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 43.4 tttm -50.85 -62.47 1.59 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.835 1.254 . . . . 0.0 109.746 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.21 -18.82 65.41 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 124.379 1.049 . . . . 0.0 113.168 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -56.76 4.28 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 18.58 0.1 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.171 -1.35 . . . . 0.0 114.219 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.99 61.99 10.19 Favored Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.816 1.808 . . . . 0.0 108.515 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.98 -21.57 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 121.61 1.611 . . . . 0.0 112.847 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -29.67 67.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.338 2.255 . . . . 0.0 113.448 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.887 HD11 ' HG ' ' A' ' 29' ' ' LEU . 7.1 tp -66.14 157.27 31.67 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.687 ' H ' HD12 ' A' ' 40' ' ' LEU . 29.6 m -150.96 149.35 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 106.789 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -72.88 89.2 1.38 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.031 -1.841 . . . . 0.0 106.031 165.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.4 OUTLIER -54.18 -54.53 20.31 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.644 0 C-N-CA 124.58 1.152 . . . . 0.0 110.517 168.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.8 t60 174.97 170.87 0.27 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.357 2.663 . . . . 0.0 105.84 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -168.5 2.25 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.011 0.924 . . . . 0.0 109.077 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.83 131.74 2.04 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -78.1 128.09 8.85 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.929 1.865 . . . . 0.0 111.209 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 m -78.35 -56.71 4.23 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.188 0.449 . . . . 0.0 110.624 175.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -72.23 169.79 15.42 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.378 1.471 . . . . 0.0 111.292 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.41 133.42 44.88 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 123.141 1.448 . . . . 0.0 112.808 -159.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -89.57 -62.6 1.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.579 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -73.13 59.74 0.54 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.164 2.586 . . . . 0.0 111.492 -167.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -71.67 68.15 0.59 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.599 2.359 . . . . 0.0 110.28 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -76.79 -28.72 55.74 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.924 1.689 . . . . 0.0 112.166 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.585 1.954 . . . . 0.0 107.544 170.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -166.5 159.2 14.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 145.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.55 -50.11 2.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.813 1.197 . . . . 0.0 115.341 162.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -63.77 -43.73 77.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.251 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.58 -61.92 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 CA-C-N 121.244 1.48 . . . . 0.0 110.384 159.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.3 m -92.36 74.07 5.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -158.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.05 130.31 25.19 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 158.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.95 167.21 0.77 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.207 1.803 . . . . 0.0 109.355 -174.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.1 156.73 51.48 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.018 1.145 . . . . 0.0 110.065 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -82.9 43.17 0.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.44 123.86 21.17 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 127.477 2.311 . . . . 0.0 109.886 166.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.73 54.03 2.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.443 1.897 . . . . 0.0 111.561 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -72.29 81.8 1.02 Allowed 'General case' 0 C--O 1.223 -0.311 0 O-C-N 120.726 -1.233 . . . . 0.0 107.877 163.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -65.98 86.22 0.09 Allowed 'General case' 0 C--O 1.221 -0.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.365 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -97.47 154.05 3.8 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 126.364 1.865 . . . . 0.0 114.123 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 35.7 t -86.11 127.66 34.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.65 -0.656 . . . . 0.0 109.371 167.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.5 163.19 26.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 158.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.418 ' HA ' HG11 ' A' ' 43' ' ' VAL . 71.3 p -33.79 -51.66 0.4 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.116 2.567 . . . . 0.0 117.399 -167.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 27.54 0.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 126.34 1.856 . . . . 0.0 110.945 -166.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.08 -1.4 8.56 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.547 1.546 . . . . 0.0 112.759 -165.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.55 89.2 2.18 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 129.885 3.274 . . . . 0.0 108.048 -166.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -65.87 143.71 57.27 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.713 -0.617 . . . . 0.0 109.55 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.77 151.96 47.53 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 127.121 2.168 . . . . 0.0 109.096 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 m -65.53 -18.68 65.51 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.706 1.603 . . . . 0.0 114.736 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -164.26 154.81 13.09 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 125.914 1.686 . . . . 0.0 109.597 166.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.93 -20.63 38.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.108 1.872 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.4 t -60.0 -58.2 9.57 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.172 168.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.5 mmm -61.12 -34.01 74.29 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.09 1.314 . . . . 0.0 112.928 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.945 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -54.76 -65.09 0.64 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.178 0.899 . . . . 0.0 109.242 166.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -28.08 69.68 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.991 -173.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -63.23 1.37 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -42.93 -52.87 4.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.956 2.102 . . . . 0.0 111.62 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 37' ' ' ASN . 40.2 tttm -48.42 -62.13 1.65 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.166 1.786 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -72.28 -16.43 61.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.489 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.73 -67.89 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 171.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.11 22.86 0.68 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.288 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 33' ' ' LYS . 9.5 t-20 -129.3 56.87 26.44 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-N 119.208 1.504 . . . . 0.0 109.167 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -58.95 -21.6 58.91 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 CA-C-N 122.587 1.96 . . . . 0.0 113.012 -171.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.13 -34.15 77.4 Favored 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.001 4.12 . . . . 0.0 114.657 173.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.945 HD11 ' HG ' ' A' ' 29' ' ' LEU . 7.4 tp -65.63 153.84 40.49 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 125.437 1.495 . . . . 0.0 107.914 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.486 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.7 m -149.62 151.16 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 124.863 1.265 . . . . 0.0 109.212 169.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.67 85.83 3.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.61 -34.98 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.395 1.478 . . . . 0.0 110.456 172.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 179.67 170.24 1.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.734 2.414 . . . . 0.0 107.319 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -85.72 177.5 7.66 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 158.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.08 139.67 0.88 Allowed Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.728 1.156 . . . . 0.0 111.68 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -85.52 152.57 10.39 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.555 2.837 . . . . 0.0 112.478 -165.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.422 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 62.4 m -85.93 -32.21 21.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.715 166.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -66.43 165.6 14.01 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.341 1.456 . . . . 0.0 109.765 164.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -153.82 3.42 0.27 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.816 1.646 . . . . 0.0 110.604 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -79.17 -22.59 44.79 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.536 -1.353 . . . . 0.0 112.804 -173.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.23 133.53 41.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.808 1.243 . . . . 0.0 112.228 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.73 55.66 0.9 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.373 1.869 . . . . 0.0 107.823 164.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -85.06 172.5 11.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.119 0.568 . . . . 0.0 110.166 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.864 1.665 . . . . 0.0 111.49 177.836 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -72.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.17 1.788 . . . . 0.0 107.446 160.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.84 51.82 4.36 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.872 2.177 . . . . 0.0 111.98 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.35 -53.49 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 C-N-CA 127.102 2.161 . . . . 0.0 107.784 173.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.87 -42.32 46.31 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.125 1.217 . . . . 0.0 112.11 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.0 m -101.53 99.91 10.28 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.04 0.837 . . . . 0.0 109.586 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -136.62 78.36 1.7 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 159.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -156.33 166.4 16.56 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.433 1.093 . . . . 0.0 110.79 -165.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.71 161.73 24.53 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.914 2.41 . . . . 0.0 112.212 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.9 mtp-105 -75.06 44.47 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.923 1.289 . . . . 0.0 111.046 167.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.37 131.28 46.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.531 1.132 . . . . 0.0 110.643 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -85.98 43.07 1.02 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.997 2.119 . . . . 0.0 110.329 167.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -92.52 61.7 3.78 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 120.719 -1.238 . . . . 0.0 107.749 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -58.58 142.5 49.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -159.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.71 168.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.023 0.929 . . . . 0.0 112.186 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 t -114.12 136.51 52.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.13 163.34 22.09 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 158.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -52.87 -27.36 18.16 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 118.823 2.897 . . . . 0.0 118.823 -164.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.75 -13.7 59.88 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.185 0.994 . . . . 0.0 112.216 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.76 -3.17 65.03 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -159.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.89 87.54 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.941 2.896 . . . . 0.0 107.846 -175.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -66.53 143.5 57.02 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 173.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -125.1 155.7 39.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.212 2.205 . . . . 0.0 107.692 174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.1 t -58.15 -29.6 65.7 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.866 0.866 . . . . 0.0 112.307 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -163.9 160.41 17.06 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.247 1.419 . . . . 0.0 108.509 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.84 -18.92 36.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.314 2.01 . . . . 0.0 111.632 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.0 t -67.54 -45.82 74.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.711 0.404 . . . . 0.0 110.524 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.4 mtp -62.66 -37.36 86.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.03 0.832 . . . . 0.0 111.573 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.958 ' HG ' HD11 ' A' ' 40' ' ' LEU . 4.0 tt -60.08 -66.62 0.49 Allowed 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.616 0.766 . . . . 0.0 109.879 170.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.34 -32.68 66.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.852 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.68 -70.47 0.11 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 173.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.86 -52.94 0.94 Allowed 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 126.531 1.933 . . . . 0.0 111.993 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -48.69 -64.21 0.87 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.466 1.507 . . . . 0.0 110.7 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.99 -26.64 68.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.266 0.979 . . . . 0.0 112.338 176.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -70.23 -59.7 2.73 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -178.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.11 21.27 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.524 -1.154 . . . . 0.0 113.946 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -130.16 54.09 13.56 Favored Pre-proline 0 C--O 1.221 -0.443 0 CA-C-N 119.434 1.617 . . . . 0.0 109.537 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -59.4 -22.34 65.39 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 CA-C-N 122.933 2.083 . . . . 0.0 113.074 -170.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.3 -30.45 71.5 Favored 'General case' 0 CA--C 1.534 0.336 1 C-N-CA 132.616 4.366 . . . . 0.0 115.313 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.958 HD11 ' HG ' ' A' ' 29' ' ' LEU . 1.5 tp -65.37 158.8 25.6 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.838 1.255 . . . . 0.0 107.888 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.68 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.3 m -153.63 155.7 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 126.591 1.956 . . . . 0.0 108.072 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -75.81 88.07 2.83 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 164.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -54.63 -48.86 70.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 122.583 0.353 . . . . 0.0 110.211 169.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.04 155.63 23.45 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.334 1.053 . . . . 0.0 108.223 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.06 170.32 15.71 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 161.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.94 156.2 0.07 OUTLIER Glycine 0 CA--C 1.544 1.847 0 O-C-N 121.006 -1.059 . . . . 0.0 112.13 -162.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -91.05 164.96 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 CA-C-N 119.263 1.532 . . . . 0.0 113.592 -164.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.9 m -85.79 -53.98 4.8 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.432 0.693 . . . . 0.0 109.169 167.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.28 134.25 44.16 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 123.112 0.565 . . . . 0.0 110.06 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -153.72 34.73 0.44 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.234 1.413 . . . . 0.0 107.263 166.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -129.47 92.44 3.35 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.843 1.257 . . . . 0.0 109.669 -165.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -173.16 167.73 4.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.602 2.361 . . . . 0.0 107.395 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.6 t60 -158.13 101.17 1.74 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -93.72 160.84 14.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.358 1.463 . . . . 0.0 110.794 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.251 1.174 0 C-N-CA 125.216 1.406 . . . . 0.0 111.594 -179.06 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.478 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -170.91 134.55 0.99 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 171.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.44 -41.39 1.15 Allowed Glycine 0 CA--C 1.533 1.214 0 N-CA-C 115.849 1.1 . . . . 0.0 115.849 164.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.6 -47.04 83.42 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 119.701 1.75 . . . . 0.0 110.46 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -55.42 -43.27 59.92 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.321 2.014 . . . . 0.0 113.065 165.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.4 m -105.38 66.1 0.74 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.765 1.226 . . . . 0.0 111.992 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -79.14 -0.04 30.15 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.641 0.776 . . . . 0.0 112.061 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.04 165.3 17.26 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -159.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.45 164.18 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.908 2.405 . . . . 0.0 111.173 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -81.61 43.38 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.582 -0.699 . . . . 0.0 110.104 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.84 124.9 24.23 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.459 1.904 . . . . 0.0 110.846 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.92 43.55 0.93 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.419 1.088 . . . . 0.0 109.791 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -84.62 60.69 6.25 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.833 -1.167 . . . . 0.0 109.104 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.6 mmm-85 -53.07 140.2 26.16 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.247 1.819 . . . . 0.0 112.735 -162.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.99 156.63 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.551 0 C-N-CA 123.898 0.879 . . . . 0.0 111.498 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.408 ' HB2' ' N ' ' A' ' 48' ' ' CYS . 52.9 t -94.47 141.82 28.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 118.002 0.364 . . . . 0.0 110.774 174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.88 166.29 24.81 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 160.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.464 ' HA ' HG11 ' A' ' 43' ' ' VAL . 96.0 p -49.65 -19.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 118.737 2.866 . . . . 0.0 118.737 -176.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -85.63 -8.32 58.31 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.323 1.42 . . . . 0.0 111.986 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.27 -9.65 69.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.06 -1.025 . . . . 0.0 110.85 -160.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -64.91 92.97 0.1 Allowed 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 128.336 2.654 . . . . 0.0 110.934 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -66.06 144.06 56.95 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.549 0.74 . . . . 0.0 110.366 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -122.84 157.69 31.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.811 2.844 . . . . 0.0 108.625 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 m -62.64 -30.8 71.63 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.53 1.532 . . . . 0.0 113.909 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 10.5 p30 -163.81 163.46 15.88 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 127.497 2.319 . . . . 0.0 107.301 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 25' ' ' ASN . 56.2 Cg_endo -71.67 -16.36 30.13 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 121.31 1.34 . . . . 0.0 112.014 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 t -67.55 -46.84 71.57 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.654 170.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 mmm -59.43 -39.75 84.53 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.599 1.09 . . . . 0.0 111.024 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.1 tt -56.71 -69.44 0.15 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.994 0.918 . . . . 0.0 109.42 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -30.92 68.22 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.095 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.53 -70.74 0.09 Allowed 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.3 -53.05 2.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.407 1.883 . . . . 0.0 112.191 172.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -46.64 -61.47 1.81 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.819 1.247 . . . . 0.0 110.716 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -21.18 64.6 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 8.5 tt0 -79.74 -31.12 41.01 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.541 1.064 . . . . 0.0 110.721 -177.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.73 21.13 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 CA-C-O 117.993 -1.449 . . . . 0.0 114.824 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.7 64.77 70.38 Favored Pre-proline 0 C--O 1.224 -0.267 0 CA-C-N 120.004 1.902 . . . . 0.0 110.055 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.71 -17.49 59.24 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 CA-C-N 121.222 1.472 . . . . 0.0 112.961 -174.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.58 -26.26 41.36 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.935 2.494 . . . . 0.0 113.308 177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.928 HD11 ' HG ' ' A' ' 29' ' ' LEU . 4.7 tp -66.37 152.01 45.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.598 ' H ' HD12 ' A' ' 40' ' ' LEU . 31.0 m -150.06 153.22 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.391 0.676 . . . . 0.0 109.831 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -74.53 85.76 2.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -53.7 -56.37 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 C-N-CA 124.441 1.097 . . . . 0.0 110.62 164.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.76 -171.47 2.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.837 2.455 . . . . 0.0 106.426 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.74 -137.8 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.792 2.037 . . . . 0.0 107.194 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 52.98 122.76 0.01 OUTLIER Glycine 0 CA--C 1.543 1.788 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.55 144.0 35.25 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 CA-C-N 119.992 1.896 . . . . 0.0 111.706 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.408 ' N ' ' HB2' ' A' ' 16' ' ' CYS . 33.3 m -86.03 -31.94 21.72 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.652 0.381 . . . . 0.0 110.106 172.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.34 148.64 37.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.95 1.3 . . . . 0.0 112.478 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -156.46 95.43 1.57 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -163.8 117.92 1.53 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.99 155.4 16.86 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.845 0.831 . . . . 0.0 111.265 171.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -151.62 51.58 0.82 Allowed 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -172.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -57.95 -63.66 1.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.99 1.716 . . . . 0.0 110.403 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 117.322 -1.323 . . . . 0.0 109.237 172.5 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 121.19 0.519 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -157.79 160.22 37.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 140.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.06 -50.99 2.76 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.43 1.014 . . . . 0.0 113.918 167.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -63.56 -45.34 83.06 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.109 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -57.21 -61.36 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 121.758 1.639 . . . . 0.0 111.099 166.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.45 59.1 5.32 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.402 -0.811 . . . . 0.0 112.122 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.88 -11.16 59.83 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.078 -0.389 . . . . 0.0 111.706 166.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.1 164.66 55.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.886 1.674 . . . . 0.0 113.928 -171.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.97 164.36 13.57 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.893 2.395 . . . . 0.0 111.727 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -79.59 43.9 0.59 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.499 1.12 . . . . 0.0 111.162 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.11 129.06 38.51 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.738 1.615 . . . . 0.0 110.332 170.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.95 43.84 1.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.481 1.513 . . . . 0.0 111.755 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -81.7 64.85 6.58 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.757 -1.214 . . . . 0.0 109.175 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -57.46 142.75 43.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -160.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.66 169.88 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 117.68 -1.152 . . . . 0.0 111.63 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.552 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 0.4 OUTLIER -118.57 137.04 53.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.611 1.096 . . . . 0.0 111.907 178.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.26 164.72 28.5 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.58 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.2 p -36.21 -41.04 0.25 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 128.535 2.734 . . . . 0.0 115.929 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.67 -1.91 3.14 Favored 'General case' 0 N--CA 1.436 -1.165 1 C-N-CA 135.019 5.328 . . . . 0.0 111.939 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.91 -8.37 11.85 Favored Glycine 0 CA--C 1.539 1.559 0 CA-C-N 119.391 0.996 . . . . 0.0 112.025 -165.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.47 95.89 0.23 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 130.487 3.515 . . . . 0.0 109.335 -170.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.2 m -66.45 143.7 56.95 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.072 0.463 . . . . 0.0 110.404 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -119.86 157.57 28.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 128.113 2.565 . . . . 0.0 107.512 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 m -59.16 -31.79 69.3 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.466 1.106 . . . . 0.0 112.745 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -163.73 160.42 17.4 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 125.338 1.455 . . . . 0.0 108.779 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.01 -15.19 32.44 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.705 1.603 . . . . 0.0 111.399 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.33 -40.04 64.77 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 123.233 0.613 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.7 ttp -65.01 -44.84 87.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -54.77 -63.5 1.13 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.125 174.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.13 -31.51 70.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.994 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -68.48 0.18 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.68 -53.11 3.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 127.524 2.33 . . . . 0.0 111.856 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -45.37 -61.27 1.74 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.355 1.462 . . . . 0.0 110.722 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -66.01 -27.94 68.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.624 0.77 . . . . 0.0 112.545 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.76 -26.22 40.78 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.211 0.204 . . . . 0.0 111.33 -173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 17.87 0.02 OUTLIER Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.296 -1.28 . . . . 0.0 115.066 -177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -131.7 54.38 14.15 Favored Pre-proline 0 C--O 1.22 -0.456 0 CA-C-N 119.557 1.678 . . . . 0.0 109.099 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.2 -23.1 60.19 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 CA-C-N 122.545 1.945 . . . . 0.0 112.859 -170.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.24 -32.66 74.33 Favored 'General case' 0 CA--C 1.533 0.316 1 C-N-CA 132.882 4.473 . . . . 0.0 114.922 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.928 HD11 ' HG ' ' A' ' 29' ' ' LEU . 1.8 tp -65.37 157.79 28.32 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.959 1.303 . . . . 0.0 107.674 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.6 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.0 m -152.8 146.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 128.339 2.656 . . . . 0.0 107.676 173.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.97 83.69 5.84 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 166.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 41' ' ' VAL . 1.4 m -53.64 -40.56 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 125.641 1.577 . . . . 0.0 109.625 -176.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -155.98 162.51 40.34 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 159.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.78 -179.74 5.58 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 163.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.11 149.22 0.09 OUTLIER Glycine 0 CA--C 1.544 1.874 0 O-C-N 120.796 -1.19 . . . . 0.0 112.534 -161.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.65 152.56 17.41 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.125 1.883 . . . . 0.0 111.7 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.552 ' H ' ' HB2' ' A' ' 16' ' ' CYS . 59.1 m -86.64 -74.86 0.41 Allowed 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.716 0.769 . . . . 0.0 109.048 169.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -173.89 -175.72 1.1 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.722 2.809 . . . . 0.0 107.291 -162.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 163.43 -43.56 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.688 2.395 . . . . 0.0 111.492 158.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -127.19 111.22 13.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -53.96 127.01 24.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.757 1.623 . . . . 0.0 110.216 168.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -106.91 30.33 6.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.419 1.888 . . . . 0.0 111.77 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -69.88 162.51 27.82 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.888 0.875 . . . . 0.0 111.337 -173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.3 t80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.864 -1.541 . . . . 0.0 109.867 -175.121 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -163.29 165.4 24.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 153.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.58 9.86 82.43 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.243 0.925 . . . . 0.0 115.246 158.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.613 ' H ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.29 -44.02 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 126.961 2.104 . . . . 0.0 112.64 172.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 4' ' ' ASN . 8.4 Cg_endo -56.43 -50.69 11.18 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.73 2.287 . . . . 0.0 112.457 163.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 2.0 m -95.23 107.99 20.11 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 123.74 0.816 . . . . 0.0 110.286 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -140.92 52.93 1.59 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.071 1.348 . . . . 0.0 108.071 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -144.77 163.43 33.51 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -161.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.57 166.84 13.59 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.255 2.637 . . . . 0.0 111.813 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -83.15 46.1 1.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.928 0.891 . . . . 0.0 109.734 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.88 123.08 18.82 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 124.117 0.967 . . . . 0.0 109.203 168.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.03 43.09 0.5 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.129 1.772 . . . . 0.0 111.975 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 25' ' ' ASN . 0.6 OUTLIER -78.6 76.71 5.1 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 169.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -61.59 141.3 57.86 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.686 -1.259 . . . . 0.0 110.957 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 m -150.18 164.98 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 124.71 1.204 . . . . 0.0 110.884 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -108.94 135.76 49.59 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.3 163.6 23.08 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 158.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.448 ' HA ' HG11 ' A' ' 43' ' ' VAL . 82.5 p -43.87 -39.1 3.71 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -165.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.15 2.09 5.05 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.489 1.041 . . . . 0.0 112.969 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.09 5.68 80.03 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 120.919 -1.113 . . . . 0.0 111.523 -161.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -71.79 90.21 1.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.119 2.968 . . . . 0.0 109.831 -169.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.4 m -65.92 143.89 57.13 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.076 0.853 . . . . 0.0 110.781 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.02 154.01 41.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 127.6 2.36 . . . . 0.0 107.831 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 p -66.06 -24.21 66.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.915 1.686 . . . . 0.0 114.106 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 13' ' ' HIS . 14.3 p30 -164.01 156.31 14.88 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 126.714 2.006 . . . . 0.0 109.748 170.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB3' HE22 ' A' ' 42' ' ' GLN . 55.7 Cg_endo -69.74 -17.03 37.9 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.939 1.759 . . . . 0.0 111.57 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.9 t -66.19 -48.19 71.47 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.518 168.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.8 mmm -58.09 -39.77 79.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.312 0.96 . . . . 0.0 111.565 175.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.922 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.7 tt -57.39 -67.47 0.32 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.124 0.97 . . . . 0.0 109.783 171.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 t -60.01 -29.28 68.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.987 -173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -57.87 -71.36 0.11 Allowed 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -36.91 -52.99 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.409 1.884 . . . . 0.0 111.932 172.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -48.08 -64.16 0.87 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.818 1.247 . . . . 0.0 110.893 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -65.55 -20.17 66.22 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 124.005 0.815 . . . . 0.0 112.763 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -74.63 -62.69 1.44 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.54 0.3 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.341 -1.255 . . . . 0.0 113.822 -174.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -128.69 63.08 64.05 Favored Pre-proline 0 C--O 1.221 -0.409 0 CA-C-N 119.193 1.497 . . . . 0.0 109.604 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -61.11 -19.08 61.82 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 CA-C-N 121.206 1.466 . . . . 0.0 112.744 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.67 -22.82 43.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.202 2.601 . . . . 0.0 113.557 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.922 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.0 tp -66.52 153.91 41.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 173.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.653 ' H ' HD12 ' A' ' 40' ' ' LEU . 28.9 m -150.9 152.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.174 1.39 . . . . 0.0 108.59 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.416 HE22 ' HB3' ' A' ' 26' ' ' PRO . 40.6 tp60 -75.34 83.9 2.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 166.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -53.52 -54.45 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.69 168.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.23 -170.44 2.09 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.809 2.043 . . . . 0.0 107.502 174.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -137.3 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.06 1.744 . . . . 0.0 106.881 167.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.32 118.25 0.01 OUTLIER Glycine 0 CA--C 1.539 1.57 0 C-N-CA 127.555 2.502 . . . . 0.0 118.664 158.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.7 137.65 30.41 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.189 1.926 . . . . 0.0 111.908 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 69.0 m -85.92 -64.74 1.1 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.75 131.08 47.7 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.636 0.774 . . . . 0.0 111.247 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -153.73 159.52 42.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.773 2.029 . . . . 0.0 108.11 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -163.85 -30.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.336 1.454 . . . . 0.0 109.521 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -54.01 147.38 12.62 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 129.664 3.186 . . . . 0.0 112.125 163.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.21 44.18 0.42 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.304 1.841 . . . . 0.0 109.376 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -70.78 165.88 22.16 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.777 -0.577 . . . . 0.0 110.171 171.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.0 p90 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.815 -173.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 4.5 p90 . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 122.233 1.016 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -169.0 162.57 11.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 143.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.92 -64.65 1.92 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 125.56 1.552 . . . . 0.0 112.087 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -43.33 80.57 Favored Pre-proline 0 N--CA 1.454 -0.233 0 CA-C-O 116.364 -1.779 . . . . 0.0 115.108 -172.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HB2' ' HA ' ' A' ' 31' ' ' CYS . 15.7 Cg_endo -50.0 -26.61 14.72 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 122.072 1.776 . . . . 0.0 113.35 168.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.6 m -105.01 22.01 16.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.127 1.771 . . . . 0.0 111.609 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -66.85 73.66 0.1 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.47 1.108 . . . . 0.0 109.524 170.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.09 167.93 11.77 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 126.416 1.886 . . . . 0.0 109.905 -166.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.8 157.33 24.35 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.598 2.199 . . . . 0.0 110.936 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -79.06 43.7 0.53 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.492 -0.755 . . . . 0.0 110.233 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.07 140.84 58.28 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.417 1.487 . . . . 0.0 110.786 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.61 43.82 1.06 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.898 1.679 . . . . 0.0 110.497 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -89.58 46.13 1.34 Allowed 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.332 -1.48 . . . . 0.0 110.509 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -49.01 145.78 3.8 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.575 1.95 . . . . 0.0 115.262 -164.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.6 m -148.53 174.31 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.237 1.415 . . . . 0.0 110.606 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -116.53 137.09 52.44 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.946 0.794 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.58 163.55 22.75 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.216 0.898 . . . . 0.0 112.059 161.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.45 ' HA ' HG11 ' A' ' 43' ' ' VAL . 80.9 p -54.64 -17.73 3.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 118.653 2.835 . . . . 0.0 118.653 -168.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -9.32 59.36 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.354 0.662 . . . . 0.0 111.724 171.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.7 -3.93 65.75 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.739 1.161 . . . . 0.0 111.043 -171.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.14 113.91 8.66 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 127.487 2.315 . . . . 0.0 109.902 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -66.15 144.77 56.45 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 122.207 -0.308 . . . . 0.0 110.424 167.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -122.53 150.33 42.71 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.946 2.098 . . . . 0.0 107.156 173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 m -60.64 -27.31 67.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.399 1.08 . . . . 0.0 113.498 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -163.79 163.43 15.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 127.673 2.389 . . . . 0.0 107.028 174.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.99 -17.1 32.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.042 1.161 . . . . 0.0 112.065 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 -40.32 93.13 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.487 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.4 mmm -66.15 -40.87 90.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.751 1.159 . . . . 0.0 111.86 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.97 ' HG ' HD11 ' A' ' 40' ' ' LEU . 2.3 tt -59.25 -65.24 0.7 Allowed 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.453 0.701 . . . . 0.0 109.163 171.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -31.5 70.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.797 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 5' ' ' PRO . 3.9 t -52.77 -69.01 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.39 -53.06 3.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.516 1.526 . . . . 0.0 111.589 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -50.57 -63.71 1.04 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 126.034 1.734 . . . . 0.0 110.914 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -62.31 -26.75 68.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.814 1.646 . . . . 0.0 112.221 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -63.32 1.2 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.0 20.27 0.29 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.179 -1.345 . . . . 0.0 114.479 -173.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -124.95 63.84 41.45 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 119.859 1.83 . . . . 0.0 110.139 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.59 -16.06 45.67 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 CA-C-N 121.506 1.574 . . . . 0.0 113.392 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -22.97 33.73 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.28 2.632 . . . . 0.0 113.508 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.97 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.47 150.59 48.72 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 174.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.596 ' H ' HD12 ' A' ' 40' ' ' LEU . 30.6 m -153.63 159.77 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 125.712 1.605 . . . . 0.0 108.784 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -73.44 82.07 1.44 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.4 m -59.72 -42.17 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 170.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -157.24 140.3 15.33 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.554 1.141 . . . . 0.0 108.627 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.12 37.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.111 1.365 . . . . 0.0 112.697 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.15 159.99 27.75 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 107.123 -2.391 . . . . 0.0 107.123 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.73 148.95 29.34 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.234 1.956 . . . . 0.0 111.632 -167.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.3 m -86.14 -71.28 0.55 Allowed 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.273 1.029 . . . . 0.0 108.54 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -173.31 162.75 4.43 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 127.06 2.144 . . . . 0.0 107.967 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -170.35 155.46 5.21 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.881 2.472 . . . . 0.0 107.04 164.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -139.97 33.33 1.96 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -173.28 -175.26 1.14 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.836 2.455 . . . . 0.0 106.243 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -141.4 80.43 1.73 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 163.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -55.3 164.08 1.03 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.104 0.961 . . . . 0.0 110.465 164.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.9 p90 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.407 1.883 . . . . 0.0 107.827 -177.075 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -176.44 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.415 1.886 . . . . 0.0 108.319 151.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.8 61.96 3.97 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 126.66 2.076 . . . . 0.0 111.023 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.92 -54.93 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 126.964 2.106 . . . . 0.0 107.463 170.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.01 -49.97 7.13 Favored 'Trans proline' 0 C--N 1.354 0.858 0 CA-C-N 120.337 1.156 . . . . 0.0 111.705 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.1 m -91.42 87.24 6.35 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.804 0.729 . . . . 0.0 109.242 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -141.2 48.59 1.67 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.584 1.154 . . . . 0.0 108.406 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.64 164.85 38.41 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -163.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -82.86 168.48 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.068 2.512 . . . . 0.0 112.169 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -85.15 44.31 1.08 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.01 0.924 . . . . 0.0 110.968 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.33 135.01 56.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.133 1.373 . . . . 0.0 109.663 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -85.99 43.37 1.04 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.453 2.301 . . . . 0.0 114.131 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -78.45 82.25 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 O-C-N 120.709 -1.244 . . . . 0.0 107.649 169.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.48 120.05 9.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 119.569 -1.957 . . . . 0.0 107.588 172.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 m -138.36 155.29 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -107.64 136.81 46.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.782 0.719 . . . . 0.0 110.319 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.54 163.81 24.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.498 ' HA ' HG11 ' A' ' 43' ' ' VAL . 1.1 p -34.23 -41.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.131 2.972 . . . . 0.0 116.184 -172.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 0.04 5.16 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.436 4.694 . . . . 0.0 111.75 -172.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.38 -4.81 39.49 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.373 0.987 . . . . 0.0 111.65 -165.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -76.49 106.12 7.94 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 127.229 2.211 . . . . 0.0 110.632 -170.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -66.24 144.29 56.71 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.453 0.57 . . . . 0.0 111.302 171.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -124.28 152.06 43.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.772 2.429 . . . . 0.0 107.041 175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.477 1.111 . . . . 0.0 113.838 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -163.91 156.52 15.27 Favored Pre-proline 0 C--N 1.343 0.303 0 C-N-CA 126.958 2.103 . . . . 0.0 109.331 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.45 -18.65 43.66 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.412 2.075 . . . . 0.0 111.274 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 t -66.46 -42.52 87.44 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 118.69 -0.672 . . . . 0.0 111.005 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 86.4 mtp -61.61 -41.6 97.69 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.549 1.068 . . . . 0.0 112.031 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.735 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -56.86 -64.93 0.71 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.684 0.794 . . . . 0.0 109.73 171.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.498 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -61.39 -30.04 70.3 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.843 -173.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.15 -69.63 0.13 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -40.18 -53.04 2.54 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.284 1.833 . . . . 0.0 111.053 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -48.06 -62.51 1.44 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.597 1.559 . . . . 0.0 110.632 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -18.14 63.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.227 -0.892 . . . . 0.0 112.799 177.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -79.97 -51.34 9.2 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.942 0.792 . . . . 0.0 108.885 -177.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.9 22.51 0.11 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.153 -1.359 . . . . 0.0 114.641 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -129.57 61.3 56.91 Favored Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 120.015 1.908 . . . . 0.0 110.338 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -58.04 -24.64 66.82 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 121.814 1.676 . . . . 0.0 112.703 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.16 -30.44 68.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 131.163 3.785 . . . . 0.0 115.042 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.735 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.2 tp -66.33 155.27 37.76 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.588 ' H ' HD12 ' A' ' 40' ' ' LEU . 26.3 m -153.76 153.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.067 1.747 . . . . 0.0 109.788 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -74.86 83.37 2.17 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.8 m -57.37 -38.27 61.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 122.775 0.43 . . . . 0.0 110.378 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -162.89 138.38 6.89 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.652 1.181 . . . . 0.0 109.502 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.18 68.25 10.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.452 1.024 . . . . 0.0 108.805 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.99 157.46 20.2 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.51 153.99 13.81 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.965 1.776 . . . . 0.0 112.76 -159.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m -86.58 -49.39 7.58 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.875 1.27 . . . . 0.0 107.761 167.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -76.12 83.63 2.96 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.994 2.118 . . . . 0.0 110.341 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -166.53 -177.4 3.96 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.048 2.139 . . . . 0.0 107.174 171.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -143.24 -40.18 0.31 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.93 0.787 . . . . 0.0 113.013 -175.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -173.76 173.39 3.32 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.207 2.203 . . . . 0.0 107.231 -167.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.38 54.35 1.84 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 160.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -143.43 124.0 14.04 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.375 -0.828 . . . . 0.0 110.202 -158.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.108 0 CA-C-O 116.678 -1.63 . . . . 0.0 109.677 175.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -176.93 -86.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.669 2.388 . . . . 0.0 105.873 166.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.88 -26.49 68.99 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 118.982 -0.899 . . . . 0.0 113.277 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.3 -48.49 82.54 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 119.593 1.697 . . . . 0.0 111.072 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.67 -65.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.388 2.059 . . . . 0.0 113.09 161.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.8 m -88.64 74.65 8.39 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.378 -0.826 . . . . 0.0 112.639 -158.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -126.91 8.89 6.84 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.866 1.266 . . . . 0.0 112.528 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.44 164.63 59.62 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 120.844 -1.16 . . . . 0.0 113.089 -175.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.39 169.18 20.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.882 2.388 . . . . 0.0 111.95 -174.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -75.17 43.73 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.539 1.536 . . . . 0.0 111.04 171.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.16 114.01 4.96 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 124.888 1.275 . . . . 0.0 108.888 168.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.7 101.86 5.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -148.47 79.86 1.44 Allowed 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.51 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 15.4 mmm180 -59.43 132.15 53.11 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.391 -0.818 . . . . 0.0 110.004 -170.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.98 167.38 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 C-N-CA 123.507 0.723 . . . . 0.0 111.527 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.8 t -115.55 134.29 55.21 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.132 0.973 . . . . 0.0 110.887 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.24 164.96 23.7 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.983 1.277 . . . . 0.0 110.631 164.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.419 ' HA ' HG11 ' A' ' 43' ' ' VAL . 4.9 p -41.54 -40.37 1.83 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -164.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.78 0.03 4.82 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.589 1.556 . . . . 0.0 112.799 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.13 -0.71 88.43 Favored Glycine 0 CA--C 1.541 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 112.073 -159.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.02 94.22 0.85 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.959 2.104 . . . . 0.0 110.174 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.9 m -66.19 143.59 57.17 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -130.96 153.65 48.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.464 3.106 . . . . 0.0 110.254 177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 7.1 m -45.62 -40.15 8.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 130.67 3.588 . . . . 0.0 116.157 172.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -163.76 158.73 17.02 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 126.603 1.961 . . . . 0.0 108.941 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.54 -19.82 27.84 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.519 1.479 . . . . 0.0 111.674 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -60.65 -46.84 88.81 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 5.3 mmm -63.35 -32.56 74.02 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.915 ' HG ' HD11 ' A' ' 40' ' ' LEU . 1.1 tt -61.67 -61.1 2.75 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 119.382 0.992 . . . . 0.0 109.022 172.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -60.5 -32.91 71.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.479 -1.288 . . . . 0.0 110.815 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -62.06 2.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.83 -52.99 6.34 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.903 2.081 . . . . 0.0 111.556 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 40' ' ' LEU . 41.5 tttm -50.18 -60.96 2.45 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.381 1.073 . . . . 0.0 109.762 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 -17.14 63.56 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 124.259 0.974 . . . . 0.0 112.512 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -79.54 -44.55 20.94 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.811 0.732 . . . . 0.0 110.532 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.33 17.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.105 -1.386 . . . . 0.0 114.121 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -120.4 63.71 10.14 Favored Pre-proline 0 C--O 1.22 -0.485 0 CA-C-N 119.797 1.799 . . . . 0.0 109.38 -177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -60.22 -22.44 70.42 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.122 1.881 . . . . 0.0 112.988 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.44 -26.12 55.12 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 128.122 2.569 . . . . 0.0 113.441 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.915 HD11 ' HG ' ' A' ' 29' ' ' LEU . 5.9 tp -66.05 154.53 39.28 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.655 ' H ' HD12 ' A' ' 40' ' ' LEU . 27.1 m -150.8 148.15 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 176.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -75.13 85.25 2.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 18' ' ' SER . 0.3 OUTLIER -54.19 -58.99 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.46 1.104 . . . . 0.0 109.893 167.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -170.38 -173.26 1.42 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.361 1.464 . . . . 0.0 109.243 177.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -177.15 6.32 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.968 2.107 . . . . 0.0 109.929 170.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.14 141.96 1.14 Allowed Glycine 0 CA--C 1.54 1.624 0 CA-C-N 119.248 0.931 . . . . 0.0 113.909 171.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -82.88 145.9 12.8 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.113 1.876 . . . . 0.0 111.756 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 m -86.48 -34.83 19.93 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 172.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.24 140.17 54.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -85.08 67.11 10.07 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.588 0.709 . . . . 0.0 109.776 -165.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -100.32 -84.87 0.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.247 1.419 . . . . 0.0 110.432 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.71 166.34 4.5 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 128.77 2.828 . . . . 0.0 105.524 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -147.05 65.73 1.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.543 0.737 . . . . 0.0 109.064 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -144.35 -171.54 3.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.019 2.128 . . . . 0.0 109.162 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--O 1.256 1.397 0 CA-C-O 116.854 -1.546 . . . . 0.0 110.863 -174.033 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.468 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -176.68 -65.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.122 0.969 . . . . 0.0 110.514 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.26 -14.62 44.33 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.766 2.127 . . . . 0.0 114.674 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -55.04 3.88 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.325 2.25 . . . . 0.0 110.925 168.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB2' ' CA ' ' A' ' 31' ' ' CYS . 37.5 Cg_endo -71.29 -53.79 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.929 2.42 . . . . 0.0 110.724 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 21.5 m -87.65 124.38 33.49 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 120.34 1.427 . . . . 0.0 108.94 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.14 29.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.468 1.507 . . . . 0.0 110.922 -173.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 164.98 13.59 Favored Pre-proline 0 C--O 1.236 0.355 0 O-C-N 121.677 -0.639 . . . . 0.0 111.043 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.69 172.92 13.44 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.268 1.979 . . . . 0.0 109.688 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -78.12 46.32 0.59 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.96 1.304 . . . . 0.0 110.373 171.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.64 123.89 20.9 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.29 49.71 1.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.113 1.365 . . . . 0.0 109.638 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.659 ' O ' HG13 ' A' ' 15' ' ' VAL . 10.2 m170 -80.18 58.96 3.17 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -48.06 122.92 5.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.852 1.205 . . . . 0.0 111.329 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 13' ' ' HIS . 23.0 m -134.23 178.15 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 C-N-CA 124.571 1.148 . . . . 0.0 111.153 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.6 144.11 51.13 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.76 171.05 31.34 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.559 ' HA ' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -53.18 -24.58 11.16 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 175.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -84.24 0.08 50.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.419 1.888 . . . . 0.0 112.516 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.24 -7.55 36.96 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.823 -1.173 . . . . 0.0 111.859 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.58 107.34 1.37 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.182 1.393 . . . . 0.0 107.447 -176.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 7.4 m -66.27 146.25 54.81 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.466 ' CD2' HD12 ' A' ' 29' ' ' LEU . 60.1 m-85 -123.9 139.94 53.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.796 2.039 . . . . 0.0 106.488 176.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.6 t -45.45 -32.08 2.01 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.997 2.119 . . . . 0.0 112.206 171.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -163.56 154.7 14.2 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.555 2.342 . . . . 0.0 111.135 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -74.91 -24.4 13.05 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 111.159 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -28.01 69.26 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.023 -0.423 . . . . 0.0 112.049 176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.7 -36.03 60.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.76 170.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.856 ' HG ' HD11 ' A' ' 40' ' ' LEU . 8.8 tt -56.43 -67.34 0.31 Allowed 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -50.27 -37.33 35.43 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.556 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' CA ' ' HB2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -52.09 -71.78 0.06 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 175.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -41.9 -51.11 4.42 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.099 2.16 . . . . 0.0 110.872 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.99 -66.29 0.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -15.17 60.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.41 1.084 . . . . 0.0 112.664 173.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 1' ' ' PHE . 0.0 OUTLIER -73.86 -67.31 0.61 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.751 0.82 . . . . 0.0 108.86 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.75 39.97 0.25 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 126.489 1.995 . . . . 0.0 110.162 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -138.08 59.78 20.11 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.888 1.344 . . . . 0.0 111.341 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.92 -8.66 14.31 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.047 1.831 . . . . 0.0 112.764 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -90.5 -24.52 20.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.011 2.125 . . . . 0.0 113.769 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.856 HD11 ' HG ' ' A' ' 29' ' ' LEU . 3.1 tp -66.4 150.32 49.07 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.487 ' H ' HD12 ' A' ' 40' ' ' LEU . 9.6 m -149.2 152.11 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -78.24 83.63 4.49 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 171.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 18' ' ' SER . 1.7 m -57.12 -46.15 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.861 0.865 . . . . 0.0 111.534 170.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -164.47 157.01 16.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 125.177 1.391 . . . . 0.0 109.084 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -87.68 54.99 3.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.964 2.906 . . . . 0.0 110.54 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.73 150.13 21.61 Favored Glycine 0 C--O 1.226 -0.358 0 O-C-N 119.836 -1.79 . . . . 0.0 109.041 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.2 146.62 28.7 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.235 1.956 . . . . 0.0 111.599 -174.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m -86.44 -65.55 1.0 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.714 1.206 . . . . 0.0 110.502 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.97 -76.86 0.06 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.679 1.592 . . . . 0.0 111.368 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.93 176.68 4.14 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.401 1.48 . . . . 0.0 110.255 173.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -152.25 76.73 1.18 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.22 154.99 3.97 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.781 0.8 . . . . 0.0 110.449 172.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.72 46.98 0.72 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.91 161.12 30.57 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.624 0.769 . . . . 0.0 110.577 172.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.9 p90 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 116.713 -1.613 . . . . 0.0 108.399 -178.411 . . . . . . . . 0 0 . 1 stop_ save_